<SEC-DOCUMENT>0001104659-23-036697.txt : 20230324
<SEC-HEADER>0001104659-23-036697.hdr.sgml : 20230324
<ACCEPTANCE-DATETIME>20230324171403
ACCESSION NUMBER:		0001104659-23-036697
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		22
CONFORMED PERIOD OF REPORT:	20230320
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Changes in Control of Registrant
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
ITEM INFORMATION:		Change in Shell Company Status
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230324
DATE AS OF CHANGE:		20230324

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Zura Bio Ltd
		CENTRAL INDEX KEY:			0001855644
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40598
		FILM NUMBER:		23760782

	BUSINESS ADDRESS:	
		STREET 1:		4225 EXECUTIVE SQUARE
		STREET 2:		SUITE 600
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		858-247-0520

	MAIL ADDRESS:	
		STREET 1:		4225 EXECUTIVE SQUARE
		STREET 2:		SUITE 600
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	JATT Acquisition Corp
		DATE OF NAME CHANGE:	20210407
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2310353d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:zura="http://jattacquisitioncorp.com/20230320">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03A_zura_jattacquisitioncorp.com_20230320 -->
<!-- Field: Set; Name: xdx; ID: xdx_04B_20230320_20230320 -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001855644 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_072_SO_T%2D%2D\DeptFiles%2DiXBRL 8%2DK Covers Templates\+++%2DROOT%2DElement%2D+++\DocumentInformationLineItems.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-03-20to2023-03-20" name="dei:EntityCentralIndexKey">0001855644</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-03-20to2023-03-20" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-03-20to2023-03-20" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-03-20to2023-03-20" id="xdx2ixbrl0018" name="dei:EntityTaxIdentificationNumber">00-0000000</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="zura-20230320.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-03-20to2023-03-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001855644</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-20</xbrli:startDate>
        <xbrli:endDate>2023-03-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-202023-03-20_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001855644</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-20</xbrli:startDate>
        <xbrli:endDate>2023-03-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-202023-03-20_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001855644</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-20</xbrli:startDate>
        <xbrli:endDate>2023-03-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span id="xdx_912_eus-gaap--CommonClassAMember_zRC8tlOXyvI9" style="display: none; visibility: hidden">Ordinary Shares [Member]</span></p>
<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span id="xdx_912_eus-gaap--WarrantMember_zRC8tlOXyvI9" style="display: none; visibility: hidden">Warrants [Member]</span></p>

<!-- Field: Rule-Page --><div style="text-align: center; margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; text-align: center; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160; </b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM <span id="xdx_90E_edei--DocumentType_c20230320__20230320_zfF506xieJdl"><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #212529"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #212529"><b>PURSUANT TO SECTION 13 OR 15(D)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #212529"><b>OF THE SECURITIES EXCHANGE ACT
OF 1934</b></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #212529"><b>Date of Report (Date of earliest
event reported): March 24, 2023 (<span id="xdx_90D_edei--DocumentPeriodEndDate_c20230320__20230320_z7IrOOIiLGHc"><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">March 20, 2023</ix:nonNumeric></span>)</b></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_902_edei--EntityRegistrantName_c20230320__20230320_zstOyvto6cK4"><b><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" name="dei:EntityRegistrantName">Zura
Bio Limited</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Exact name of registrant
as specified in its charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20230320__20230320_zUv9ebvNgN79"><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode">Cayman Islands</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_901_edei--EntityFileNumber_c20230320__20230320_z2PXbTMhU4Ag"><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" name="dei:EntityFileNumber">001-40598</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_dxL_c20230320__20230320_zXQCR0S22o82" title="::XDX::00-0000000"><span style="-sec-ix-hidden: xdx2ixbrl0018">N/A</span></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt"><b>(State or other jurisdiction <br />
of incorporation)</b></span></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>(Commission <br />
File Number)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>(I.R.S. Employer <br />
    Identification No.)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #212529"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20230320__20230320_zAjWSAQh0Ahk"><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" name="dei:EntityAddressAddressLine1">4225 Executive Square</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressAddressLine2_c20230320__20230320_zBR6ZYiRhBxa"><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" name="dei:EntityAddressAddressLine2">Suite
600</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #212529"><b><span id="xdx_906_edei--EntityAddressCityOrTown_c20230320__20230320_zrZC6G61IKRa"><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" name="dei:EntityAddressCityOrTown">La Jolla</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressCountry_c20230320__20230320_zhPa4hdOcfG1"><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" name="dei:EntityAddressCountry">CA</ix:nonNumeric></span> <span id="xdx_906_edei--EntityAddressPostalZipCode_c20230320__20230320_zHz8z0TGEQ3e"><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" name="dei:EntityAddressPostalZipCode">92037</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #212529"><b>(Address of principal executive
offices, including zip code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #212529"><b>(<span id="xdx_905_edei--CityAreaCode_c20230320__20230320_zu5knwmJF4rd"><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" name="dei:CityAreaCode">858</ix:nonNumeric></span>) <span id="xdx_909_edei--LocalPhoneNumber_c20230320__20230320_zvAt2OZBLrjh"><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" name="dei:LocalPhoneNumber">247-0520</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #212529"><b>(Registrant&#8217;s telephone
number, including area code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #212529"><b>(Former name or former address,
if changed since last report)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_90D_edei--WrittenCommunications_c20230320__20230320_zI6wyl6lGabj"><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_90C_edei--SolicitingMaterial_c20230320__20230320_z1BQIsztVTsc"><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_90A_edei--PreCommencementTenderOffer_c20230320__20230320_zKXFAhtzhtn3"><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_906_edei--PreCommencementIssuerTenderOffer_c20230320__20230320_zvNVLJFUmT89"><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 44%; padding-top: 1.05pt; padding-right: 1.05pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="width: 2%; padding-top: 1.05pt; padding-right: 1.05pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 18%; padding-top: 1.05pt; padding-right: 1.05pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading</b></span><span style="font-size: 10pt">&#160;<b>Symbol(s)</b></span></td>
    <td style="width: 2%; padding-top: 1.05pt; padding-right: 1.05pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 34%; padding-top: 1.05pt; padding-right: 1.05pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 1.3pt; padding-right: 1.3pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--Security12bTitle_c20230320__20230320__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zqSzu89lL3da"><ix:nonNumeric contextRef="From2023-03-202023-03-20_us-gaap_CommonClassAMember" name="dei:Security12bTitle">Class A Ordinary Shares, par value $0.0001 per share</ix:nonNumeric></span></b></span></td>
    <td style="padding-top: 1.3pt; padding-right: 1.3pt">&#160;</td>
    <td style="padding-top: 1.3pt; padding-right: 1.3pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--TradingSymbol_c20230320__20230320__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zQeN9jhRjYmg"><ix:nonNumeric contextRef="From2023-03-202023-03-20_us-gaap_CommonClassAMember" name="dei:TradingSymbol">ZURA</ix:nonNumeric></span></b></span></td>
    <td style="padding-top: 1.3pt; padding-right: 1.3pt">&#160;</td>
    <td style="padding-top: 1.3pt; padding-right: 1.3pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--SecurityExchangeName_c20230320__20230320__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zOtwRBjkU4yd"><ix:nonNumeric contextRef="From2023-03-202023-03-20_us-gaap_CommonClassAMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 1.3pt; padding-right: 1.3pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--Security12bTitle_c20230320__20230320__us-gaap--StatementClassOfStockAxis__us-gaap--WarrantMember_zjlAPIPfb02g"><ix:nonNumeric contextRef="From2023-03-202023-03-20_us-gaap_WarrantMember" name="dei:Security12bTitle">Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share</ix:nonNumeric></span></b></span></td>
    <td style="padding-top: 1.3pt; padding-right: 1.3pt">&#160;</td>
    <td style="padding-top: 1.3pt; padding-right: 1.3pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--TradingSymbol_c20230320__20230320__us-gaap--StatementClassOfStockAxis__us-gaap--WarrantMember_zRrrMul1bTlj"><ix:nonNumeric contextRef="From2023-03-202023-03-20_us-gaap_WarrantMember" name="dei:TradingSymbol">ZURAW</ix:nonNumeric></span></b></span></td>
    <td style="padding-top: 1.3pt; padding-right: 1.3pt">&#160;</td>
    <td style="padding-top: 1.3pt; padding-right: 1.3pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--SecurityExchangeName_c20230320__20230320__us-gaap--StatementClassOfStockAxis__us-gaap--WarrantMember_zKfQozS3tBSd"><ix:nonNumeric contextRef="From2023-03-202023-03-20_us-gaap_WarrantMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market</ix:nonNumeric></span></b></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #212529">Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company <span style="font-family: Wingdings"><span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20230320__20230320_zacgH2KBQCW"><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#120;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings"><span id="xdx_902_edei--EntityExTransitionPeriod_c20230320__20230320_z9lyZ5GlVoU"><ix:nonNumeric contextRef="From2023-03-20to2023-03-20" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#168;</ix:nonNumeric></span></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #212529"><b>Introductory Note</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Overview</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">This Current Report on Form 8-K is being filed to report
matters under items 1.01, 2.01, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 5.06, and 9.01 of Form 8-K. On March 20, 2023 (the &#8220;<b><i>Closing
Date</i></b>&#8221;), Zura Bio Limited, a limited company incorporated under the laws of England and Wales (&#8220;<b><i>Zura</i></b>&#8221;),
JATT Acquisition Corp, a Cayman Islands exempted company (&#8220;<b><i>JATT</i></b>&#8221;), JATT Merger Sub, a Cayman Islands exempted
company and wholly owned subsidiary of JATT (&#8220;<b><i>Merger Sub</i></b>&#8221;), JATT Merger Sub 2, a Cayman Islands exempted company
and wholly owned subsidiary of JATT (&#8220;<b><i>Merger Sub 2</i></b>&#8221;) and Zura Bio Holdings Ltd, a Cayman Islands exempted company
(&#8220;<b><i>Holdco</i></b>&#8221;), consummated the closing of the transactions contemplated by the Business Combination Agreement,
dated June 16, 2022, as amended on September 20, 2022, November 14, 2022 and January 13, 2023, by and among Zura, JATT, Merger Sub, Merger
Sub 2, and Holdco (the &#8220;<b><i>Business Combination Agreement</i></b>&#8221;), following the approval at an extraordinary general
meeting of JATT&#8217;s shareholders held on March 16, 2023 (the &#8220;<b><i>Extraordinary General Meeting</i></b>&#8221; and the consummation
of such transactions, the &#8220;<b><i>Closing</i></b>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Pursuant to the Business Combination Agreement, (i)
Merger Sub merged with and into Holdco, with Holdco continuing as the surviving company and a wholly owned subsidiary of JATT (the &#8220;<b><i>Merger</i></b>&#8221;);
(ii) immediately following the Merger, Holdco merged with and into Merger Sub 2, with Merger Sub 2 continuing as the surviving company
and a wholly owned subsidiary of JATT (the &#8220;<b><i>Subsequent Merger</i></b>&#8221; and, together with the Merger and the other transactions
contemplated by the Business Combination Agreement, the &#8220;<b><i>Business Combination</i></b>&#8221;); and (iii) JATT changed its
name to &#8220;Zura Bio Limited&#8221; (the &#8220;<b><i>Company</i></b>&#8221; or &#8220;<b><i>Zura Bio Limited</i></b>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">In connection with JATT&#8217;s shareholder proposal
to amend its amended and restated memorandum and articles of association to extend the date by which JATT was required to consummate a
business combination, which was approved at an extraordinary general meeting held on January 12, 2023, the holders of 12,111,022 of JATT&#8217;s
ordinary shares, par value $0.0001 per share (the &#8220;<b><i>JATT Class A Ordinary Shares</i></b>&#8221;), exercised their right to
redeem their shares for cash at a redemption price of approximately $10.26 per share for an aggregate redemption amount of approximately
$124,226,450.64. In connection with the Extraordinary General Meeting and the Business Combination, the holders of an additional 1,506,480
Ordinary Shares exercised their right to redeem their shares for cash at a redemption price of approximately $10.26 per share for an aggregate
redemption amount of approximately $15,456,484.80. Prior to the Business Combination, holders of an aggregate of 13,617,502 Ordinary Shares
exercised their right to redeem their shares for cash for an aggregate redemption amount of approximately $139,682,935.44.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Conversion and Exchange of Equity in the Business
Combination</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Pursuant to the Business Combination Agreement, all
outstanding Holdco shares as of immediately prior to the Business Combination were cancelled in exchange for the right to receive a number
of newly issued ordinary shares of JATT, par value $0.0001 per share (&#8220;<b><i>Company Class A Ordinary Shares</i></b>&#8221;), equal
to the Exchange Ratio (as defined in the Business Combination Agreement) and all outstanding options to purchase shares of capital in
Zura were exchanged for a number of options exercisable for newly issued Company Class A Ordinary Shares based upon the Exchange Ratio.
The total consideration received by securityholders of Holdco at the Closing consisted of newly issued Company Class A Ordinary Shares
(or options to purchase such shares) with an aggregate value equal to $165 million (the &#8220;<b><i>Merger Consideration</i></b>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Subject to, and in accordance with, the terms and conditions
of the Business Combination Agreement, in connection with the Merger and the Subsequent Merger, at the Closing, (i) each JATT unit was
(to the extent not already separated) automatically separated and the holder thereof was deemed to hold one JATT Class A Ordinary Share
and one-half of a JATT warrant; (ii) in consideration for the Merger, JATT issued to holders of Holdco&#8217;s issued and outstanding
shares immediately prior to the Effective Time (as defined in the Business Combination Agreement) an aggregate of 14,558,067 JATT Class
A Ordinary Shares (including 499,993 JATT Class A Ordinary Shares underlying restricted stock units granted to Amit Munshi, the Company&#8217;s
Non-Executive Chairman) plus 1,941,933 options to acquire JATT Class A Ordinary Shares for which outstanding options to acquire Holdco
ordinary shares were exchanged on Closing; and (iii) pursuant to the terms and conditions of JATT&#8217;s existing amended and restated
memorandum and articles of association, all then-outstanding Class B ordinary shares, par value $0.0001 per share, were automatically
converted into JATT Class A Ordinary Shares on a one-for-one basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">A description of the Business Combination and the terms
of the Business Combination Agreement are included in the final prospectus and definitive proxy statement, dated&#160;February 28, 2023&#160;(the
&#8220;<b><i>Proxy Statement/Prospectus</i></b>&#8221;) filed by JATT with the Securities and Exchange Commission (the &#8220;<b><i>SEC</i></b>&#8221;)
in the section titled &#8220;<i>Proposal 1&#8212;The Business Combination Proposal</i>&#8221; beginning on page 110 of the&#160;Proxy
Statement/Prospectus. The foregoing description of the Business Combination Agreement is a summary only and is qualified in its entirety
by the full text of the Business Combination Agreement, a copy of which is attached hereto as Exhibits 2.1, 2.2. 2.3 and 2.4, which are
incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>PIPE Subscription Agreements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">On the Closing Date, Ewon Comfortech Co., Ltd. (&#8220;<b><i>Ewon</i></b><i>&#8221;</i>),
an institutional accredited investor which is an indirect investor in Zura through its equity interest in Hana Immunotherapeutics LLC
(&#8220;<b><i>Hana</i></b>&#8221;), purchased from JATT 2,000,000 JATT Class A Ordinary Shares and Eugene Investment &amp; Securities
Co., Ltd (&#8220;<b><i>Eugene</i></b>&#8221;), an unaffiliated institutional credited investor, purchased from JATT 9,950 JATT Class A
Ordinary Shares (Ewon, together with Eugene, the &#8220;<b><i>PIPE Investors</i></b>&#8221;), for an aggregate of 2,009,950 JATT Class
A Ordinary Shares (the &#8220;<b><i>PIPE Shares</i></b>&#8221;) at a price of $10.00 per share, for an aggregate purchase price of $20,099,500
(the &#8220;<b><i>PIPE Financing</i></b>&#8221;), pursuant to the subscription agreement entered into by JATT and the Ewon as of June
16, 2022, as amended on November 25, 2022 (the &#8220;<b><i>Ewon PIPE Subscription Agreement</i></b>&#8221;) and the subscription agreement
entered into by JATT and Eugene as of March 13, 2023 (the &#8220;<b><i>Eugene PIPE Subscription Agreement</i></b>&#8221; and, together
with the Ewon PIPE Subscription Agreement, the &#8220;<b><i>PIPE Subscription Agreements</i></b>&#8221;). Pursuant to the PIPE Subscription
Agreements, JATT granted certain registration rights to the PIPE Investors with respect to the PIPE Shares. The sale of the PIPE Shares
was consummated concurrently with the closing of the Business Combination. A description of the Ewon PIPE Subscription Agreement is included
in the&#160;Proxy Statement/Prospectus&#160;in the section titled &#8220;<i>The Business Combination Agreement&#8212;Other Ancillary Agreements
Related to the Business Combination&#8212;PIPE Financing Subscription Agreement&#8221;</i>&#160;on page 148 of the&#160;Proxy Statement/Prospectus.
The foregoing description of the Ewon PIPE Subscription Agreement and the Eugene PIPE Subscription Agreement is a summary only and is
qualified in its entirety by the full text of the Ewon PIPE Subscription Agreement, attached hereto as Exhibits 10.6 and 10.7, and the
Eugene PIPE Subscription Agreement, attached hereto as Exhibit 10.17, which are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Forward Purchase Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">At the Closing of the Business Combination, Athanor
Master Fund, LP and Athanor International Master Fund, LP (collectively, the &#8220;<b><i>FPA Investors</i></b>&#8221;), each of which
is an unaffiliated institutional investor, purchased (i) an aggregate of 3,000,000 JATT Class A Ordinary Shares at $10 per share for $30,000,000;
(ii) an aggregate of 1,301,633 JATT Class A Ordinary Shares at $10 per share for $13,016,330 (the &#8220;<b><i>Redemption Backstop</i></b>&#8221;)
as public share redemptions were greater than 90% at the time of the Business Combination (the &#8220;<b><i>Excess Redemptions</i></b>&#8221;);
and (iii) an additional 2,500,000 JATT Class A Ordinary Shares in consideration for the FPA Investors entering into the latest amendment,
but for no additional monetary consideration, pursuant to the forward purchase agreements JATT and the FPA Investors entered into on August
5, 2021, as amended and restated on January 27, 2022 and as amended on March 8, 2023 (the &#8220;<b><i>Forward Purchase Agreement</i></b>&#8221;).
A description of the Forward Purchase Agreement is included in the Proxy Statement/Prospectus in the section titled &#8220;<i>The Business
Combination Agreement&#8212;Other Ancillary Agreements Related to the Business Combination&#8212;The Forward Purchase Agreements&#8221;</i>&#160;beginning
on page 148 of the Proxy Statement/Prospectus. The foregoing description of the Forward Purchase Agreement is a summary only and is qualified
in its entirety by the full text of the Forward Purchase Agreement attached hereto as Exhibit 10.5 and Exhibit 10.16, which is incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Sponsor Support Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Concurrently with the execution of the Business Combination
Agreement, JATT, Zura, JATT Ventures, L.P., a Cayman Islands exempted limited partnership (the &#8220;<b><i>Sponsor</i></b>&#8221;) and
certain directors and officers of JATT entered into a support agreement dated June 16, 2022 (the &#8220;<b><i>Sponsor Support Agreement</i></b>&#8221;),
pursuant to which, among other things, the Sponsor and directors and officers of JATT agreed to (i) vote all of the JATT Class A Ordinary
Shares beneficially owned by them, including any additional shares to which they acquire ownership of or the power to vote, in favor of
the SPAC Shareholder Voting Matters (as defined in the Business Combination Agreement), (ii) not to redeem any of their JATT Class A Ordinary
Shares in conjunction with shareholder approval of the Business Combination and (iii) be bound by certain transfer restrictions with respect
to their JATT Class A Ordinary Shares. The Sponsor Support Agreement is described in the&#160;Proxy Statement/Prospectus<span style="text-decoration: underline">&#160;</span>in
the section titled &#8220;<i>The Business Combination Agreement&#8212;Certain Related Agreements and Arrangements&#8212;Sponsor Support
Agreement</i>&#8221; on page 147 of the&#160;Proxy Statement/Prospectus. The foregoing description of the agreement is a summary only
and is qualified in its entirety by the full text of the Sponsor Support Agreement, a copy of which is attached hereto as Exhibit 10.8,
which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Company Shareholder Support Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Concurrently with the execution of the Business Combination
Agreement, JATT, Zura and the shareholders of Zura entered into a support agreement dated June 16, 2022 (the &#8220;<b><i>Company Shareholder
Support Agreement</i></b>&#8221;), pursuant to which the Zura shareholders agreed to vote all Zura ordinary shares beneficially owned
by them, including any additional shares of Zura they acquire ownership of or the power to vote, in favor of the Business Combination
and related transactions. The Company Shareholder Support Agreement is described in the&#160;Proxy Statement/Prospectus&#160;in the section
titled &#8220;<i>The Business Combination Agreement&#8212;Certain Related Agreements and Arrangements&#8212;Company Shareholder Support
Agreement</i>&#8221; on page 147 of the Proxy Statement/Prospectus. The foregoing description of the Company Shareholder Support Agreement
is a summary only and is qualified in its entirety by the full text of the Company Shareholder Support Agreement, a copy of which is attached
hereto as Exhibit 10.9, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Sponsor Forfeiture Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Contemporaneously with the execution of the Business
Combination Agreement, the Sponsor entered into a sponsor forfeiture agreement (the &#8220;<b><i>Sponsor Forfeiture Agreement</i></b>&#8221;)
with JATT and Zura, pursuant to which at the Closing, the Sponsor forfeited 4,133,466 of its private placement warrants to purchase JATT
Class A Ordinary Shares, exercisable at $11.50 per share (the &#8220;<b><i>Forfeited Private Placement Warrants</i></b>&#8221;), acquired
by the Sponsor in July 2021 upon JATT&#8217;s initial public offering, which were transferred to the FPA Investors and Ewon on a pro rata
basis in accordance with the FPA Investors&#8217; and Ewon&#8217;s total invested capital. The FPA Investors received an aggregate of
2,480,000 Forfeited Private Placement Warrants and Ewon received 1,653,466 Forfeited Private Placement Warrants. The Sponsor Forfeiture
Agreement is described in the&#160;Proxy Statement/Prospectus in the section titled &#8220;<i>Summary of the Proxy Statement&#8212;The
Business Combination Agreement&#8212;Certain Related Agreements and Arrangements&#8212;Sponsor Forfeiture Agreement</i>&#8221; on page
32 of the Proxy Statement/Prospectus. The foregoing description of the Sponsor Forfeiture Agreement is a summary only and is qualified
in its entirety by the full text of the Sponsor Forfeiture Agreement, a copy of which is attached hereto as Exhibit 10.10, which is incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Lock-Up Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Contemporaneously with the execution of the Business
Combination Agreement, JATT, the Sponsor, certain affiliates of the Sponsor and the Zura shareholders and optionholders, entered into
a lock-up agreement (the &#8220;<b><i>Lock-Up Agreement</i></b>&#8221;), which took effect at Closing, containing restrictions on transfer
with respect to Company Class A Ordinary Shares held by each such holder (subject to certain exceptions, the &#8220;<b><i>Lock-Up Shares</i></b>&#8221;)
for a period as follows: one-third (1/3) of the Lock-Up Shares will be restricted until 6 months after the Closing, one-third (1/3) of
the Lock-Up Shares will be restricted until 12 months after the Closing, and one-third (1/3) of the Lock-Up Shares shall be restricted
until 24 months after the Closing; provided, that each portion of the Lock-Up Shares will be freely tradable on the earlier of (i) the
date on which the closing price of the JATT ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends,
reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period on a VWAP (as defined below)
basis during the relevant lock-up period; and (ii) the date on which JATT consummates a liquidation, merger, capital share exchange, reorganization,
or other similar transaction that results in all of JATT&#8217;s shareholders having the right to exchange their JATT ordinary shares
for cash, securities or other property. For purposes of the Lock-Up Agreement, &#8220;VWAP&#8221; means, for any date, the daily volume
weighted average price of the JATT ordinary shares for such date (or the nearest preceding date) on the trading market on which the JATT
ordinary shares are then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to
4:00 p.m. (New York City time)). The terms of the Lock-Up Agreement are described in the Proxy Statement/Prospectus&#160;in the section
titled &#8220;<i>Summary of the Proxy Statement&#8212;The Business Combination Agreement&#8212;Certain Related Agreements and Arrangements&#8212;Lock-Up
Agreement</i>&#8221; on page 32 of the Proxy Statement/Prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The foregoing description of the Lock-Up Agreement
is qualified in its entirety by the full text of the Lock-Up Agreement, a copy of which is attached hereto as Exhibit 10.1 and incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Amendment to the Insider Letter Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">In connection with the execution of the Business Combination
Agreement, JATT, the Sponsor, members of JATT&#8217;s board of directors and certain other individuals (collectively, the &#8220;<b><i>Insiders</i></b>&#8221;)
entered into an Amendment to the Insider Letter Agreement (the &#8220;<b><i>Amended Insider Letter Agreement</i></b>&#8221;), which provides,
among other things, that certain of JATT&#8217;s Class B ordinary shares (the &#8220;<b><i>Founder Shares</i></b>&#8221;) (and any JATT
Class A Ordinary Shares issuable upon conversion thereof) shall be subject to certain time and share-performance-based vesting provisions
which are described below. The Sponsor and the Insiders agreed that they shall not transfer any Founder Shares until the earlier of (A)
six months after the completion of the initial business combination and (B) the date following the completion of an initial business combination
on which JATT completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the
public shareholders having the right to exchange their JATT Class A Ordinary Shares for cash, securities or other property. Notwithstanding
the foregoing, if, subsequent to the Business Combination, the closing price of the JATT Class A Ordinary Shares equals or exceeds $12.00
per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days
within any 30- trading day period commencing at least 150 days after the Business Combination, the Founder Shares shall be released from
the lock-up restrictions. The terms of the Amended Insider Letter Agreement are described in the Proxy Statement/Prospectus in the section
titled &#8220;<i>Certain Relationships And Related Party Transactions &#8212;Certain Transactions of JATT&#8212;Insider Letter Agreement
and Amendment</i>&#8221; on page 308 of the Proxy Statement/Prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The foregoing description of the Amended Insider Letter
Agreement is qualified in its entirety by reference to the full text of the Amended Insider Letter Agreement, a copy of which is attached
hereto as Exhibit 10.14 and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 1in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                            1.01</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entry
into a Material Definitive Agreement.</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Lilly Lock-Up Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Pursuant to the Equity Grant Agreement (the &#8220;<b><i>JATT
Equity Grant Agreement</i></b>&#8221;) entered into on December 8, 2023, by and between JATT and Eli Lilly and Company (&#8220;<b><i>Lilly</i></b>&#8221;),
JATT and Lilly entered into a Lock-Up Agreement (the &#8220;<b><i>Lilly Lock-Up Agreement</i></b>&#8221;), on the Closing Date. The Lilly
Lock-Up Agreement contains restrictions on transfer with respect to the shares issued to Lilly under the JATT Equity Grant Agreement (subject
to certain exceptions, the &#8220;<b><i>Lilly Lock-Up Shares</i></b>&#8221;) for a period as follows: one-third (1/3) of the Lilly Lock-Up
Shares will be restricted until 6 months after the Closing, one-third (1/3) of the Lilly Lock-Up Shares will be restricted until 12 months
after the Closing, and one-third (1/3) of the Lilly Lock-Up Shares shall be restricted until 24 months after the Closing; provided, that
each portion of the Lilly Lock-Up Shares will be freely tradable on the earlier of (i) the date on which the closing price of the JATT
ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period on a VWAP (as defined below) basis during the relevant lock-up
period; and (ii) the date on which JATT consummates a liquidation, merger, capital share exchange, reorganization, or other similar transaction
that results in all of JATT&#8217;s shareholders having the right to exchange their JATT ordinary shares for cash, securities or other
property. For purposes of the Lilly Lock-Up Agreement, &#8220;VWAP&#8221; means, for any date, the daily volume weighted average price
of the JATT ordinary shares for such date (or the nearest preceding date) on the trading market on which the JATT ordinary shares are
then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:00 p.m. (New York
City time)). The terms of the Lilly Lock-Up Agreement are described in the Proxy Statement/Prospectus&#160;in the section titled &#8220;<i>Certain
Relationships and Related Party Transactions&#8212;Certain Transactions of JATT&#8212;Lilly Lock-Up Agreement</i>&#8221; on page 311 of
the Proxy Statement/Prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The foregoing description of the Lilly Lock-Up Agreement
is qualified in its entirety by the full text of the Lilly Lock-Up Agreement, a copy of which is attached hereto as Exhibit 10.15 and
incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Amended and Restated Registration and Shareholders
Rights Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">In connection with the Closing, Zura, JATT and certain
securityholders of each of Zura and JATT who received JATT Class A Ordinary Shares pursuant to the Business Combination Agreement, entered
into an amended and restated registration and shareholders rights agreement (the &#8220;<b><i>Registration Rights Agreement</i></b>&#8221;),
which became effective upon the consummation of the Business Combination. The Registration Rights Agreement governs the registration of
certain of the Company Class A Ordinary Shares for resale and includes certain customary demand and &#8220;piggy-back&#8221; registration
rights with respect to the Company Class A Ordinary Shares held by the parties thereto. The terms of the Registration Rights Agreement
are described in the Proxy Statement/Prospectus in the section titled &#8220;<i>The Business Combination Agreement&#8212;Certain Related
Agreements and Arrangements&#8212;Amended and Restated Registration Rights Agreement </i>&#8221; on page 147 of the&#160;Proxy Statement/Prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The foregoing description of the Registration Rights
Agreement is qualified in its entirety by reference to the full text of the Registration Rights Agreement, a copy of which is attached
hereto as Exhibit 10.2 and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Hydra Promissory Note</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">On December 8, 2022, Zura and Hydra LLC, a Cayman Islands
limited liability company managed and controlled by Verender  Badial and Someit Sidhu (&#8220;<b><i>Hydra</i></b>&#8221;), entered into
a promissory note (the &#8220;<b><i>Hydra Promissory Note</i></b>&#8221;) pursuant to which (i) Hydra loaned to Zura a principal amount
(the &#8220;<b><i>Principal Amount</i></b>&#8221;) of $8 million (including an original issue discount of $400,000) with an interest rate
equal to 9.0% per annum, compounding daily. Under the Hydra Promissory Note, Hydra had the right to accelerate the Hydra Promissory Note
and receive an amount equal to 120% of the Principal Amount because the registration statement on Form S-4 relating to the Business Combination
was not declared effective by the SEC on or before February 15, 2023. On March 8, 2023, Zura and Hydra signed a limited waiver letter
under the Hydra Promissory Note (the &#8220;<b><i>Waiver Letter</i></b>&#8221;), pursuant to which Hydra agreed to waive its acceleration
right in consideration of Zura paying to Hydra 125% of the Principal Amount (equal to $10,000,000 in the aggregate) on the earlier of
December 8, 2023 and five business days after the consummation of the Business Combination. On March 21, 2023, Zura repaid the Hydra Promissory
Note in full and the Hydra Promissory Note was terminated. The terms of the Hydra Promissory Note are described in the Proxy Statement/Prospectus
in the section titled &#8220;<i>Certain Relationships And Related Party Transactions &#8212;Certain Relationships and Related Party Transactions
of Zura&#8212;Hydra Promissory Note</i>&#8221; on page 313 of the Proxy Statement/Prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 1in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                            2.01</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Completion
of Acquisition or Disposition of Assets.</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The disclosure set forth in the &#8220;<i>Introductory
Note</i>&#8221; above is incorporated by reference into this Item 2.01 of this Current Report on Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">As of the Closing Date and following the completion
of the Business Combination, the Company had the following outstanding securities (including derivative securities):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%">&#160;</td>
    <td style="vertical-align: top; width: 4%"><span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 92%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,552,148 Company Class A Ordinary Shares (including 499,993 Company Class A Ordinary Shares underlying restricted stock units (the &#8220;<b><i>RSUs</i></b>&#8221;));</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,900,000 public warrants, each exercisable for one Company Class A Ordinary Share at a price of $11.50 per share (the &#8220;<b><i>Public Warrants</i></b>&#8221;);</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,910,000 private placement warrants, each exercisable for one Company Class A Ordinary Share at a price of $11.50 per share (the &#8220;<b><i>Private Placement Warrants</i></b>&#8221;); and</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,248,306 options, each
    exercisable for one Company Class A Ordinary Share (the &#8220;<b><i>Options</i></b>&#8221;).</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #212529"><b>FORM 10 INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Item 2.01(f) of Form 8-K states that if the predecessor
registrant was a shell company, as JATT was immediately before the Business Combination, then the registrant must disclose the information
that would be required if the registrant were filing a general form for registration of securities on Form 10. Accordingly, the Company,
as the successor registrant to JATT, is providing the information below that would be included in a Form 10 if it were to file a Form
10. Please note that the information provided below relates to the combined company after the consummation of the Business Combination
unless otherwise specifically indicated or the context otherwise requires.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Forward-Looking Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The Company makes forward-looking statements in this
Current Report on Form 8-K and in documents incorporated herein by reference. All statements, other than statements of present or historical
fact included in or incorporated by reference in this Current Report on Form 8-K, regarding the Company&#8217;s future financial performance,
as well as the Company&#8217;s strategy, future operations, financial position, estimated revenues, and losses, projected costs, prospects,
plans and objectives of management are forward-looking statements. When used in this Current Report on Form 8-K, the words &#8220;anticipate,&#8221;
&#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intends,&#8221;
&#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221;
&#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; the negative of such terms and other similar expressions are intended to
identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking
statements are based on management&#8217;s current expectations, assumptions, hopes, beliefs, intentions and strategies regarding future
events and are based on currently available information as to the outcome and timing of future events. The Company cautions you that these
forward-looking statements are subject to all of the risks and uncertainties, most of which are difficult to predict and many of which
are beyond the control of the Company, incident to its business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">These forward-looking statements are based on information
available as of the date of this Current Report on Form 8-K, and current expectations, forecasts and assumptions, and involve a number
of risks and uncertainties. Accordingly, forward-looking statements in this Current Report on Form 8-K and in any document incorporated
herein by reference should not be relied upon as representing the Company&#8217;s views as of any subsequent date, and the Company does
not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether
as a result of new information, future events or otherwise, except as may be required under applicable securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">As a result of a number of known and unknown risks
and uncertainties, the Company&#8217;s actual results or performance may be materially different from those expressed or implied by these
forward-looking statements. Some factors that could cause actual results to differ include:&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the
Company&#8217;s ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things,
competition and the ability of the Company to grow and manage growth profitably following the Closing Date;</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the anticipated costs associated with the Business Combination;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the Company&#8217;s financial and business performance following the Business Combination, including financial projections and business metrics;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the Company&#8217;s ability to effectively expand operations;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the potential business or economic disruptions caused by current and future pandemics, such as the COVID-19 pandemic;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the ability to maintain the listing of the Company&#8217;s ordinary shares and warrants on a stock exchange, and the potential liquidity and trading of its securities;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the impact from future regulatory, judicial and legislative changes in the Company&#8217;s industry;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the Company&#8217;s ability to raise financing in the future;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the Company&#8217;s officers and directors allocating their time to other businesses and potentially having conflicts of interest with the Company&#8217;s business;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the Company's ability to retain existing and attract new qualified directors, officers, employees and key personnel and the effectiveness of the Company&#8217;s compensation strategies and leadership;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the projected financial information, growth rate, strategies and market opportunities for the Company;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the Company&#8217;s ability to successfully expand in its existing markets and into new domestic and international markets;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the Company&#8217;s ability, assessment of and strategies to compete with its competitors in a highly competitive market;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the competition from larger pharmaceutical and biotechnology companies that have greater resources, technology, relationships and/or expertise;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the ability to protect and enhance the Company&#8217;s corporate reputation, brand and intellectual property; </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the Company&#8217;s ability to maintain its licenses and operate in regulated industries;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the Company&#8217;s ability to prevent and guard against cybersecurity attacks;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the Company's future capital requirements and sources and uses of cash;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">the Company&#8217;s ability to research,
discover and develop product candidates;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Company&#8217;s ability to obtain and maintain regulatory approval of any of its product candidates; and </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">the outcome of any known and unknown litigation and regulatory proceedings, including the occurrence of any event, change or other circumstances, including the outcome of any legal proceedings that may be instituted against the Company.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Please see the other risks and uncertainties set forth
in the Proxy Statement/Prospectus in the section titled &#8220;<i>Risk Factors</i>&#8221; beginning on page 47 of the&#160;Proxy Statement/Prospectus,
which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">In addition, statements that &#8220;Zura believes&#8221;
and similar statements reflect Zura&#8217;s beliefs and opinions on the relevant subject. These statements are based upon information
available to Zura, as of the date of this Current Report on Form 8-K, and while Zura believes such information forms a reasonable basis
for such statements, such information may be limited or incomplete, and such statements should not be read to indicate that such party
has conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently
uncertain and investors are cautioned not to unduly rely upon these statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Business and Properties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The business and properties of Zura and JATT prior
to the Business Combination are described in the Proxy Statement/Prospectus in the sections titled &#8220;<i>Business of Zura Bio Limited&#8221;</i>&#160;and
&#8220;<i>Business of JATT&#8221;</i> beginning on pages 208 and 199, respectively, of the Proxy Statement/Prospectus, and such descriptions
are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Risk Factors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The risks associated with the Company&#8217;s business
are described in the Proxy Statement/Prospectus in the section titled &#8220;<i>Risk Factors</i>&#8221; beginning on page 47 of the Proxy
Statement/Prospectus and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Financial Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The audited financial statements of Zura as of March
31, 2022 and for the period from January 18, 2022 (Zura&#8217;s inception) through March 31, 2022 and the related notes are included in
the Proxy Statement/Prospectus beginning on page F-48 of the&#160;Proxy Statement/Prospectus&#160;and are incorporated herein by reference.
The unaudited interim financials of Zura as of September 30, 2022 and for the six months ended September 30, 2022 and the related notes
are included in the Proxy Statement/Prospectus beginning on page F-59 of the&#160;Proxy Statement/Prospectus&#160;and are incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The audited financial statements of JATT as of December
31, 2021 and for the period from March 10, 2021 (JATT&#8217;s inception) to December 31, 2021 and the related notes are included in the
Proxy Statement/Prospectus beginning on page F-3 of the Proxy Statement/Prospectus and are incorporated herein by reference. The unaudited
interim financials of JATT as of September 30, 2022, and for the three and nine months ended September 30, 2022, for the three months
ended September 30, 2021, for the period from March 10, 2021 (JATT&#8217;s inception) through September 30, 2021 and the related notes
are included in the Proxy Statement/Prospectus beginning on page F-22 of the&#160;Proxy Statement/Prospectus&#160;and are incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The unaudited pro forma condensed combined balance
sheet of the Company as of September 30, 2022, the unaudited pro forma condensed combined statement of operations for the fiscal year
ended March 31, 2022 and the unaudited pro forma condensed combined statement of operations for the nine months ended September 30, 2022
are attached hereto as Exhibit 99.1 and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Management&#8217;s Discussion and Analysis of Financial
Condition and Results of Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Management&#8217;s discussion and analysis of the financial
condition and results of operations of Zura as of and for the three months ended September 30, 2022, as of and for the six months ended
September 30, 2022, and for the period from January 18, 2022 (Zura&#8217;s inception) through March 31, 2022 is described in the Proxy
Statement/Prospectus in the section entitled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations
of Zura&#8221; beginning on page 252 of the&#160;Proxy Statement/Prospectus and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Management&#8217;s discussion and analysis of the financial
condition and results of operations of JATT as of and for the three months ended September 30, 2022, as of and for the nine months ended
September 30, 2022, as of and for the three months ended September 30, 2021, and for the period from March 10, 2021 (JATT&#8217;s inception)
through September 30, 2021 is described in the Proxy Statement/Prospectus in the section entitled &#8220;Management&#8217;s Discussion
and Analysis of Financial Condition and Results of Operations of JATT&#8221; beginning on page 202 of the&#160;Proxy Statement/Prospectus
and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Directors and Executive Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">After the Closing Date, the Company&#8217;s directors
and executive officers are as follows, with each person&#8217;s biography and familial relationship, if any, described in the Proxy Statement/Prospectus
in the section titled &#8220;<i>Combined Company Management and Governance After the Business Combination</i>&#8221; beginning on page
276 of the Proxy Statement/Prospectus, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="padding-bottom: 1pt; vertical-align: top; width: 3%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age*</b></span></td>
    <td style="padding-bottom: 1pt; vertical-align: top; width: 3%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 46%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Executive Officers</i></b></span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Someit Sidhu</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Director</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Verender
    Badial</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim Chief Financial Officer</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preston Klassen</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Operating Officer</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chris Cabell</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Medical Officer and Executive Vice President</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kim Davis</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General Counsel</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Theresa Lowry</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Human Resources Officer</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary Whale</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Technology Officer</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael Howell</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior Vice President, Translation Medicine</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Non-Employee Directors</i></b></span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amit Munshi</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director, Chairman of the Board</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sandeep Kulkarni</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Garry Neil</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steve Schoch</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jennifer Jarrett</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neil Graham</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">As of the Closing Date.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b><i>Executive Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Information with respect to the compensation of the
Company&#8217;s Chief Executive Officer is described in the Proxy Statement/Prospectus in the section titled &#8220;<i>Combined Company
Management and Governance After The Business Combination</i>&#8221; beginning on page 276 of the Proxy Statement/Prospectus, which is
incorporated herein by reference. Information with respect to the compensation of the Company&#8217;s two other most highly compensated
officers is described in the Proxy Statement/Prospectus in the section titled &#8220;<i>Zura&#8217;s Executive and Director Compensation</i>&#8221;
beginning on page 273 of the&#160;Proxy Statement/Prospectus, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Upon the Closing Date, the Company&#8217;s Chief Executive
Officer and two other most highly compensated officers, are eligible to participate in the Zura Bio Limited 2023 Equity Incentive Plan
(the &#8220;<b><i>Equity Incentive Plan</i></b>&#8221;) and the Zura Bio Limited 2023 Employee Share Purchase Plan (the &#8220;<b><i>ESPP</i></b>&#8221;),
subject to the terms and conditions of the aforementioned plans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The Equity Incentive Plan and ESPP are
filed as Exhibits 10.11 and 10.12, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b><i>Director Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Information with respect to the compensation of the
Company&#8217;s directors is described in the Proxy Statement/Prospectus in the sections titled &#8220;<i>Zura&#8217;s Executive and Director
Compensation&#8212;Director Compensation</i>&#8221; beginning on page 274 of the&#160;Proxy Statement/Prospectus, which is incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Upon the Closing Date, each of the Company&#8217;s
non-employee directors are eligible to participate in the Equity Incentive Plan, subject to the terms and conditions of the plan. The
Equity Incentive Plan is filed as Exhibit 10.11 to this Current Report on Form 8-K and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Security Ownership of Certain Beneficial Owners
and Management</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The following table sets forth information regarding
the beneficial ownership of the Company Class A Ordinary Shares as of the Closing Date, after giving effect to the Closing, by:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.5in; text-align: left"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
person known by the Company to be the beneficial owner of more than 5% of the Company Class A Ordinary Shares;</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr>
    <td style="width: 0.5in">&#160;</td>
    <td style="vertical-align: top; width: 0.5in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each of the Company&#8217;s executive officers and directors; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
  <tr>
    <td style="width: 0.5in">&#160;</td>
    <td style="vertical-align: top; width: 0.5in"><span style="font-family: Symbol">&#183;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all of the Company&#8217;s executive officers and directors as a group.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Beneficial ownership is determined according to the
rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared
voting or investment power over that security, including warrants, options and restricted stock units that are currently exercisable or
vested or that will become exercisable or vest within 60 days. This table is based upon information supplied by officers, directors and
principal shareholders and Schedules 13G or 13D filed with the SEC. Unless otherwise indicated in the footnotes to this table and subject
to community property laws where applicable, the Company believes that all persons named in the table have sole voting and investment
power with respect to all Company Class A Ordinary Shares beneficially owned by them. The beneficial ownership percentages set forth in
the table below are based on 27,552,148 Company Class A Ordinary Shares issued and outstanding as of the Closing Date, including the redemption
of the Ordinary Shares, the conversion of Holdco shares and the consummation of the transactions contemplated by the PIPE Subscription
Agreements and the Forward Purchase Agreement, each as described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-size: 10pt"><b>Name and Address of Beneficial Owner(1)</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Number of <br />
Shares</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Percentage of<br />
Shares</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><i>5% and Greater Shareholders:</i></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 73%; padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">JATT Ventures, L.P.<sup>(2)</sup></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><span style="font-size: 10pt">2,743,904</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><span style="font-size: 10pt">9.4</span></td>
    <td style="width: 1%"><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Athanor Capital, L.P.<sup>(3)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">9,281,633</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">27.0</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Hana Immunotherapeutics LLC<sup>(4)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">5,404,274</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">19.6</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Pfizer Inc.<sup>(5)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">2,970,022</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">10.8</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Willow Gate LLC<sup>(6)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">2,702,623</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">9.8</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Stone Peach Properties LLC<sup>(7)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">2,701,543</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">9.8</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Ewon Comfortech Co., Ltd.<sup>(8)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">3,653,466</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">12.5</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-size: 10pt"><i>Executive Officers and Directors:</i></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Someit Sidhu<sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">5,081,534</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">17.3</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Verender Badial</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">30,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Preston Klassen<sup>(9)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">--</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Chris Cabell<sup>(10)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">--</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Kim Davis<sup>(11)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">--</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Theresa Lowry<sup>(12)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">--</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Gary Whale<sup>(13)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">--</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Michael Howell<sup>(14)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">--</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Amit Munshi<sup>(15)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Sandeep Kulkarni<sup>(16)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">82,360</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Garry Neil<sup>(17)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">--</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Steve Schoch<sup>(18)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">--</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Jennifer Jarrett<sup>(19)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">--</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">Neil Graham<sup>(20)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">--</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 30pt; text-indent: -10pt"><span style="font-size: 10pt">All directors and executive officers (14 individuals) as a group</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">112,360</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">* </span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="width: 95%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than one percent.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise noted, the business address of each
    of the beneficial owners is c/o Zura Bio Limited, 4225 Executive Square, Suite 600, La Jolla, CA 92037. Unless otherwise indicated, the
    Company believes that all persons named in the table have sole voting and investment power with respect to all ordinary shares
    beneficially owned by them.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Sponsor is the record holder of 2,743,904 Company
    Class A Ordinary Shares, including 1,776,534 Company Class A Ordinary Shares underlying Private Placement Warrants. Dr. Someit Sidhu
    is the sole director of JATT Ventures, Ltd., which is the sole general partner of the Sponsor, and has voting and dispositive power
    over the shares held by the Sponsor and directly and beneficially owns an additional 2,337,630 Company Class A Ordinary Shares. </span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of (i) 6,492,502 Company Class A Ordinary Shares, including 1,734,760 Company Class A Ordinary Shares underlying Private Placement Warrants, which are held of record by Athanor Master Fund, LP, a Cayman Islands limited partnership (&#8220;Athanor MF&#8221;) and (ii) 2,789,131 Company Class A Ordinary Shares, including 745,240 Company Class A Ordinary Shares underlying Private Placement Warrants, which are held of record by Athanor International Master Fund, LP, a Cayman Islands limited partnership (&#8220;Athanor IMF&#8221;). Athanor Capital Partners, LP, a Delaware limited partnership (&#8220;Master GP&#8221;), is the general partner of Athanor MF. Athanor International Fund GP, LP, a Delaware limited partnership (&#8220;International Master GP&#8221;), is the general partner of Athanor IMF. Athanor Capital, LP, a Delaware limited partnership (&#8220;Athanor Capital&#8221;) is the investment adviser to Athanor MF and Athanor IMF. Athanor Capital GP, LLC, a Delaware limited liability company (&#8220;Athanor Capital GP&#8221;), is the general partner of Athanor Capital. Parvinder Thiara is the managing member of (i) Athanor Capital GP, (ii) Athanor Capital Partners GP, LLC (&#8220;ACPGP&#8221;), the general partner of Master GP, and (iii) Athanor International Fund Ultimate GP, LLC (&#8220;AIFUGP&#8221;), the general partner of International Master GP and has voting and dispositive power over the shares held by Athanor MF and Athanor IMF. The business address of each of Athanor MF, Athanor IMF, Master GP, International Master GP, Athanor Capital, Athanor Capital GP, ACPGP, AIFUGP and Parvinder Thiara is 888 Seventh Avenue, 21st Floor, New York, NY 10019.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of Company Class A Ordinary Shares, which are held of record by Hana. Chris Kim is the controlling shareholder of Hana. Mr. Kim has voting and dispositive power over, and may be deemed to be the beneficial owner of, the shares held by Hana. The business address of Hana is 6 Centerpointe Dr. #625, La Palma, CA 90623. </span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of Company Class A Ordinary Shares, which are held of record by Pfizer Inc. (&#8220;Pfizer&#8221;). The business address of Pfizer is 235 East 42nd Street, New York, NY 10017. </span></td></tr>

<tr style="vertical-align: top">
    <td style="width: 5%"><span style="font-size: 10pt">(6)</span></td>
    <td style="text-align: justify; width: 95%"><span style="font-size: 10pt">Consists of Company Class A Ordinary Shares, which are held of record by Willow Gate LLC (&#8220;Willow Gate&#8221;). Shashibhushan Borade has voting and dispositive power over the shares held by Willow Gate. The business address of Willow Gate is 35 Bethune St, New York, NY 10014.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(7)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of Company Class A Ordinary Shares, which are held of record by Stone
Peach Properties LLC (&#8220;Stone Peach&#8221;). Baljit Lehal has voting and dispositive power over the shares held by Stone Peach. The
business address of Stone Peach is 2057 Stanton Rd, East Point, GA 30344.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(8)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of Company Class A Ordinary Shares, including
1,653,466 Company Class A Ordinary Shares underlying Private Placement Warrants, which are held of record by Ewon. The business address
of Ewon is 8 Cheomdan 1-ro Jeongeup, Jeonbuk, 56212 Republic of South Korea.</span></td></tr>

<tr style="vertical-align: top">
    <td style="width: 5%"><span style="font-size: 10pt">(9)</span></td>
    <td style="width: 95%; text-align: justify"><span style="font-size: 10pt">Excludes options to purchase 476,756 Company Class A Ordinary Shares held by Mr. Klassen, 0 shares of which are exercisable and vest within 60 days of the Closing Date.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(10)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Excludes options to purchase 270,100 Company Class A Ordinary Shares held by Dr. Cabell, 0 shares of which are exercisable and vest within 60 days of the Closing Date.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(11)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Excludes options to purchase 206,547 Company Class A Ordinary Shares held by Ms. Davis, 0 shares of which are exercisable and vest within 60 days of the Closing Date.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(12)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Excludes options to purchase 158,882 Company Class A Ordinary Shares held by Ms. Lowry, 0 shares of which are exercisable and vest within 60 days of the Closing Date.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(13)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Excludes options to purchase 158,882 Company Class A Ordinary Shares held by Mr. Whale, 0 shares of which are exercisable and vest within 60 days of the Closing Date.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(14)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Excludes options to purchase 190,659 Company Class A Ordinary Shares held by Dr. Howell, 0 shares of which are exercisable and vest within 60 days of the Closing Date.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(15)</span></td>
    <td><span style="font-size: 10pt">Excludes equity grants as of Closing consisting of (i) 499,993 Company Class A Ordinary Shares underlying restricted stock units granted to Mr. Munshi which will vest in four equal annual installments commencing on March 18, 2024 and (ii) performance shares providing Mr. Munshi the option to purchase 306,373 Company Class A Ordinary Shares at an exercise price per share equal to $8.16, the fair market value of a Company Class A Ordinary Share &#160;on March 20, 2023 (the date of grant), which will become exercisable if the 20-day volume weighted average trading price of the Company Class A Ordinary Shares is over $30 per share at any time prior to the fifth anniversary of the Closing. The shares underlying the restricted stock units are excluded because they do not vest and will not be issued within 60 days of the Closing Date. The performance shares underlying the options are excluded because it is indeterminable whether such options will become exercisable within 60 days of Closing.</span></td></tr>
  </table>

<p style="margin: 0"></p>



<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%"><span style="font-size: 10pt">(16)</span></td>
    <td style="width: 95%"><span style="font-size: 10pt">Excludes options to purchase 345,867 Company Class A Ordinary Shares held by Dr. Kulkarni, 82,360 shares of which are exercisable and vest within 60 days of the Closing Date.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(17)</span></td>
    <td><span style="font-size: 10pt">Excludes options to purchase 12,754 Company Class A Ordinary Shares held by Dr. Neil, 0 shares of which are exercisable and vest within 60 days of the Closing Date.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(18)</span></td>
    <td><span style="font-size: 10pt">Excludes options to purchase 12,754 Company Class A Ordinary Shares held by Mr. Schoch, 0 shares of which are exercisable and vest within 60 days of the Closing Date.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(19)</span></td>
    <td><span style="font-size: 10pt">Excludes options to purchase 12,754 Company Class A Ordinary Shares held by Ms. Jarrett, 0 shares of which are exercisable and vest within 60 days of the Closing Date.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(20)</span></td>
    <td><span style="font-size: 10pt">Excludes options to purchase 12,754 Company Class A Ordinary Shares held by Dr. Graham, 0 shares of which are exercisable and vest within 60 days of the Closing Date.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Certain Relationships and Related Party Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Certain relationships and related party transactions
are described in the Proxy Statement/Prospectus in the section titled &#8220;<i>Certain Relationships and Related Transactions</i>&#8221;
beginning on page 307 of the&#160;Proxy Statement/Prospectus&#160;and such descriptions are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Legal Proceedings</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The Company is not currently involved in, nor is it
aware of any legal proceedings, investigations or claims that management believes may have a material adverse effect to the Company&#8217;s
business, financial condition, or results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Market Price of and Dividends on the Registrant&#8217;s
Class A Ordinary Shares and Related Stockholder Matters</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b><i>Market Information and Holders</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">JATT&#8217;s units, public Class A Ordinary Shares
and public warrants were historically quoted on The New York Stock Exchange under the symbols &#8220;JATT U,&#8221; &#8220;JATT&#8221;
and &#8220;JATT WS,&#8221; respectively. The Company Class A Ordinary Shares and Warrants commenced trading on The Nasdaq Capital Market
under the new trading symbols &#8220;ZURA&#8221; and &#8220;ZURAW,&#8221; respectively, on March 21, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">In connection with the Closing, each JATT unit was
separated into its components, which consisted of one JATT Class A Ordinary Share and one-half of one redeemable warrant, and such units
no longer exist. As of the Closing Date and following the completion of the Business Combination, there were 27,552,148 Company Class
A Ordinary Shares issued and outstanding held of record by 15 holders and 6,900,000 Public Warrants outstanding held of record
by  1 holder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b><i>Dividends</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The Company has not paid dividends on the Company Class
A Ordinary Shares to date and does not intend to pay cash dividends. The payment of cash dividends in the future will be dependent upon
revenues and earnings, if any, capital requirements and general financial condition. The payment of any dividends will be within the discretion
of the Company&#8217;s board of directors. It is the present intention of the Company&#8217;s board of directors to retain all earnings,
if any, for use in the Company&#8217;s business operations and, accordingly, the board of directors does not anticipate declaring any
dividends in the foreseeable future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Recent Sales of Unregistered Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Reference is made to the disclosure set forth under
Item 3.02 of this Current Report on Form 8-K concerning recent sales of unregistered securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Description of Registrant&#8217;s Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b><i>Ordinary Shares</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">A description of the Company Class A Ordinary Shares
is included in the Proxy Statement/Prospectus in the section titled &#8220;<i>Description of New JATT Securities</i>&#8221; beginning
on page 298 of the&#160;Proxy Statement/Prospectus, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b><i>Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">A description of the Public Warrants is included in
the Proxy Statement/Prospectus in the section titled &#8220;<i>Description of New JATT Securities&#8212;Redeemable Warrants</i>&#8221;
beginning on page 299 of the Proxy Statement/Prospectus, which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Indemnification of Directors and Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Effective immediately upon the consummation of the
Business Combination, the Company entered into indemnification agreements with each of the newly elected directors and newly appointed
executive officers which provide that the Company will indemnify such directors and executive officers under the circumstances and to
the extent provided for therein, from and against all losses, claims, damages, liabilities, joint or several, expenses (including legal
fees and expenses), judgments, fines, penalties, interest, settlements or other amounts arising from any and all threatened, pending or
completed claim, demand, action, suit or proceeding, whether civil, criminal, administrative or investigative, and whether formal or informal,
and including appeals, in which he or she may be involved, or is threatened to be involved, as a party or otherwise, to the fullest extent
permitted under the laws of the Cayman Islands and our Second Amended and Restated Memorandum and Articles of Association.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The foregoing description of the indemnification agreements
is qualified in its entirety by the full text of the form of indemnification agreement, a copy of which is attached hereto as Exhibit
10.13 and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Financial Statements and Supplementary Data</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Reference is made to the disclosure set forth under
Item 9.01 of this Current Report on Form 8-K concerning the Company&#8217;s financial statements and supplementary data.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Changes in and Disagreements with Accountants on
Accounting and Financial Disclosure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Reference is made to the disclosure set forth under
Item 4.01 of this Current Report on Form 8-K concerning the changes in certifying accountant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The information set forth in Item 9.01 of this Current
Report on Form 8-K is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 1in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                            3.02</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unregistered
Sales of Equity Securities.</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The disclosure set forth in the &#8220;<i>Introductory
Note</i>&#8221; above is incorporated by reference into this Item 3.02 of this Current Report on Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The securities issued in connection with the PIPE Subscription
Agreements and Forward Purchase Agreement have not been registered under the Securities Act, in reliance on the exemption from registration
provided by Section 4(a)(2) of the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 1in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                            3.03</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Material
Modification to Rights of Security Holders.</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The information set forth&#160;in Item 5.03 of this
Current Report on Form 8-K is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 1in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                            5.01</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Changes
in Control of Registrant.</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The information set forth in the section titled &#8220;<i>Introductory
Note</i>&#8221; and in the section titled &#8220;<i>Security Ownership of Certain Beneficial Owners and Management</i>&#8221; in Item
2.01 of this Current Report on Form 8-K is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">As a result of the completion of the Business Combination
pursuant to the Business Combination Agreement, a change of control of JATT has occurred. The shareholders of JATT as of immediately prior
to the Closing Date held approximately 13.2% of the issued and outstanding Company Class A Ordinary Shares following the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 1in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                            5.02</b></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The information set forth in the sections titled &#8220;<i>Directors
and Executive Officers</i>&#8221; and &#8220;<i>Certain Relationships and Related Transactions</i>&#8221; in Item 2.01 of this Current
Report on Form 8-K is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Zura Bio Limited 2023 Equity Incentive Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">At the Extraordinary General Meeting, the JATT shareholders
considered and approved the Equity Incentive Plan. The Equity Incentive Plan was previously approved, subject to shareholder approval,
by JATT&#8217;s board of directors. The Equity Incentive Plan became effective immediately upon the Closing Date. The Equity Incentive
Plan initially makes available for issuance a maximum number of 4,029,898 Company Class A Ordinary Shares. Additionally, the number of
shares reserved for issuance under the Equity Incentive Plan will automatically increase on January 1st of each year, beginning on January
1, 2024 and continuing through and including January 1, 2029, in an amount equal to the lesser of (i) five percent (5%) of the Company
Class A Ordinary Shares outstanding on the final day of the immediately preceding calendar year, (ii) 8,059,796 Company Class A Ordinary
Shares or (iii) such smaller number of shares as determined by the Company&#8217;s board of directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">A summary of the terms of the Equity Incentive Plan
is set forth in the Proxy Statement/Prospectus in the section titled &#8220;<i>Proposal 5&#8212;The Equity Incentive Plan Proposal</i>&#8221;
beginning on page 157 of the Proxy Statement/Prospectus, which is incorporated herein by reference. Such summary and the foregoing description
are qualified in their entirety by reference to the text of the Equity Incentive Plan, a copy of which is attached hereto as Exhibit 10.11
and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Zura Bio Limited 2023 Employee Stock Purchase Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">At the Extraordinary General Meeting, the JATT shareholders
considered and approved the ESPP. The ESPP was previously approved, subject to shareholder approval, by JATT&#8217;s board of directors.
The ESPP became effective immediately upon the Closing Date. The maximum number of Company Class A Ordinary Shares that may be issued
under the ESPP is 4,029,898, plus the aggregate number of Company Class A Ordinary Shares that are added under the Equity Incentive Plan
on January 1st of each calendar year, beginning on January 1, 2024 and ending on and including January 1, 2029.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">A summary of the terms of the ESPP is set forth in
the Proxy Statement/Prospectus in the section titled &#8220;<i>Proposal 7&#8212;The ESPP Proposal</i>&#8221; beginning on page 167 of
the Proxy Statement/Prospectus, which is incorporated herein by reference. Such summary and the foregoing description are qualified in
their entirety by reference to the text of the ESPP, a copy of which is attached hereto as Exhibit 10.12 and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>Appointment of New Directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">At the Extraordinary General Meeting, the JATT shareholders
elected seven directors that took office upon consummation of the Business Combination. Someit Sidhu, our Chief Executive Officer, was
elected as a director and Amit Munshi, Sandeep Kulkarni, Garry Neil, Steve Schoch, Jennifer Jarrett and Neil Graham were elected as non-employee
directors. Each director&#8217;s term will expire at the annual meeting of shareholders to be held in 2024. The Board has determined that
each of Amit Munshi, Sandeep Kulkarni, Garry Neil, Steve Schoch, Jennifer Jarrett and Neil Graham is &#8220;independent&#8221; as that
term is defined under the Nasdaq listing standards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Additional information regarding the Company&#8217;s
directors and executive officers is set forth in the Proxy Statement/Prospectus in the section titled &#8220;<i>Combined Company Management
and Governance After the Business Combination</i>&#8221; beginning on page 276 of the Proxy Statement/Prospectus, which is incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 1in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                            5.03</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amendments
to Articles of Incorporation or Bylaws; Change in Fiscal Year.</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">At the Extraordinary General Meeting, the JATT shareholders
considered and approved, among other things, Proposal 2&#8212;The Binding Organizational Documents Proposals (the &#8220;<b><i>Binding
Organizational Documents Proposals</i></b>&#8221;) and Proposal 3&#8212;The Advisory Governance Proposals (the &#8220;<b><i>Advisory Governance
Proposals</i></b>&#8221;), which are described in greater detail in the Proxy Statement/Prospectus beginning on page 150 and page 152,
respectively, of the Proxy Statement/Prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The Second Amended and Restated Memorandum and Articles
of Association of the Company (the &#8220;<b><i>Second A&amp;R MAA</i></b>&#8221;), which became effective on March 20, 2023 and was filed
with the Registrar of Companies of the Cayman Islands on March 21, 2023, includes the amendments proposed by the Binding Organizational
Documents Proposals and the Advisory Governance Proposals.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">A copy of the Second A&amp;R MAA is attached hereto
as Exhibit 3.1 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The description of the Second A&amp;R MAA and the general
effect of the Second A&amp;R MAA upon the rights of holders of the Company&#8217;s securities are included in the Proxy Statement/Prospectus
under the section titled &#8220;<i>Description of New JATT Securities</i>&#8221; beginning on page 298 of the&#160;Proxy Statement/Prospectus,
which is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 1in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                            5.05</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amendments
to the Registrant&#8217;s Code of Ethics, or Waiver of a Provision of the Code of Ethics.</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">In connection with the Business Combination, on March
20, 2023, the Company&#8217;s board of directors approved and adopted a new Code of Ethics and Conduct Policy applicable to all employees,
officers and directors of the Company, as well as all of the Company&#8217;s contractors, suppliers, and agents in connection with their
work for the Company. A copy of the Code of Ethics and Conduct Policy is attached hereto as Exhibit 14.1 and can be found in the Investor
Relations section of the Company&#8217;s website at <i>www.zurabio.com</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 1in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                            5.06</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
in Shell Company Status.</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">As a result of the&#160;Business Combination, the Company
ceased being a shell company. Reference is made to the disclosure in the Proxy Statement/Prospectus in the section titled &#8220;<i>Proposal
1&#8212;The Business Combination Proposal</i>&#8221; beginning on page 110 of the&#160;Proxy Statement/Prospectus, and such disclosure
is incorporated herein by reference. Further reference is made to the information contained in Item 2.01 of this Current Report on Form
8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 1in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                            9.01</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
Statements and Exhibits.</b></span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>(a) Financial Statements of Business Acquired.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The audited financial statements of Zura as of March
31, 2022 and for the period from January 18, 2022 (Zura&#8217;s inception) through March 31, 2022 and the related notes are included in
the Proxy Statement/Prospectus beginning on page F-47 of the&#160;Proxy Statement/Prospectus&#160;and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The unaudited condensed consolidated financial statements
of Zura as of September 30, 2022 and for the three and six months ended September 30, 2022 and the related notes are included in the Proxy
Statement/Prospectus beginning on page F-59 of the&#160;Proxy Statement/Prospectus&#160;and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The audited financial statements of JATT as of December
31, 2021 and for the period from March 10, 2021 (JATT&#8217;s inception) to December 31, 2021 and the related notes are included in the
Proxy Statement/Prospectus beginning on page F-2 of the Proxy Statement/Prospectus and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The unaudited condensed consolidated financial statements
of JATT as of September 30, 2022 and for the three and nine months ended September 30, 2022, the three months ended September 30, 2021
and the period from March 10, 2021 (JATT&#8217;s inception) to September 30, 2021 and the related notes are included in the Proxy Statement/Prospectus
beginning on page F-22 of the&#160;Proxy Statement/Prospectus&#160;and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>(b) Pro Forma Financial Information.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">The unaudited pro forma condensed combined balance
sheet of the Company as of September 30, 2022, the unaudited pro forma condensed combined statement of operations for the fiscal year
ended March 31, 2022 and the unaudited pro forma condensed combined statement of operations for the nine months ended September 30, 2022
and the related notes are included  in Exhibit 99.1 hereto and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"><b>(c) Exhibits.</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt; vertical-align: top">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporated by Reference</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    </tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left; white-space: nowrap; width: 6%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br />
Number</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center; width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Schedule/</b></span><span style="font-size: 10pt"><br />
<b>Form</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>File No.</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Filing Date</b></span></td>
    <td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex2-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1+</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex2-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business Combination Agreement, dated as of June 16, 2022, by and among JATT Acquisition Corp, JATT Merger Sub, JATT Merger Sub 2, Zura Bio Holdings Ltd and Zura Bio Limited.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex2-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex2-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40598</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex2-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex2-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 17</span><span style="font-size: 10pt">, 2022</span></a></td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922111238/tm2218919d12_ex2-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922111238/tm2218919d12_ex2-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First Amendment dated as of September 20, 2022 to the Business Combination Agreement by and among JATT Acquisition Corp, JATT Merger Sub, JATT Merger Sub 2 and Zura Bio Holdings Ltd and Zura Bio Limited.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922111238/tm2218919d12_ex2-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-4</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922111238/tm2218919d12_ex2-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-267005</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922111238/tm2218919d12_ex2-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922111238/tm2218919d12_ex2-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 25, 2022</span></a></td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922127098/jatt-20220930xex2d3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3&#160;</span></a></td>
    <td>&#160;</td>
    <td><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922127098/jatt-20220930xex2d3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Amendment dated as of November 14, 2022 to the Business Combination Agreement by and among JATT Acquisition Corp, JATT Merger Sub, JATT Merger Sub 2, Zura Bio Holdings Ltd and Zura Bio Limited.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922127098/jatt-20220930xex2d3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922127098/jatt-20220930xex2d3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;001-40598</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922127098/jatt-20220930xex2d3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922127098/jatt-20220930xex2d3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;November 15, 2022</span></a></td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465923005068/tm233516d1_ex2-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></a></td>
    <td>&#160;</td>
    <td><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465923005068/tm233516d1_ex2-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third Amendment dated as of January 13, 2023 to the Business Combination Agreement by and among JATT Acquisition Corp, JATT Merger Sub, JATT Merger Sub 2, Zura Bio Holdings Ltd and Zura Bio Limited.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465923005068/tm233516d1_ex2-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465923005068/tm233516d1_ex2-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40598</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465923005068/tm233516d1_ex2-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465923005068/tm233516d1_ex2-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 19, 2023</span></a></td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><a href="tm2310353d1_ex3-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1*</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="tm2310353d1_ex3-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Amended and Restated Memorandum and Articles of Association of Zura Bio Limited.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465921093483/tm2122413d1_ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465921093483/tm2122413d1_ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Agreement, dated as of July 13, 2021, by and between JATT Acquisition Corp and Continental Stock Transfer &amp; Trust Company.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465921093483/tm2122413d1_ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465921093483/tm2122413d1_ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40598</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465921093483/tm2122413d1_ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465921093483/tm2122413d1_ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 19, 2021</span></a></td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-5.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-5.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lock-Up Agreement, dated as of June 16, 2022, by and among JATT Acquisition Corp and each of the other parties signatories thereto.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-5.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-5.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40598</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-5.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-5.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 17, 2022</span></a></td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><a href="tm2310353d1_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2*</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="tm2310353d1_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Registration Rights Agreement dated March 20, 2023, by and among Zura Bio Limited and the other parties signatories thereto.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; padding-right: 5pt; text-align: right">&#160;</td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057821000340/jatt-20210930xex10d1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057821000340/jatt-20210930xex10d1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward Purchase Agreement, dated as of August 5, 2021, between JATT Acquisition Corp and Athanor International Master Fund, LP.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057821000340/jatt-20210930xex10d1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057821000340/jatt-20210930xex10d1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40598</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057821000340/jatt-20210930xex10d1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057821000340/jatt-20210930xex10d1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 19, 2021</span></a></td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057821000340/jatt-20210930xex10d2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057821000340/jatt-20210930xex10d2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward Purchase Agreement, dated as of August 5, 2021, between JATT Acquisition Corp and Athanor Master Fund, LP.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057821000340/jatt-20210930xex10d2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057821000340/jatt-20210930xex10d2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40598</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057821000340/jatt-20210930xex10d2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057821000340/jatt-20210930xex10d2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 19, 2021</span></a></td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057822000860/jatt-20211231xex10d9.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></a></td>
    <td>&#160;</td>
    <td><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057822000860/jatt-20211231xex10d9.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended Forward Purchase Agreements, dated as of January 27, 2022, by and between JATT Acquisition Corp and Athanor Master Fund LP and Athanor International Master Fund LP. </span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057822000860/jatt-20211231xex10d9.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057822000860/jatt-20211231xex10d9.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40598</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057822000860/jatt-20211231xex10d9.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000141057822000860/jatt-20211231xex10d9.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 11, 2022</span></a></td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PIPE Subscription Agreement, dated as of June 16, 2022, by and between JATT Acquisition Corp and the other parties signatories thereto.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40598</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 17, 2022</span></a></td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922127098/jatt-20220930xex10d23.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922127098/jatt-20220930xex10d23.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First Amendment to the PIPE Subscription Agreement, dated November 25, 2022, by and between JATT Acquisition Corp and the other parties signatories thereto.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922127098/jatt-20220930xex10d23.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-4</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922127098/jatt-20220930xex10d23.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-267005</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922127098/jatt-20220930xex10d23.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922127098/jatt-20220930xex10d23.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 15, 2022 </span></a></td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsor Support Agreement, dated as of June 16, 2022, by and among JATT Acquisition Corp, JATT Ventures, L.P. and the other parties signatories thereto.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40598</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 17, 2022</span></a></td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Shareholder Support Agreement, dated as of June 16, 2022, by and among JATT Acquisition Corp, Zura Bio Limited and the other parties signatories thereto.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40598</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 17, 2022</span></a></td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="text-align: left; white-space: nowrap; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsor Forfeiture Agreement, dated as of June 16, 2022, by and among JATT Ventures, L.P., JATT Acquisition Corp and Zura Bio Limited.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40598</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></a></td>
    <td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-4.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 17, 2022</span></a></td>
    <td>&#160;</td>
    </tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: top; width: 6%"><a href="tm2310353d1_ex10-11.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11*#</span></a></td>
    <td style="width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 46%"><a href="tm2310353d1_ex10-11.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zura
    Bio Limited 2023 Equity Incentive Plan.</span></a></td>
    <td style="width: 2%">&#160;</td>
    <td style="vertical-align: top; text-align: right; width: 8%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 8%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="vertical-align: top; text-align: right; width: 8%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="vertical-align: top; text-align: right; width: 13%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    </tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2310353d1_ex10-12.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12*#</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="tm2310353d1_ex10-12.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zura
    Bio Limited 2023 Employee Stock Purchase Plan.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2310353d1_ex10-13.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13*</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="tm2310353d1_ex10-13.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Indemnity Agreement of Zura</span> <span style="font-size: 10pt">Bio Limited.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-7.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-7.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment
    to the Insider Letter Agreement, dated as of June 16, 2022, by and among JATT Acquisition Corp and the other parties signatories
    thereto.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-7.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-7.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40598</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-7.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right"><a href="https://www.sec.gov/Archives/edgar/data/1855644/000110465922072223/tm2218710d1_ex10-7.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    17, 2022</span></a></td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2310353d1_ex10-15.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15*</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><a href="tm2310353d1_ex10-15.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lock-Up
    Agreement, dated as of March 20, 2023, by and between JATT Acquisition Corp and Eli Lilly and Company.</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td>
    <td>&#160;</td>
    </tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1855644/000110465923030711/tm239063d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</span></a></td>
    <td>&#160;</td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1855644/000110465923030711/tm239063d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment
    to the Amended Forward Purchase Agreements, dated as of March 8, 2023, by and between JATT Acquisition Corp and Athanor Master Fund
    LP and Athanor International Master Fund LP. </span></a></td>
    <td>&#160;</td>
    <td style="text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1855644/000110465923030711/tm239063d1_ex10-1.htm" style="-sec-extract: exhibit">8-K</a></td>
    <td>&#160;</td>
    <td style="text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1855644/000110465923030711/tm239063d1_ex10-1.htm" style="-sec-extract: exhibit">001-40598</a></td>
    <td>&#160;</td>
    <td style="text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1855644/000110465923030711/tm239063d1_ex10-1.htm" style="-sec-extract: exhibit">10.1</a></td>
    <td>&#160;</td>
    <td style="text-align: right"><a href="http://www.sec.gov/Archives/edgar/data/1855644/000110465923030711/tm239063d1_ex10-1.htm" style="-sec-extract: exhibit">June
    10, 2022</a></td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td><a href="tm2310353d1_ex10-17.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17*</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2310353d1_ex10-17.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
    Agreement, dated as of March 13, 2023, by and between JATT Acquisition Corp and Eugene Investment &amp; Securities Co., Ltd.</span></a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td><a href="tm2310353d1_ex14-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1*</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2310353d1_ex14-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code
    of Ethics and Conduct Policy.</span></a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top"><a href="tm2310353d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1*</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2310353d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unaudited
    pro forma condensed combined financial information as of and for the nine months ended September 30, 2022 and for the fiscal year
    ended March 31, 2022.</span></a></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive
    Data File (embedded within the Inline XBRL document)</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="width: 97%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed herewith.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601. The Company agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates a management contract or compensatory plan, contract or arrangement.</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #212529"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #212529"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2" style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Zura Bio Limited</b></span></td></tr>
  <tr>
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: March 24, 2023</span></td>
    <td colspan="2" style="vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="width: 50%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 47%">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="white-space: nowrap; vertical-align: bottom">
    <p style="border-bottom: black 0.75pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Someit Sidhu</p></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Someit Sidhu</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"></p>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #212529"></p>


</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxVTu9KwzAQf4K+w5HPY0siBek3LTqGnYwyRRA/ZOtNwppcuWTTPZJvaZoyxHBw/O73L0LMxJIebY8Mb/dtA1t0Q28iQosHZPR7TIp69VRB2i1+2hDZ+Jjh1VhT8mDylHMld4nI0rMN2FWg1ELLhVYgb6uyhM1aFCNfkz/YDn20pgfjO9gwDWwxGr5MCVvzTZ7cJVe9IgdLPsXN5UT/gJZKwzOdzRfxMUDT1KKY5VeIJdNpGGtOIZKDhx5d6gqT9W/yV/ZZU714G8Ma3Q45HaXUN1LdjWX/iYzgfcIf15xf4CtevQ== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>tm2310353d1_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 3.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B>THE COMPANIES ACT (<FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">As Revised</FONT>)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF THE CAYMAN ISLANDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMPANY LIMITED BY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECOND AMENDED AND RESTATED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MEMORANDUM AND ARTICLES OF ASSOCIATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ZURA BIO LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>(adopted
by special resolution dated March 16, 2023 and effective on<BR>
March 20, 2023)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>THE
COMPANIES ACT (As Revised)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF THE CAYMAN ISLANDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMPANY LIMITED BY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECOND AMENDED AND RESTATED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MEMORANDUM OF ASSOCIATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ZURA BIO LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>(adopted
by special resolution dated March 16, 2023 and effective on<BR>
March 20, 2023)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1</TD><TD STYLE="text-align: justify">The name of the Company is <B>Zura Bio Limited</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2</TD><TD STYLE="text-align: justify">The Company was formerly known as JATT Acquisition Corp</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3</TD><TD STYLE="text-align: justify">The Registered Office of the Company shall be at the offices of Maples Corporate Services Limited, PO
Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands, or at such other place within the Cayman Islands as the Directors may decide.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4</TD><TD STYLE="text-align: justify">The objects for which the Company is established are unrestricted and the Company shall have full power
and authority to carry out any object not prohibited by the laws of the Cayman Islands.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5</TD><TD STYLE="text-align: justify">The liability of each Member is limited to the amount unpaid on such Member's shares.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6</TD><TD STYLE="text-align: justify">The share capital of the Company is US$30,100 divided into <FONT STYLE="font-size: 10pt">300,000,000</FONT>
Class A ordinary shares of a par value of US$0.0001 each, no Class B ordinary shares of a par value of US$0.0001 each and 1,000,000 preference
shares of a par value of US$0.0001 each.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7</TD><TD STYLE="text-align: justify">The Company has power to register by way of continuation as a body corporate limited by shares under the
laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8</TD><TD STYLE="text-align: justify">Capitalised terms that are not defined in this Second Amended and Restated Memorandum of Association bear
the respective meanings given to them in the Second Amended and Restated Articles of Association of the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>THE
COMPANIES ACT (As Revised)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF THE CAYMAN ISLANDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMPANY LIMITED BY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECOND AMENDED AND RESTATED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLES OF ASSOCIATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ZURA BIO LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>(adopted
by special resolution dated March 16, 2023 and effective on<BR>
March 20, 2023)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="text-align: justify">Interpretation</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.1</TD><TD STYLE="text-align: justify">In the Articles, Table A in the First Schedule to the Statute does not apply and, unless there is something
in the subject or context inconsistent therewith:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 94%; border-collapse: collapse; margin-left: 0.5in">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 27%; text-align: left"><B>&quot;Affiliate&quot;</B></TD>
    <TD STYLE="width: 73%; text-align: justify">in respect of a person, means any other person that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such person, and (a) in the case of a natural person, shall include, without limitation, such person&rsquo;s spouse, parents, children, siblings, mother-in-law and father-in-law and brothers and sisters-in-law, whether by blood, marriage or adoption or anyone residing in such person&rsquo;s home, a trust for the benefit of any of the foregoing, a company, partnership or any natural person or entity wholly or jointly owned by any of the foregoing and (b) in the case of an entity, shall include a partnership, a corporation or any natural person or entity which directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, such entity.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Applicable Law&quot;</B></TD>
    <TD STYLE="text-align: justify">means, with respect to any person, all provisions of laws, statutes, ordinances, rules, regulations, permits, certificates, judgments, decisions, decrees or orders of any governmental authority applicable to such person.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Articles&quot;</B></TD>
    <TD STYLE="text-align: justify">means these second amended and restated articles of association of the Company.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Audit Committee&quot;</B></TD>
    <TD STYLE="text-align: justify">means the audit committee of the board of directors of the Company established pursuant to the Articles, or any successor committee.</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 94%; border-collapse: collapse; margin-left: 0.5in">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 27%; text-align: left"><B>&quot;Auditor&quot;</B></TD>
    <TD STYLE="width: 73%; text-align: justify">means the person for the time being performing the duties of auditor of the Company (if any).</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;business day&quot;</B></TD>
    <TD STYLE="text-align: justify">means any day other than a Saturday, a Sunday or a legal holiday or a day on which banking institutions or trust companies are authorised or obligated by law to close in either New York City or the Cayman Islands.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Clearing House&quot;</B></TD>
    <TD STYLE="text-align: justify">means a clearing house recognised by the laws of the jurisdiction in which the Shares (or depositary receipts therefor) are listed or quoted on a stock exchange or interdealer quotation system in such jurisdiction.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Class A Share&quot;</B></TD>
    <TD STYLE="text-align: justify">means a Class A ordinary share of a par value of US$0.0001 in the share capital of the Company.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Class B Share&quot;</B></TD>
    <TD STYLE="text-align: justify">means a Class B ordinary share of a par value of US$0.0001 in the share capital of the Company.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Company&quot;</B></TD>
    <TD STYLE="text-align: justify">means the above named company.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Company&rsquo;s Website&quot;</B></TD>
    <TD STYLE="text-align: justify">means the website of the Company and/or its web-address or domain name (if any).</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Compensation Committee&quot;</B></TD>
    <TD STYLE="text-align: justify">means the compensation committee of the board of directors of the Company established pursuant to the Articles, or any successor committee.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Designated Stock Exchange&quot;</B></TD>
    <TD STYLE="text-align: justify">means any United States national securities exchange on which the securities of the Company are listed for trading, including the New York Stock Exchange.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Directors&quot;</B></TD>
    <TD STYLE="text-align: justify">means the directors for the time being of the Company.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Dividend&quot;</B></TD>
    <TD STYLE="text-align: justify">means any dividend (whether interim or final) resolved to be paid on Shares pursuant to the Articles.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Electronic Communication&quot;</B></TD>
    <TD STYLE="text-align: justify">means a communication sent by electronic means, including electronic posting to the Company&rsquo;s Website, transmission to any number, address or internet website (including the website of the Securities and Exchange Commission) or other electronic delivery methods as otherwise decided and approved by the Directors.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Electronic Record&quot;</B></TD>
    <TD STYLE="text-align: justify">has the same meaning as in the Electronic Transactions Act.</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 94%; border-collapse: collapse; margin-left: 0.5in">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 27%; text-align: left"><B>&quot;Electronic Transactions Act&quot;</B></TD>
    <TD STYLE="width: 73%; text-align: justify">means the Electronic Transactions Act (As Revised) of the Cayman Islands.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Exchange Act&quot;</B></TD>
    <TD STYLE="text-align: justify">means the United States Securities Exchange Act of 1934, as amended, or any similar U.S. federal statute and the rules and regulations of the Securities and Exchange Commission thereunder, all as the same shall be in effect at the time.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Independent Director&quot;</B></TD>
    <TD STYLE="text-align: justify">has the same meaning as in the rules and regulations of the Designated Stock Exchange or in Rule 10A-3 under the Exchange Act, as the case may be.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Member&quot;</B></TD>
    <TD STYLE="text-align: justify">has the same meaning as in the Statute.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Memorandum&quot;</B></TD>
    <TD STYLE="text-align: justify">means the second amended and restated memorandum of association of the Company.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Officer&quot;</B></TD>
    <TD STYLE="text-align: justify">means a person appointed to hold an office in the Company.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Ordinary Resolution&quot;</B></TD>
    <TD STYLE="text-align: justify">means a resolution passed by a simple majority of the Members as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting. In computing the majority when a poll is demanded regard shall be had to the number of votes to which each Member is entitled by the Articles.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Preference Share&quot;</B></TD>
    <TD STYLE="text-align: justify">means a preference share of a par value of US$0.0001 in the share capital of the Company.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Register of Members&quot;</B></TD>
    <TD STYLE="text-align: justify">means the register of Members maintained in accordance with the Statute and includes (except where otherwise stated) any branch or duplicate register of Members.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Registered Office&quot;</B></TD>
    <TD STYLE="text-align: justify">means the registered office for the time being of the Company.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Seal&quot;</B></TD>
    <TD STYLE="text-align: justify">means the common seal of the Company and includes every duplicate seal.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Securities and Exchange Commission&quot;</B></TD>
    <TD STYLE="text-align: justify">means the United States Securities and Exchange Commission.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><B>&quot;Share&quot;</B></TD>
    <TD STYLE="text-align: justify">means a Class A Share, a Class B Share or a Preference Share and includes a fraction of a share in the Company.</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 94%; border-collapse: collapse; margin-left: 0.5in">
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: left"><B>&quot;Special Resolution&quot;</B></TD>
<TD COLSPAN="2" STYLE="text-align: justify">subject to Articles 18.4 and 29.3(b), has the same meaning as in the Statute.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: left">&nbsp;</TD>
<TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: left"><B>&quot;Statute&quot;</B></TD>
<TD COLSPAN="2" STYLE="text-align: justify">means the Companies Act (As Revised) of the Cayman Islands.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: left">&nbsp;</TD>
<TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: left"><B>&quot;Supermajority Vote&quot;</B></TD>
<TD COLSPAN="2">means the affirmative vote of such Members: &nbsp; &nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: left">&nbsp;</TD>
<TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 27%">&nbsp;</TD>
<TD STYLE="width: 6%">(a)</TD>
<TD STYLE="text-align: justify; width: 67%">as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting of which notice specifying the intention to propose the resolution as a special resolution has been duly given; and</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: left">&nbsp;</TD>
<TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: left">&nbsp;</TD>
<TD>(b)</TD>
<TD STYLE="text-align: justify">between such Members, hold and vote in favour of such special resolution Shares carrying at least two-thirds of the total votes attaching to all then-issued and outstanding Shares entitled to vote thereon (voting together as a single class).</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: left">&nbsp;</TD>
<TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: left"><B>&quot;Tax Filing Authorised Person&quot;</B></TD>
<TD COLSPAN="2" STYLE="text-align: justify">means such person as any Director shall designate from time to time, acting severally.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: left">&nbsp;</TD>
<TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: left"><B>&quot;Treasury Share&quot;</B></TD>
<TD COLSPAN="2" STYLE="text-align: justify">means a Share held in the name of the Company as a treasury share in accordance with the Statute.</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.2</TD><TD STYLE="text-align: justify">In the Articles:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(a)</TD><TD STYLE="text-align: justify">words importing the singular number include the plural number and vice versa;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(b)</TD><TD STYLE="text-align: justify">words importing the masculine gender include the feminine gender;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(c)</TD><TD STYLE="text-align: justify">words importing persons include corporations as well as any other legal or natural person;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(d)</TD><TD STYLE="text-align: justify">&quot;written&quot; and &quot;in writing&quot; include all modes of representing or reproducing words
in visible form, including in the form of an Electronic Record;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(e)</TD><TD STYLE="text-align: justify">&quot;shall&quot; shall be construed as imperative and &quot;may&quot; shall be construed as permissive;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(f)</TD><TD STYLE="text-align: justify">references to provisions of any law or regulation shall be construed as references to those provisions
as amended, modified, re-enacted or replaced;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(g)</TD><TD STYLE="text-align: justify">any phrase introduced by the terms &quot;including&quot;, &quot;include&quot;, &quot;in particular&quot;
or any similar expression shall be construed as illustrative and shall not limit the sense of the words preceding those terms;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(h)</TD><TD STYLE="text-align: justify">the term &quot;and/or&quot; is used herein to mean both &quot;and&quot; as well as &quot;or.&quot; The
use of &quot;and/or&quot; in certain contexts in no respects qualifies or modifies the use of the terms &quot;and&quot; or &quot;or&quot;
in others. The term &quot;or&quot; shall
not be interpreted to be exclusive and the term &quot;and&quot; shall not be interpreted to require the conjunctive (in each case, unless
the context otherwise requires);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.5pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(i)</TD><TD STYLE="text-align: justify">headings are inserted for reference only and shall be ignored in construing the Articles;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(j)</TD><TD STYLE="text-align: justify">any requirements as to delivery under the Articles include delivery in the form of an Electronic Record;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(k)</TD><TD STYLE="text-align: justify">any requirements as to execution or signature under the Articles including the execution of the Articles
themselves can be satisfied in the form of an electronic signature as defined in the Electronic Transactions Act;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(l)</TD><TD STYLE="text-align: justify">sections 8 and 19(3) of the Electronic Transactions Act shall not apply;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(m)</TD><TD STYLE="text-align: justify">the term &quot;clear days&quot; in relation to the period of a notice means that period excluding the
day when the notice is received or deemed to be received and the day for which it is given or on which it is to take effect; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(n)</TD><TD STYLE="text-align: justify">the term &quot;holder&quot; in relation to a Share means a person whose name is entered in the Register
of Members as the holder of such Share.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="text-align: justify">Commencement of Business</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.1</TD><TD STYLE="text-align: justify">The business of the Company may be commenced as soon after incorporation of the Company as the Directors
shall see fit.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.2</TD><TD STYLE="text-align: justify">The Directors may pay, out of the capital or any other monies of the Company, all expenses incurred in
or about the formation and establishment of the Company, including the expenses of registration.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3</FONT></TD><TD STYLE="text-align: justify">Issue of Shares and other Securities</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.1</TD><TD STYLE="text-align: justify">Subject to the provisions, if any, in the Memorandum (and to any direction that may be given by the Company
in general meeting) and, where applicable, the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission
and/or any other competent regulatory authority or otherwise under Applicable Law, and without prejudice to any rights attached to any
existing Shares, the Directors may allot, issue, grant options over or otherwise dispose of Shares (including fractions of a Share) with
or without preferred, deferred or other rights or restrictions, whether in regard to Dividends or other distributions, voting, return
of capital or otherwise and to such persons, at such times and on such other terms as they think proper, and may also (subject to the
Statute and the Articles) vary such rights.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.2</TD><TD STYLE="text-align: justify">The Company may issue rights, options, warrants or convertible securities or securities of similar nature
conferring the right upon the holders thereof to subscribe for, purchase or receive any class of Shares or other securities in the
Company on such terms as the Directors may from time to time determine.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.3</TD><TD STYLE="text-align: justify">The Company may issue units of securities in the Company, which may be comprised of whole or fractional
Shares, rights, options, warrants or convertible securities or securities of similar nature conferring the right upon the holders thereof
to subscribe for, purchase or receive any class of Shares or other securities in the Company, upon such terms as the Directors may from
time to time determine.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.4</TD><TD STYLE="text-align: justify">The Company shall not issue Shares to bearer.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">4</FONT></TD><TD STYLE="text-align: justify">Register of Members</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.1</TD><TD STYLE="text-align: justify">The Company shall maintain or cause to be maintained the Register of Members in accordance with the Statute.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.2</TD><TD STYLE="text-align: justify">The Directors may determine that the Company shall maintain one or more branch registers of Members in
accordance with the Statute. The Directors may also determine which register of Members shall constitute the principal register and which
shall constitute the branch register or registers, and to vary such determination from time to time.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5</FONT></TD><TD STYLE="text-align: justify">Closing Register of Members or Fixing Record Date</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.1</TD><TD STYLE="text-align: justify">For the purpose of determining Members entitled to notice of, or to vote at any meeting of Members or
any adjournment thereof, or Members entitled to receive payment of any Dividend or other distribution, or in order to make a determination
of Members for any other purpose, the Directors may, after notice has been given by advertisement in an appointed newspaper or any other
newspaper or by any other means in accordance with the rules and regulations of the Designated Stock Exchange, the Securities and Exchange
Commission and/or any other competent regulatory authority or otherwise under Applicable Law, provide that the Register of Members shall
be closed for transfers for a stated period which shall not in any case exceed forty days.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.2</TD><TD STYLE="text-align: justify">In lieu of, or apart from, closing the Register of Members, the Directors may fix in advance or arrears
a date as the record date for any such determination of Members entitled to notice of, or to vote at any meeting of the Members or any
adjournment thereof, or for the purpose of determining the Members entitled to receive payment of any Dividend or other distribution,
or in order to make a determination of Members for any other purpose.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.3</TD><TD STYLE="text-align: justify">If the Register of Members is not so closed and no record date is fixed for the determination of Members
entitled to notice of, or to vote at, a meeting of Members or Members entitled to receive payment of a Dividend or other distribution,
the date on which notice of the meeting is sent or the date on which the resolution of the Directors resolving to pay such Dividend or
other distribution is passed, as the case may be, shall be the record date for such determination of Members. When a determination of
Members entitled to vote at any meeting of Members has been made as provided in this Article, such determination shall apply to any adjournment
thereof.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">6</FONT></TD><TD STYLE="text-align: justify">Certificates for Shares</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.1</TD><TD STYLE="text-align: justify">A Member shall only be entitled to a share certificate if the Directors resolve that share certificates
shall be issued. Share certificates representing Shares, if any, shall be in such form as the Directors may determine. Share certificates
shall be signed by one or more Directors or other person authorised by the Directors. The Directors may authorise certificates to be issued
with the authorised signature(s) affixed by mechanical process. All certificates for Shares shall be consecutively numbered or otherwise
identified and shall specify the Shares to which they relate. All certificates surrendered to the Company for transfer shall be cancelled
and, subject to the Articles, no new certificate shall be issued until the former certificate representing a like number of relevant Shares
shall have been surrendered and cancelled.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.2</TD><TD STYLE="text-align: justify">The Company shall not be bound to issue more than one certificate for Shares held jointly by more than
one person and delivery of a certificate to one joint holder shall be a sufficient delivery to all of them.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.3</TD><TD STYLE="text-align: justify">If a share certificate is defaced, worn out, lost or destroyed, it may be renewed on such terms (if any)
as to evidence and indemnity and on the payment of such expenses reasonably incurred by the Company in investigating evidence, as the
Directors may prescribe, and (in the case of defacement or wearing out) upon delivery of the old certificate.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.4</TD><TD STYLE="text-align: justify">Every share certificate sent in accordance with the Articles will be sent at the risk of the Member or
other person entitled to the certificate. The Company will not be responsible for any share certificate lost or delayed in the course
of delivery.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.5</TD><TD STYLE="text-align: justify">Share certificates shall be issued within the relevant time limit as prescribed by the Statute, if applicable,
or as the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory
authority or otherwise under Applicable Law may from time to time determine, whichever is shorter, after the allotment or, except in the
case of a Share transfer which the Company is for the time being entitled to refuse to register and does not register, after lodgement
of a Share transfer with the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">7</FONT></TD><TD STYLE="text-align: justify">Transfer of Shares</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.1</TD><TD STYLE="text-align: justify">Subject to the terms of the Articles, any Member may transfer all or any of his Shares by an instrument
of transfer provided that such transfer complies with the rules and regulations of the Designated Stock Exchange, the Securities and Exchange
Commission and/or any other competent regulatory authority or otherwise under Applicable Law. If the Shares in question were issued in
conjunction with rights, options, warrants or units issued pursuant to the Articles on terms that one cannot be transferred without the
other, the Directors shall refuse to register the transfer of any such Share without evidence satisfactory to them of the like transfer
of such right, option, warrant or unit.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.2</TD><TD STYLE="text-align: justify">The instrument of transfer of any Share shall be in writing in the usual or common form or in a form prescribed
by the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other
competent regulatory authority or otherwise under Applicable Law or in any other form approved by the Directors and shall be executed
by or on behalf of the transferor (and if the Directors so require, signed by or on behalf of the transferee) and may be under hand or,
if the transferor or transferee is a Clearing House or its nominee(s), by hand or by machine imprinted signature or by such other manner
of execution as the Directors may approve from time to time. The transferor shall be deemed to remain the holder of a Share until the
name of the transferee is entered in the Register of Members.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">8</FONT></TD><TD STYLE="text-align: justify">Redemption, Repurchase and Surrender of Shares</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.1</TD><TD STYLE="text-align: justify">Subject to the provisions of the Statute, and, where applicable, the rules and regulations of the Designated
Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law,
the Company may issue Shares that are to be redeemed or are liable to be redeemed at the option of the Member or the Company. The redemption
of such Shares shall be effected in such manner and upon such other terms as the Company may, by Special Resolution, determine before
the issue of such Shares.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.2</TD><TD STYLE="text-align: justify">Subject to the provisions of the Statute, and, where applicable, the rules and regulations of the Designated
Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law,
the Company may purchase its own Shares (including any redeemable Shares) in such manner and on such other terms as the Directors may
agree with the relevant Member.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.3</TD><TD STYLE="text-align: justify">The Company may make a payment in respect of the redemption or purchase of its own Shares in any manner
permitted by the Statute, including out of capital.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.4</TD><TD STYLE="text-align: justify">The Directors may accept the surrender for no consideration of any fully paid Share.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">9</FONT></TD><TD STYLE="text-align: justify">Treasury Shares</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.1</TD><TD STYLE="text-align: justify">The Directors may, prior to the purchase, redemption or surrender of any Share, determine that such Share
shall be held as a Treasury Share.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.2</TD><TD STYLE="text-align: justify">The Directors may determine to cancel a Treasury Share or transfer a Treasury Share on such terms as they
think proper (including, without limitation, for nil consideration).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10</FONT></TD><TD STYLE="text-align: justify">Variation of Rights of Shares</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.1</TD><TD STYLE="text-align: justify">Subject to Article 3.1, if at any time the share capital of the Company is divided into different classes
of Shares, all or any of the rights attached to any class (unless otherwise provided by the terms of issue of the Shares of that class)
may, whether or not the Company is being wound up, be varied without the consent of the holders of the issued Shares of that class where
such variation is considered by the Directors not to have a material adverse effect upon such rights; otherwise, any such variation shall
be made only with the consent in writing of the holders of not less than two thirds of the issued Shares of that class, or with the approval
of a resolution passed by a majority of not less than two thirds of the votes
cast at a separate meeting of the holders of the Shares of that class. For the avoidance of doubt, the Directors reserve the right, notwithstanding
that any such variation may not have a material adverse effect, to obtain consent from the holders of Shares of the relevant class. To
any such meeting all the provisions of the Articles relating to general meetings shall apply <I>mutatis mutandis</I>, except that the
necessary quorum shall be one person holding or representing by proxy at least one third of the issued Shares of the class and that any
holder of Shares of the class present in person or by proxy may demand a poll.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.2</TD><TD STYLE="text-align: justify">For the purposes of a separate class meeting, the Directors may treat two or more or all the classes of
Shares as forming one class of Shares if the Directors consider that such class of Shares would be affected in the same way by the proposals
under consideration, but in any other case shall treat them as separate classes of Shares.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.3</TD><TD STYLE="text-align: justify">The rights conferred upon the holders of the Shares of any class issued with preferred or other rights
shall not, unless otherwise expressly provided by the terms of issue of the Shares of that class, be deemed to be varied by the creation
or issue of further Shares ranking pari passu therewith or Shares issued with preferred or other rights.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">11</FONT></TD><TD STYLE="text-align: justify">Commission on Sale of Shares</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company may, in so far as the Statute
permits, pay a commission to any person in consideration of his subscribing or agreeing to subscribe (whether absolutely or conditionally)
or procuring or agreeing to procure subscriptions (whether absolutely or conditionally) for any Shares. Such commissions may be satisfied
by the payment of cash and/or the issue of fully or partly paid-up Shares. The Company may also on any issue of Shares pay such brokerage
as may be lawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">12</FONT></TD><TD STYLE="text-align: justify">Non Recognition of Trusts</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company shall not be bound by or
compelled to recognise in any way (even when notified) any equitable, contingent, future or partial interest in any Share, or (except
only as is otherwise provided by the Articles or the Statute) any other rights in respect of any Share other than an absolute right to
the entirety thereof in the holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">13</FONT></TD><TD STYLE="text-align: justify">Lien on Shares</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.1</TD><TD STYLE="text-align: justify">The Company shall have a first and paramount lien on all Shares (whether fully paid-up or not) registered
in the name of a Member (whether solely or jointly with others) for all debts, liabilities or engagements to or with the Company (whether
presently payable or not) by such Member or his estate, either alone or jointly with any other person, whether a Member or not, but the
Directors may at any time declare any Share to be wholly or in part exempt from the provisions of this Article. The registration of a
transfer of any such Share shall operate as a waiver of the Company's lien thereon. The Company's lien on a Share shall also extend to
any amount payable in respect of that Share.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.2</TD><TD STYLE="text-align: justify">The Company may sell, in such manner as the Directors think fit, any Shares on which the Company has a
lien, if a sum in respect of which the lien exists is presently payable, and is not paid within fourteen clear days after
notice has been received or deemed to have been received by the holder of the Shares, or to the person entitled to it in consequence of
the death or bankruptcy of the holder, demanding payment and stating that if the notice is not complied with the Shares may be sold.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.3</TD><TD STYLE="text-align: justify">To give effect to any such sale the Directors may authorise any person to execute an instrument of transfer
of the Shares sold to, or in accordance with the directions of, the purchaser. The purchaser or his nominee shall be registered as the
holder of the Shares comprised in any such transfer, and he shall not be bound to see to the application of the purchase money, nor shall
his title to the Shares be affected by any irregularity or invalidity in the sale or the exercise of the Company's power of sale under
the Articles.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.4</TD><TD STYLE="text-align: justify">The net proceeds of such sale after payment of costs, shall be applied in payment of such part of the
amount in respect of which the lien exists as is presently payable and any balance shall (subject to a like lien for sums not presently
payable as existed upon the Shares before the sale) be paid to the person entitled to the Shares at the date of the sale.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">14</FONT></TD><TD STYLE="text-align: justify">Call on Shares</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.1</TD><TD STYLE="text-align: justify">Subject to the terms of the allotment and issue of any Shares, the Directors may make calls upon the Members
in respect of any monies unpaid on their Shares (whether in respect of par value or premium), and each Member shall (subject to receiving
at least fourteen clear days' notice specifying the time or times of payment) pay to the Company at the time or times so specified the
amount called on the Shares. A call may be revoked or postponed, in whole or in part, as the Directors may determine. A call may be required
to be paid by instalments. A person upon whom a call is made shall remain liable for calls made upon him notwithstanding the subsequent
transfer of the Shares in respect of which the call was made.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.2</TD><TD STYLE="text-align: justify">A call shall be deemed to have been made at the time when the resolution of the Directors authorising
such call was passed.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.3</TD><TD STYLE="text-align: justify">The joint holders of a Share shall be jointly and severally liable to pay all calls in respect thereof.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.4</TD><TD STYLE="text-align: justify">If a call remains unpaid after it has become due and payable, the person from whom it is due shall pay
interest on the amount unpaid from the day it became due and payable until it is paid at such rate as the Directors may determine (and
in addition all expenses that have been incurred by the Company by reason of such non-payment), but the Directors may waive payment of
the interest or expenses wholly or in part.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.5</TD><TD STYLE="text-align: justify">An amount payable in respect of a Share on issue or allotment or at any fixed date, whether on account
of the par value of the Share or premium or otherwise, shall be deemed to be a call and if it is not paid all the provisions of the Articles
shall apply as if that amount had become due and payable by virtue of a call.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.6</TD><TD STYLE="text-align: justify">The Directors may issue Shares with different terms as to the amount and times of payment of calls, or
the interest to be paid.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.7</TD><TD STYLE="text-align: justify">The Directors may, if they think fit, receive an amount from any Member willing to advance all or any
part of the monies uncalled and unpaid upon any Shares held by him, and may (until the amount would otherwise become payable) pay interest
at such rate as may be agreed upon between the Directors and the Member paying such amount in advance.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.8</TD><TD STYLE="text-align: justify">No such amount paid in advance of calls shall entitle the Member paying such amount to any portion of
a Dividend or other distribution payable in respect of any period prior to the date upon which such amount would, but for such payment,
become payable.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">15</FONT></TD><TD STYLE="text-align: justify">Forfeiture of Shares</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.1</TD><TD STYLE="text-align: justify">If a call or instalment of a call remains unpaid after it has become due and payable the Directors may
give to the person from whom it is due not less than fourteen clear days' notice requiring payment of the amount unpaid together with
any interest which may have accrued and any expenses incurred by the Company by reason of such non-payment. The notice shall specify where
payment is to be made and shall state that if the notice is not complied with the Shares in respect of which the call was made will be
liable to be forfeited.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.2</TD><TD STYLE="text-align: justify">If the notice is not complied with, any Share in respect of which it was given may, before the payment
required by the notice has been made, be forfeited by a resolution of the Directors. Such forfeiture shall include all Dividends, other
distributions or other monies payable in respect of the forfeited Share and not paid before the forfeiture.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.3</TD><TD STYLE="text-align: justify">A forfeited Share may be sold, re-allotted or otherwise disposed of on such terms and in such manner as
the Directors think fit and at any time before a sale, re-allotment or disposition the forfeiture may be cancelled on such terms as the
Directors think fit. Where for the purposes of its disposal a forfeited Share is to be transferred to any person the Directors may authorise
some person to execute an instrument of transfer of the Share in favour of that person.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.4</TD><TD STYLE="text-align: justify">A person any of whose Shares have been forfeited shall cease to be a Member in respect of them and shall
surrender to the Company for cancellation the certificate for the Shares forfeited and shall remain liable to pay to the Company all monies
which at the date of forfeiture were payable by him to the Company in respect of those Shares together with interest at such rate as the
Directors may determine, but his liability shall cease if and when the Company shall have received payment in full of all monies due and
payable by him in respect of those Shares.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.5</TD><TD STYLE="text-align: justify">A certificate in writing under the hand of one Director or Officer that a Share has been forfeited on
a specified date shall be conclusive evidence of the facts stated in it as against all persons claiming to be entitled to the Share. The
certificate shall (subject to the execution of an instrument of transfer) constitute a good title to the Share and the person to whom
the Share is sold or otherwise disposed of shall not be bound to see to the application of the purchase money, if any, nor shall his title
to the Share be affected by any irregularity
or invalidity in the proceedings in reference to the forfeiture, sale or disposal of the Share.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.6</TD><TD STYLE="text-align: justify">The provisions of the Articles as to forfeiture shall apply in the case of non payment of any sum which,
by the terms of issue of a Share, becomes payable at a fixed time, whether on account of the par value of the Share or by way of premium
as if it had been payable by virtue of a call duly made and notified.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">16</FONT></TD><TD STYLE="text-align: justify">Transmission of Shares</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.1</TD><TD STYLE="text-align: justify">If a Member dies, the survivor or survivors (where he was a joint holder), or his legal personal representatives
(where he was a sole holder), shall be the only persons recognised by the Company as having any title to his Shares. The estate of a deceased
Member is not thereby released from any liability in respect of any Share, for which he was a joint or sole holder.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.2</TD><TD STYLE="text-align: justify">Any person becoming entitled to a Share in consequence of the death or bankruptcy or liquidation or dissolution
of a Member (or in any other way than by transfer) may, upon such evidence being produced as may be required by the Directors, elect,
by a notice in writing sent by him to the Company, either to become the holder of such Share or to have some person nominated by him registered
as the holder of such Share. If he elects to have another person registered as the holder of such Share he shall sign an instrument of
transfer of that Share to that person. The Directors shall, in either case, have the same right to decline or suspend registration as
they would have had in the case of a transfer of the Share by the relevant Member before his death or bankruptcy or liquidation or dissolution,
as the case may be.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.3</TD><TD STYLE="text-align: justify">A person becoming entitled to a Share by reason of the death or bankruptcy or liquidation or dissolution
of a Member (or in any other case than by transfer) shall be entitled to the same Dividends, other distributions and other advantages
to which he would be entitled if he were the holder of such Share. However, he shall not, before becoming a Member in respect of a Share,
be entitled in respect of it to exercise any right conferred by membership in relation to general meetings of the Company and the Directors
may at any time give notice requiring any such person to elect either to be registered himself or to have some person nominated by him
be registered as the holder of the Share (but the Directors shall, in either case, have the same right to decline or suspend registration
as they would have had in the case of a transfer of the Share by the relevant Member before his death or bankruptcy or liquidation or
dissolution or any other case than by transfer, as the case may be). If the notice is not complied with within ninety days of being received
or deemed to be received (as determined pursuant to the Articles), the Directors may thereafter withhold payment of all Dividends, other
distributions, bonuses or other monies payable in respect of the Share until the requirements of the notice have been complied with.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">17</FONT></TD><TD STYLE="text-align: justify">Class A Shares and Class B Shares</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.1</TD><TD STYLE="text-align: justify">The rights attaching to the Class A Shares and Class B Shares shall rank <I>pari passu</I> in all respects,
and the Class A Shares and Class B Shares shall vote together as a single class on all matters.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">18</FONT></TD><TD STYLE="text-align: justify">Amendments of Memorandum and Articles of Association and Alteration of Capital</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.1</TD><TD STYLE="text-align: justify">The Company may by Ordinary Resolution:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(a)</TD><TD STYLE="text-align: justify">increase its share capital by such sum as the Ordinary Resolution shall prescribe and with such rights,
priorities and privileges annexed thereto, as the Company in general meeting may determine;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(b)</TD><TD STYLE="text-align: justify">consolidate and divide all or any of its share capital into Shares of larger amount than its existing
Shares;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(c)</TD><TD STYLE="text-align: justify">convert all or any of its paid-up Shares into stock, and reconvert that stock into paid-up Shares of any
denomination;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(d)</TD><TD STYLE="text-align: justify">by subdivision of its existing Shares or any of them divide the whole or any part of its share capital
into Shares of smaller amount than is fixed by the Memorandum or into Shares without par value; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(e)</TD><TD STYLE="text-align: justify">cancel any Shares that at the date of the passing of the Ordinary Resolution have not been taken or agreed
to be taken by any person and diminish the amount of its share capital by the amount of the Shares so cancelled.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.2</TD><TD STYLE="text-align: justify">All new Shares created in accordance with the provisions of the preceding Article shall be subject to
the same provisions of the Articles with reference to the payment of calls, liens, transfer, transmission, forfeiture and otherwise as
the Shares in the original share capital.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.3</TD><TD STYLE="text-align: justify">Subject to the provisions of the Statute, and the provisions of the Articles as regards the matters to
be dealt with by Ordinary Resolution and Article 18.4, the Company may by Special Resolution:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(a)</TD><TD STYLE="text-align: justify">change its name;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(b)</TD><TD STYLE="text-align: justify">alter or add to the Articles;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(c)</TD><TD STYLE="text-align: justify">alter or add to the Memorandum with respect to any objects, powers or other matters specified therein;
and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(d)</TD><TD STYLE="text-align: justify">reduce its share capital or any capital redemption reserve fund.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.4</TD><TD STYLE="text-align: justify">Notwithstanding any other provision of the Articles but subject to the provisions of the Statute, the
Company may only:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(a)</TD><TD STYLE="text-align: justify">alter, amend or repeal, in whole or in part, any provision of the Articles or the Memorandum; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(b)</TD><TD STYLE="text-align: justify">adopt any provision inconsistent therewith, by a Special Resolution
passed by a Supermajority Vote.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">19</FONT></TD><TD STYLE="text-align: justify">Offices and Places of Business</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Subject to the provisions of the Statute,
the Company may by resolution of the Directors change the location of its Registered Office. The Company may, in addition to its Registered
Office, maintain such other offices or places of business as the Directors determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">20</FONT></TD><TD STYLE="text-align: justify">General Meetings</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.1</TD><TD STYLE="text-align: justify">All general meetings other than annual general meetings shall be called extraordinary general meetings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.2</TD><TD STYLE="text-align: justify">The Company may, but shall not (unless required by the Statute) be obliged to, in each year hold a general
meeting as its annual general meeting, and shall specify the meeting as such in the notices calling it. Any annual general meeting shall
be held at such time and place as the Directors shall appoint. At these meetings the report of the Directors (if any) shall be presented.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.3</TD><TD STYLE="text-align: justify">The Directors, the chief executive officer or the chairman of the board of Directors may call general
meetings, and they shall on a Members' requisition forthwith proceed to convene an extraordinary general meeting of the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.4</TD><TD STYLE="text-align: justify">A Members' requisition is a requisition of Members holding at the date of deposit of the requisition not
less than ten per cent in par value of the issued Shares which as at that date carry the right to vote at general meetings of the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.5</TD><TD STYLE="text-align: justify">The Members' requisition must state the objects of the meeting and must be signed by the requisitionists
and deposited at the Registered Office, and may consist of several documents in like form each signed by one or more requisitionists.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.6</TD><TD STYLE="text-align: justify">If there are no Directors as at the date of the deposit of the Members' requisition or if the Directors
do not within twenty-one days from the date of the deposit of the Members' requisition duly proceed to convene a general meeting to be
held within a further twenty-one days, the requisitionists, or any of them representing more than one-half of the total voting rights
of all of the requisitionists, may themselves convene a general meeting, but any meeting so convened shall be held no later than the day
which falls three months after the expiration of the said twenty-one day period.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.7</TD><TD STYLE="text-align: justify">A general meeting convened as aforesaid by requisitionists shall be convened in the same manner as nearly
as possible as that in which general meetings are to be convened by Directors.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.8</TD><TD STYLE="text-align: justify">Members seeking to bring business before the annual general meeting or to nominate candidates for appointment
as Directors at the annual general meeting must deliver notice to the principal executive offices of the Company not less than 120 calendar
days before the date of the Company&rsquo;s proxy statement released to Members in connection with the previous year&rsquo;s annual general
meeting or, if the Company did not hold an annual general meeting the previous year, or if the date of the current year's annual general
meeting has been changed by more than 30 days from the date of the previous year&rsquo;s annual
general meeting, then the deadline shall be set by the board of Directors with such deadline being a reasonable time before the Company
begins to print and send its related proxy materials.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">21</FONT></TD><TD STYLE="text-align: justify">Notice of General Meetings</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.1</TD><TD STYLE="text-align: justify">At least five clear days' notice shall be given of any general meeting. Every notice shall specify the
place, the day and the hour of the meeting and the general nature of the business to be conducted at the general meeting and shall be
given in the manner hereinafter mentioned or in such other manner if any as may be prescribed by the Company, provided that a general
meeting of the Company shall, whether or not the notice specified in this Article has been given and whether or not the provisions of
the Articles regarding general meetings have been complied with, be deemed to have been duly convened if it is so agreed:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(a)</TD><TD STYLE="text-align: justify">in the case of an annual general meeting, by all of the Members entitled to attend and vote thereat; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(b)</TD><TD STYLE="text-align: justify">in the case of an extraordinary general meeting, by a majority in number of the Members having a right
to attend and vote at the meeting, together holding not less than ninety-five per cent in par value of the Shares giving that right.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.2</TD><TD STYLE="text-align: justify">The accidental omission to give notice of a general meeting to, or the non receipt of notice of a general
meeting by, any person entitled to receive such notice shall not invalidate the proceedings of that general meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">22</FONT></TD><TD STYLE="text-align: justify">Proceedings at General Meetings</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.1</TD><TD STYLE="text-align: justify">No business shall be transacted at any general meeting unless a quorum is present. The holders of a majority
of the Shares being individuals present in person or by proxy or if a corporation or other non-natural person by its duly authorised representative
or proxy shall be a quorum.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.2</TD><TD STYLE="text-align: justify">A person may participate at a general meeting by conference telephone or other communications equipment
by means of which all the persons participating in the meeting can communicate with each other. Participation by a person in a general
meeting in this manner is treated as presence in person at that meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.3</TD><TD STYLE="text-align: justify">A resolution (including a Special Resolution) may only be passed at, and any other action required or
permitted to be taken by the Members may only be effected by, a general meeting of the Company duly convened and held.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.4</TD><TD STYLE="text-align: justify">If a quorum is not present within half an hour from the time appointed for the meeting to commence or
if during such a meeting a quorum ceases to be present, the meeting, if convened upon a Members' requisition, shall be dissolved and in
any other case it shall stand adjourned to the same day in the next week at the same time and/or place or to such other day, time and/or
place as the Directors may determine, and if at the adjourned meeting a quorum is not present within half an hour from the time appointed for the
meeting to commence, the Members present shall be a quorum.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.5</TD><TD STYLE="text-align: justify">The Directors may, at any time prior to the time appointed for the meeting to commence, appoint any person
to act as chairman of a general meeting of the Company or, if the Directors do not make any such appointment, the chairman, if any, of
the board of Directors shall preside as chairman at such general meeting. If there is no such chairman, or if he shall not be present
within fifteen minutes after the time appointed for the meeting to commence, or is unwilling to act, the Directors present shall elect
one of their number to be chairman of the meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.6</TD><TD STYLE="text-align: justify">If no Director is willing to act as chairman or if no Director is present within fifteen minutes after
the time appointed for the meeting to commence, the Members present shall choose one of their number to be chairman of the meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.7</TD><TD STYLE="text-align: justify">The chairman may, with the consent of a meeting at which a quorum is present (and shall if so directed
by the meeting) adjourn the meeting from time to time and from place to place, but no business shall be transacted at any adjourned meeting
other than the business left unfinished at the meeting from which the adjournment took place.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.8</TD><TD STYLE="text-align: justify">When a general meeting is adjourned for thirty days or more, notice of the adjourned meeting shall be
given as in the case of an original meeting. Otherwise it shall not be necessary to give any such notice of an adjourned meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.9</TD><TD STYLE="text-align: justify">A resolution put to the vote of the meeting shall be decided on a poll.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.10</TD><TD STYLE="text-align: justify">A poll shall be taken as the chairman directs, and the result of the poll shall be deemed to be the resolution
of the general meeting at which the poll was demanded.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.11</TD><TD STYLE="text-align: justify">A poll demanded on the election of a chairman or on a question of adjournment shall be taken forthwith.
A poll demanded on any other question shall be taken at such date, time and place as the chairman of the general meeting directs, and
any business other than that upon which a poll has been demanded or is contingent thereon may proceed pending the taking of the poll.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.12</TD><TD STYLE="text-align: justify">In the case of an equality of votes the chairman shall be entitled to a second or casting vote.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">23</FONT></TD><TD STYLE="text-align: justify">Votes of Members</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.1</TD><TD STYLE="text-align: justify">Subject to any rights or restrictions attached to any Shares, every Member present in any such manner
shall have one vote for every Share of which he is the holder.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.2</TD><TD STYLE="text-align: justify">In the case of joint holders the vote of the senior holder who tenders a vote, whether in person or by
proxy (or, in the case of a corporation or other non-natural person, by its duly authorised representative or proxy), shall be accepted
to the exclusion of the votes of the other joint holders, and seniority shall be determined by the order in which the names of the holders
stand in the Register of Members.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.3</TD><TD STYLE="text-align: justify">A Member of unsound mind, or in respect of whom an order has been made by any court, having jurisdiction
in lunacy, may vote by his committee, receiver, curator bonis, or other person on such Member's behalf appointed by that court, and any
such committee, receiver, curator bonis or other person may vote by proxy.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.4</TD><TD STYLE="text-align: justify">No person shall be entitled to vote at any general meeting unless he is registered as a Member on the
record date for such meeting nor unless all calls or other monies then payable by him in respect of Shares have been paid.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.5</TD><TD STYLE="text-align: justify">No objection shall be raised as to the qualification of any voter except at the general meeting or adjourned
general meeting at which the vote objected to is given or tendered and every vote not disallowed at the meeting shall be valid. Any objection
made in due time in accordance with this Article shall be referred to the chairman whose decision shall be final and conclusive.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.6</TD><TD STYLE="text-align: justify">Votes may be cast either personally or by proxy (or in the case of a corporation or other non-natural
person by its duly authorised representative or proxy). A Member may appoint more than one proxy or the same proxy under one or more instruments
to attend and vote at a meeting. Where a Member appoints more than one proxy the instrument of proxy shall specify the number of Shares
in respect of which each proxy is entitled to exercise the related votes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.7</TD><TD STYLE="text-align: justify">A Member holding more than one Share need not cast the votes in respect of his Shares in the same way
on any resolution and therefore may vote a Share or some or all such Shares either for or against a resolution and/or abstain from voting
a Share or some or all of the Shares and, subject to the terms of the instrument appointing him, a proxy appointed under one or more instruments
may vote a Share or some or all of the Shares in respect of which he is appointed either for or against a resolution and/or abstain from
voting a Share or some or all of the Shares in respect of which he is appointed.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">24</FONT></TD><TD STYLE="text-align: justify">Proxies</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.1</TD><TD STYLE="text-align: justify">The instrument appointing a proxy shall be in writing and shall be executed under the hand of the appointor
or of his attorney duly authorised in writing, or, if the appointor is a corporation or other non natural person, under the hand of its
duly authorised representative. A proxy need not be a Member.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.2</TD><TD STYLE="text-align: justify">The Directors may, in the notice convening any meeting or adjourned meeting, or in an instrument of proxy
sent out by the Company, specify the manner by which the instrument appointing a proxy shall be deposited and the place and the time (being
not later than the time appointed for the commencement of the meeting or adjourned meeting to which the proxy relates) at which the instrument
appointing a proxy shall be deposited. In the absence of any such direction from the Directors in the notice convening any meeting or
adjourned meeting or in an instrument of proxy sent out by the Company, the instrument appointing a proxy shall be deposited physically
at the Registered Office not less than 48 hours before the time appointed for the meeting or adjourned meeting to commence at which the
person named in the instrument proposes to vote.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.3</TD><TD STYLE="text-align: justify">The chairman may in any event at his discretion declare that an instrument of proxy shall be deemed to
have been duly deposited. An instrument of proxy that is not deposited in the manner permitted, or which has not been declared to have
been duly deposited by the chairman, shall be invalid.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.4</TD><TD STYLE="text-align: justify">The instrument appointing a proxy may be in any usual or common form (or such other form as the Directors
may approve) and may be expressed to be for a particular meeting or any adjournment thereof or generally until revoked. An instrument
appointing a proxy shall be deemed to include the power to demand or join or concur in demanding a poll.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.5</TD><TD STYLE="text-align: justify">Votes given in accordance with the terms of an instrument of proxy shall be valid notwithstanding the
previous death or insanity of the principal or revocation of the proxy or of the authority under which the proxy was executed, or the
transfer of the Share in respect of which the proxy is given unless notice in writing of such death, insanity, revocation or transfer
was received by the Company at the Registered Office before the commencement of the general meeting, or adjourned meeting at which it
is sought to use the proxy.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">25</FONT></TD><TD STYLE="text-align: justify">Corporate Members</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">25.1</TD><TD STYLE="text-align: justify">Any corporation or other non-natural person which is a Member may in accordance with its constitutional
documents, or in the absence of such provision by resolution of its directors or other governing body, authorise such person as it thinks
fit to act as its representative at any meeting of the Company or of any class of Members, and the person so authorised shall be entitled
to exercise the same powers on behalf of the corporation which he represents as the corporation could exercise if it were an individual
Member.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">25.2</TD><TD STYLE="text-align: justify">If a Clearing House (or its nominee(s)), being a corporation, is a Member, it may authorise such persons
as it sees fit to act as its representative at any meeting of the Company or at any meeting of any class of Members provided that the
authorisation shall specify the number and class of Shares in respect of which each such representative is so authorised. Each person
so authorised under the provisions of this Article shall be deemed to have been duly authorised without further evidence of the facts
and be entitled to exercise the same rights and powers on behalf of the Clearing House (or its nominee(s)) as if such person was the registered
holder of such Shares held by the Clearing House (or its nominee(s)).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">26</FONT></TD><TD STYLE="text-align: justify">Shares that May Not be Voted</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Shares in the Company that are beneficially
owned by the Company shall not be voted, directly or indirectly, at any meeting and shall not be counted in determining the total number
of outstanding Shares at any given time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">27</FONT></TD><TD STYLE="text-align: justify">Directors</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27.1</TD><TD STYLE="text-align: justify">There shall be a board of Directors of the Company. Subject to the rights of any holders of Preference
Shares to appoint Directors, the number of Directors that shall constitute the board of Directors shall be as determined from time to
time exclusively by the then-existing board of Directors by the vote of a majority
of the remaining Directors then in office, although less than a quorum (as defined in the Articles), or by the sole remaining Director.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27.2</TD><TD STYLE="text-align: justify">Unless re-appointed pursuant to the provisions of Article 29.1 or removed from office pursuant to the
provisions of Article 29.3, each Director shall be appointed for a term expiring at the next-following annual general meeting of the Company.
At any such annual general meeting, Directors will be appointed by Ordinary Resolution. At each annual general meeting of the Company,
each Director appointed at such meeting shall be appointed to hold office for a one-year term and until the appointment of their respective
successors in office or removal pursuant to Articles 29.1 and 29.3.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">28</FONT></TD><TD STYLE="text-align: justify">Powers of Directors</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.1</TD><TD STYLE="text-align: justify">Subject to the provisions of the Statute, the Memorandum and the Articles and to any directions given
by Special Resolution, the business of the Company shall be managed by the Directors who may exercise all the powers of the Company. No
alteration of the Memorandum or Articles and no such direction shall invalidate any prior act of the Directors which would have been valid
if that alteration had not been made or that direction had not been given. A duly convened meeting of Directors at which a quorum is present
may exercise all powers exercisable by the Directors.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.2</TD><TD STYLE="text-align: justify">All cheques, promissory notes, drafts, bills of exchange and other negotiable or transferable instruments
and all receipts for monies paid to the Company shall be signed, drawn, accepted, endorsed or otherwise executed as the case may be in
such manner as the Directors shall determine by resolution.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.3</TD><TD STYLE="text-align: justify">The Directors on behalf of the Company may pay a gratuity or pension or allowance on retirement to any
Director who has held any other salaried office or place of profit with the Company or to his widow or dependants and may make contributions
to any fund and pay premiums for the purchase or provision of any such gratuity, pension or allowance.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.4</TD><TD STYLE="text-align: justify">The Directors may exercise all the powers of the Company to borrow money and to mortgage or charge its
undertaking, property and assets (present and future) and uncalled capital or any part thereof and to issue debentures, debenture stock,
mortgages, bonds and other such securities whether outright or as security for any debt, liability or obligation of the Company or of
any third party.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">29</FONT></TD><TD STYLE="text-align: justify">Appointment and Removal of Directors</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.1</TD><TD STYLE="text-align: justify">The Company may by Ordinary Resolution appoint any person to be a Director.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.2</TD><TD STYLE="text-align: justify">The Directors may appoint any person to be a Director, either to fill a vacancy or as an additional Director
provided that the appointment does not cause the number of Directors to exceed any number fixed by or in accordance with the Articles
as the maximum number of Directors. Any Director so appointed shall, if still a Director, be automatically removed from office at the
next annual general meeting after his or
her appointment and be eligible to stand for appointment as a Director at such meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.3</TD><TD STYLE="text-align: justify">A Director may be removed only:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(a)</TD><TD STYLE="text-align: justify">by the board of Directors in accordance with Article 29.4; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(b)</TD><TD STYLE="text-align: justify">by a Special Resolution passed by a Supermajority Vote.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.4</TD><TD STYLE="text-align: justify">The board of Directors may remove a Director for cause in its sole discretion by the vote of a majority
of the Directors then in office (not including the Director whose service is being terminated), either by a resolution passed by a majority
of the other Directors at a meeting of the Directors duly convened and held in accordance with the Articles or by a resolution in writing
signed by a majority of the other Directors. Reasons for a cause termination may include, but are not limited to, frequently missed meetings
of the board of Directors or a committee of the board of Directors, disclosing confidential or sensitive information about the Company
to unauthorised persons, becoming involved with a competitor of the Company, using the Company for his or her own personal gain, material
violation of the policies or code of ethics of the Company, taking part in illegal activities regarding the Company's Shares or other
securities, the Director being indicted on charges of, convicted of, or entering a plea of guilty or nolo contendere to, a felony or a
crime involving fraud, dishonesty or moral turpitude and creating an unhealthy or dysfunctional boardroom through inappropriate behaviour
or disrespecting the Members or other members of the board of Directors.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">30</FONT></TD><TD STYLE="text-align: justify">Vacation of Office of Director</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The office of a Director shall be vacated
if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(a)</TD><TD STYLE="text-align: justify">the Director gives notice in writing to the Company that he resigns the office of Director; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(b)</TD><TD STYLE="text-align: justify">the Director absents himself (for the avoidance of doubt, without being represented by proxy) from three
consecutive meetings of the board of Directors without special leave of absence from the Directors, and the Directors pass a resolution
that he has by reason of such absence vacated office; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(c)</TD><TD STYLE="text-align: justify">the Director dies, becomes bankrupt or makes any arrangement or composition with his creditors generally;
or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(d)</TD><TD STYLE="text-align: justify">the Director is found to be or becomes of unsound mind; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(e)</TD><TD STYLE="text-align: justify">the Director is removed pursuant to Article 29.3.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">31</FONT></TD><TD STYLE="text-align: justify">Proceedings of Directors</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.1</TD><TD STYLE="text-align: justify">The quorum for the transaction of the business of the Directors may be fixed by the Directors, and unless
so fixed shall be a majority of the Directors then in office.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.2</TD><TD STYLE="text-align: justify">Subject to the provisions of the Articles, the Directors may regulate their proceedings as they think
fit. Questions arising at any meeting shall be decided by a majority of votes. In the case of an equality of votes, the chairman shall
have a second or casting vote.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.3</TD><TD STYLE="text-align: justify">A person may participate in a meeting of the Directors or any committee of Directors by conference telephone
or other communications equipment by means of which all the persons participating in the meeting can communicate with each other at the
same time. Participation by a person in a meeting in this manner is treated as presence in person at that meeting. Unless otherwise determined
by the Directors, the meeting shall be deemed to be held at the place where the chairman is located at the start of the meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.4</TD><TD STYLE="text-align: justify">A resolution in writing (in one or more counterparts) signed by all the Directors or all the members of
a committee of the Directors or, in the case of a resolution in writing relating to the removal of any Director or the vacation of office
by any Director, a majority of the Directors other than the Director who is the subject of such resolution shall be as valid and effectual
as if it had been passed at a meeting of the Directors, or committee of Directors as the case may be, duly convened and held.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.5</TD><TD STYLE="text-align: justify">A Director may, or other Officer on the direction of a Director shall, call a meeting of the Directors
by at least two days' notice in writing to every Director which notice shall set forth the general nature of the business to be considered
unless notice is waived by all the Directors either at, before or after the meeting is held. To any such notice of a meeting of the Directors
all the provisions of the Articles relating to the giving of notices by the Company to the Members shall apply <I>mutatis mutandis.</I></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.6</TD><TD STYLE="text-align: justify">The continuing Directors (or a sole continuing Director, as the case may be) may act notwithstanding any
vacancy in their body, but if and so long as their number is reduced below the number fixed by or pursuant to the Articles as the necessary
quorum of Directors the continuing Directors or Director may act for the purpose of increasing the number of Directors to be equal to
such fixed number, or of summoning a general meeting of the Company, but for no other purpose.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.7</TD><TD STYLE="text-align: justify">The Directors may elect a chairman of their board and determine the period for which he is to hold office;
but if no such chairman is elected, or if at any meeting the chairman is not present within five minutes after the time appointed for
the meeting to commence, the Directors present may choose one of their number to be chairman of the meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.8</TD><TD STYLE="text-align: justify">All acts done by any meeting of the Directors or of a committee of the Directors shall, notwithstanding
that it is afterwards discovered that there was some defect in the appointment of any Director, and/or that they or any of them were disqualified,
and/or had vacated their office and/or were not entitled to vote, be as valid as if every such person had been duly appointed and/or not
disqualified to be a Director and/or had not vacated their office and/or had been entitled to vote, as the case may be.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.9</TD><TD STYLE="text-align: justify">A Director may be represented at any meetings of the board of Directors by a proxy appointed in writing
by him. The proxy shall count towards the quorum and the vote of the proxy shall for all purposes be deemed to be that of the appointing
Director.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">32</FONT></TD><TD STYLE="text-align: justify">Presumption of Assent</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A Director who is present at a meeting
of the board of Directors at which action on any Company matter is taken shall be presumed to have assented to the action taken unless
his dissent shall be entered in the minutes of the meeting or unless he shall file his written dissent from such action with the person
acting as the chairman or secretary of the meeting before the adjournment thereof or shall forward such dissent by registered post to
such person immediately after the adjournment of the meeting. Such right to dissent shall not apply to a Director who voted in favour
of such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">33</FONT></TD><TD STYLE="text-align: justify">Directors' Interests</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.1</TD><TD STYLE="text-align: justify">A Director may hold any other office or place of profit under the Company (other than the office of Auditor)
in conjunction with his office of Director for such period and on such terms as to remuneration and otherwise as the Directors may determine.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.2</TD><TD STYLE="text-align: justify">A Director may act by himself or by, through or on behalf of his firm in a professional capacity for the
Company and he or his firm shall be entitled to remuneration for professional services as if he were not a Director.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.3</TD><TD STYLE="text-align: justify">A Director may be or become a director or other officer of or otherwise interested in any company promoted
by the Company or in which the Company may be interested as a shareholder, a contracting party or otherwise, and no such Director shall
be accountable to the Company for any remuneration or other benefits received by him as a director or officer of, or from his interest
in, such other company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.4</TD><TD STYLE="text-align: justify">No person shall be disqualified from the office of Director or prevented by such office from contracting
with the Company, either as vendor, purchaser or otherwise, nor shall any such contract or any contract or transaction entered into by
or on behalf of the Company in which any Director shall be in any way interested be or be liable to be avoided, nor shall any Director
so contracting or being so interested be liable to account to the Company for any profit realised by or arising in connection with any
such contract or transaction by reason of such Director holding office or of the fiduciary relationship thereby established. A Director
shall be at liberty to vote in respect of any contract or transaction in which he is interested provided that the nature of the interest
of any Director in any such contract or transaction shall be disclosed by him at or prior to its consideration and any vote thereon.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.5</TD><TD STYLE="text-align: justify">A general notice that a Director is a shareholder, director, officer or employee of any specified firm
or company and is to be regarded as interested in any transaction with such firm or company shall be sufficient disclosure for the purposes
of voting on a resolution in respect of a contract or transaction in which he has an interest, and after such general notice it shall
not be necessary to give special notice relating to any particular transaction.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">34</FONT></TD><TD STYLE="text-align: justify">Minutes</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Directors shall cause minutes to
be made in books kept for the purpose of recording all appointments of Officers made by the Directors, all proceedings at meetings of
the Company or the holders of any class of Shares and of the Directors, and of committees of the Directors, including the names of the
Directors present at each meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD><TD STYLE="text-align: justify">Delegation of Directors' Powers</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.1</TD><TD STYLE="text-align: justify">The Directors may delegate any of their powers, authorities and discretions, including the power to sub-delegate,
to any committee consisting of one or more Directors (including, without limitation, the Audit Committee and the Compensation Committee).
Any such delegation may be made subject to any conditions the Directors may impose and either collaterally with or to the exclusion of
their own powers and any such delegation may be revoked or altered by the Directors. Subject to any such conditions, the proceedings of
a committee of Directors shall be governed by the Articles regulating the proceedings of Directors, so far as they are capable of applying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.2</TD><TD STYLE="text-align: justify">The Directors may establish any committees, local boards or agencies or appoint any person to be a manager
or agent for managing the affairs of the Company and may appoint any person to be a member of such committees, local boards or agencies.
Any such appointment may be made subject to any conditions the Directors may impose, and either collaterally with or to the exclusion
of their own powers and any such appointment may be revoked or altered by the Directors. Subject to any such conditions, the proceedings
of any such committee, local board or agency shall be governed by the Articles regulating the proceedings of Directors, so far as they
are capable of applying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.3</TD><TD STYLE="text-align: justify">The Directors may adopt formal written charters for committees and, if so adopted, shall review and assess
the adequacy of such formal written charters on an annual basis. Each of these committees shall be empowered to do all things necessary
to exercise the rights of such committee set forth in the Articles and shall have such powers as the Directors may delegate pursuant to
the Articles and as required by the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or
any other competent regulatory authority or otherwise under Applicable Law. Each of the Audit Committee and the Compensation Committee,
if established, shall consist of such number of Directors as the Directors shall from time to time determine (or such minimum number as
may be required from time to time by the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission
and/or any other competent regulatory authority or otherwise under Applicable Law). For so long as any class of Shares is listed on the
Designated Stock Exchange, the Audit Committee and the Compensation Committee and shall be made up of such number of Independent Directors
as is required from time to time by the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission
and/or any other competent regulatory authority or otherwise under Applicable Law.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.4</TD><TD STYLE="text-align: justify">The Directors may by power of attorney or otherwise appoint any person to be the agent of the Company
on such conditions as the Directors may determine, provided that the delegation is not to the exclusion of their own powers and may be
revoked by the Directors at any time.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.5</TD><TD STYLE="text-align: justify">The Directors may by power of attorney or otherwise appoint any company, firm, person or body of persons,
whether nominated directly or indirectly by the Directors, to be the attorney or authorised signatory of the Company for such purpose
and with such powers, authorities and discretions (not exceeding those vested in or exercisable by the Directors under the Articles) and
for such period and subject to such conditions as they may think fit, and any such powers of attorney or other appointment may contain
such provisions for the protection and convenience of persons dealing with any such attorneys or authorised signatories as the Directors
may think fit and may also authorise any such attorney or authorised signatory to delegate all or any of the powers, authorities and discretions
vested in him.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.6</TD><TD STYLE="text-align: justify">The Directors may appoint such Officers as they consider necessary on such terms, at such remuneration
and to perform such duties, and subject to such provisions as to disqualification and removal as the Directors may think fit. Unless otherwise
specified in the terms of his appointment an Officer may be removed by resolution of the Directors or Members. An Officer may vacate his
office at any time if he gives notice in writing to the Company that he resigns his office.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">36</FONT></TD><TD STYLE="text-align: justify">No Minimum Shareholding</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company in general meeting may fix
a minimum shareholding required to be held by a Director, but unless and until such a shareholding qualification is fixed a Director is
not required to hold Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">37</FONT></TD><TD STYLE="text-align: justify">Remuneration of Directors</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">37.1</TD><TD STYLE="text-align: justify">The remuneration to be paid to the Directors, if any, shall be such remuneration as the Directors shall
determine. The Directors shall also be entitled to be paid all travelling, hotel and other expenses properly incurred by them in connection
with their attendance at meetings of Directors or committees of Directors, or general meetings of the Company, or separate meetings of
the holders of any class of Shares or debentures of the Company, or otherwise in connection with the business of the Company or the discharge
of their duties as a Director, or to receive a fixed allowance in respect thereof as may be determined by the Directors, or a combination
partly of one such method and partly the other.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">37.2</TD><TD STYLE="text-align: justify">The Directors may by resolution approve additional remuneration to any Director for any services which
in the opinion of the Directors go beyond his ordinary routine work as a Director. Any fees paid to a Director who is also counsel, attorney
or solicitor to the Company, or otherwise serves it in a professional capacity shall be in addition to his remuneration as a Director.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">38</FONT></TD><TD STYLE="text-align: justify">Seal</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">38.1</TD><TD STYLE="text-align: justify">The Company may, if the Directors so determine, have a Seal. The Seal shall only be used by the authority
of the Directors or of a committee of the Directors authorised by the Directors. Every instrument to which the Seal has been affixed shall
be signed by at least one person who shall be either a Director or some Officer or other person appointed by the Directors for the purpose.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">38.2</TD><TD STYLE="text-align: justify">The Company may have for use in any place or places outside the Cayman Islands a duplicate Seal or Seals
each of which shall be a facsimile of the common Seal of the Company and, if the Directors so determine, with the addition on its face
of the name of every place where it is to be used.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">38.3</TD><TD STYLE="text-align: justify">A Director or Officer, representative or attorney of the Company may without further authority of the
Directors affix the Seal over his signature alone to any document of the Company required to be authenticated by him under seal or to
be filed with the Registrar of Companies in the Cayman Islands or elsewhere wheresoever.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">39</FONT></TD><TD STYLE="text-align: justify">Dividends, Distributions and Reserve</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.1</TD><TD STYLE="text-align: justify">Subject to the Statute and this Article and except as otherwise provided by the rights attached to any
Shares, the Directors may resolve to pay Dividends and other distributions on Shares in issue and authorise payment of the Dividends or
other distributions out of the funds of the Company lawfully available therefor. A Dividend shall be deemed to be an interim Dividend
unless the terms of the resolution pursuant to which the Directors resolve to pay such Dividend specifically state that such Dividend
shall be a final Dividend. No Dividend or other distribution shall be paid except out of the realised or unrealised profits of the Company,
out of the share premium account or as otherwise permitted by law.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.2</TD><TD STYLE="text-align: justify">Except as otherwise provided by the rights attached to any Shares, all Dividends and other distributions
shall be paid according to the par value of the Shares that a Member holds. If any Share is issued on terms providing that it shall rank
for Dividend as from a particular date, that Share shall rank for Dividend accordingly.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.3</TD><TD STYLE="text-align: justify">The Directors may deduct from any Dividend or other distribution payable to any Member all sums of money
(if any) then payable by him to the Company on account of calls or otherwise.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.4</TD><TD STYLE="text-align: justify">The Directors may resolve that any Dividend or other distribution be paid wholly or partly by the distribution
of specific assets and in particular (but without limitation) by the distribution of shares, debentures, or securities of any other company
or in any one or more of such ways and where any difficulty arises in regard to such distribution, the Directors may settle the same as
they think expedient and in particular may issue fractional Shares and may fix the value for distribution of such specific assets or any
part thereof and may determine that cash payments shall be made to any Members upon the basis of the value so fixed in order to adjust
the rights of all Members and may vest any such specific assets in trustees in such manner as may seem expedient to the Directors.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.5</TD><TD STYLE="text-align: justify">Except as otherwise provided by the rights attached to any Shares, Dividends and other distributions may
be paid in any currency. The Directors may determine the basis of conversion for any currency conversions that may be required and how
any costs involved are to be met.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.6</TD><TD STYLE="text-align: justify">The Directors may, before resolving to pay any Dividend or other distribution, set aside such sums as
they think proper as a reserve or reserves which shall, at the discretion of the Directors, be applicable for any purpose of the Company
and pending such application may, at the discretion of the Directors, be employed in the business of the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.7</TD><TD STYLE="text-align: justify">Any Dividend, other distribution, interest or other monies payable in cash in respect of Shares may be
paid by wire transfer to the holder or by cheque or warrant sent through the post directed to the registered address of the holder or,
in the case of joint holders, to the registered address of the holder who is first named on the Register of Members or to such person
and to such address as such holder or joint holders may in writing direct. Every such cheque or warrant shall be made payable to the order
of the person to whom it is sent. Any one of two or more joint holders may give effectual receipts for any Dividends, other distributions,
bonuses, or other monies payable in respect of the Share held by them as joint holders.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.8</TD><TD STYLE="text-align: justify">No Dividend or other distribution shall bear interest against the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.9</TD><TD STYLE="text-align: justify">Any Dividend or other distribution which cannot be paid to a Member and/or which remains unclaimed after
six months from the date on which such Dividend or other distribution becomes payable may, in the discretion of the Directors, be paid
into a separate account in the Company's name, provided that the Company shall not be constituted as a trustee in respect of that account
and the Dividend or other distribution shall remain as a debt due to the Member. Any Dividend or other distribution which remains unclaimed
after a period of six years from the date on which such Dividend or other distribution becomes payable shall be forfeited and shall revert
to the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">40</FONT></TD><TD STYLE="text-align: justify">Capitalisation</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Directors may at any time capitalise
any sum standing to the credit of any of the Company's reserve accounts or funds (including the share premium account and capital redemption
reserve fund) or any sum standing to the credit of the profit and loss account or otherwise available for distribution; appropriate such
sum to Members in the proportions in which such sum would have been divisible amongst such Members had the same been a distribution of
profits by way of Dividend or other distribution; and apply such sum on their behalf in paying up in full unissued Shares for allotment
and distribution credited as fully paid-up to and amongst them in the proportion aforesaid. In such event the Directors shall do all acts
and things required to give effect to such capitalisation, with full power given to the Directors to make such provisions as they think
fit in the case of Shares becoming distributable in fractions (including provisions whereby the benefit of fractional entitlements accrue
to the Company rather than to the Members concerned). The Directors may authorise any person to enter on behalf of all of the Members
interested into an agreement with the Company providing for such capitalisation and matters incidental or relating thereto and any agreement
made under such authority shall be effective and binding on all such Members and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">41</FONT></TD><TD STYLE="text-align: justify">Books of Account</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">41.1</TD><TD STYLE="text-align: justify">The Directors shall cause proper books of account (including, where applicable, material&nbsp;underlying
documentation including contracts and invoices) to be kept with respect to all sums of money received and expended by the Company and
the matters in respect of which the receipt or expenditure takes place, all sales and purchases of goods by the Company and the assets
and liabilities of the Company. Such books
of account must be retained for a minimum period of five years from the date on which they are prepared. Proper books shall not be deemed
to be kept if there are not kept such books of account as are necessary to give a true and fair view of the state of the Company's affairs
and to explain its transactions.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">41.2</TD><TD STYLE="text-align: justify">The Directors shall determine whether and to what extent and at what times and places and under what conditions
or regulations the accounts and books of the Company or any of them shall be open to the inspection of Members not being Directors and
no Member (not being a Director) shall have any right of inspecting any account or book or document of the Company except as conferred
by Statute or authorised by the Directors or by the Company in general meeting.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">41.3</TD><TD STYLE="text-align: justify">The Directors may cause to be prepared and to be laid before the Company in general meeting profit and
loss accounts, balance sheets, group accounts (if any) and such other reports and accounts as may be required by law.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">42</FONT></TD><TD STYLE="text-align: justify">Audit</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.1</TD><TD STYLE="text-align: justify">The Directors may appoint an Auditor of the Company who shall hold office on such terms as the Directors
determine.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.2</TD><TD STYLE="text-align: justify">Without prejudice to the freedom of the Directors to establish any other committee, if the Shares (or
depositary receipts therefor) are listed or quoted on the Designated Stock Exchange, and if required by the rules and regulations of the
Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable
Law, the Directors shall establish and maintain an Audit Committee as a committee of the Directors and shall adopt a formal written Audit
Committee charter and review and assess the adequacy of the formal written charter on an annual basis. The composition and responsibilities
of the Audit Committee shall comply with the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission
and/or any other competent regulatory authority or otherwise under Applicable Law. The Audit Committee shall meet at least once every
financial quarter, or more frequently as circumstances dictate.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.3</TD><TD STYLE="text-align: justify">If the Shares (or depositary receipts therefor) are listed or quoted on the Designated Stock Exchange,
the Company shall conduct an appropriate review of all related party transactions on an ongoing basis and shall utilise the Audit Committee
for the review and approval of potential conflicts of interest.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.4</TD><TD STYLE="text-align: justify">The remuneration of the Auditor shall be fixed by the Audit Committee (if one exists).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.5</TD><TD STYLE="text-align: justify">If the office of Auditor becomes vacant by resignation or death of the Auditor, or by his becoming incapable
of acting by reason of illness or other disability at a time when his services are required, the Directors shall fill the vacancy and
determine the remuneration of such Auditor.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.6</TD><TD STYLE="text-align: justify">Every Auditor of the Company shall have a right of access at all times to the books and accounts and vouchers
of the Company and shall be entitled to require from the Directors and Officers such information and explanation as may be necessary for
the performance of the duties of the Auditor.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.7</TD><TD STYLE="text-align: justify">Auditors shall, if so required by the Directors, make a report on the accounts of the Company during their
tenure of office at the next annual general meeting following their appointment in the case of a company which is registered with the
Registrar of Companies as an ordinary company, and at the next extraordinary general meeting following their appointment in the case of
a company which is registered with the Registrar of Companies as an exempted company, and at any other time during their term of office,
upon request of the Directors or any general meeting of the Members.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.8</TD><TD STYLE="text-align: justify">Any payment made to members of the Audit Committee (if one exists) shall require the review and approval
of the Directors, with any Director interested in such payment abstaining from such review and approval.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.9</TD><TD STYLE="text-align: justify">At least one member of the Audit Committee shall be an &quot;audit committee financial expert&quot; as
determined by the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent
regulatory authority or otherwise under Applicable Law. The &quot;audit committee financial expert&quot; shall have such past employment
experience in finance or accounting, requisite professional certification in accounting, or any other comparable experience or background
which results in the individual&rsquo;s financial sophistication.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">43</FONT></TD><TD STYLE="text-align: justify">Notices</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">43.1</TD><TD STYLE="text-align: justify">Notices shall be in writing and may be given by the Company to any Member either personally or by sending
it by courier, post, cable, telex, fax or e-mail to him or to his address as shown in the Register of Members (or where the notice is
given by e-mail by sending it to the e-mail address provided by such Member). Notice may also be served by Electronic Communication in
accordance with the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent
regulatory authority or by placing it on the Company&rsquo;s Website.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">43.2</TD><TD STYLE="text-align: justify">Where a notice is sent by:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(a)</TD><TD STYLE="text-align: justify">courier; service of the notice shall be deemed to be effected by delivery of the notice to a courier company,
and shall be deemed to have been received on the third day (not including Saturdays or Sundays or public holidays) following the day on
which the notice was delivered to the courier;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(b)</TD><TD STYLE="text-align: justify">post; service of the notice shall be deemed to be effected by properly addressing, pre paying and posting
a letter containing the notice, and shall be deemed to have been received on the fifth day (not including Saturdays or Sundays or public
holidays in the Cayman Islands) following the day on which the notice was posted;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(c)</TD><TD STYLE="text-align: justify">cable, telex or fax; service of the notice shall be deemed to be effected by properly addressing and sending
such notice and shall be deemed to have been received on the same day that it was transmitted;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(d)</TD><TD STYLE="text-align: justify">e-mail or other Electronic Communication; service of the notice shall be deemed to be effected by transmitting
the e-mail to the e-mail address provided by the intended recipient and shall be deemed to have been received on the same day that it
was sent, and it shall not be necessary for the receipt of the e-mail to be acknowledged by the recipient; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(e)</TD><TD STYLE="text-align: justify">placing it on the Company&rsquo;s Website; service of the notice shall be deemed to have been effected
one hour after the notice or document was placed on the Company&rsquo;s Website.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">43.3</TD><TD STYLE="text-align: justify">A notice may be given by the Company to the person or persons which the Company has been advised are entitled
to a Share or Shares in consequence of the death or bankruptcy of a Member in the same manner as other notices which are required to be
given under the Articles and shall be addressed to them by name, or by the title of representatives of the deceased, or trustee of the
bankrupt, or by any like description at the address supplied for that purpose by the persons claiming to be so entitled, or at the option
of the Company by giving the notice in any manner in which the same might have been given if the death or bankruptcy had not occurred.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">43.4</TD><TD STYLE="text-align: justify">Notice of every general meeting shall be given in any manner authorised by the Articles to every holder
of Shares carrying an entitlement to receive such notice on the record date for such meeting except that in the case of joint holders
the notice shall be sufficient if given to the joint holder first named in the Register of Members and every person upon whom the ownership
of a Share devolves by reason of his being a legal personal representative or a trustee in bankruptcy of a Member where the Member but
for his death or bankruptcy would be entitled to receive notice of the meeting, and no other person shall be entitled to receive notices
of general meetings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">44</FONT></TD><TD STYLE="text-align: justify">Winding Up</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">44.1</TD><TD STYLE="text-align: justify">If the Company shall be wound up, the liquidator shall apply the assets of the Company in satisfaction
of creditors' claims in such manner and order as such liquidator thinks fit. Subject to the rights attaching to any Shares, in a winding
up:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(a)</TD><TD STYLE="text-align: justify">if the assets available for distribution amongst the Members shall be insufficient to repay the whole
of the Company's issued share capital, such assets shall be distributed so that, as nearly as may be, the losses shall be borne by the
Members in proportion to the par value of the Shares held by them; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.5pt"></TD><TD STYLE="width: 36pt">(b)</TD><TD STYLE="text-align: justify">if the assets available for distribution amongst the Members shall be more than sufficient to repay the
whole of the Company's issued share capital at the commencement of the winding up, the surplus shall be distributed amongst the Members
in proportion to the par value of the Shares held by them at the commencement of the winding up subject to a deduction from those Shares
in respect of which there are monies due, of all monies payable to the Company for unpaid calls or otherwise.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">44.2</TD><TD STYLE="text-align: justify">If the Company shall be wound up the liquidator may, subject to the rights attaching to any Shares and
with the approval of a Special Resolution of the Company and any other approval required by the Statute, divide amongst the Members in
kind the whole or any part of the assets of the Company (whether such assets shall consist of property of the same kind or not) and may
for that purpose value any assets and determine how the division shall be carried out as between the Members or different classes of Members.
The liquidator may, with the like approval, vest the whole or any part of such assets in trustees upon such trusts for the benefit of
the Members as the liquidator, with the like approval, shall think fit, but so that no Member shall be compelled to accept any asset upon
which there is a liability.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">45</FONT></TD><TD STYLE="text-align: justify">Indemnity and Insurance</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">45.1</TD><TD STYLE="text-align: justify">Every Director and Officer (which for the avoidance of doubt, shall not include auditors of the Company),
together with every former Director and former Officer (each an &quot;<B>Indemnified Person</B>&quot;) shall be indemnified out of the
assets of the Company against any liability, action, proceeding, claim, demand, costs, damages or expenses, including legal expenses,
whatsoever which they or any of them may incur as a result of any act or failure to act in carrying out their functions other than such
liability (if any) that they may incur by reason of their own actual fraud, wilful neglect or wilful default. No Indemnified Person shall
be liable to the Company for any loss or damage incurred by the Company as a result (whether direct or indirect) of the carrying out of
their functions unless that liability arises through the actual fraud, wilful neglect or wilful default of such Indemnified Person. No
person shall be found to have committed actual fraud, wilful neglect or wilful default under this Article unless or until a court of competent
jurisdiction shall have made a finding to that effect.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">45.2</TD><TD STYLE="text-align: justify">The Company shall advance to each Indemnified Person reasonable attorneys' fees and other costs and expenses
incurred in connection with the defence of any action, suit, proceeding or investigation involving such Indemnified Person for which indemnity
will or could be sought. In connection with any advance of any expenses hereunder, the Indemnified Person shall execute an undertaking
to repay the advanced amount to the Company if it shall be determined by final judgment or other final adjudication that such Indemnified
Person was not entitled to indemnification pursuant to this Article. If it shall be determined by a final judgment or other final adjudication
that such Indemnified Person was not entitled to indemnification with respect to such judgment, costs or expenses, then such party shall
not be indemnified with respect to such judgment, costs or expenses and any advancement shall be returned to the Company (without interest)
by the Indemnified Person.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">45.3</TD><TD STYLE="text-align: justify">The Directors, on behalf of the Company, may purchase and maintain insurance for the benefit of any Director
or Officer against any liability which, by virtue of any rule of law, would otherwise attach to such person in respect of any negligence,
default, breach of duty or breach of trust of which such person may be guilty in relation to the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">46</FONT></TD><TD STYLE="text-align: justify">Financial Year</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Unless the Directors otherwise prescribe,
the financial year of the Company shall end on 31st December in each year and, following the year of incorporation, shall begin on 1st
January in each year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">47</FONT></TD><TD STYLE="text-align: justify">Transfer by Way of Continuation</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If the Company is exempted as defined
in the Statute, it shall, subject to the provisions of the Statute and with the approval of a Special Resolution, have the power to register
by way of continuation as a body corporate under the laws of any jurisdiction outside the Cayman Islands and to be deregistered in the
Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">48</FONT></TD><TD STYLE="text-align: justify">Mergers and Consolidations</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">The Company shall
have the power to merge or consolidate with one or more other constituent companies (as defined in the Statute) upon such terms as the
Directors may determine and (to the extent required by the Statute) with the approval of a Special Resolution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">49</FONT></TD><TD STYLE="text-align: justify">Certain Tax Filings</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Each Tax Filing Authorised Person and
any such other person, acting alone, as any Director shall designate from time to time, are authorised to file tax forms SS-4, W-8 BEN,
W-8 IMY, W-9, 8832 and 2553 and such other similar tax forms as are customary to file with any US state or federal governmental authorities
or foreign governmental authorities in connection with the formation, activities and/or elections of the Company and such other tax forms
as may be approved from time to time by any Director or Officer. The Company further ratifies and approves any such filing made by any
Tax Filing Authorised Person or such other person prior to the date of the Articles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">50</FONT></TD><TD STYLE="text-align: justify">Business Opportunities</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">50.1</TD><TD STYLE="text-align: justify">To the fullest extent permitted by Applicable Law, no individual serving as a Director or an Officer (&quot;<B>Management</B>&quot;)
shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same
or similar business activities or lines of business as the Company. To the fullest extent permitted by Applicable Law, the Company renounces
any interest or expectancy of the Company in, or in being offered an opportunity to participate in, any potential transaction or matter
which may be a corporate opportunity for Management, on the one hand, and the Company, on the other. Except to the extent expressly assumed
by contract, to the fullest extent permitted by Applicable Law, Management shall have no duty to communicate or offer any such corporate
opportunity to the Company and shall not be liable to the Company or its Members for breach of any fiduciary duty as a Member, Director
and/or Officer solely by reason of the fact that such party pursues or acquires such corporate opportunity for itself, himself or herself,
directs such corporate opportunity to another person, or does not communicate information regarding such corporate opportunity to the
Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">50.2</TD><TD STYLE="text-align: justify">Except as provided elsewhere in this Article, the Company hereby renounces any interest or expectancy
of the Company in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a
corporate opportunity for both the Company and Management, about which a Director and/or Officer who is also a member of Management acquires
knowledge.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">50.3</TD><TD STYLE="text-align: justify">To the extent a court might hold that the conduct of any activity related to a corporate opportunity that
is renounced in this Article to be a breach of duty to the Company or its Members, the Company hereby waives, to the fullest extent permitted
by Applicable Law, any and all claims and causes of action that the Company may have for such activities. To the fullest extent permitted
by Applicable Law, the provisions of this Article apply equally to activities conducted in the future and that have been conducted in
the past.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">51</FONT></TD><TD STYLE="text-align: justify">Exclusive Jurisdiction and Forum</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">51.1</TD><TD STYLE="text-align: justify">Unless the Company consents in writing to the selection of an alternative forum, the courts of the Cayman
Islands shall have exclusive jurisdiction over any claim or dispute arising out of or in connection with the Memorandum, the Articles
or otherwise related in any way to each Member's shareholding in the Company, including but not limited to:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.9pt"></TD><TD STYLE="width: 36pt">(a)</TD><TD STYLE="text-align: justify">any derivative action or proceeding brought on behalf of the Company;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.9pt"></TD><TD STYLE="width: 36pt">(b)</TD><TD STYLE="text-align: justify">any action asserting a claim of breach of any fiduciary or other duty owed by any current or former Director,
Officer or other employee of the Company to the Company or the Members;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.9pt"></TD><TD STYLE="width: 36pt">(c)</TD><TD STYLE="text-align: justify">any action asserting a claim arising pursuant to any provision of the Statute, the Memorandum or the Articles;
or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.9pt"></TD><TD STYLE="width: 36pt">(d)</TD><TD STYLE="text-align: justify">any action asserting a claim against the Company governed by the &quot;Internal Affairs Doctrine&quot;
(as such concept is recognised under the laws of the United States of America).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">51.2</TD><TD STYLE="text-align: justify">Each Member irrevocably submits to the exclusive jurisdiction of the courts of the Cayman Islands over
all such claims or disputes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">51.3</TD><TD STYLE="text-align: justify">Without prejudice to any other rights or remedies that the Company may have, each Member acknowledges
that damages alone would not be an adequate remedy for any breach of the selection of the courts of the Cayman Islands as exclusive forum
and that accordingly the Company shall be entitled, without proof of special damages, to the remedies of injunction, specific performance
or other equitable relief for any threatened or actual breach of the selection of the courts of the Cayman Islands as exclusive forum.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">51.4</TD><TD STYLE="text-align: justify">This Article 51 shall not apply to any action or suits brought to enforce any liability or duty created
by the US Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, or any claim for which the federal district
courts of the United States of America are, as a matter of the laws of the United States, the sole and exclusive forum for determination
of such a claim.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 34; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>tm2310353d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">AMENDED AND RESTATED<BR>
 REGISTRATION
RIGHTS AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">THIS AMENDED AND RESTATED REGISTRATION
RIGHTS AGREEMENT (this &#8220;<B><I>Agreement</I></B>&#8221;), dated as of March 20, 2023, is made and entered into by and among:
(i) Zura Bio Limited (formerly known as JATT Acquisition Corp), a Cayman Islands exempted company (the
 &#8220;<B><I>Company</I></B>&#8221;); (ii) JATT Ventures, L.P., a Cayman Islands exempted limited partnership (the
 &#8220;<B><I>Sponsor</I></B>&#8221;); (iii) the persons or entities identified as &#8220;New Holders&#8221; on the signature pages
hereto (collectively, the &#8220;<B><I>New Holders</I></B>&#8221;); and (iv) the persons or entities identified as &#8220;Existing
Holders&#8221; on the signature pages hereto (the &#8220;<B><I>Existing Holders</I></B>,&#8221; and together with the Sponsor, the
New Holders and any person or entity who hereafter becomes a party to this Agreement pursuant to <U>Section 6.2</U> or <U>Section
6.11</U> of this Agreement, each a &#8220;<B><I>Holder</I></B>&#8221; and collectively the &#8220;<B><I>Holders</I></B>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">RECITALS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>,
the Company, the Sponsor and the Existing Holders are party to that certain Registration Rights Agreement, dated as of July 13, 2021 (the
 &#8220;<B><I>Original RRA</I></B>&#8221;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>,
pursuant to, and upon the terms and subject to the conditions set forth in, the Business Combination Agreement dated as of June 16, 2022
as the same may be amended, restated, amended and restated, supplemented or otherwise modified from time to time, the &#8220;<B><I>BCA</I></B>&#8221;),
among the Company, Zura Bio Limited, a limited company incorporated under the laws of England and Wales (&#8220;<B><I>Zurabio</I></B>&#8221;),
JATT Merger Sub, a Cayman Islands exempted company and wholly owned subsidiary of the Company (&#8220;<B><I>JATT Merger Sub</I></B>&#8221;),
JATT Merger Sub 2, a Cayman Islands exempted company and wholly owned subsidiary of the Company (&#8220;<B><I>JATT Merger Sub 2</I></B>&#8221;),
Zura Bio Holdings Ltd, a Cayman Islands exempted company (&#8220;<B><I>Holdco</I></B>&#8221;), the following transactions (collectively,
the &#8220;<B><I>Transaction</I></B>&#8221;) will occur on the Closing Date (as defined below): (i) JATT Merger Sub will merge with and
into Holdco, with Holdco continuing as the surviving company of the merger and a wholly owned subsidiary of the Company; and (ii) immediately
following the transaction described in (i), Holdco will merge with and into JATT Merger Sub 2, with JATT Merger Sub 2 continuing as the
surviving company of the merger;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>,
pursuant to the BCA, among other things, (i) the Zurabio shareholders exchanged all their Zurabio shares for shares in Holdco, such that
Holdco owned all of the outstanding shares of Zurabio, (ii) the Company issued 16,500,000 Class A ordinary shares to the Holdco shareholders
in exchange for all of the outstanding Holdco shares, and (iii) the issued and outstanding Class B ordinary shares, par value $0.0001
per share, of the Company, all of which were held by the Sponsor and the Existing Holders, automatically converted into 3,450,000 ordinary
shares on a one-for-one basis (such ordinary shares received upon the conversion, the &#8220;<B><I>Founder Shares</I></B>&#8221;) (together
with the other transactions contemplated by the BCA, the &#8220;<B><I>Business Combination</I></B>&#8221;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>,
pursuant to the second amended and restated memorandum and articles of the Company (such amended and restated memorandum and articles,
as the same may be amended, restated, amended and restated, supplemented or otherwise modified form time (the &#8220;<B><I>Company Charter</I></B>&#8221;)),
the Company is authorized to issue the following classes of stock: (i) shares, par value $0.0001 per share, of the Company (the &#8220;<B><I>ordinary
shares</I></B>&#8221; or the &#8220;<B><I>Ordinary Shares</I></B>&#8221;), and (ii) preference shares, par value $0.0001 per share of
the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>,
in connection with the Business Combination, the Company conducted a private placement of its ordinary shares (the &#8220;<B><I>PIPE Investment</I></B>&#8221;)
pursuant to the terms of (i) one or more Subscription Agreements and (ii) two Forward Purchase Agreements, and certain Holders purchased
additional ordinary shares pursuant thereto (collectively, the &#8220;<B><I>PIPE Shares</I></B>&#8221;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>,
Z33 Bio Inc., an affiliate of Zurabio, entered into a License Agreement (the &#8220;<B><I>Lilly License</I></B>&#8221;) with Eli Lilly
and Company (&#8220;<B><I>Lilly</I></B>&#8221;), pursuant to which Lilly agreed to license certain intellectual property rights to Z33
Bio Inc., and whereas, in connection with the Lilly License, the Company entered into a Grant Agreement with Lilly, pursuant to which
Lilly is entitled to receive 550,000 ordinary shares of the Company upon the closing of the Business Combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>,
pursuant to Section 6.8 of the Original RRA, the provisions, covenants and conditions set forth therein may be amended or modified upon
the written consent of the Company and the holders of a majority-in-interest of the &#8220;Registrable Securities&#8221; (as such term
is defined in the Original RRA) at the time in question; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>,
the Company and the Sponsor desire to amend and restate the Original RRA in its entirety as set forth herein and the Company and the Existing
Holders desire to enter into this Agreement, pursuant to which the Company shall grant the Holders certain registration rights with respect
to the Registrable Securities (as defined below) on the terms and conditions set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>NOW</B>,
<B>THEREFORE</B>, in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby
agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0.05pt"><FONT STYLE="color: #010000">ARTICLE
I </FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0.05pt">DEFINITIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><FONT STYLE="color: #010000">1.1 </FONT><U>Definitions</U>.
The terms defined in this <U>Article I</U> shall, for all purposes of this Agreement, have the respective meanings set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B><I>&#8220;Additional Holder&#8221;</I></B> has the meaning
given in <U>Section 6.11</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B><I>&#8220;Additional Holder Shares&#8221;</I></B> has the
meaning given in <U>Section 6.11</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Adverse
Disclosure</I></B>&#8221; shall mean any public disclosure of material non-public information, which disclosure, after consultation with
counsel to the Company, in the good faith judgment of the Chief Executive Officer or Chief Financial Officer of the Company or the Board,
(i) would be required to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus
not to contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein
(in the case of any prospectus and any preliminary prospectus, in the light of the circumstances under which they were made) not misleading,
(ii) would not be required to be made at such time if the Registration Statement were not being filed, declared effective or used, as
the case may be, and (iii) the Company has a <I>bona fide</I> business purpose for not making such information public.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Affiliate</I></B>&#8221;
means, with respect to any Person, any other Person who, directly or indirectly, controls, is controlled by, or is under direct or indirect
common control with, such Person, and, in the case of an individual, also includes any member of such individual&#8217;s Immediate Family;
provided that the Company and its subsidiaries will not be deemed to be Affiliates of any Holder of Registrable Securities. As used in
this definition, &#8220;control&#8221; (including, with its correlative meanings, &#8220;controlling&#8221;, &#8220;controlled by&#8221;
and &#8220;under common control&#8221;) shall mean possession, directly or indirectly, of power to direct or cause the direction of the
management and policies of a Person, directly or indirectly, whether through ownership of voting securities or partnership or other ownership
interests by contract or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Agreement</I></B>&#8221;
shall have the meaning given in the Preamble hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>BCA</I></B>&#8221; shall have the meaning given in the Recitals hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Block
Trade</I></B>&#8221; means an offering or sale of Registrable Securities by any Holder on a block trade or underwritten basis (whether
firm commitment or otherwise) effected pursuant to a Registration Statement without substantial marketing efforts prior to pricing, including,
without limitation, a same day trade, overnight trade or similar transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Board</I></B>&#8221; shall
mean the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Business Combination</I></B>&#8221; shall have
the meaning given in the Recitals hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Business Day</I></B>&#8221;
means any day other than a Saturday, Sunday or any other day on which commercial banks are required or authorized to close in the State
of New York or the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Closing</I></B>&#8221; shall have the meaning
given in the BCA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Closing Date</I></B>&#8221; shall have the meaning given in the BCA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Commission</I></B>&#8221; shall mean the U.S.
Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Company</I></B>&#8221; shall
have the meaning given in the Preamble hereto and includes the Company&#8217;s successors by recapitalization, merger, consolidation,
spin-off, reorganization or similar transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Company Charter</I></B>&#8221; shall
have the meaning given in the Recitals hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Demanding Holder</I></B>&#8221; shall have the meaning given in <U>Section
2.1.4</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Effectiveness Deadline</I></B>&#8221; shall have
the meaning given in <U>subsection 2.1.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Exchange Act</I></B>&#8221; shall mean the U.S.
Securities Exchange Act of 1934, as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Existing Holders</I></B>&#8221; shall have the meaning given
in the Recitals hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Filing Deadline</I></B>&#8221; shall have the
meaning given in <U>Section 2.1.1</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>FINRA</I></B>&#8221; shall mean the Financial
Industry Regulatory Authority, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Form S-1 Shelf</I></B>&#8221; shall have the meaning given in <U>Section 2.1.1</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Form S-3 Shelf</I></B>&#8221; shall have the
meaning given in <U>Section 2.1.1</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><I>&#8220;<B>Founder Shares</B>&#8221;</I> shall have
the meaning given in the Recitals hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Holdco</I></B>&#8221; shall have the meaning given in the Recitals hereto</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Holder Information</I></B>&#8221; shall have
the meaning given in <U>Section 4.1.2</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Holders</I></B>&#8221;
shall have the meaning given in the Preamble hereto, for so long as such person or entity holds any Registrable Securities, and includes
any transferee of the Registrable Securities (so long as they remain Registrable Securities) of a Holder permitted under this Agreement
and the Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 36.05pt">&#8220;<B><I>Immediate
Family</I></B>&#8221; shall mean any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law,
son-in-law, daughter-in-law, brother-in-law, sister-in-law and shall include adoptive relationships.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Insider
Letter</I></B>&#8221; means that certain letter agreement, dated as of July 13, 2021, by and among the Company, the Sponsor and certain
of the Company&#8217;s current and former officers and directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Joinder</I></B>&#8221; shall have the meaning
given in <U>Section 6.11</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Lock-up
Agreement</I></B>&#8221; means, as applicable: (i) that certain lock-up agreement, dated as of the date hereof, by and among the Company
and certain holders of securities of the Company, entered into in connection with the Business Combination, and (ii) the Lilly Lock-Up
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Lilly
Lock-Up Agreement</I></B>&#8221; shall mean that certain lock-up agreement dated as of March &nbsp;<U>&nbsp;&nbsp;&nbsp;</U>, 2023, between
the Company and Eli Lilly and Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Lock-up
Periods</I></B>&#8221; shall mean each of the periods beginning on the Closing Date and ending, (i) with respect to the New Holder&#8217;s
Shares, the Sponsor&#8217;s and the Existing Holders&#8217; Founder Shares, the period ending on the earlier of (x) 6 months after the
Closing Date with respect to one-third of the shares, and (b) 12 months after the Closing Date with respect to one-third of the shares,
and (c) 24 months after the Closing Date with respect to one-third of the shares; provided that such shares may be released prior to each
of the 6-month, 12-month and 24-month periods on the date on which the daily volume weighted average price (&#8220;<B><I>VWAP</I></B>&#8221;)
reported sale price of the ordinary shares equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any 20 trading days within any 30-trading day period, or (y) the earlier date on which the Company
completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Company&#8217;s
shareholders having the right to exchange their ordinary shares for cash, securities or other property (the &#8220;<B><I>Founder Shares
Lock-up Period</I></B>&#8221; and <B><I>New Holders Lock-up Period&#8221;</I></B> ); and (ii) with respect to the Sponsor&#8217;s (or
its transferees as permitted by the Lock-Up Agreement) Private Warrant Shares, 30 days from the Closing Date (the &#8220;<B><I>Private
Placement Lock-up Period</I></B>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Lock-up
Shares</I></B>&#8221; shall mean, (i) with respect to the Sponsor, the Existing Holders and any transferees as permitted by the Lock-Up
Agreement, the ordinary shares held by them immediately following the Closing (other than PIPE Shares subscribed in connection with the
PIPE Investment, if any) and any ordinary shares issued or issuable upon exercise of the Private Placement Warrants; and (ii) with respect
to the New Holders and their respective transferees as permitted by the applicable Lock-Up Agreement, the ordinary shares held by them
immediately following the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Maximum Number of Securities</I></B>&#8221;
shall have the meaning given in <U>Section 2.1.5</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Minimum Takedown
Threshold</I></B>&#8221; shall have the meaning given in <U>Section 2.1.4</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Misstatement</I></B>&#8221;
shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement
or Prospectus or necessary to make the statements in a Registration Statement or Prospectus (in the case of a Prospectus, in the light
of the circumstances under which they were made) not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>New Holders</I></B>&#8221; shall have
the meaning given in the Preamble hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Original RRA</I></B>&#8221; shall have the meaning given in the Recitals hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>ordinary shares</I></B>&#8221; shall have the meaning given in the Recitals hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Piggyback Registration</I></B>&#8221; shall
have the meaning given in <U>Section 2.2.1</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>PIPE Investment</I></B>&#8221; shall
have the meaning given in the Recitals hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>PIPE Shares</I></B>&#8221; shall have the meaning given in the Recitals hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 35.95pt">&#8220;<B><I>Private
Placement Warrants</I></B>&#8221; shall mean the 5,910,000 Private Placement Warrants issued by the Company that were privately purchased
simultaneously with the consummation of the Company&#8217;s initial public offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Private
Warrant Shares</I></B>&#8221; shall mean the ordinary shares issued or issuable upon exercise of the &#8220;Private Placement Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Prospectus</I></B>&#8221;
shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended
by any and all post-effective amendments and including all material incorporated by reference in such prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 35.95pt">&#8220;<B><I>Registrable
Security</I></B>&#8221; shall mean (a) the Founder Shares and the ordinary shares issued or issuable upon the conversion of any
Founder Shares, (b) the Private Placement Warrants and the ordinary shares issued or issuable upon the exercise of any Private
Placement Warrants, (c) any issued and outstanding ordinary shares or any other equity security (including the ordinary shares
issued or issuable upon the exercise of any other equity security) of the Company held by a Holder as of the date of this Agreement,
(d) any equity securities (including the ordinary shares issued or issuable upon the exercise of any such equity security) of the
Company issuable upon conversion of any Working Capital Warrants in an amount up to $1,500,000 made to the Company by a Holder, (e)
any PIPE Shares held by a Holder, (f) any other equity securities (including ordinary shares) of the Company held by a New Holder at
the Closing Date and (g) any other equity security of the Company or its subsidiaries issued or issuable with respect to any such
ordinary shares referenced in (a), (b), (c), (d), (e) or (f) above by way of a share capitalization or share split or in connection
with a combination of shares, recapitalization, merger, consolidation or reorganization; <U>provided</U>, <U>however</U>, that, as
to any particular Registrable Security, such securities shall cease to be Registrable Securities when: (i) a Registration Statement
with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been
sold, transferred, disposed of or exchanged in accordance with such Registration Statement by the applicable Holder; (ii) such
securities shall have been otherwise transferred, new certificates for such securities not bearing (or book entry positions not
subject to) a legend restricting further transfer shall have been delivered by the Company and subsequent public distribution of
such securities shall not require registration under the Securities Act; (iii) such securities shall have ceased to be outstanding;
(iv) following the third anniversary of the Agreement, such securities may be sold without registration pursuant to Rule 144 (but
without the requirement to comply with any limitations) and (v) such securities have been sold to, or through, a broker, dealer or
underwriter in a public distribution or other public securities transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Registration</I></B>&#8221;
shall mean a registration effected by preparing and filing a Registration Statement, Prospectus or similar document in compliance with
the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement
becoming effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Registration
Expenses</I></B>&#8221; shall mean the documented, out-of-pocket expenses of a Registration, including, without limitation, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(A)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;
</FONT>all registration and filing fees (including fees with respect to filings required to be made with FINRA) and any national securities
exchange on which the ordinary shares are then listed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(B)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;
</FONT>fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of outside counsel
for the Underwriters in connection with blue sky qualifications of Registrable Securities);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(C)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;
</FONT>fees and disbursements of underwriters customarily paid by issuers of securities in a secondary offering, but excluding underwriting
discounts and commissions and transfer taxes, if any, with respect to Registrable Securities sold by Holders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> (D)&nbsp;&nbsp; printing, messenger, telephone and delivery expenses;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> (E)&nbsp;&nbsp; reasonable fees and disbursements of counsel for the Company;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(F)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;
</FONT>reasonable fees and disbursements of all independent registered public accountants of the Company incurred specifically in connection
with such Registration; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(G)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>reasonable fees and expenses of one legal counsel selected by the majority-in-interest of the Demanding Holders in an Underwritten
Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Registration
Statement</I></B>&#8221; shall mean any registration statement filed by the Company with the Commission that covers the Registrable Securities
pursuant to the provisions of this Agreement, including the Prospectus included in such registration statement, amendments (including
post-effective amendments) and supplements to such registration statement, and all exhibits to and all material incorporated by reference
in such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Requesting Holders</I></B>&#8221; shall have
the meaning given in <U>Section 2.1.5</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Retained Company Shares</I></B>&#8221; shall
have the meaning given in the BCA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Rule 144</I></B>&#8221;
shall mean Rule 144 promulgated under the Securities Act, as amended from time to time, or any similar successor rule thereto that may
be promulgated by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Securities Act</I></B>&#8221; shall mean the
U.S. Securities Act of 1933, as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Shelf</I></B>&#8221;
shall mean the Form S-1 Shelf, the Form S-3 Shelf or any Subsequent Shelf Registration, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Shelf
Registration</I></B>&#8221; shall mean a registration of securities pursuant to a registration statement filed with the Commission in
accordance with and pursuant to Rule 415 promulgated under the Securities Act, as amended from time to time, or any similar successor
rule thereto that may be promulgated by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Shelf
Takedown</I></B>&#8221; shall mean an Underwritten Shelf Takedown or any proposed transfer or sale using a Registration Statement, including
a Piggyback Registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Sponsor</I></B>&#8221; shall have the meaning
given in the Preamble hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Subsequent Shelf Registration</I></B>&#8221;
shall have the meaning given in <U>Section 2.1.2</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Transfer</I></B>&#8221;
shall mean the (i) sale or assignment of, offer to sell, contract or agreement to sell, hypothecation, pledge, grant of any option to
purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent
position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Exchange Act
with respect to, any security, (ii) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the
economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash
or otherwise, or (iii) public announcement of any intention to effect any transaction specified in clause (i) or (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Underwriter</I></B>&#8221;
shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such
dealer&#8217;s market-making activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Underwritten Lock-up
Period</I></B>&#8221; shall have the meaning given in <U>Section 2.3</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Underwritten Offering</I></B>&#8221;
shall mean a Registration in which securities of the Company are sold to an Underwriter in a firm commitment underwriting for distribution
to the public, including a Block Trade.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Underwritten Shelf
Takedown</I></B>&#8221; shall have the meaning given in <U>Section 2.1.4</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Withdrawal Notice</I></B>&#8221; shall have the
meaning given in <U>Section 2.1.6</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Working Capital Warrants</I></B>&#8221;
shall mean any warrants issued in payment for working capital loans from the Sponsor to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Yearly Limit</I></B>&#8221; shall have the meaning
given in <U>Section 2.1.4</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Zurabio</I></B>&#8221; shall have the meaning
given in the Recitals hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="color: #010000">ARTICLE
II</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="color: #010000"></FONT>REGISTRATIONS AND OFFERINGS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="color: #010000">2.1&nbsp;</FONT> <U>Shelf Registration</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.1.1<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT></FONT><U>Filing</U>.
The Company shall, subject to <U>Section 3.4</U> hereof, submit or file within 30 days of the Closing Date (the &#8220;<B><I>Filing
Deadline</I></B>&#8221;), and use commercially reasonable efforts to cause to be declared effective as soon as practicable
thereafter, a Registration Statement for a Shelf Registration on Form S-1 (the &#8220;<B><I>Form S-1 Shelf</I></B>&#8221;), or, if
the Company is eligible to use a Registration Statement on Form S-3, a Shelf Registration on Form S-3 (the &#8220;<B><I>Form S-3
Shelf</I></B>&#8221;), in each case, covering the resale of all the Registrable Securities (determined as of two Business Days prior
to such submission or filing) on a delayed or continuous basis and shall use its commercially reasonable efforts to have the Shelf
declared effective after the filing thereof, but no later than the earlier of (i) the 60th calendar day (or 90th calendar day if the
Commission notifies the Company that it will &#8220;review&#8221; the Registration Statement) following the earlier of (A) the
filing of the Registration Statement and (B) the Filing Deadline, and (ii) the 10th Business Day after the date the Company is
notified (orally or in writing, whichever is earlier) by the Commission that the Registration Statement will not be
 &#8220;reviewed&#8221; or will not be subject to further review (such deadline the &#8220;<B><I>Effectiveness
Deadline</I></B>&#8221;), <I>provided,</I> that if the Filing Deadline or Effectiveness Deadline falls on Saturday, Sunday or other
day that the Commission is closed for business, the Filing Deadline or Effectiveness Deadline, as the case may be, shall be extended
to the next Business Day on which the Commission is open for business. Such Shelf shall provide for the resale of the Registrable
Securities included therein pursuant to any method or combination of methods legally available to, and requested by, any Holder
named therein. Subject to <U>Sections 2.1.2</U> and <U>3.4</U> hereof, the Company shall maintain a Shelf in accordance with the
terms hereof, and shall prepare and file with the Commission such amendments, including post-effective amendments, and supplements
as may be necessary to keep a Shelf continuously effective, available for use by the Holders named therein to sell their Registrable
Securities included therein, and in compliance with the provisions of the Securities Act until such time as there are no longer any
Registrable Securities. In the event the Company files a Form S-1 Shelf, the Company shall use its commercially reasonable efforts
to convert the Form S-1 Shelf (and any Subsequent Shelf Registration) to a Form S-3 Shelf as soon as reasonably practicable after
the Company is eligible to use Form S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.1.2<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT></FONT><U>Subsequent
Shelf Registration</U>. If any Shelf ceases to be effective under the Securities Act for any reason at any time while Registrable
Securities are still outstanding, the Company shall, subject to <U>Section 3.4</U> hereof, use its commercially reasonable efforts
to, as promptly as is reasonably practicable, cause such Shelf to again become effective under the Securities Act (including using
its commercially reasonable efforts to obtain the prompt withdrawal of any order suspending the effectiveness of such Shelf), and
shall use its commercially reasonable efforts to, as promptly as is reasonably practicable, amend such Shelf in a manner reasonably
expected to result in the withdrawal of any order suspending the effectiveness of such Shelf or file an additional registration
statement as a Shelf Registration (a &#8220;<B><I>Subsequent Shelf Registration</I></B>&#8221;) registering the resale of all
Registrable Securities under such Shelf (determined as of two Business Days prior to such filing), and pursuant to any method or
combination of methods legally available to, and requested by, any Holder named therein. If a Subsequent Shelf Registration is
filed, the Company shall use its commercially reasonable efforts to (i) cause such Subsequent Shelf Registration to become effective
under the Securities Act as promptly as is reasonably practicable after the filing thereof (it being agreed that the Subsequent
Shelf Registration shall be an automatic shelf registration statement (as defined in Rule 405 promulgated under the Securities Act)
if the Company is a well-known seasoned issuer (as defined in Rule 405 promulgated under the Securities Act) at the most recent
applicable eligibility determination date) and (ii) keep such Subsequent Shelf Registration continuously effective, available for
use by the Holders named therein to sell their Registrable Securities included therein, and in compliance with the provisions of the
Securities Act until such time as there are no longer any Registrable Securities. Any such Subsequent Shelf Registration shall be on
Form S-3, to the extent that the Company is eligible to use such form. Otherwise, such Subsequent Shelf Registration shall be on
another appropriate form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.1.3<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>Additional Registrable Securities</U>. Subject to <U>Section 3.4</U> hereof, in the event that any Holder or Holders,
collectively, hold Registrable Securities that are not registered for resale on a delayed or continuous basis, the Company, upon request
of any such Holder or Holders, shall promptly use its commercially reasonable efforts to cause the resale of such Registrable Securities
to be covered by either, at the Company&#8217;s option, any then-available Shelf (including by means of a post-effective amendment) or
a Subsequent Shelf Registration and cause the same to become effective as soon as practicable after such filing and such Shelf or Subsequent
Shelf Registration shall be subject to the terms hereof; <I>provided, however</I>, that (i) the Company shall only be required to cause
such Registrable Securities to be covered if the total offering price thereof is reasonably expected to exceed, in the aggregate, $10
million and (ii) the Company shall only be required to register Registrable Securities pursuant to this <U>Section 2.1.3</U> twice per
calendar year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.1.4<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT></FONT><U>Requests
for Underwritten Shelf Takedowns</U>. Following the expiration of the Founder Shares Lock-up Period, the New Holders Lock-up Period
or the Private Placement Lock-up Period, as applicable, at any time and from time to time when an effective Shelf is on file with
the Commission, any New Holder, Existing Holder, or the Sponsor, or any combination thereof (any of the New Holders, Existing
Holders, or the Sponsor making such demand, a &#8220;<B><I>Demanding Holder</I></B>&#8221;) may request to sell all or any portion
of its Registrable Securities in an Underwritten Offering or other coordinated offering that is registered pursuant to a Shelf
(each, an &#8220;<B><I>Underwritten Shelf Takedown</I></B>&#8221;); <I>provided</I> that the Company shall only be obligated to
effect an Underwritten Shelf Takedown if such offering shall include (a) Registrable Securities proposed to be sold by the Demanding
Holder, either individually or together with other Demanding Holders, with a total offering price reasonably expected to exceed, in
the aggregate, $10million (the &#8220;<B><I>Minimum Takedown Threshold</I></B>&#8221;) or (b) if the Demanding Holders hold
Registrable Securities with a total offering price reasonably expected to be less than the Minimum Takedown Threshold, all of the
Registrable Securities held by a Demanding Holder. All requests for Underwritten Shelf Takedowns shall be made by giving written
notice to the Company, which shall specify the approximate number of Registrable Securities proposed to be sold in the Underwritten
Shelf Takedown. The Company shall have the right to select the Underwriters for such offering (which shall consist of one or more
reputable nationally recognized investment banks), subject to the prior approval by the Demanding Holder(s) (which shall not be
unreasonably withheld, conditioned or delayed). The New Holders, on the one hand, and the Existing Holders and the Sponsor,
collectively, on the other hand, may each demand Underwritten Shelf Takedowns pursuant to this <U>Section 2.1.4</U> not more than
two times in any twelve (12) month period (the &#8220;<B><I>Yearly Limit</I></B>&#8221;). Notwithstanding anything to the contrary
in this Agreement, the Company may effect any Underwritten Offering pursuant to any then-effective Registration Statement, including
a Form S-3, which is then available for such offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.1.5<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>Reduction of Underwritten Offering</U>. If the managing Underwriter or Underwriters in an Underwritten Shelf Takedown,
in good faith, advise(s) the Company, the Demanding Holder(s) and the Holders requesting piggy back rights pursuant to this Agreement
with respect to such Underwritten Shelf Takedown (the &#8220;<B><I>Requesting Holders</I></B>&#8221;) (if any) in writing that the dollar
amount or number of Registrable Securities that the Demanding Holder(s) and the Requesting Holders (if any) desire to sell, taken together
with all other ordinary shares or other equity securities that the Company desires to sell and all other ordinary shares or other equity
securities, if any, that have been requested to be sold in such Underwritten Offering pursuant to separate written contractual piggy-
back registration rights held by any other shareholders who desire to sell, exceeds the maximum dollar amount or maximum number of equity
securities that can be sold in the Underwritten Offering without adversely affecting the proposed offering price, the timing, the distribution
method or the probability of success of such offering (such maximum dollar amount or maximum number of such securities, as applicable,
the &#8220;<B><I>Maximum Number of Securities</I></B>&#8221;), then the Company shall include in such Underwritten Offering, before including
any ordinary shares or other equity securities proposed to be sold by the Company or by other holders of ordinary shares or other equity
securities, the Registrable Securities of the Demanding Holders and the Requesting Holders (if any) (pro rata based on the respective
number of Registrable Securities that each Demanding Holder and Requesting Holder (if any) has requested be included in such Underwritten
Shelf Takedown without exceeding the Maximum number of Securities).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.1.6<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT></FONT><U>Underwritten
Shelf Takedown Withdrawal</U>. Prior to the filing of the applicable &#8220;red herring&#8221; prospectus or prospectus supplement
used for marketing such Underwritten Shelf Takedown, a majority-in-interest of the Demanding Holders initiating an Underwritten
Shelf Takedown shall have the right to withdraw from such Underwritten Shelf Takedown for any or no reason whatsoever upon written
notification (a &#8220;<B><I>Withdrawal Notice</I></B>&#8221;) to the Company and the Underwriter or Underwriters (if any) of their
intention to withdraw from such Underwritten Shelf Takedown; <I>provided</I> that any other Demanding Holder(s) may elect to have
the Company continue an Underwritten Shelf Takedown if the Minimum Takedown Threshold would still be satisfied by the Registrable
Securities proposed to be sold in the Underwritten Shelf Takedown by the Demanding Holder(s). If withdrawn, a demand for an
Underwritten Shelf Takedown shall constitute a demand for an Underwritten Shelf Takedown by the withdrawing Demanding Holder for
purposes of <U>Section 2.1.4</U> hereof and shall count toward the Yearly Limit, unless either (i) the Demanding Holder(s) making
the withdrawal has not previously withdrawn any Underwritten Shelf Takedown or (ii) the Demanding Holder(s) making the withdrawal
reimburses the Company for all Registration Expenses with respect to such Underwritten Shelf Takedown (or, if there is more than one
Demanding Holder, a <I>pro rata</I> portion of such Registration Expenses based on the respective number of Registrable Securities
that each Demanding Holder has requested be included in such Underwritten Shelf Takedown); <U>provided</U> that, if any other
Demanding Holder(s) elects to continue an Underwritten Shelf Takedown pursuant to the proviso in the immediately preceding sentence,
such Underwritten Shelf Takedown shall instead count as an Underwritten Shelf Takedown demanded by the Demanding Holders for
purposes of <U>Section 2.1.4</U> hereof and shall count toward the Yearly Limit. Following the receipt of any Withdrawal Notice, the
Company shall promptly forward such Withdrawal Notice to any other Demanding Holders and Requesting Holders. Notwithstanding
anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection
with a Shelf Takedown prior to its withdrawal under this <U>Section 2.1.6</U>, other than if a Demanding Holder elects to pay such
Registration Expenses pursuant to clause (ii) of the second sentence of this <U>Section 2.1.6</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="color: #010000">2.2&nbsp;</FONT> <U>Piggyback Registration</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.2.1<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT></FONT><U>Piggyback
Rights</U>. If the Company or any Holder proposes to conduct a registered offering of, or if the Company proposes to file a
Registration Statement under the Securities Act with respect to the Registration of, equity securities, or securities or other
obligations exercisable or exchangeable for, or convertible into equity securities, for its own account or for the account of
shareholders of the Company (or by the Company and by the shareholders of the Company including, without limitation, an Underwritten
Shelf Takedown pursuant to <U>Section 2.1</U> hereof), other than a Registration Statement (or any registered offering with respect
thereto) (i) filed in connection with any employee stock option or other benefit plan, (ii) for an exchange offer or offering of
securities solely to the Company&#8217;s existing shareholders, (iii) pursuant to a Registration Statement on Form S-4 (or similar
form that relates to a transaction subject to Rule 145 under the Securities Act or any successor rule thereto), (iv) for an offering
of debt that is convertible into equity securities of the Company or (v) for a dividend reinvestment plan, then the Company shall
give written notice of such proposed offering to all of the Holders of Registrable Securities as soon as practicable but not less
than ten days before the anticipated filing date of such Registration Statement or, in the case of an Underwritten Offering pursuant
to a Shelf Registration, the applicable &#8220;red herring&#8221; prospectus or prospectus supplement used for marketing such
offering, which notice shall (A) describe the amount and type of securities to be included in such offering, the intended method(s)
of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, in such offering, and (B) offer to all
of the Holders of Registrable Securities the opportunity to include in such registered offering such number of Registrable
Securities as such Holders may request in writing within five days after receipt of such written notice (such Registration, a
 &#8220;<B><I>Piggyback Registration</I></B>&#8221;). Subject to <U>Section 2.2.2</U> hereof, the Company shall, in good faith, cause
such Registrable Securities to be included in such Piggyback Registration and, if applicable, shall use its commercially reasonable
efforts to cause the managing Underwriter or Underwriters of such Piggyback Registration to permit the Registrable Securities
requested by the Holders pursuant to this <U>Section 2.2.1</U> to be included therein on the same terms and conditions as any
similar securities of the Company included in such registered offering and to permit the sale or other disposition of such
Registrable Securities in accordance with the intended method(s) of distribution thereof. The inclusion of any Holder&#8217;s
Registrable Securities in a Piggyback Registration shall be subject to such Holder&#8217;s agreement to enter into an underwriting
agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by the Company. For the avoidance of
doubt, the notice periods set forth in this <U>Section 2.2.1</U> shall not apply to an Underwritten Shelf Takedown conducted in
accordance with <U>Section 2.1.4</U> or Block Trades conducted in accordance with <U>Section 2.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.2.2<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>Reduction of Piggyback Registration</U>. If the managing Underwriter or Underwriters in an Underwritten Offering that
is to be a Piggyback Registration, in good faith, advise(s) the Company and the Holders of Registrable Securities participating in the
Piggyback Registration in writing that the dollar amount or number of ordinary shares or other equity securities that the Company or the
Demanding Holders desire to sell, taken together with (i) the number of ordinary shares or other equity securities, if any, as to which
Registration or a registered offering has been demanded pursuant to separate written contractual arrangements with persons or entities
other than the Holders of Registrable Securities hereunder, (ii) the Registrable Securities as to which Registration has been requested
pursuant to <U>Section 2.2.1</U> and (iii) the number of ordinary shares or other equity securities, if any, as to which Registration
or a registered offering has been requested pursuant to separate written contractual piggy-back registration rights of persons or entities
other than the Holders of Registrable Securities hereunder, exceeds the Maximum Number of Securities, then:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT>if
the Registration or registered offering is undertaken for the Company&#8217;s account, the Company shall include in any such
Registration or registered offering (A) first, the number of ordinary shares or other equity securities that the Company desires to
sell, which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of
Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to
register their Registrable Securities pursuant to <U>Section 2.2.1</U> hereof, <I>pro rata</I>, based on the respective number of
Registrable Securities that each Holder has requested be included in such Underwritten Offering and the aggregate number of
Registrable Securities that the Holders have requested to be included in such Underwritten Offering, which can be sold without
exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum Number of Securities has not been reached
under the foregoing clauses (A) and (B), the number of ordinary shares or other equity securities, if any, as to which Registration
or a registered offering has been requested pursuant to separate written contractual piggy-back registration rights of persons or
entities other than the Holders of Registrable Securities hereunder, which can be sold without exceeding the Maximum Number of
Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 107.95pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>if the Registration or registered offering is pursuant to a request by persons or entities other than the Holders of Registrable
Securities, then the Company shall include in any such Registration or registered offering (A) first, the number of ordinary shares or
other equity securities, if any, of such requesting persons or entities, other than the Holders of Registrable Securities, which can be
sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been
reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities
pursuant to <U>Section 2.2.1</U> hereof, <I>pro rata</I>, based on the respective number of Registrable Securities that each Holder has
requested be included in such Underwritten Offering and the aggregate number of Registrable Securities that the Holders have requested
to be included in such Underwritten Offering, which can be sold without exceeding the Maximum Number of Securities; (C) third, to the
extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), the number of ordinary shares
or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and
(D) fourth, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A), (B) and (C), the
number of ordinary shares or other equity securities, if any, as to which Registration or a registered offering has been requested pursuant
to separate written contractual piggy-back registration rights of such persons or entities other than the Holders of Registrable Securities
hereunder, which can be sold without exceeding the Maximum Number of Securities; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 107.95pt">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;
</FONT>if the Registration or registered offering is pursuant to a request by Holder(s) of Registrable Securities pursuant to <U>Section
2.1</U> hereof, then the Company shall include in any such Registration or registered offering securities in the priority set forth in
<U>Section 2.1.5</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">2.2.3<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>Piggyback Registration Withdrawal</U>. Any Holder of Registrable Securities (other than a Demanding Holder, whose right
to withdraw from an Underwritten Shelf Takedown, and related obligations, shall be governed by <U>Section 2.1.6</U> hereof) shall have
the right to withdraw from a Piggyback Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter
or Underwriters (if any) of his, her or its intention to withdraw from such Piggyback Registration prior to the effectiveness of the Registration
Statement filed with the Commission with respect to such Piggyback Registration or, in the case of a Piggyback Registration pursuant to
a Shelf Registration, the filing of the applicable &#8220;red herring&#8221; prospectus or prospectus supplement with respect to such
Piggyback Registration used for marketing such transaction without any liability to the applicable Holder. The Company (whether on its
own good faith determination or as the result of a request for withdrawal by persons or entities pursuant to separate written contractual
obligations) may withdraw a Registration Statement filed with the Commission in connection with a Piggyback Registration at any time prior
to the effectiveness of such Registration Statement. Notwithstanding anything to the contrary in this Agreement (other than <U>Section
2.1.6</U> hereof), the Company shall be responsible for the Registration Expenses incurred in connection with the Piggyback Registration
prior to its withdrawal under this <U>Section 2.2.3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">2.2.4</FONT> <U>&nbsp;Unlimited
Piggyback Registration Rights</U>. For purposes of clarity, subject to <U>Section</U> <U>2.1.6</U> hereof, any Piggyback Registration
effected pursuant to <U>Section 2.2</U> hereof shall not be counted as a demand for an Underwritten Shelf Takedown under <U>Section 2.1.4
</U>hereof and shall not count toward the Yearly Limit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">2.3<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT></FONT><U>Market
Stand-off</U>. In connection with any Underwritten Offering of equity securities of the Company (other than a Block Trade) or any
Company-initiated Registration for the account of the Company (subject to the Company&#8217;s compliance with <U>Section 2.2</U>
hereof), each Holder that is an executive officer, director or Holder in excess of 5% of the then-outstanding ordinary shares
(calculated, in the case of each New Holder, as if all of its Class B ordinary shares and Retained Company Shares are exchanged for
ordinary shares) agrees that it shall not Transfer any ordinary shares or other equity securities of the Company (other than those
included in such offering pursuant to this Agreement), without the prior written consent of the Company, during the 90-day period
(or such shorter time agreed to by the managing Underwriters) beginning on the date of pricing of such offering (the
 &#8220;<B><I>Underwritten Lock-up Period</I></B>&#8221;), except as expressly permitted by such lock-up agreement or in the event
the Underwriters managing the offering otherwise consent in writing. Each Holder in excess of 5% of the then-outstanding ordinary
shares agrees to execute a customary lock-up agreement in favor of the Underwriters to such effect (in each case on substantially
the same terms and conditions as the Company&#8217;s directors and executive officers or the other shareholders of the Company). The
Company will not be obligated to undertake an Underwritten Shelf Takedown during any Underwritten Lock-up Period binding on the
Holders, nor will the Company be obligated to include in any Piggyback Registration any Registrable Securities that are then subject
to a &#8220;lock-up&#8221; agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="color: #010000">2.4&nbsp;</FONT> <U>Block Trades</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.4.1<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>Notwithstanding any other provisions of this Agreement, but subject to <U>Section 3.4</U>, if a Demanding Holder desires
to effect a Block Trade, with a total offering price reasonably expected to exceed, in the aggregate, either (x) the Minimum Takedown
Threshold or (y) all remaining Registrable Securities held by such Demanding Holder, then notwithstanding the time periods provided for
in <U>Section 2.2.1</U>, such Demanding Holder only needs to notify the Company of the Block Trade at least three (3) business days prior
to the day such offering is to commence and the Company shall as promptly as is reasonably practicable, use its commercially reasonable
efforts to facilitate such Block Trade; <U>provided</U> that the Demanding Holder wishing to engage in the Block Trade shall use its commercially
reasonable efforts to work with the Company and any Underwriters or placement agents or sales agents prior to making such request in order
to facilitate preparation of the registration statement, prospectus and other offering documentation related to such Block Trade.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.4.2<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>Prior to the filing of the applicable &#8220;red herring&#8221; prospectus or prospectus supplement used in connection with
a Block Trade, the Demanding Holder that initiated such Block Trade shall have the right to submit a Withdrawal Notice to the Company
and the Underwriter or Underwriters or placement agents or sales agents (if any) of their intention to withdraw from such Block Trade.
Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in
connection with a Block Trade prior to its withdrawal under this <U>Section 2.4.2</U> in the first instance of any such withdrawal; provided,
that the Holder shall be responsible for the Registration Expenses incurred in connection with a Block Trade prior to any subsequent withdrawal
under this <U>Section 2.4.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.4.3<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>Notwithstanding anything to the contrary in this Agreement, <U>Section 2.2</U> hereof shall not apply to a Block Trade initiated
by a Demanding Holder pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.4.4<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>The Demanding Holder wishing to engage in a Block Trade shall have the right to select the Underwriters, placement agents
or sales agents (if any) for such Block Trade (which shall consist of one or more reputable nationally recognized investment banks), <I>provided</I>,
that such selection shall be subject to the consent of the Company, which consent shall not be unreasonably withheld, conditioned or delayed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">2.4.5<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT></FONT>A
Holder in the aggregate may demand no more than two Block Trades pursuant to this <U>Section 2.4</U> in any 12-month period. For the
avoidance of doubt, any Block Trade effected pursuant to this <U>Section 2.4</U> shall not be counted as a demand for an
Underwritten Shelf Takedown pursuant to <U>Section 2.1.4</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">2.5<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>Restrictions on Registration Rights</U>. If (A) during the period starting with the date sixty (60) days prior to the
Company&#8217;s good faith estimate of the date of the filing of, and ending on a date one hundred and twenty (120) days after the effective
date of, a Company initiated Registration and provided that the Company has delivered written notice to the Holders prior to receipt of
a request for an Underwritten Shelf Takedown pursuant to <U>Section 2.1.4</U> hereof and it continues to actively employ, in good faith,
all reasonable best efforts to cause the applicable Registration Statement to become effective; (B) the Holders have requested an Underwritten
Registration and the Company and the Holders are unable to obtain the commitment of underwriters to firmly underwrite the offer; or (C)
in the good faith judgment of the Board such Underwritten Offering would be seriously detrimental to the Company and the Board concludes
as a result that it is essential to defer the undertaking of such Underwritten Offering at such time, then in each case, as applicable,
the Company shall furnish to such Holders a certificate signed by the Chairman of the Board stating the applicable reason(s) set forth
in Clauses (A) through (C) above underlying the Company&#8217;s decision to defer the undertaking of such Underwritten Offering. In such
event, the Company shall have the right to defer such offering for a period of not more than sixty (60) days; <U>provided</U>, <U>however</U>,
that the Company shall not defer its obligations in this manner more than once in any twelve (12) month period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="color: #010000">ARTICLE
III</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="color: #010000"></FONT>COMPANY PROCEDURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">3.1<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT> <U>General Procedures</U>. In connection with any Shelf and/or Shelf Takedown, the Company shall use its commercially reasonable
efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the intended plan of distribution
thereof, and pursuant thereto the Company shall, as expeditiously as possible:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.1.1<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>prepare and file with the Commission, as soon as reasonably practicable, a Registration Statement with respect to such Registrable
Securities and use its commercially reasonable efforts to cause such Registration Statement to become effective and remain effective until
all Registrable Securities have ceased to be Registrable Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">3.1.2<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such
supplements to the Prospectus, as may be reasonably requested by any Holder that holds at least 5% percent of the Registrable Securities
registered on such Registration Statement or any Underwriter of Registrable Securities or as may be required by the rules, regulations
or instructions applicable to the registration form used by the Company or by the Securities Act or rules and regulations thereunder to
keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance
with the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.1.3<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>prior to filing a Registration Statement or Prospectus, or any amendment or supplement thereto, furnish without charge to
the Underwriters, if any, and the Holders of Registrable Securities included in such Registration, and such Holders&#8217; legal counsel,
copies of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case
including all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement
(including each preliminary Prospectus) and such other documents as the Underwriters and the Holders of Registrable Securities included
in such Registration or the legal counsel for any such Holders may request in order to facilitate the disposition of the Registrable Securities
owned by such Holders; <U>provided</U> that the Company will not have any obligation to provide any document pursuant to this <U>Section
3.1.3</U> that is available on the Commission&#8217;s EDGAR system;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.1.4<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>prior to any public offering of Registrable Securities, use its commercially reasonable efforts to (i) register or qualify
the Registrable Securities covered by the Registration Statement under such securities or &#8220;blue sky&#8221; laws of such jurisdictions
in the United States as the Holders of Registrable Securities included in such Registration Statement (in light of their intended plan
of distribution) may request (or provide evidence satisfactory to such Holders that the Registrable Securities are exempt from such registration
or qualification) and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be
registered with or approved by such other governmental authorities or securities exchanges, including the New York Stock Exchange, as
may be necessary by virtue of the business and operations of the Company and do any and all other acts and things that may be necessary
or advisable to enable the Holders of Registrable Securities included in such Registration Statement to consummate the disposition of
such Registrable Securities in such jurisdictions; <I>provided, however</I>, that the Company shall not be required to qualify generally
to do business in any jurisdiction where it would not otherwise be required to qualify or take any action to which it would be subject
to general service of process or taxation in any such jurisdiction where it is not then otherwise so subject;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.1.5<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>cause all such Registrable Securities to be listed on each national securities exchange or automated quotation system on
which similar securities issued by the Company are then listed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.1.6<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>provide a transfer agent and registrar for all such Registrable Securities no later than the effective date of such Registration
Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.1.7<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of
the issuance of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening
of any proceeding for such purpose, and promptly use its commercially reasonable efforts to prevent the issuance of any stop order or
to obtain its withdrawal if such stop order should be issued;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.1.8<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT></FONT>at
least three days (or in the case of a Block Trade, at least one day) prior to the filing of any Registration Statement or Prospectus
or any amendment or supplement to such Registration Statement or Prospectus (or such shorter period of time as may be necessary in
order to comply with the Securities Act, the Exchange Act and the rules and regulations promulgated under the Securities Act or
Exchange Act, as applicable), furnish a copy thereof to each seller of such Registrable Securities or its counsel; <U>provided</U>
that the Company will not have any obligation to provide any document pursuant to this <U>Section 3.1.8</U> that is available on the
Commission&#8217;s EDGAR system;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.1.9<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under
the Securities Act, of the happening of any event as a result of which the Prospectus included in such Registration Statement, as then
in effect, includes a Misstatement, and then to correct such Misstatement as set forth in <U>Section 3.4</U> hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.1.10<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>in the event of an Underwritten Offering, a Block Trade or other coordinated offering that is registered pursuant to a Registration
Statement, permit a representative of the Holders (such representative to be selected by a majority-in-interest of the participating Holders),
the Underwriters or other financial institutions facilitating such Underwritten Offering, Block Trade or other coordinated offering that
is registered pursuant to a Registration Statement, if any, and any attorney or accountant retained by such Holders or Underwriter to
participate, at each such person&#8217;s own expense (except as otherwise provided in this Agreement), in the preparation of the Registration
Statement, and cause the Company&#8217;s officers, directors and employees to supply all information reasonably requested by any such
representative, Underwriter, attorney or accountant in connection with the Registration; <I>provided, however</I>, that such representatives
or Underwriters enter into a confidentiality agreement, in form and substance reasonably satisfactory to the Company, prior to the release
or disclosure of any such information;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.1.11<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>obtain a &#8220;cold comfort&#8221; letter from the Company&#8217;s independent registered public accountants in the event
of an Underwritten Offering, a Block Trade or other coordinated offering that is registered pursuant to a Registration Statement, in customary
form and covering such matters of the type customarily covered by &#8220;cold comfort&#8221; letters as the managing Underwriter or other
similar type of sales agent, placement agent or Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest
of the participating Holders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.1.12<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>in the event of an Underwritten Offering, a Block Trade or other coordinated offering that is registered pursuant to a Registration
Statement, on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion and negative
assurance letter, dated such date, of counsel representing the Company for the purposes of such Registration, addressed to the placement
agent or sales agent, if any, and the Underwriters, if any, covering such legal matters with respect to the Registration in respect of
which such opinion is being given as the placement agent, sales agent, or Underwriter may reasonably request and as are customarily included
in such opinions and negative assurance letters;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.1.13<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>in the event of any Underwritten Offering, Block Trade or other coordinated offering that is registered pursuant to a Registration
Statement, enter into and perform its obligations under an underwriting agreement, sales agreement or placement agreement, in usual and
customary form, with the managing Underwriter, sales agent or placement agent of such offering;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.1.14<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of
at least 12 months beginning with the first day of the Company&#8217;s first full calendar quarter after the effective date of the Registration
Statement which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule thereto);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.1.15<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>with respect to an Underwritten Offering pursuant to <U>Section 2.1.4</U> hereof, use its commercially reasonable efforts
to make available senior executives of the Company to participate in customary &#8220;road show&#8221; presentations that may be reasonably
requested by the Underwriter in such Underwritten Offering; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.1.16<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the
Holders participating in such Registration, in connection with such Registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Notwithstanding the foregoing, the
Company shall not be required to provide any documents or information to an Underwriter or other sales agent or placement agent if such
Underwriter or other sales agent or placement agent has not then been named with respect to the applicable Underwritten Offering or other
coordinated offering that is registered pursuant to a Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">3.2<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT> <U>Registration Expenses</U>. Except as set forth in <U>Section 2.1.6</U>, the Registration Expenses of all Registrations
shall be borne by the Company. It is acknowledged by the Holders that the Holders shall bear all incremental selling expenses relating
to the sale of Registrable Securities, such as Underwriters&#8217; or agents&#8217; commissions and discounts, brokerage fees, Underwriter
marketing costs and, other than as set forth in the definition of &#8220;Registration Expenses,&#8221; all reasonable fees and expenses
of any legal counsel representing the Holders, in each case pro rata based on the number of Registrable Securities that such Holders have
sold in such Registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">3.3<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT></FONT><U>Requirements
for Participation in Underwritten Offerings</U>. Notwithstanding anything in this Agreement to the contrary, if any Holder does not
timely provide the Company with its requested Holder Information (as defined below), the Company may exclude such Holder&#8217;s
Registrable Securities from the applicable Registration Statement or Prospectus if the Company determines, based on the advice of
counsel, that such information is necessary to effect the registration and such Holder continues thereafter to withhold such
information. No person may participate in any Underwritten Offering or other coordinated offering for equity securities of the
Company pursuant to a Registration initiated by the Company hereunder unless such person (i) agrees to sell such person&#8217;s
securities on the basis provided in any arrangements approved by the Company in the case of an Underwritten Offering initiated by
the Company, and approved by the Demanding Holders in the case of an Underwritten Offering initiated by the Demanding Holders and
(ii) timely completes and executes all customary questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting
or other agreements and other customary documents as may be reasonably required under the terms of such arrangements. The exclusion
of a Holder&#8217;s Registrable Securities as a result of this <U>Section 3.3</U> shall not affect the registration of the other
Registrable Securities to be included in such Registration. The Company will use its commercially reasonable efforts to ensure that
the underwriting agreement related to such Registration shall provide that any liability of a Holder to any Underwriter or other
person pursuant to such underwriting agreement shall be limited to liability (i) arising from a breach of such Holder&#8217;s
representations and warranties thereto, (ii) will be several, and not joint and several, and (iii) will be limited to the net
proceeds (after deducting discounts and commission, but not expenses) received by such Holder from the sale of such Holder&#8217;s
Registrable Securities pursuant to such underwriting agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="color: #010000">3.4&nbsp;</FONT> <U>Suspension of Sales; Adverse Disclosure; Restrictions on Registration Rights</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.4.1<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains a Misstatement, each
of the Holders shall forthwith discontinue disposition of Registrable Securities until he, she or it has received copies of a supplemented
or amended Prospectus correcting the Misstatement (it being understood that the Company hereby covenants to prepare and file such supplement
or amendment as soon as practicable after the time of such notice), or until he, she or it is advised in writing by the Company that the
use of the Prospectus may be resumed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.4.2<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT></FONT>Subject
to <U>Section 3.4.4</U>, if the filing, initial effectiveness or continued use of a Registration Statement in respect of any
Registration at any time would (i) require the Company to make an Adverse Disclosure, (ii) require the inclusion in such
Registration Statement of financial statements that are unavailable to the Company for reasons beyond the Company&#8217;s control or
(iii) in the good faith judgment of the majority of the Board, be seriously detrimental to the Company and the majority of the Board
concludes as a result that it is essential to defer such filing, initial effectiveness or continued use at such time, the Company
may, upon giving prompt written notice of such action to the Holders, delay the filing or initial effectiveness of, or suspend use
of, such Registration Statement for the shortest period of time, but in no event more than ninety (90) days in any 12-month period,
determined in good faith by the Company to be necessary for such purpose. In the event the Company exercises its rights under this <U>Section
3.4.2</U>, the Holders agree to suspend, immediately upon their receipt of the notice referred to above, their use of the Prospectus
relating to any Registration in connection with any sale or offer to sell Registrable Securities until such Holder receives written
notice from the Company that such sales or offers of Registrable Securities may be resumed, and in each case maintain the
confidentiality of such notice and its contents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.4.3<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT></FONT>Subject
to <U>Section 3.4.4</U>, if (i) during the period starting with the date 60 days prior to the Company&#8217;s good faith estimate of
the date of the filing of, and ending on a date 120 days after the effective date of, a Company-initiated Registration, and provided
that the Company continues to actively employ, in good faith, all reasonable best efforts to maintain the effectiveness of the
applicable Shelf, or (ii) pursuant to <U>Section 2.1.4</U> hereof, Holders have requested an Underwritten Shelf Takedown and the
Company and such Holders are unable to obtain the commitment of underwriters to firmly underwrite such offering, then, in each case,
the Company may, upon giving prompt written notice of such action to the Holders, delay any other registered offering pursuant to <U>Section
2.1.4 </U>hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">3.4.4<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>The right to delay or suspend any filing, initial effectiveness or continued use of a Registration Statement pursuant to
<U>Section 3.4.2</U> or a registered offering pursuant to <U>Section 3.4.3</U> shall be exercised by the Company, in the aggregate, not
more than two (2) times or for more than sixty (60) consecutive calendar days, or for more than one hundred and twenty (120) total calendar
days, in each case during any 12-month period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">3.5<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>Reporting Obligations</U>. As long as any Holder shall own Registrable Securities, the Company, at all times while it
shall be a reporting company under the Exchange Act, covenants to use reasonable best efforts to file timely (or obtain extensions in
respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant
to Section 13(a) or 15(d) of the Exchange Act. The Company further covenants that it shall take such further action as any Holder may
reasonably request, to the extent required from time to time to enable such Holder to sell Registrable Securities held by such Holder
without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities
Act (or any successor rule promulgated thereafter by the Commission), including providing any customary legal opinions. Upon the request
of any Holder, the Company shall deliver to such Holder a written certification of a duly authorized officer as to whether it has complied
with such requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="color: #010000">ARTICLE
IV</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="color: #010000"></FONT>INDEMNIFICATION AND CONTRIBUTION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="color: #010000">4.1&nbsp;</FONT> <U>Indemnification</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.1.1<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>The Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers and
directors and each person or entity who controls such Holder (within the meaning of the Securities Act) against all losses, claims, damages,
liabilities and reasonable out-of-pocket expenses (including, without limitation, reasonable outside attorneys&#8217; fees and inclusive
of all reasonable attorneys&#8217; fees arising out of the enforcement of each such persons&#8217; rights under this <U>Section 4.1</U>)
arising out of or resulting from any any untrue or alleged untrue statement of material fact contained in or incorporated by reference
in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or
alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar
as the same are caused by or contained in any information or affidavit so furnished in writing to the Company by or on behalf of such
Holder expressly for use therein. The Company shall indemnify the Underwriters, their officers and directors and each person who controls
such Underwriters (within the meaning of the Securities Act) to the same extent as provided in the foregoing with respect to the indemnification
of the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.1.2<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT></FONT>In
connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish
(or cause to be furnished) to the Company in writing such information and affidavits as the Company reasonably requests for use in
connection with any such Registration Statement or Prospectus (the &#8220;<B><I>Holder Information</I></B>&#8221;) and, to the
extent permitted by law, shall indemnify the Company, its directors, officers, employees, advisors and agents, representatives and
each person or entity who controls the Company (within the meaning of the Securities Act) against all losses, claims, damages,
liabilities and reasonable out-of-pocket expenses (including, without limitation, reasonable outside attorneys&#8217; fees and
inclusive of all reasonable attorney&#8217;s fees arising out of the enforcement of each such persons&#8217; rights under this <U>Section
4.1</U>) caused by any untrue or alleged untrue statement of material fact contained in or incorporated by reference in any
Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or
alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, but
only to the extent that such untrue statement is contained in (or not contained in, in the case of an omission) any information or
affidavit so furnished in writing to the Company by or on behalf of such Holder expressly for use therein; <I>provided, however</I>,
that the obligation to indemnify shall be several, not joint and several, among such Holders of Registrable Securities, and the
liability of each such Holder of Registrable Securities shall be in proportion to and limited to the net proceeds received by such
Holder from the sale of Registrable Securities pursuant to such Registration Statement. The Holders of Registrable Securities shall
indemnify the Underwriters, their officers, directors and each person who controls such Underwriters (within the meaning of the
Securities Act) to the same extent as provided in the foregoing with respect to indemnification of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.1.3<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>Any person or entity entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of
any claim with respect to which it seeks indemnification (<I>provided </I>that the failure to give prompt notice shall not impair any
person&#8217;s or entity&#8217;s right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying
party) and (ii) unless in such indemnified party&#8217;s reasonable judgment a conflict of interest between such indemnified and indemnifying
parties may exist with respect to such claim or there may be reasonable defenses available to the indemnified party that are different
from or additional to those available to the indemnifying party, permit such indemnifying party to assume the defense of such claim with
counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any
liability for any settlement made by the indemnified party without its consent (but such consent shall not be unreasonably withheld).
An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and
expenses of more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable
judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties
with respect to such claim. No indemnifying party shall, without the consent of the indemnified party, not to be unreasonably withheld
or delayed, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of
money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement includes a statement
or admission of fault and culpability on the part of such indemnified party or which settlement does not include as an unconditional term
thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or
litigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.1.4<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation
made by or on behalf of the indemnified party or any officer, director, employee, advisor, agent, representative, shareholder, member
or controlling person or entity of such indemnified party and shall survive the transfer of securities. The Company and each Holder of
Registrable Securities participating in an offering also agrees to make such provisions as are reasonably requested by any indemnified
party for contribution to such party in the event the Company&#8217;s or such Holder&#8217;s indemnification is unavailable for any reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">4.1.5<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT></FONT>If
the indemnification provided under <U>Section 4.1</U> hereof from the indemnifying party is unavailable or insufficient to hold
harmless an indemnified party in respect of any losses, claims, damages, liabilities and out-of-pocket expenses referred to herein,
then the indemnifying party, in lieu of indemnifying the indemnified party, shall to the extent permitted by law contribute to the
amount paid or payable by the indemnified party as a result of such losses, claims, damages, liabilities and out-of-pocket expenses
in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as well as
any other relevant equitable considerations. The relative fault of the indemnifying party and indemnified party shall be determined
by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material
fact or omission or alleged omission to state a material fact, was made by (or not made by, in the case of an omission), or relates
to information supplied by (or not supplied by in the case of an omission), such indemnifying party or indemnified party, and the
indemnifying party&#8217;s and indemnified party&#8217;s relative intent, knowledge, access to information and opportunity to
correct or prevent such action; <I>provided, however</I>, that the liability of any Holder under this <U>Section 4.1.5</U> shall be
limited to the amount of the net proceeds received by such Holder in such offering giving rise to such liability. The amount paid or
payable by a party as a result of the losses or other liabilities referred to above shall be deemed to include, subject to the
limitations set forth in <U>Sections 4.1.1</U>, <U>4.1.2</U> and <U>4.1.3</U> hereof, any legal or other fees, charges or
out-of-pocket expenses reasonably incurred by such party in connection with any investigation or proceeding. The parties hereto
agree that it would not be just and equitable if contribution pursuant to this <U>Section 4.1.5 </U>were determined by <I>pro
rata</I> allocation or by any other method of allocation, which does not take account of the equitable considerations referred to in
this <U>Section 4.1.5</U>. No person or entity guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution pursuant to this <U>Section 4.1.5</U> from any person or entity who was not guilty
of such fraudulent misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="color: #010000">ARTICLE
V</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="color: #010000"></FONT>LOCK-UP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.1<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>Lock-up</U>. Pursuant to the applicable Lock-Up Agreement, the Sponsor, the Existing Holders and the New Holders agree
that they shall not Transfer any Lock-up Shares until the end of the Founder Shares Lock-up Period, the Private Placement Lock-up Period,
or the New Holders Lock-up Period, as applicable, except as permitted by and in accordance with the applicable Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0.05pt"><FONT STYLE="color: #010000">ARTICLE
VI</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="color: #010000"></FONT>MISCELLANEOUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.1<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>Notices</U>. Any notice or communication under this Agreement must be in writing and given by (i) deposit in the United
States mail, addressed to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii) delivery
in person or by courier service providing evidence of delivery or (iii) transmission by hand delivery, electronic mail or facsimile. Each
notice or communication that is mailed, delivered or transmitted in the manner described above shall be deemed sufficiently given, served,
sent and received, in the case of mailed notices, on the third Business Day following the date on which it is mailed and, in the case
of notices delivered by courier service, hand delivery, electronic mail or facsimile, at such time as it is delivered to the addressee
(with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation. Any
notice or communication under this Agreement must be addressed, if to the Company, to Zura Bio Limited, 3<SUP>rd</SUP> Floor, 1 Ashley
Road, Altrincham, WA14 2DT, United Kingdom, Attention: Chief Executive Officer and, if to any Holder, at such Holder&#8217;s address or
contact information as set forth in the Company&#8217;s books and records. Any party may change its address for notice at any time and
from time to time by written notice to the other parties hereto, and such change of address shall become effective 30 days after delivery
of such notice as provided in this <U>Section 6.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="color: #010000">6.2&nbsp;</FONT> <U>Assignment; No Third-Party Beneficiaries</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.2.1<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company
in whole or in part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.2.2<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>This Agreement and the rights, duties and obligations of the Holders hereunder may not be assigned or delegated by the Holders
in whole or in part, <I>provided, however,</I> that subject to <U>Section 6.2.5</U> hereof, a Holder may assign the rights and obligations
of such Holder hereunder relating to particular Registrable Securities in connection with the transfer of such Registrable Securities
to a transferee in accordance with the Lock-Up Agreement but only if such transferee agrees to become bound by the restrictions set forth
in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.2.3<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and
its successors and the permitted assigns of the Holders, which shall include transferees permitted by the Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.2.4<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>This Agreement shall not confer any rights or benefits on any Persons that are not parties hereto, other than as expressly
set forth in this Agreement and this <U>Section 6.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">6.2.5<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT>No assignment by any party hereto of such party&#8217;s rights, duties and obligations hereunder shall be binding upon or
obligate the Company unless and until the Company shall have received (a) written notice of such assignment as provided in <U>Section
6.1</U> hereof and (b) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms
and provisions of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer
or assignment made other than as provided in this <U>Section 6.2</U> shall be null and void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 35.95pt"><FONT STYLE="color: #010000">6.3<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>Counterparts</U>. This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts),
each of which shall be deemed an original, and all of which together shall constitute the same instrument, but only one of which need
be produced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.4<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>Adjustments</U>. If there are any changes in the Ordinary Shares as a result of share split, share dividend, combination
or reclassification, or through merger, consolidation, recapitalization or other similar event, appropriate adjustment shall be made in
the provisions of this Agreement, as may be required, so that the rights, privileges, duties and obligations under this Agreement shall
continue with respect to the Ordinary Shares as so changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.5<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>Governing Law; Venue</U>. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO,
THE PARTIES EXPRESSLY AGREE THAT THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED NEW YORK RESIDENTS ENTERED INTO AND TO BE PERFORMED
ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS OF SUCH JURISDICTION. ANY LEGAL SUIT, ACTION OR PROCEEDING
ARISING OUT OF OR BASED UPON THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY MAY BE INSTITUTED IN THE FEDERAL COURTS OF THE UNITED
STATES OR THE COURTS OF THE STATE OF NEW YORK, IN EACH CASE, LOCATED IN THE CITY AND COUNTY OF NEW YORK, AND EACH PARTY IRREVOCABLY SUBMITS
TO THE EXCLUSIVE JURISDICTION OF SUCH COURTS IN ANY SUCH SUIT, ACTION OR PROCEEDING.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.6<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>WAIVER OF JURY TRIAL</U>. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE UNDER THIS AGREEMENT
IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY, UNCONDITIONALLY AND VOLUNTARILY
WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY ACTION, SUIT
OR PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.7<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>Amendments and Modifications</U>. Upon the written consent of (i) the Company and (ii) the Holders of a majority-in-interest
of the Registrable Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in this
Agreement may be waived, or any of such provisions, covenants or conditions may be amended or modified; <I>provided, however</I>, that
any amendment hereto or waiver hereof that adversely affects one Holder, solely in his, her or its capacity as a holder of the shares
of capital stock of the Company, in a manner that is materially different from the other Holders (in such capacity), shall require the
consent of the Holder so affected. No course of dealing between any Holder or the Company and any other party hereto or any failure or
delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement shall operate as a waiver of any
rights or remedies of any Holder or the Company. No single or partial exercise of any rights or remedies under this Agreement by a party
shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder by such party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.8<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>Other Registration Rights</U>. Other than (i) the subscribers in the PIPE Investment who have registration rights with
respect to the ordinary shares purchased in the PIPE Investment pursuant to their respective Subscription Agreements, and (ii) as provided
in the Warrant Agreement, dated as of July 16, 2021, between the Company and Continental Stock Transfer &amp; Trust Company, the Company
represents and warrants that no person or entity, other than a Holder of Registrable Securities, has any right to require the Company
to register any securities of the Company for sale or to include such securities of the Company in any Registration Statement filed by
the Company for the sale of securities for its own account or for the account of any other person or entity. Further, the Company represents
and warrants that this Agreement supersedes any other registration rights agreement or agreement with similar terms and conditions, and
in the event of a conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.9<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>Term</U>. This Agreement shall terminate on the earlier of (a) the fifth anniversary of the date of this Agreement or
(b) with respect to any Holder on the date that such Holder no longer holds any Registrable Securities. The provisions of <U>Article IV</U>
hereof shall survive any termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.10<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>Holder Information</U>. Each Holder agrees, if requested in writing, to represent to the Company the total number of
Registrable Securities held by such Holder in order for the Company to make determinations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.11<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT></FONT><U>Additional
Holders; Joinder</U>. In addition to persons or entities who may become Holders pursuant to <U>Section 6.2 </U>hereof, subject to
the prior written consent of the Sponsor, each Existing Holder, and each New Holder (in each case, so long as such Holder and its
Affiliates hold, in the aggregate, at least 5% of the outstanding ordinary shares of the Company (calculated, in the case of each
New Holder as if all of its Class C ordinary shares and Retained Company Shares are exchanged for ordinary shares)), the Company may
make any person or entity who acquires ordinary shares or rights to acquire ordinary shares after the date hereof a party to this
Agreement (each such person or entity, an &#8220;<B><I>Additional Holder</I></B>&#8221;) by obtaining an executed joinder to this
Agreement from such Additional Holder in the form of <U>Exhibit A</U> attached hereto (a &#8220;<B><I>Joinder</I></B>&#8221;). Such
Joinder shall specify the rights and obligations of the applicable Additional Holder under this Agreement. Upon the execution and
delivery and subject to the terms of a Joinder by such Additional Holder, the ordinary shares of the Company then owned, or
underlying any rights then owned, by such Additional Holder (the &#8220;<B><I>Additional Holder Shares</I></B>&#8221;) shall be
Registrable Securities to the extent provided herein and therein, and such Additional Holder shall be a Holder under this Agreement
with respect to such Additional Holder Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.12<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>Severability</U>. It is the desire and intent of the parties that the provisions of this Agreement be enforced to the
fullest extent permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought. Accordingly,
if any particular provision of this Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, prohibited or unenforceable
for any reason, such provision, as to such jurisdiction, shall be ineffective, without invalidating the remaining provisions of this Agreement
or affecting the validity or enforceability of this Agreement or affecting the validity or enforceability of such provision in any other
jurisdiction. Notwithstanding the foregoing, if such provision could be more narrowly drawn so as not to be invalid, prohibited or unenforceable
in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Agreement
or affecting the validity or enforceability of such provision in any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.13<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT></FONT><U>Entire Agreement; Restatement</U>. This Agreement constitutes the full and entire agreement and understanding between
the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings relating to such subject
matter. Upon the Closing, the Original RRA shall no longer be of any force or effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>Signature Pages Follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned have
caused this Agreement to be executed as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>COMPANY:</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 50%">&nbsp;</TD>
<TD STYLE="width: 3%">&nbsp;</TD>
<TD STYLE="width: 3%">&nbsp;</TD>
<TD STYLE="width: 44%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>ZURA BIO LIMITED</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="3"><FONT STYLE="font-size: 10pt">a Cayman Islands exempted company</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
<TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Sandeep Kulkarni</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">Name:&nbsp;&nbsp;</FONT></TD>
<TD><FONT STYLE="font-size: 10pt">Sandeep Kulkarni&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
<TD><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="3"><B>SPONSOR:</B></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>JATT VENTURES, L.P.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="3" STYLE="text-align: justify">a Cayman Islands exempted limited partnership </TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD STYLE="text-align: justify">By:</TD>
<TD COLSPAN="2" STYLE="text-align: justify">JATT VENTURES LTD., General Partners</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
<TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Someit Sidhu</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
<TD><FONT STYLE="font-size: 10pt">Someit Sidhu</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
<TD><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="3"><B>EXISTING HOLDERS:</B></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>VERENDER S. BADIAL,&nbsp;</B>in their individual capacity</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
<TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Verender S. Badial</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
<TD><FONT STYLE="font-size: 10pt">Verender S. Badial</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>TAUHID ALI,&nbsp;</B>in their individual capacity</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
<TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Tauhid Ali</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
<TD><FONT STYLE="font-size: 10pt">Tauhid Ali</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>JAVIER COTE-SIERRA,&nbsp;</B>in their individual capacity</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
<TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Javier Cote-Sierra</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
<TD><FONT STYLE="font-size: 10pt">Javier Cote-Sierra</FONT></TD></TR>

<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>ARNOUT PLOOS VAN AMSTEL</B></FONT><FONT STYLE="font-size: 10pt">, in their individual capacity</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: top"><FONT STYLE="font-size: 10pt">/s/ Arnout Ploos van Amstel</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top"><FONT STYLE="font-size: 10pt">Name:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Arnout Ploos van Amstel</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt"><B>GRAEME SLOAN</B>, in their individual capacity</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: top"><FONT STYLE="font-size: 10pt">/s/ Graeme Sloan</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Graeme Sloan</FONT></TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>NEW HOLDERS:</B></FONT></TD></TR>

<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>OLIVER LEVY</B>, in their individual capacity</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 44%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Kim Davis</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD>Kim Davis, Attorney-in-Fact</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>DAVID BRADY</B>, in their individual capacity</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Kim Davis</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD>Kim Davis, Attorney-in-Fact</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>PFIZER, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Raechy Wang</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">Name:&nbsp;&nbsp;</FONT></TD>
    <TD>Raechy Wang</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>Vice President, Corporate Development</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>HANA IMMUNOTHERAPEUTICS LLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Chris Kim</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chris Kim</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">CEO</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>ELI LILLY AND COMPANY</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Kenneth Custer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Kenneth Custer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD> <FONT STYLE="font-size: 10pt">Sr. VP of Business Development</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>MARLYN MATHEW</B>, in their individual capacity</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Marlyn Mathew</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD>Marlyn Mathew</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>SANDEEP KULKARNI</B>, in their individual capacity</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Sandeep Kulkarni</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD>Sandeep Kulkarni</TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>STONE PEACH PROPERTIES LLC</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
<TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Baljit Lehal</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
<TD><FONT STYLE="font-size: 10pt">Baljit Lehal</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
<TD><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD COLSPAN="3"><B>WILLOW GATE LLC</B></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
<TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Shashibhushan Borade</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
<TD><FONT STYLE="font-size: 10pt">Shashibhushan Borade</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
<TD><FONT STYLE="font-size: 10pt">Managing Member</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[Signature Page to Amended and Restated Registration Rights
Agreement]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>4
<FILENAME>tm2310353d1_ex10-11.htm
<DESCRIPTION>EXHIBIT 10.11
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right"><B>Exhibit 10.11</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ZURA BIO LIMITED</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in">2023 EQUITY INCENTIVE
PLAN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>1.</B></TD><TD STYLE="text-align: left"><B>Purpose</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The purpose of this Zura Bio Limited
2023 Equity Incentive Plan (the &#8220;<B><I>Plan</I></B>&#8221;) is to promote and closely align the interests of employees, officers,
non- employee directors and other service providers of Zura Bio Limited, a Cayman Islands exempted company formerly known as JATT Acquisition
Corp (the &#8220;<B><I>Company</I></B>&#8221;), and its shareholders by providing share-based compensation and other performance-based
compensation. The objectives of the Plan are to attract and retain the talented employees and service providers for positions of substantial
responsibility and to motivate Participants to optimize the profitability and growth of the Company through incentives that are consistent
with the Company&#8217;s goals and that link the personal interests of Participants to those of the Company&#8217;s shareholders. The
Plan provides for the grant of Options, Stock Appreciation Rights, Restricted Stock Units, Restricted Stock and Other Share-Based Awards
and for Incentive Bonuses, which may be paid in cash, Common Shares or a combination thereof, as determined by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>2.</B></TD><TD><B>Definitions</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">As used in the Plan, the following
terms shall have the meanings set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Act</I></B>&#8221; means the U.S. Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Affiliate</I></B>&#8221; means any entity
in which the Company has a substantial direct or indirect equity interest, as determined by the Committee from time to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Award</I></B>&#8221;
means an Option, Stock Appreciation Right, Restricted Stock Unit, Restricted Stock, Other Share-Based Award or Incentive Bonus granted
to a Participant pursuant to the provisions of the Plan, any of which may be subject to performance conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Award
Agreement</I></B>&#8221; means a written or electronic agreement or other instrument as may be approved from time to time by the Committee
and designated as such implementing the grant of each Award. An Award Agreement may be in the form of an agreement to be executed by both
the Participant and the Company (or an authorized representative of the Company) or certificates, notices or similar instruments as approved
by the Committee and designated as such.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Beneficial Owner</I></B>&#8221;
shall have the meaning set forth in Rule 13d-3 under the Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Board</I></B>&#8221; means the Board of Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Cause</I></B>&#8221;
has the meaning set forth in the written employment, offer, services or severance agreement or letter between the Participant and the
Company or an Affiliate, or, if there is no such agreement or no such term is defined in such agreement, means a Participant&#8217;s Termination
of Employment by the Company or an Affiliate by reason of (i) the Participant&#8217;s material breach of any agreement between the Participant
and the Company or an Affiliate or any policy of the Company of an Affiliate; (ii) the willful failure or refusal by the Participant to
substantially perform his or her duties; (iii) the commission or conviction of the Participant of, or the entering of a plea of nolo contendere
by the Participant with respect to, (A) a felony or (B) a misdemeanor involving moral turpitude; or (iv) the Participant&#8217;s gross
misconduct that causes harm to the reputation of the Company. A Participant&#8217;s employment or service will be deemed to have been
terminated for Cause if it is determined subsequent to such Participant&#8217;s Termination of Employment that grounds for a Termination
of Employment for Cause existed at the time of such Termination of Employment, as determined by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Change in Control</I></B>&#8221;
means, except as otherwise provided in an Award Agreement, the occurrence of any one of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any Person is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company (not including in the securities beneficially
owned by such Person or any securities acquired directly from the Company or its Affiliates) representing 50% or more of the combined
voting power of the Company&#8217;s then outstanding securities, excluding any Person who becomes such a Beneficial Owner in connection
with a transaction described in <U>Section 2(h</U>)(i<U>ii</U>) below;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the following individuals cease for any reason to constitute a majority of the number of directors then serving: (A) individuals
who, on the Effective Date (as defined below), constitute the Board and (B) any new director (other than a director whose initial assumption
of office is in connection with an actual or threatened election contest, including a consent solicitation, relating to the election of
directors of the Company) whose appointment or election by the Board or nomination for election by the Company&#8217;s shareholders was
approved or recommended by a vote of at least a majority of the directors then still in office who were either directors on the Effective
Date or whose appointment, election or nomination for election was previously so approved or recommended;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>there is consummated a merger or consolidation of the Company or any direct or indirect subsidiary of the Company with any other
corporation, other than a merger or consolidation which would result in the holders of the voting securities of the Company outstanding
immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or by being converted into
voting securities of the surviving entity or any parent thereof) at least 50% of the combined voting power of the securities of the Company
or such surviving entity or any parent thereof outstanding immediately after such merger or consolidation; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>there is consummated a sale or disposition by the Company of all or substantially all of the Company&#8217;s assets, other than
a sale or disposition by the Company of all or substantially all of the Company&#8217;s assets to an entity, at least 50% of the combined
voting power of the voting securities of which is owned by shareholders of the Company in substantially the same proportions as their
ownership of the Company immediately prior to such sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Code</I></B>&#8221;
means the U.S. Internal Revenue Code of 1986, as amended from time to time, and the rulings and regulations issued thereunder.
 &#8220;<B><I>Committee</I></B>&#8221; means the Compensation Committee of the Board (or any successor committee) or such other
committee as designated by the Board to administer the Plan under <U>Section 6</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Common
Share</I></B>&#8221; means shares of the Company&#8217;s common stock, or such other class or kind of shares or other securities as may
be applicable under <U>Section 16</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Company</I></B>&#8221;
means Zura Bio Limited, a Cayman Islands exempted company formerly known as JATT Acquisition Corp, and except as utilized in the definition
of Change in Control, any successor corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Disability</I></B>&#8221;
has the meaning set forth in a written employment, offer, services or severance agreement or letter between the Participant and the Company
or an Affiliate, or, if there is no such agreement or no such term is defined in such agreement, means the inability of the Participant
to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment. A determination of
Disability shall be made by the Committee on the basis of such medical evidence as the Committee deems warranted under the circumstances,
and in this respect, Participants shall submit to an examination by a physician upon request by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Dividend
Equivalent</I></B>&#8221; mean an amount payable in cash or Common Shares, as determined by the Committee, equal to the dividends that
would have been paid to the Participant if the Common Share with respect to which the Dividend Equivalent relates had been owned by the
Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Effective Date</I></B>&#8221;
means the date on which the Plan takes effect, as defined pursuant to <U>Section 4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Eligible
Person</I></B>&#8221; any current or prospective employee, officer, non-employee director or other service provider of the Company or
any of its Subsidiaries; provided however that Incentive Stock Options may only be granted to employees of the Company or any of its &#8220;subsidiary
corporations&#8221; within the meaning of Section 424 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Fair
Market Value</I></B>&#8221; means as of any date, the value of a Common Share determined as follows: (i) if the Common Shares are listed
on any established stock exchange, system or market, the Fair Market Value shall be the closing price for a Common Share as quoted on
such exchange, system or market as reported in the Wall Street Journal or such other source as the Committee deems reliable (or, if no
sale of Common Shares is reported for such date, on the next preceding date on which any sale shall have been reported); and (ii) in the
absence of an established market for the Common Shares, the Fair Market Value thereof shall be determined in good faith by the Committee
by the reasonable application of a reasonable valuation method, taking into account factors consistent with Treas. Reg. &sect;409A-1(b)(5)(iv)(B)
as the Committee deems appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B>Good
Reason</B>&#8221; shall have the meaning set forth in the written employment, offer, services or severance agreement or letter between
the Participant and the Company or an Affiliate, or, if there is no such agreement or no such term is defined in such agreement, shall
mean any action taken by the Participant&#8217;s employer that results in a material negative change to the Participant&#8217;s employment
relationship, such as the duties to be performed, the conditions under which such duties are to be performed (including a relocation of
where services art to be performance that is over thirty 30 miles) or the total compensation to be received for performing such services.
A termination of employment by the Participant shall not constitute termination for Good Reason unless the Participant shall first have
delivered to the employer written notice setting forth with specificity the occurrence deemed to give rise to a right to terminate for
Good Reason (which notice must be given no later than 90 days after the occurrence of such event), and there shall have passed a reasonable
time (not less than 30 days) within which the employer may take action to correct, rescind or otherwise substantially reverse the occurrence
supporting termination for Good Reason as identified by the Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Incentive
Bonus</I></B>&#8221; means a bonus opportunity awarded under <U>Section 12</U> pursuant to which a Participant may become entitled to
receive an amount based on satisfaction of such performance criteria established for a specified performance period as specified in the
Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Incentive
Stock Option</I></B>&#8221; means an Option that is intended to qualify as an &#8220;incentive stock option&#8221; within the meaning
of Section 422 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Nonqualified Stock Option</I></B>&#8221; means an Option that is not intended to qualify as
an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Option</I></B>&#8221;
means a right to purchase a number of Common Shares at such exercise price, at such times and on such other terms and conditions as are
specified in or determined pursuant to an Award Agreement. Options granted pursuant to the Plan may be Incentive Stock Options or Nonqualified
Stock Options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Other Share-Based Award</I></B>&#8221; means
an Award granted to an Eligible Person under <U>Section 11</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Participant</I></B>&#8221;
means any Eligible Person to whom Awards have been granted from time to time by the Committee and any authorized transferee of such individual.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<B><I>Person</I></B>&#8221;
shall have the meaning given in Section 3(a)(9) of the Act, as modified and used in <U>Sections 14(d</U>) and <U>15(d</U>) thereof, except
that such term shall not include (i) the Company or any of its Affiliates, (ii) a trustee or other fiduciary holding securities under
an employee benefit plan of the Company or any of its Subsidiaries, (iii) an underwriter temporarily holding securities pursuant to an
offering of such securities or (iv) a corporation owned, directly or indirectly, by the shareholders of the Company in substantially
the same proportions as their ownership of the Company&#8217;s stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Restricted
Stock</I></B>&#8221; means an Award or issuance of Common Share the grant, issuance, vesting and/or transferability of which is subject
during specified periods of time to such conditions (including continued employment or engagement or performance conditions) and terms
as the Committee deems appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Restricted
Stock Unit</I></B>&#8221; means an Award denominated in units of Common Shares under which the issuance of Common Shares (or cash payment
in lieu thereof) is subject to such conditions (including continued employment or engagement or performance conditions) and terms as the
Committee deems appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Separation
from Service</I></B>&#8221; or &#8220;<B><I>Separates from Service</I></B>&#8221; means a Termination of Employment that constitutes a
 &#8220;separation from service&#8221; within the meaning of Section 409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Stock
Appreciation Right</I></B>&#8221; or &#8220;<B><I>SAR</I></B>&#8221; means a right granted that entitles the Participant to receive, in
cash or Common Shares or a combination thereof, as determined by the Committee, value equal to the excess of (i) the Fair Market Value
of a specified number of Common Shares at the time of exercise over (ii) the exercise price of the right, as established by the Committee
on the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Subsidiary</I></B>&#8221;
means any business association (including a corporation or a partnership, other than the Company) in an unbroken chain of such associations
beginning with the Company if each of the associations other than the last association in the unbroken chain owns equity interests (including
shares or partnership interests) possessing 50% or more of the total combined voting power of all classes of equity interests in one of
the other associations in such chain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Substitute
Awards</I></B>&#8221; means Awards granted or Common Shares issued by the Company in assumption of, or in substitution or exchange for,
awards previously granted, or the right or obligation to make future awards, by a company acquired by the Company or any Subsidiary or
with which the Company or any Subsidiary combines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Termination
of Employment</I></B>&#8221; means ceasing to serve as an employee of the Company and its Subsidiaries or, with respect to a non- employee
director or other service provider, ceasing to serve as such for the Company and its Subsidiaries, except that with respect to all or
any Awards held by a Participant (i) the Committee may determine that a leave of absence or employment on a less than full-time basis
is considered a &#8220;Termination of Employment,&#8221; (ii) the Committee may determine that a transition from employment to service
with a partnership, joint venture or corporation not meeting the requirements of a Subsidiary in which the Company or a Subsidiary is
a party is not considered a &#8220;Termination of Employment,&#8221; (iii) service as a member of the Board (or another capacity as a
service provider) shall constitute continued employment with respect to Awards granted to a Participant while he or she served as an employee,
(iv) service as an employee of the Company or a Subsidiary shall constitute continued employment with respect to Awards granted to a Participant
while he or she served as a member of the Board or other service provider, and (v) the Committee may determine that a transition from
employment with the Company or a Subsidiary to service to the Company or a Subsidiary other than as an employee shall constitute a &#8220;Termination
of Employment&#8221;. The Committee shall determine whether any corporate transaction, such as a sale or spin-off of a division or Subsidiary
that employs or engages a Participant, shall be deemed to result in a Termination of Employment with the Company and its Subsidiaries
for purposes of any affected Participant&#8217;s Awards, and the Committee&#8217;s decision shall be final and binding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>3.</B></TD><TD><B>Eligibility</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Any Eligible Person is eligible for
selection by the Committee to receive an Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>4.</B></TD><TD><B>Effective Date and Termination of Plan</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">This Plan became
effective on March 20, 2023 (the &#8220;<B><I>Effective Date</I></B>&#8221;). The Plan shall remain available for the grant of
Awards until the 10<FONT STYLE="font-size: 10pt">th </FONT>anniversary of the Effective Date. Notwithstanding the foregoing, the
Plan may be terminated at such earlier time as the Board may determine. Termination of the Plan will not affect the rights and
obligations of the Participants and the Company arising under Awards theretofore granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>5.</B></TD><TD><B>Shares Subject to the Plan and to Awards</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><I>Aggregate
Limits</I>. The maximum aggregate number of Common Shares issuable under the Plan shall be equal to 4,029,898. The reserved number
of Common Shares will increase on January 1st of each calendar year beginning on January 1, 2024 and ending on and including January
1, 2029 (each, an &#8220;Evergreen Date&#8221;), in an amount equal to the lesser of (i) 5.0% of the total number of Common Shares
outstanding on the December 31st immediately preceding the applicable Evergreen Date, (ii) 8,059,796 Common Shares or (iii) such
lesser number of shares of Common Stock as determined to be appropriate by the Committee in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Adjustment of Share Pool</I>. The aggregate number of Common Shares available for grant under this Plan and the number of Common
Shares subject to Awards outstanding at the time of any event described in <U>Section 16</U> shall be subject to adjustment as provided
in <U>Section 16</U>. The Common Shares issued pursuant to Awards granted under this Plan may be shares that are authorized and unissued
or shares that were reacquired by the Company, including shares purchased in the open market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Issuance of Shares</I>. For purposes of <U>Section 5(a</U>), the aggregate number of Common Shares issued under this Plan at
any time shall equal only the number of Common Shares actually issued upon exercise or settlement of an Award. Common Shares subject to
Awards that have been canceled, expired, forfeited or otherwise not issued under an Award and Common Shares subject to Awards settled
in cash shall not count as Common Shares issued under this Plan. The aggregate number of shares available for issuance under this Plan
at any time shall not be reduced by (i) shares subject to Awards that have been terminated, expired unexercised, forfeited or settled
in cash, (ii) shares subject to Awards that have been retained or withheld by the Company in payment or satisfaction of the exercise price,
purchase price or tax withholding obligation of an Award, or (iii) shares subject to Awards that otherwise do not result in the issuance
of shares in connection with payment or settlement thereof. In addition, shares that have been delivered (either actually or by attestation)
to the Company in payment or satisfaction of the exercise price, purchase price or tax withholding obligation of an Award shall be available
for issuance under this Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Substitute Awards</I>. Substitute Awards shall not reduce the Common Shares authorized for issuance under the Plan or authorized
for grant to a Participant in any calendar year. Additionally, in the event that a company acquired by the Company or any Subsidiary,
or with which the Company or any Subsidiary combines, has shares available under a pre-existing plan approved by shareholders and not
adopted in contemplation of such acquisition or combination, the shares available for grant pursuant to the terms of such pre-existing
plan (as adjusted, to the extent appropriate, using the exchange ratio or other adjustment or valuation ratio or formula used in such
acquisition or combination to determine the consideration payable to the holders of Common Share of the entities party to such acquisition
or combination) may be used for Awards under the Plan and shall not reduce the Common Shares authorized for issuance under the Plan; provided
that, Awards using such available shares (i) shall not be made after the date awards or grants could have been made under the terms of
the pre-existing plan, absent the acquisition or combination, (ii) shall only be made to individuals who were employees of such acquired
or combined company before such acquisition or combination, and (iii) shall comply with the requirements of any stock exchange or market
or quotation system on which the Common Share is traded, listed or quoted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT> <I>Tax
Code Limits</I>. The aggregate number of Common Shares that may be issued pursuant to the exercise of Incentive Stock Options
granted under this Plan shall be equal to 8,059,796, which number shall be calculated and adjusted pursuant to <U>Section 16</U>
only to the extent that such calculation or adjustment will not affect the status of any Option intended to qualify as an Incentive
Stock Option under Section 422 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><I>Limits
on Non-Employee Director Compensation. </I>The aggregate dollar value of equity-based (based on the grant date Fair Market Value of
equity-based Awards) and cash compensation granted under this Plan or otherwise during any calendar year to any non-employee
director shall not exceed $750,000; provided, however, that (i) in the calendar year in which a non-employee director first joins
the Board, the maximum aggregate dollar value of equity-based and cash compensation granted to the non-employee director may be up
to $1,000,000, (ii) effective as of the closing of the merger of Zura Bio Limited with JATT Acquisition Corp (the
 &#8220;Closing&#8221;), the Chair of the Board shall receive a special one-time grant of 500,000 time-based restricted stock units
and 250,000 performance-based restricted stock units, and (iii) the Chair of the Board in place as of the Closing shall receive
$25,000 per month for so long as he is providing expanded responsibilities in such capacity, as agreed to in writing by the Company,
and after completion of such responsibilities, annual retainers that are in no event more than $200,000 per calendar year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>6.</B></TD><TD><B>Administration of the Plan</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Administrator of the Plan</I>. The Plan shall be administered by the Committee. Any power of the Committee may also be exercised
by the Board, except to the extent that the grant or exercise of such authority would cause any Award or transaction to become subject
to (or lose an exemption under) the short-swing profit recovery provisions of Section 16 of the Act. To the extent that any permitted
action taken by the Board conflicts with action taken by the Committee, the Board action shall control. To the maximum extent permissible
under applicable law, the Committee (or any successor) may by resolution delegate any or all of its authority to one or more subcommittees
composed of one or more directors and/or officers of the Company, and any such subcommittee shall be treated as the Committee for all
purposes under this Plan. Notwithstanding the foregoing, if the Board or the Committee (or any successor) delegates to a subcommittee
the authority to grant Awards, the resolution so authorizing such subcommittee shall specify the total number of Common Shares such subcommittee
may award pursuant to such delegated authority, and no such subcommittee shall designate any officer serving thereon or any officer (within
the meaning of Section 16 of the Act) or non-employee director of the Company as a recipient of any Awards granted under such delegated
authority. The Committee may further designate and delegate to one or more additional officers or employees of the Company or any Subsidiary,
and/or one or more agents, authority to assist the Committee in any or all aspects of the day-to-day administration of the Plan and/or
of Awards granted under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Powers of Committee</I>. Subject to the express provisions of this Plan, the Committee shall be authorized and empowered to
do all things that it determines to be necessary or appropriate in connection with the administration of this Plan, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> (i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to prescribe, amend and rescind rules and regulations relating to this Plan and to define terms not otherwise defined herein;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>to determine which Persons are Eligible Persons, to which of such Eligible Persons, if any, Awards shall be granted hereunder and
the timing of any such Awards;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> (iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to prescribe and amend the terms of the Award Agreements, to grant Awards and determine the terms and conditions thereof;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>to establish and verify the extent of satisfaction of any performance goals or other conditions applicable to the grant, issuance,
retention, vesting, exercisability or settlement of any Award;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>to prescribe and amend the terms of or form of any document or notice required to be delivered to the Company by Participants under
this Plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> (vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to determine the extent to which adjustments are required pursuant to <U>Section 16</U>;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>to interpret and construe this Plan, any rules and regulations under this Plan and the terms and conditions of any Award granted
hereunder, and to make exceptions to any such provisions if the Committee, in good faith, determines that it is appropriate to do so;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> (viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to approve corrections in the documentation or administration of any Award;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> (ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to make all other determinations deemed necessary or advisable for the administration of this Plan; and</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>to adopt such procedures and sub-plans as are necessary or appropriate (A) to permit or facilitate participation in this Plan by
persons eligible to receive Awards under this Plan who are not citizens of or subject to taxation by, or who are employed outside, the
United States or (B) to allow Awards to qualify for special tax treatment in a jurisdiction other than the United States. Committee approval
will not be necessary for immaterial modifications to this Plan or any Award Agreement that are required for compliance with the laws
of the relevant jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Notwithstanding
anything in this Plan to the contrary, the Committee shall exercise its discretion in a manner that causes Awards to be compliant
with or exempt from the requirements of Section 409A of the Code. Without limiting the foregoing, unless expressly agreed to in
writing by the Participant holding an Award that is &#8220;deferred compensation&#8221; under Section 409A of the Code, the
Committee shall not take any action with respect to any Award which constitutes (x) a modification of a stock right within the
meaning of Treas. Reg. &sect; 1.409A-1(b)(5)(v)(B) so as to constitute the grant of a new stock right, (y)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp; </FONT>an
extension of a stock right, including the addition of a feature for the deferral of compensation within the meaning of Treas. Reg.
 &sect; 1.409A-1 (b)(5)(v) (C), or (z) an impermissible acceleration of a payment date or a subsequent deferral of a stock right
subject to Section 409A of the Code within the meaning of Treas. Reg. &sect; 1.409A-1(b)(5)(v)(E).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Committee may, in its sole
and absolute discretion, without amendment to the Plan but subject to the limitations otherwise set forth in <U>Section 20</U>, waive
or amend the operation of Plan provisions respecting exercise after Termination of Employment. The Committee or any member thereof may,
in its sole and absolute discretion, except as otherwise provided in <U>Section 20</U>, waive, settle or adjust any of the terms of any
Award so as to avoid unanticipated consequences or address unanticipated events (including any temporary closure of an applicable stock
exchange, disruption of communications or natural catastrophe).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Determinations by the Committee</I>. All decisions, determinations and interpretations by the Committee regarding the Plan,
any rules and regulations under the Plan and the terms and conditions of, or operation of, any Award granted hereunder, shall be final
and binding on all Participants, beneficiaries, heirs, assigns or other persons holding or claiming rights under the Plan or any Award.
The Committee shall consider such factors as it deems relevant, in its sole and absolute discretion, to making such decisions, determinations
and interpretations, including the recommendations or advice of any officer or other employee of the Company and such attorneys, consultants
and accountants as it may select. Members of the Board and members of the Committee acting under the Plan shall be fully protected in
relying in good faith upon the advice of counsel and shall incur no liability except for as a result of gross negligence or willful misconduct
in the performance of their duties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Subsidiary Awards</I>. In the case of a grant of an Award to any Participant employed by a Subsidiary, such grant may, if the
Committee so directs, be implemented by the Company issuing any subject Common Shares to the Subsidiary, for such lawful consideration
as the Committee may determine, upon the condition or understanding that the Subsidiary will transfer the Common Shares to the Participant
in accordance with the terms of the Award specified by the Committee pursuant to the provisions of the Plan. Notwithstanding any other
provision hereof, such Award may be issued by and in the name of the Subsidiary and shall be deemed granted on such date as the Committee
shall determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>7.</B></TD><TD><B>Plan Awards</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Terms Set Forth in Award Agreement</I>. Awards may be granted to Eligible Persons as determined by the Committee at any time
and from time to time prior to the termination of the Plan. The terms and conditions of each Award shall be set forth in an Award Agreement
in a form approved by the Committee for such Award, which Award Agreement may contain such terms and conditions as specified from time
to time by the Committee, provided such terms and conditions do not conflict with the Plan. The Award Agreement for any Award (other than
Restricted Stock Awards) shall include the time or times at or within which and the consideration, if any, for which any Common Shares
or cash, as applicable, may be acquired from the Company. The terms of Awards may vary among Participants, and the Plan does not impose
upon the Committee any requirement to make Awards subject to uniform terms. Accordingly, the terms of individual Award Agreements may
vary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Termination of Employment</I>. Subject to the express provisions of the Plan, the Committee shall specify before, at, or after
the time of grant of an Award the provisions governing the effect(s) upon an Award of a Participant&#8217;s Termination of Employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><I>Rights of a Shareholder</I>. A Participant shall have no rights as a shareholder with respect to Common Shares covered
by an Award (including voting rights) until the date the Participant becomes the holder of record of such Common Shares. No adjustment
shall be made for dividends or other rights for which the record date is prior to such date, except as provided in <U>Sections 10(b</U>),
<U>11(b</U>) or <U>16</U> of this Plan or as otherwise provided by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>8.</B></TD><TD><B>Options</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><I>Grant,
Term and Price</I>. The grant, issuance, retention, vesting and/or settlement of any Option shall occur at such time and be subject
to such terms and conditions as determined by the Committee or under criteria established by the Committee, which may include
conditions based on continued employment or engagement, passage of time, attainment of age and/or service requirements, and/or
satisfaction of performance conditions. The term of an Option shall in no event be greater than 10 years; provided, however, the
term of an Option (other than an Incentive Stock Option) shall be automatically extended if, at the time of its scheduled
expiration, the Participant holding such Option is prohibited by law or the Company&#8217;s insider trading policy from exercising
the Option, which extension shall expire on the 30th day following the date such prohibition no longer applies. The Committee will
establish the price at which Common Shares may be purchased upon exercise of an Option, which in no event will be less than the Fair
Market Value of such shares on the date of grant; provided, however, that the exercise price per Common Share with respect to an
Option that is granted as a Substitute Award may be less than the Fair Market Value of the Common Shares on the date such Option is
granted if such exercise price is based on a formula set forth in the terms of the options held by such optionees or in the terms of
the agreement providing for such merger or other acquisition that satisfies the requirements of (i) Section 409A of the Code, if
such options held by such optionees are not intended to qualify as &#8220;incentive stock options&#8221; within the meaning of
Section 422 of the Code, and (ii) Section 424(a) of the Code, if such options held by such optionees are intended to qualify as
 &#8220;incentive stock options&#8221; within the meaning of Section 422 of the Code. The exercise price of any Option may be paid in
cash or such other method as determined by the Committee, including an irrevocable commitment by a broker to pay over such amount
from a sale of the Common Shares issuable under an Option, the delivery of previously owned Common Shares or withholding of Common
Shares deliverable upon exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Repricing</I>. Other than in connection with a change in the Company&#8217;s capitalization (as described in <U>Section 16</U>)
or within the first twenty- four months after the Effective Date, the Committee shall not, without shareholder approval, reduce the exercise
price of a previously awarded Option, provided, however, that at any time when the exercise price of an Option previously awarded at least
two years ago is at least 100% greater than the Fair Market Value of a Common Share over a period of 90 trading days, the Committee may,
in its sole discretion and without shareholder approval, cancel and re-grant or exchange such Option for cash or a new Award with a lower
(or no) exercise price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> <I>No Reload Grants</I>. Options shall not be granted under the Plan in consideration for, and shall not be conditioned upon the
delivery of, Common Shares to the Company in payment of the exercise price and/or tax withholding obligation under any other employee
stock option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Incentive Stock Options</I>. Notwithstanding anything to the contrary in this <U>Section 8</U>, in the case of the grant of
an Incentive Stock Option, if the Participant owns shares possessing more than 10% of the combined voting power of all classes of shares
of the Company, the exercise price of such Option must be at least 110% of the Fair Market Value of the Common Shares on the date of grant
and the Option must expire within a period of not more than five years from the date of grant. Notwithstanding anything in this <U>Section
8</U> to the contrary, Options designated as Incentive Stock Options shall not be eligible for treatment under the Code as Incentive Stock
Options (and will be deemed to be Nonqualified Stock Options) to the extent that either (i) the aggregate Fair Market Value of the Common
Shares (determined as of the time of grant) with respect to which such Options are exercisable for the first time by the Participant during
any calendar year (under all plans of the Company and any Subsidiary) exceeds $100,000, taking Options into account in the order in which
they were granted, or (ii) such Options otherwise remain exercisable but are not exercised within three months (or such other period of
time provided in Section 422 of the Code) of separation of service (as determined in accordance with Section 3401(c) of the Code and the
regulations promulgated thereunder).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>No Shareholder Rights</I>. Participants shall have no voting rights and will have no rights to receive dividends or Dividend
Equivalents in respect of an Option or any Common Shares subject to an Option until the Participant has become the holder of record of
such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>9.</B></TD><TD><B>Stock Appreciation Rights</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>General Terms</I>. The grant, issuance, retention, vesting and/or settlement of any Stock Appreciation Right shall occur at
such time and be subject to such terms and conditions as determined by the Committee or under criteria established by the Committee, which
may include conditions based on continued employment or engagement, passage of time, attainment of age and/or service requirements, and/or
satisfaction of performance conditions. Stock Appreciation Rights may be granted to Participants from time to time either in tandem with
or as a component of Options granted under the Plan (&#8220;<B><I>tandem SARs</I></B>&#8221;) or not in conjunction with other Awards
(&#8220;<B><I>freestanding SARs</I></B>&#8221;). Upon exercise of a tandem SAR as to some or all of the shares covered by the grant, the
related Option shall be canceled automatically to the extent of the number of shares covered by such exercise. Conversely, if the related
Option is exercised as to some or all of the shares covered by the grant, the related tandem SAR, if any, shall be canceled automatically
to the extent of the number of shares covered by the Option exercise. Any Stock Appreciation Right granted in tandem with an Option may
be granted at the same time such Option is granted or at any time thereafter before exercise or expiration of such Option, provided that
the Fair Market Value of Common Share on the date of the SAR&#8217;s grant is not greater than the exercise price of the related Option.
All freestanding SARs shall be granted subject to the same terms and conditions applicable to Options as set forth in <U>Section 8</U>
and all tandem SARs shall have the same exercise price as the Option to which they relate. Subject to the provisions of <U>Section 8</U>
and the immediately preceding sentence, the Committee may impose such other conditions or restrictions on any Stock Appreciation Right
as it shall deem appropriate. Stock Appreciation Rights may be settled in Common Share, cash, Restricted Stock or a combination thereof,
as determined by the Committee and set forth in the applicable Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>No Repricing without Shareholder Approval</I>. Other than in connection with a change in the Company&#8217;s capitalization
(as described in <U>Section 16</U>) or within the first twenty-four months after the Effective Date, the Committee shall not, without
shareholder approval, reduce the exercise price of a previously awarded Stock Appreciation Right, and at any time when the exercise price
of a previously awarded Stock Appreciation Right is above the Fair Market Value of a Common Share, the Committee shall not, without shareholder
approval, cancel and re-grant or exchange such Stock Appreciation Right for cash or a new Award with a lower (or no) exercise price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>No Shareholder Rights</I>. Participants shall have no voting rights and will have no rights to receive dividends or Dividend
Equivalents in respect of an Award of Stock Appreciation Rights or any Common Shares subject to an Award of Stock Appreciation Rights
until the Participant has become the holder of record of such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>10.</B></TD><TD><B>Restricted Stock and Restricted Stock Units</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Vesting and Performance Criteria</I>. The grant, issuance, vesting and/or settlement of any Award of Restricted Stock or Restricted
Stock Units shall occur at such time and be subject to such terms and conditions as determined by the Committee or under criteria established
by the Committee, which may include conditions based on continued employment or engagement, passage of time, attainment of age and/or
service requirements, and/or satisfaction of performance conditions. In addition, the Committee shall have the right to grant Restricted
Stock or Restricted Stock Unit Awards as the form of payment for grants or rights earned or due under other shareholder-approved compensation
plans or arrangements of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Dividends and Distributions</I>. Participants in whose name Restricted Stock is granted shall be entitled to receive all dividends
and other distributions paid with respect to those Common Shares, unless determined otherwise by the Committee. The Committee will determine
whether any such dividends or distributions will be automatically reinvested in additional shares of Restricted Stock and/or subject to
the same restrictions on transferability as the Restricted Stock with respect to which they were distributed or whether such dividends
or distributions will be paid in cash. Shares underlying Restricted Stock Units shall be entitled to dividends or distributions only to
the extent provided by the Committee. Notwithstanding anything herein to the contrary, in no event will dividends or Dividend Equivalents
be paid during the performance period with respect to unearned Awards of Restricted Stock or Restricted Stock Units that are subject to
performance-based vesting criteria. Dividends or Dividend Equivalents accrued on such shares shall become payable no earlier than the
date the performance-based vesting criteria have been achieved and the underlying shares or Restricted Stock Units have been earned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>11.</B></TD><TD><B>Other Share-Based Awards</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>General Terms. </I>The Committee is authorized, subject to limitations under applicable law, to grant to Eligible Persons such
other Awards that may be denominated or payable in, valued in whole or in part by reference to, or otherwise based on, or related to,
Common Shares, as deemed by the Committee to be consistent with the purposes of the Plan. The Committee shall determine the terms and
conditions of such Other Share-Based Awards. Common Shares delivered pursuant to an Other Share-Based Award in the nature of a purchase
right granted under this <U>Section 11</U> shall be purchased for such consideration, paid for at such times, by such methods, and in
such forms, including cash, Common Shares, other Awards, or other property, as the Committee shall determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Dividends and Distributions</I>. Shares underlying Other Share-Based Awards shall be entitled to dividends or distributions
only to the extent provided by the Committee. Notwithstanding anything herein to the contrary, in no event will Dividend Equivalents be
paid during the performance period with respect to unearned Other Share-Based Awards that are subject to performance-based vesting criteria.
Dividend Equivalents accrued on such shares shall become payable no earlier than the date the performance-based vesting criteria have
been achieved and the shares underlying the Other Share-Based Award have been earned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>12.</B></TD><TD><B>Incentive Bonuses</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Performance Criteria</I>. The Committee shall establish the performance criteria and level of achievement versus such criteria
that shall determine the amount payable under an Incentive Bonus, which may include a target, threshold and/or maximum amount payable
and any formula for determining such achievement, and which criteria may be based on performance conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Timing and Form of Payment</I>. The Committee shall determine the timing of payment of any Incentive Bonus. Payment of the amount
due under an Incentive Bonus may be made in cash or in Common Share, as determined by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Discretionary Adjustments</I>. Notwithstanding satisfaction of any performance goals and, the amount paid under an Incentive
Bonus on account of either financial performance or personal performance evaluations may be adjusted by the Committee on the basis of
such further considerations as the Committee shall determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>13.</B></TD><TD><B>Performance Awards</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Committee may establish performance
criteria and level of achievement versus such criteria that shall determine the number of Common Shares, Restricted Stock Units, or cash
to be granted, retained, vested, issued or issuable under or in settlement of or the amount payable pursuant to an Award (any such Award,
a &#8220;<B><I>Performance Award</I></B>&#8221;). A Performance Award may be identified as &#8220;Performance Share,&#8221; &#8220;Performance
Equity,&#8221; &#8220;Performance Unit&#8221; or other such term as chosen by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>14.</B></TD><TD><B>Section 457A</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">To the extent that any Award is determined
to constitute &#8220;nonqualified deferred compensation&#8221; from a nonqualified entity within the meaning of Section 457A (a &#8220;<B><I>457A
Award</I></B>&#8221;), the Award shall be subject to such additional rules and requirements as may be specified by the Committee from
time to time. It is intended that any such 457A Award will either be in full compliance with or be exempt from Section 457A of the Code.
The Company makes no representation or warranty and shall have no liability to any Participant under the Plan or any other Person with
respect to any penalties or taxes under Section 457A that are, or may be, imposed with respect to any Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>15.</B></TD><TD><B>Conditions and Restrictions Upon Securities Subject to Awards</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Committee may
provide that the Common Shares issued upon exercise of an Option or Stock Appreciation Right or otherwise subject to or issued under
an Award shall be subject to such further agreements, restrictions, conditions or limitations as the Committee in its discretion may
specify prior to the exercise of such Option or Stock Appreciation Right or the grant, vesting or settlement of such Award,
including conditions on vesting or transferability, forfeiture or repurchase provisions and method of payment for the Common Shares
issued upon exercise, vesting or settlement of such Award (including the actual or constructive surrender of Common Shares already
owned by the Participant) or payment of taxes arising in connection with an Award. Without limiting the foregoing, such restrictions
may address the timing and manner of any resales by the Participant or other subsequent transfers by the Participant of any Common
Shares issued under an Award, including (a) restrictions under an insider trading policy or pursuant to applicable law, (b)
restrictions designed to delay and/or coordinate the timing and manner of sales by the Participant and holders of other Company
equity compensation arrangements, (c) restrictions as to the use of a specified brokerage firm for such resales or other transfers
and (d) provisions requiring Common Shares be sold on the open market or to the Company in order to satisfy tax withholding or other
obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>16.</B></TD><TD><B>Adjustment of and Changes in the Shares</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The number and kind of Common Shares available for issuance under this Plan (including under any Awards then outstanding), and
the number and kind of Common Shares subject to the limits set forth in <U>Section 5</U>, shall be equitably adjusted by the Committee
to reflect any reorganization, reclassification, combination of shares, share split, reverse share split, spin-off, extraordinary dividend
or distribution of securities, property or cash (and not regular, quarterly cash dividends), or any other event or transaction that affects
the number or kind of Common Shares outstanding. Such adjustment may be designed to comply with Section 424 of the Code or may be designed
to treat the Common Shares available under the Plan and subject to Awards as if they were all outstanding on the record date for such
event or transaction or to increase the number of such Common Shares to reflect a deemed reinvestment in Common Shares of the amount distributed
to the Company&#8217;s securityholders. The terms of any outstanding Award shall also be equitably adjusted by the Committee as to price,
number or kind of Common Shares subject to such Award, vesting, and other terms to reflect the foregoing events, which adjustments need
not be uniform as between different Awards or different types of Awards. No fractional Common Shares shall be issued or issuable pursuant
to such an adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event there shall be any other change in the number or kind of outstanding Common Shares, or any shares or other securities
into which such Common Shares shall have been changed, or for which it shall have been exchanged, by reason of a Change in Control, other
merger, consolidation or otherwise, then the Committee shall determine the appropriate and equitable adjustment to be effected, which
adjustments need not be uniform between different Awards or different types of Awards. In addition, in the event of such change described
in this paragraph, the Committee may accelerate the time or times at which any Award may be exercised, consistent with and as otherwise
permitted under Section 409A of the Code and may provide for cancellation of such accelerated Awards that are not exercised within a time
prescribed by the Committee in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>
Unless otherwise expressly provided in the Award Agreement or another contract, including an employment, offer, services or
severance agreement or letter, or under the terms of a transaction constituting a Change in Control, the Committee shall provide
that any or all of the following shall occur upon a Participant&#8217;s Termination of Employment by the Company without Cause or by
the Participant for Good Reason within twenty-four (24) months following a Change in Control: (i) in the case of an Option or Stock
Appreciation Right, the Participant shall have the ability to exercise any portion of the Option or Stock Appreciation Right not
previously exercisable, (ii) in the case of any Award the vesting of which is in whole or in part subject to performance criteria or
an Incentive Bonus, all conditions to the grant, issuance, retention, vesting or transferability of, or any other restrictions
applicable to, such Award shall immediately lapse and the Participant shall have the right to receive a payment based on target
level achievement or actual performance through a date determined by the Committee, and (iii) in the case of outstanding Restricted
Stock, Restricted Stock Units or Other Share-Based Awards (other than those referenced in subsection (ii)), all conditions to the
grant, issuance, retention, vesting or transferability of, or any other restrictions applicable to, such Award shall immediately
lapse. Notwithstanding anything herein to the contrary, in the event of a Change in Control in which the acquiring or surviving
company in the transaction does not assume or continue outstanding Awards or issue substitute awards upon the Change in Control,
immediately prior to the Change in Control, all Awards that are not assumed, continued or substituted for shall be treated as
follows effective immediately prior to the Change in Control: (A) in the case of an Option or Stock Appreciation Right, the
Participant shall have the ability to exercise such Option or Stock Appreciation Right, including any portion of the Option or Stock
Appreciation Right not previously exercisable, (B) in the case of any Award the vesting of which is in whole or in part subject to
performance criteria or an Incentive Bonus, all conditions to the grant, issuance, retention, vesting or transferability of, or any
other restrictions applicable to, such Award shall immediately lapse and the Participant shall have the right to receive a payment
based on target level achievement or actual performance through a date determined by the Committee, as determined by the Committee,
and (C) in the case of outstanding Restricted Stock, Restricted Stock Units or Other Share-Based Awards (other than those referenced
in subsection (B)), all conditions to the grant, issuance, retention, vesting or transferability of, or any other restrictions
applicable to, such Award shall immediately lapse. In no event shall any action be taken pursuant to this <U>Section 16(c</U>) that
would change the payment or settlement date of an Award in a manner that would result in the imposition of any additional taxes or
penalties pursuant to Section 409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything in this <U>Section 16</U> to the contrary, in the event of a Change in Control, the Committee may provide
for the cancellation and cash settlement of all outstanding Awards upon such Change in Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything in this <U>Section 16</U> to the contrary, an adjustment to an Option or Stock Appreciation Right under
this <U>Section 16</U> shall be made in a manner that will not result in the grant of a new Option or Stock Appreciation Right under Section
409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>17.</B></TD><TD STYLE="text-align: justify"><B>Transferability</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Each Award may not be sold, transferred
for value, pledged, assigned, or otherwise alienated or hypothecated by a Participant other than by will or the laws of descent and distribution,
and each Option or Stock Appreciation Right shall be exercisable only by the Participant during his or her lifetime. Notwithstanding the
foregoing, (a) outstanding Options may be exercised following the Participant&#8217;s death by the Participant&#8217;s beneficiaries or
as permitted by the Committee and (b) a Participant may transfer or assign an Award as a gift to an entity wholly owned by such Participant
(an &#8220;<B><I>Assignee Entity</I></B>&#8221;), provided that such Assignee Entity shall be entitled to exercise assigned Options and
Stock Appreciation Rights only during the lifetime of the assigning Participant (or following the assigning Participant&#8217;s death,
by the Participant&#8217;s beneficiaries or as otherwise permitted by the Committee) and provided further that such Assignee Entity shall
not further sell, pledge, transfer, assign or otherwise alienate or hypothecate such Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>18.</B></TD><TD STYLE="text-align: justify"><B>Compliance with Laws and Regulations</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>This Plan, the grant, issuance, vesting, exercise and settlement of Awards hereunder, and the obligation of the Company to sell,
issue or deliver Common Shares under such Awards, shall be subject to all applicable foreign, federal, state and local laws, rules and
regulations, stock exchange rules and regulations, and to such approvals by any governmental or regulatory agency as may be required.
The Company shall not be required to register in a Participant&#8217;s name or deliver Common Shares prior to the completion of any registration
or qualification of such shares under any foreign, federal, state or local law or any ruling or regulation of any government body which
the Committee shall determine to be necessary or advisable. To the extent the Company is unable to or the Committee deems it infeasible
to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company&#8217;s counsel to be necessary
to the lawful issuance and sale of any Common Shares hereunder, the Company and its Subsidiaries shall be relieved of any liability with
respect to the failure to issue or sell such Common Shares as to which such requisite authority shall not have been obtained. No Option
shall be exercisable and no Common Share shall be issued and/or transferable under any other Award unless a registration statement with
respect to the Common Share underlying such Option is effective and current or the Company has determined, in its sole and absolute discretion,
that such registration is unnecessary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> In the event an Award is granted to or held by a Participant who is employed or providing services outside the United States,
the Committee may, in its sole discretion, modify the provisions of the Plan or of such Award as they pertain to such individual to comply
with applicable foreign law or to recognize differences in local law, currency or tax policy. The Committee may also impose conditions
on the grant, issuance, exercise, vesting, settlement or retention of Awards in order to comply with such foreign law and/or to minimize
the Company&#8217;s obligations with respect to tax equalization for Participants employed outside their home country.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>19.</B></TD><TD><B>Withholding</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">To the extent required by applicable
federal, state, local or foreign law, the Committee may, and/or a Participant shall, make arrangements satisfactory to the Company for
the satisfaction of any withholding tax obligations that arise with respect to any Award or the issuance or sale of any Common Shares.
The Company shall not be required to recognize any Participant rights under an Award, to issue Common Shares or to recognize the disposition
of such Common Shares until such obligations are satisfied. To the extent permitted or required by the Committee, these obligations may
or shall be satisfied by the Company withholding cash from any compensation otherwise payable to or for the benefit of a Participant,
the Company withholding a portion of the Common Shares that otherwise would be issued to a Participant under such Award or any other Award
held by the Participant, or by the Participant tendering to the Company cash or, if allowed by the Committee, Common Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>20.</B></TD><TD><B>Amendment of the Plan or Awards</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Board may amend, alter or discontinue
this Plan, and the Committee may amend or alter any Award Agreement or other document evidencing an Award made under this Plan; however,
except as provided pursuant to the provisions of <U>Section 16</U>, no such amendment shall, without the approval of the shareholders
of the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: left">increase the maximum number of Common Shares for which Awards may be granted under this Plan;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: left">reduce the price at which Options may be granted below the price provided for in <U>Section 8(a</U>);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: left">reprice outstanding Options or SARs other than under the exceptions described in <U>Sections 8(b</U>) and
<U>9(b</U>);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: left">extend the term of this Plan;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: left">change the class of Persons eligible to be Participants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: left">increase the individual maximum limits in <U>Section 5(e</U>); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>otherwise amend the Plan in any manner requiring shareholder approval by law or the rules of any stock exchange or market or quotation
system on which the Common Share is traded, listed or quoted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">No amendment or alteration to the
Plan or an Award or Award Agreement shall be made which would materially impair the rights of the holder of an Award without such holder&#8217;s
consent; provided that no such consent shall be required if the Committee determines in its sole discretion and prior to the date of any
Change in Control that such amendment or alteration either (i) is required or advisable in order for the Company, the Plan or the Award
to satisfy any law or regulation or to meet the requirements of, or avoid adverse financial accounting consequences under, any accounting
standard, or (ii) is not reasonably likely to significantly diminish the benefits provided under such Award, or that any such diminishment
has been adequately compensated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>21.</B></TD><TD><B>No Liability of Company</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company, any Subsidiary or
Affiliate which is in existence or hereafter comes into existence, the Board and the Committee shall not be liable to a Participant or
any other person as to: (a) the non-issuance or sale of Common Shares as to which the Company has been unable to obtain from any regulatory
body having jurisdiction the authority deemed by the Company&#8217;s counsel to be necessary to the lawful issuance and sale of any Common
Shares hereunder; and (b) any tax consequence expected, but not realized, by any Participant or other person due to the receipt, vesting,
exercise or settlement of any Award granted hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>22.</B></TD><TD><B>Non-Exclusivity of Plan</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Neither the adoption of this Plan
by the Board nor the submission of this Plan to the shareholders of the Company for approval shall be construed as creating any limitations
on the power of the Board or the Committee to adopt such other incentive arrangements as either may deem desirable, including the granting
of Restricted Stock or Options otherwise than under this Plan, and such arrangements may be either generally applicable or applicable
only in specific cases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>23.</B></TD><TD><B>Governing Law</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">This Plan and any agreements or other documents
hereunder shall be interpreted and construed in accordance with the laws of the Cayman Islands (without regard to its choice of law provisions).
Any reference in this Plan or in the agreement or other document evidencing any Awards to a provision of law or to a rule or regulation
shall be deemed to include any successor law, rule or regulation of similar effect or applicability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>24.</B></TD><TD><B>No Right to Employment, Reelection or Continued Service</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Nothing in this Plan or an Award
Agreement shall interfere with or limit in any way the right of the Company, its Subsidiaries and/or its Affiliates to terminate any Participant&#8217;s
employment, service on the Board or service at any time or for any reason not prohibited by law, nor shall this Plan or an Award itself
confer upon any Participant any right to continue his or her employment or service for any specified period of time. Neither an Award
nor any benefits arising under this Plan shall constitute an employment contract with the Company, any Subsidiary and/or its Affiliates.
Subject to <U>Sections 4</U> and <U>20</U>, this Plan and the benefits hereunder may be terminated at any time in the sole and exclusive
discretion of the Board without giving rise to any liability on the part of the Company, its Subsidiaries and/or its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>25.</B></TD><TD><B>Specified Employee Delay</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">To the extent any payment under
this Plan is considered deferred compensation subject to the restrictions contained in Section 409A of the Code, such payment may not
be made to a specified employee (as determined in accordance with a uniform policy adopted by the Company with respect to all arrangements
subject to Section 409A of the Code) upon Separation from Service before the date that is six months after the specified employee&#8217;s
Separation form Service (or, if earlier, the specified employee&#8217;s death). Any payment that would otherwise be made during this period
of delay shall be accumulated and paid on the sixth month plus one day following the specified employee&#8217;s Separation from Service
(or, if earlier, as soon as administratively practicable after the specified employee&#8217;s death).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>26.</B></TD><TD><B>No Liability of Committee Members</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">No member of the Committee shall be personally
liable by reason of any contract or other instrument executed by such member or on his or her behalf in his or her capacity as a member
of the Committee nor for any mistake of judgment made in good faith, and the Company shall indemnify and hold harmless each member of
the Committee and each other employee, officer or director of the Company to whom any duty or power relating to the administration or
interpretation of the Plan may be allocated or delegated, against any cost or expense (including counsel fees) or liability (including
any sum paid in settlement of a claim) arising out of any act or omission to act in connection with the Plan, unless arising out of such
Person&#8217;s own fraud or willful bad faith; provided, however, that approval of the Board shall be required for the payment of any
amount in settlement of a claim against any such Person. The foregoing right of indemnification shall not be exclusive of any other rights
of indemnification to which such Persons may be entitled under the Company&#8217;s Certificate of Incorporation and Bylaws (as each may
be amended from time to time), as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them
harmless.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>27.</B></TD><TD><B>Severability</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">If any provision of the Plan or
any Award is or becomes or is deemed to be invalid, illegal, or unenforceable in any jurisdiction or as to any Person or Award, or would
disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or deemed amended
to conform to the applicable laws, or if it cannot be construed or deemed amended without, in the determination of the Committee, materially
altering the intent of the Plan or the Award, such provision shall be stricken as to such jurisdiction, Person or Award, and the remainder
of the Plan and any such Award shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>28.</B></TD><TD><B>Unfunded Plan</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Plan is intended to be an unfunded
plan. Participants are and shall at all times be general creditors of the Company with respect to their Awards. If the Committee or the
Company chooses to set aside funds in a trust or otherwise for the payment of Awards under the Plan, such funds shall at all times be
subject to the claims of the creditors of the Company in the event of its bankruptcy or insolvency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>29.</B></TD><TD><B>Clawback/Recoupment</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Awards granted under this Plan
will be subject to recoupment in accordance with any clawback policy that the Company adopts or is required to adopt pursuant to the listing
standards of any national securities exchange or association on which the Company&#8217;s securities are listed or as is otherwise required
by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law. In addition, the Committee may impose such other
clawback, recovery or recoupment provisions in an Award Agreement as the Committee determines necessary or appropriate, including a reacquisition
right in respect of previously acquired Common Shares or other cash or property upon the occurrence of misconduct. No recovery of compensation
under such a clawback policy will be an event giving rise to a right to resign for Good Reason or otherwise be deemed to be a form of
 &#8220;constructive termination&#8221; (or any similar term) as such terms are used in any agreement between any Participant and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><B>30.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Failure to Accept Award</B>. If a Participant has not accepted an Award to the extent such acceptance has been requested or required
by the Company or has not taken all administrative and other steps (e.g., setting up an account with a broker designated by the Company)
necessary for the Company to issue Common Shares upon the vesting, exercise, or settlement of the Award prior to the first date the Common
Shares subject to such Award are scheduled to vest, then the portion of the Award scheduled to vest on such date will be cancelled on
such date and such Shares subject to the Award immediately will revert to the Plan for no additional consideration unless otherwise provided
by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><B>31.</B></TD><TD><B>Interpretation</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Headings are given to the Sections
and subsections of the Plan solely as a convenience to facilitate reference and shall not be deemed in any way material or relevant to
the construction or interpretation of the Plan or any provision thereof. Words in the masculine gender shall include the feminine gender,
and where appropriate, the plural shall include the singular and the singular shall include the plural. The use herein of the word &#8220;including&#8221;
following any general statement, term or matter shall not be construed to limit such statement, term or matter to the specific items or
matters set forth immediately following such word or to similar items or matters, whether or not non-limiting language (such as &#8220;without
limitation&#8221;, &#8220;but not limited to&#8221;, or words of similar import) is used with reference thereto, but rather shall be deemed
to refer to all other items or matters that could reasonably fall within the broadest possible scope of such general statement, term or
matter. References herein to any agreement, instrument or other document means such agreement, instrument or other document as amended,
supplemented and modified from time to time to the extent permitted by the provisions thereof and not prohibited by the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.12
<SEQUENCE>5
<FILENAME>tm2310353d1_ex10-12.htm
<DESCRIPTION>EXHIBIT 10.12
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 10.12</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in">ZURA BIO LIMITED</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>2023 EMPLOYEE SHARE PURCHASE PLAN</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">1.</TD><TD STYLE="text-align: justify">GENERAL; PURPOSE.</TD>
</TR></TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Plan provides a means by which Eligible Employees of the Company and certain Designated Companies may be given an opportunity to purchase
Common Shares. The Plan permits the Company to grant a series of Purchase Rights to Eligible Employees under an &#8220;employee stock
purchase plan&#8221; as such term is defined by Section&nbsp;423 of the Code. In addition, the Plan permits the Company to grant a series
of Purchase Rights to Eligible Employees that do not meet the requirements of an employee stock purchase plan.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Plan includes two components: a 423 Component and a Non-423 Component. The Company intends (but makes no undertaking or representation
to maintain) the 423 Component to qualify as an employee stock purchase plan. The provisions of the 423 Component, accordingly, will be
construed in a manner that is consistent with the requirements of Section&nbsp;423 of the Code. Except as otherwise provided in the Plan
or determined by the Board, the Non-423 Component will operate and be administered in the same manner as the 423 Component.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company, by means of the Plan, seeks to retain the services of Eligible Employees, to secure and retain the services of new Employees
and to provide incentives for such persons to exert maximum efforts for the success of the Company and its Related Corporations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD>ADMINISTRATION.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board or the Committee will administer the Plan. References herein to the Board shall be deemed to refer to the Committee except where
context dictates otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> (b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 1in; margin-top: 0pt; margin-bottom: 0pt"> (i) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To determine how and when Purchase Rights will be granted and the provisions of each Offering (which need not be identical).</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 1in; margin-top: 0pt; margin-bottom: 0pt">(ii)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To designate from time to time (A)&nbsp;which Related Corporations
will be eligible to participate in the Plan as Designated 423 Corporations, (B)&nbsp;which Related Corporations or Affiliates will
be eligible to participate in the Plan as Designated Non-423 Corporations, and (C)&nbsp;which Designated Companies will participate
in each separate Offering (to the extent that the Company makes separate Offerings).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 62.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 1in; margin-top: 0pt; margin-bottom: 0pt">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
construe and interpret the Plan and Purchase Rights, and to establish, amend and revoke rules&nbsp;and regulations for its administration.
The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan, in a manner and to the extent
it deems necessary or expedient to make the Plan fully effective.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 1in; margin-top: 0pt; margin-bottom: 0pt">(iv) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To settle all controversies regarding the Plan and Purchase Rights granted under the Plan.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 1in; margin-top: 0pt; margin-bottom: 0pt">(v) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To suspend or terminate the Plan at any time as provided in Section&nbsp;12.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 1in; margin-top: 0pt; margin-bottom: 0pt">(vi) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To amend the Plan at any time as provided in Section&nbsp;12.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 1in; margin-top: 0pt; margin-bottom: 0pt">(vii)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Generally, to exercise such powers and to perform such acts as it deems
necessary or expedient to promote the best interests of the Company and its Related Corporations and to carry out the intent that
the Plan be treated as an Employee Share Purchase Plan with respect to the 423 Component.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 62.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 1in; margin-top: 0pt; margin-bottom: 0pt">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
adopt such rules, procedures and sub-plans as are necessary or appropriate to permit or facilitate participation in the Plan by Employees
who are foreign nationals or employed or located outside the United States. Without limiting the generality of, and consistent with,
the foregoing, the Board specifically is authorized to adopt rules, procedures, and sub-plans regarding, without limitation, eligibility
to participate in the Plan, the definition of eligible &#8220;earnings,&#8221; handling and making of Contributions, establishment of
bank or trust accounts to hold Contributions, payment of interest, conversion of local currency, obligations to pay payroll tax, determination
of designation requirements, withholding procedures and handling of share issuances, any of which may vary according to applicable requirements,
and which, if applicable to a Designated Non-423 Corporation, do not have to comply with the requirements of Section&nbsp;423 of the
Code.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(c)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board may delegate some or all of the administration of
the Plan to a Committee or Committees. If administration is delegated to a Committee, the Committee will have, in connection with
the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including
the power to delegate to a subcommittee any of the administrative powers the Committee is authorized to exercise (and references in
this Plan to the Board will thereafter be to the Committee or subcommittee), subject, however, to such resolutions, not inconsistent
with the provisions of the Plan, as may be adopted from time to time by the Board. Further, to the extent not prohibited by
Applicable Law, the Board or Committee may, from time to time, delegate some or all of its authority under the Plan to one or more
officers of the Company or other persons or groups of persons as it deems necessary, appropriate or advisable under conditions or
limitations that it may set at or after the time of the delegation. The Board may retain the authority to concurrently administer
the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously delegated. Whether or not
the Board has delegated administration of the Plan to a Committee, the Board will have the final power to determine all questions of
policy and expediency that may arise in the administration of the Plan.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(d) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
determinations, interpretations and constructions made by the Board in good faith will not be subject to review by any person and will
be final, binding and conclusive on all persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">3.</FONT></TD><TD>COMMON SHARES SUBJECT TO THE PLAN.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the provisions of Section&nbsp;11(a)&nbsp;relating to Capitalization Adjustments, the maximum number of Common Shares that may be
issued under the Plan will not exceed 4,029,898 Common Shares, plus the aggregate number of Common Shares that are added under the Zura
Bio Limited 2023 Equity Incentive Plan on January&nbsp;1st of each calendar year beginning on January&nbsp;1, 2024 and ending on and
including January&nbsp;1, 2029. For the avoidance of doubt, up to the maximum number of Common Shares reserved under this Section&nbsp;3(a)&nbsp;may
be used to satisfy purchases of Common Shares under the 423 Component and any remaining portion of such maximum number of shares may be
used to satisfy purchases of Common Shares under the Non-423 Component.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
any Purchase Right granted under the Plan terminates without having been exercised in full, the Common Shares not purchased under such
Purchase Right will again become available for issuance under the Plan.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
shares purchasable under the Plan will be authorized but unissued or reacquired Common Shares, including shares repurchased by the Company
on the open market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">4.</FONT></TD><TD>GRANT OF PURCHASE RIGHTS; OFFERING.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board may from time to time grant or provide for the grant of Purchase Rights to Eligible Employees under an Offering (consisting of one
or more Purchase Periods) on an Offering Date or Offering Dates selected by the Board. Each Offering will be in such form and will contain
such terms and conditions as the Board will deem appropriate, and, with respect to the 423 Component, will comply with the requirement
of Section&nbsp;423(b)(5)&nbsp;of the Code that all Employees granted Purchase Rights will have the same rights and privileges. The
terms and conditions of an Offering shall be incorporated by reference into the Plan and treated as part of the Plan. The provisions of
separate Offerings need not be identical, but each Offering will include (through incorporation of the provisions of this Plan by reference
in the document comprising the Offering or otherwise) the period during which the Offering will be effective, which period will not exceed
27 months beginning with the Offering Date, and the substance of the provisions contained in Sections 5 through 8, inclusive.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
a Participant has more than one Purchase Right outstanding under the Plan, unless he or she otherwise indicates in forms delivered to
the Company or a third party designated by the Company (each, a &#8220;<I>Company Designee</I>&#8221;): (i)&nbsp;each form will apply
to all of his or her Purchase Rights under the Plan, and (ii)&nbsp;a Purchase Right with a lower exercise price (or an earlier-granted
Purchase Right, if different Purchase Rights have identical exercise prices) will be exercised to the fullest possible extent before a
Purchase Right with a higher exercise price (or a later-granted Purchase Right if different Purchase Rights have identical exercise prices)
will be exercised.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board will have the discretion to structure an Offering so that if the Fair Market Value of a Common Share on the first Trading Day of
a new Purchase Period within that Offering is less than or equal to the Fair Market Value of a Common Share on the Offering Date for that
Offering, then (i)&nbsp;that Offering will terminate immediately as of that first Trading Day, and (ii)&nbsp;the Participants in such
terminated Offering will be automatically enrolled in a new Offering beginning on the first Trading Day of such new Purchase Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: -15.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">5.</TD><TD STYLE="text-align: justify">ELIGIBILITY.</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase
Rights may be granted only to Employees of the Company or, as the Board may designate in accordance with Section&nbsp;2(b), to Employees
of a Related Corporation or an Affiliate. Except as provided in Section&nbsp;5(b)&nbsp;or as required by Applicable Law, an Employee
will not be eligible to be granted Purchase Rights unless, on the Offering Date, the Employee has been in the employ of the Company or
the Related Corporation or an Affiliate, as the case may be, for such continuous period preceding such Offering Date as the Board may
require, but in no event will the required period of continuous employment be equal to or greater than one year. In addition, the Board
may (unless prohibited by Applicable Law) provide that no Employee will be eligible to be granted Purchase Rights under the Plan unless,
on the Offering Date, such Employee&#8217;s customary employment with the Company, the Related Corporation, or the Affiliate is more than
20 hours per week and more than five months per calendar year or such other criteria as the Board may determine consistent with Section&nbsp;423
of the Code with respect to the 423 Component. The Board may also exclude from participation in the Plan or any Offering Employees who
are &#8220;highly compensated employees&#8221; (within the meaning of Section&nbsp;423(b)(4)(D)&nbsp;of the Code) of the Company or
a Related Corporation or a subset of such highly compensated employees.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board may provide that each person who, during the course of an Offering, first becomes an Eligible Employee will, on a date or dates
specified in the Offering which coincides with the day on which such person becomes an Eligible Employee or which occurs thereafter, receive
a Purchase Right under that Offering, which Purchase Right will thereafter be deemed to be a part of that Offering. Such Purchase Right
will have the same characteristics as any Purchase Rights originally granted under that Offering, as described herein, except that:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 62.15pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 1in">(i) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
date on which such Purchase Right is granted will be the &#8220;Offering Date&#8221; of such Purchase Right for all purposes, including
determination of the exercise price of such Purchase Right;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 62.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
period of the Offering with respect to such Purchase Right will begin on its Offering Date and end coincident with the end of such Offering;
and</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 62.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Board may provide that if such person first becomes an Eligible Employee
within a specified period of time before the end of the Offering, he or she will not receive any Purchase Right under that Offering.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Employee will be eligible for the grant of any Purchase Rights under the 423 Component if, immediately after any such Purchase Rights
are granted, such Employee owns shares possessing five percent or more of the total combined voting power or value of all classes of shares
of the Company or of any Related Corporation. For purposes of this Section&nbsp;5(c), the rules&nbsp;of Section&nbsp;424(d)&nbsp;of
the Code will apply in determining the share ownership of any Employee, and shares which such Employee may purchase under all outstanding
Purchase Rights and options will be treated as shares owned by such Employee.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(d) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
specified by Section&nbsp;423(b)(8)&nbsp;of the Code, an Eligible Employee may be granted Purchase Rights under the 423 Component only
if such Purchase Rights, together with any other rights granted under all Employee Share Purchase Plans of the Company and any Related
Corporations, do not permit such Eligible Employee&#8217;s rights to purchase shares of the Company or any Related Corporation to accrue
at a rate which, when aggregated, exceeds US $25,000 of Fair Market Value of such shares (determined at the time such rights are granted,
and which, with respect to the Plan, will be determined as of their respective Offering Dates) for each calendar year in which such rights
are outstanding at any time.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(e) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Officers
of the Company and any Designated Company, if they are otherwise Eligible Employees, will be eligible to participate in Offerings under
the Plan. Notwithstanding the foregoing, the Board may (unless prohibited by Applicable Law) provide in an Offering that Employees who
are highly compensated Employees within the meaning of Section&nbsp;423(b)(4)(D)&nbsp;of the Code will not be eligible to participate.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(f) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
anything in this Section&nbsp;5 to the contrary, in the case of an Offering under the Non-423 Component, an Eligible Employee (or group
of Eligible Employees) may be excluded from participation in the Plan or an Offering if the Board has determined, in its sole discretion,
that participation of such Eligible Employee(s)&nbsp;is not advisable or practical for any reason.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">6.</FONT></TD><TD>PURCHASE RIGHTS; PURCHASE PRICE.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
each Offering Date, each Eligible Employee, pursuant to an Offering made under the Plan, will be granted a Purchase Right to purchase
up to that number of Common Shares purchasable either with a percentage or with a maximum dollar amount, as designated by the Board, but
in either case not exceeding 15% of such Employee&#8217;s earnings (as defined by the Board in each Offering) during the period that begins
on the Offering Date (or such later date as the Board determines for a particular Offering) and ends on the date stated in the Offering,
which date will be no later than the end of the Offering.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board will establish one or more Purchase Dates during an Offering on which Purchase Rights granted for that Offering will be exercised
and Common Shares will be purchased in accordance with such Offering.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with each Offering made under the Plan, the Board shall specify a maximum number of Common Shares that may be purchased by
any Participant on any Purchase Date during such Offering,&nbsp; and may specify (i)&nbsp;a maximum aggregate number of Common Shares
that may be purchased by all Participants pursuant to such Offering and/or (ii)&nbsp;a maximum aggregate number of Common Shares that
may be purchased by all Participants on any Purchase Date under the Offering. If the aggregate purchase of Common Shares issuable upon
exercise of Purchase Rights granted under the Offering would exceed any such maximum aggregate number, then, in the absence of any Board
action otherwise, a pro rata (based on each Participant&#8217;s accumulated Contributions) allocation of the Common Shares (rounded down
to the nearest whole share) available will be made in as nearly a uniform manner as will be practicable and equitable.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(d) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
purchase price of Common Shares acquired pursuant to Purchase Rights will be specified by Board prior to the commencement of an Offering
and will not be less than the lesser of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="text-indent: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> (i) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;an amount equal to 85% of the Fair Market Value of the Common Shares on the Offering Date; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>





<P STYLE="text-indent: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> (ii) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;an amount equal to 85% of the Fair Market Value of the Common Shares on the applicable Purchase Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>





<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">7.</FONT></TD><TD>PARTICIPATION; WITHDRAWAL; TERMINATION.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
Eligible Employee may elect to participate in an Offering and authorize payroll deductions as the means of making Contributions by completing
and delivering to the Company or a Company Designee, within the time specified for the Offering, an enrollment form provided by the Company
or Company Designee. The enrollment form will specify the amount of Contributions not to exceed the maximum amount specified by the Board.
Each Participant&#8217;s Contributions will be credited to a bookkeeping account for such Participant under the Plan and will be deposited
with the general funds of the Company except where Applicable Law requires that Contributions be deposited with a third party. If permitted
in the Offering, a Participant may begin such Contributions with the first payroll occurring on or after the Offering Date (or, in the
case of a payroll date that occurs after the end of the prior Offering but before the Offering Date of the next new Offering, Contributions
from such payroll will be included in the new Offering). If permitted in the Offering, a Participant may thereafter reduce (including
to zero) or increase his or her Contributions. If required under Applicable Law or if specifically provided in the Offering and to extent
permitted by Section&nbsp;423 of the Code with respect to the 423 Component, in addition to or instead of making Contributions by payroll
deductions, a Participant may make Contributions through payment by cash, check or wire transfer prior to a Purchase Date.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
an Offering, a Participant may cease making Contributions and withdraw from the Offering by delivering to the Company or a Company Designee
a withdrawal form provided by the Company. The Company may impose a deadline before a Purchase Date for withdrawing. Upon such withdrawal,
such Participant&#8217;s Purchase Right in that Offering will immediately terminate and the Company will distribute as soon as practicable
to such Participant all of his or her accumulated but unused Contributions and such Participant&#8217;s Purchase Right in that Offering
shall thereupon terminate. A Participant&#8217;s withdrawal from that Offering will have no effect upon his or her eligibility to participate
in any other Offerings under the Plan, but such Participant will be required to deliver a new enrollment form to participate in subsequent
Offerings.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
otherwise required by Applicable Law, Purchase Rights granted pursuant to any Offering under the Plan will terminate immediately if the
Participant either (i)&nbsp;is no longer an Employee for any reason or for no reason (subject to any post-employment participation period
required by Applicable Law) or (ii)&nbsp;is otherwise no longer eligible to participate. The Company will distribute as soon as practicable
to such individual all of his or her accumulated but unused Contributions.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(d)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise determined by the Board, a Participant
whose employment transfers or whose employment terminates with an immediate rehire (with no break in service) by or between the
Company and a Designated Company or between Designated Companies will not be treated as having terminated employment for purposes of
participating in the Plan or an Offering; however, if a Participant transfers from an Offering under the 423 Component to an
Offering under the Non-423 Component, the exercise of the Participant&#8217;s Purchase Right will be qualified under the 423
Component only to the extent such exercise complies with Section&nbsp;423 of the Code. If a Participant transfers from an Offering
under the Non-423 Component to an Offering under the 423 Component, the exercise of the Purchase Right will remain non-qualified
under the Non-423 Component. The Board may establish different and additional rules&nbsp;governing transfers between separate
Offerings within the 423 Component and between Offerings under the 423 Component and Offerings under the Non-423 Component.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(e) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
a Participant&#8217;s lifetime, Purchase Rights will be exercisable only by such Participant. Purchase Rights are not transferable by
a Participant, except by will, by the laws of descent and distribution, or, if permitted by the Company, by a beneficiary designation
as described in Section&nbsp;10.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(f) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
otherwise specified in the Offering or as required by Applicable Law, the Company will have no obligation to pay interest on Contributions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">8.</FONT></TD><TD>EXERCISE OF PURCHASE RIGHTS.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
each Purchase Date, each Participant&#8217;s accumulated Contributions will be applied to the purchase of Common Shares, up to the maximum
number of Common Shares permitted by the Plan and the applicable Offering, at the purchase price specified in the Offering. No fractional
shares will be issued unless specifically provided for in the Offering.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
otherwise provided in the Offering, if any amount of accumulated Contributions remains in a Participant&#8217;s account after the purchase
of Common Shares on the final Purchase Date of an Offering, then such remaining amount will not roll over to the next Offering and will
instead be distributed in full to such Participant after the final Purchase Date of such Offering without interest (unless otherwise required
by Applicable Law).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Purchase Rights may be exercised to any extent unless the Common Shares to be issued upon such exercise under the Plan are covered by
an effective registration statement pursuant to the Securities Act and the Plan is in material compliance with all applicable U.S. federal
and state, foreign and other securities, exchange control and other laws applicable to the Plan. If on a Purchase Date the Common Shares
are not so registered or the Plan is not in such compliance, no Purchase Rights will be exercised on such Purchase Date, and, subject
to Section&nbsp;423 of the Code with respect to the 423 Component, the Purchase Date will be delayed until the Common Shares are subject
to such an effective registration statement and the Plan is in material compliance, except that the Purchase Date will in no event be
more than 27 months from the Offering Date. If, on the Purchase Date, as delayed to the maximum extent permissible, the Common Shares
are not registered and the Plan is not in material compliance with all Applicable Laws, as determined by the Company in its sole discretion,
no Purchase Rights will be exercised and all accumulated but unused Contributions will be distributed to the Participants without interest
(unless the payment of interest is otherwise required by Applicable Law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">9.</FONT></TD><TD>COVENANTS OF THE COMPANY.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">The Company
will seek to obtain from each U.S. federal or state, foreign or other regulatory commission, agency or other Governmental Body having
jurisdiction over the Plan such authority as may be required to grant Purchase Rights and issue and sell Common Shares thereunder unless
the Company determines, in its sole discretion, that doing so is not practical or would cause the Company to incur costs that are unreasonable.
If, after commercially reasonable efforts, the Company is unable to obtain the authority that counsel for the Company deems necessary
for the grant of Purchase Rights or the lawful issuance and sale of Common Shares under the Plan, and at a commercially reasonable cost,
the Company will be relieved from any liability for failure to grant Purchase Rights and/or to issue and sell Common Shares upon exercise
of such Purchase Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15.5pt">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">10.</FONT></TD><TD>DESIGNATION OF BENEFICIARY.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company may, but is not obligated to, permit a Participant to submit a form designating a beneficiary who will receive any Common Shares
and/or Contributions from the Participant&#8217;s account under the Plan if the Participant dies before such shares and/or Contributions
are delivered to the Participant. The Company may, but is not obligated to, permit the Participant to change such designation of beneficiary.
Any such designation and/or change must be on a form approved by the Company.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
a Participant dies, and in the absence of a valid beneficiary designation, the Company will deliver any Common Shares and/or Contributions
to the executor or administrator of the estate of the Participant. If no executor or administrator has been appointed (to the knowledge
of the Company), the Company, in its sole discretion, may deliver such Common Shares and/or Contributions, without interest (unless the
payment of interest is otherwise required by Applicable Law), to the Participant&#8217;s spouse, dependents or relatives, or if no spouse,
dependent or relative is known to the Company, then to such other person as the Company may designate.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">11.</FONT></TD><TD>ADJUSTMENTS UPON CHANGES IN COMMON SHARES CORPORATE TRANSACTIONS.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event of a Capitalization Adjustment, the Board will appropriately and proportionately adjust: (i)&nbsp;the class(es) and maximum
number of securities subject to the Plan pursuant to Section&nbsp;3(a), (ii)&nbsp;the class(es) and maximum number of securities by
which the share reserve is to increase each year pursuant to Section&nbsp;3(a), (iii)&nbsp;the class(es) and number of securities subject
to, and the purchase price applicable to outstanding Offerings and Purchase Rights, and (iv)&nbsp;the class(es) and number of securities
that are the subject of the purchase limits under each ongoing Offering. The Board will make these adjustments, and its determination
will be final, binding and conclusive.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event of a Corporate Transaction, then: (i)&nbsp;any surviving corporation or acquiring corporation (or the surviving or acquiring
corporation&#8217;s parent company) may assume or continue outstanding Purchase Rights or may substitute similar rights (including a right
to acquire the same consideration paid to the shareholders in the Corporate Transaction) for outstanding Purchase Rights, or (ii)&nbsp;if
any surviving or acquiring corporation (or its parent company) does not assume or continue such Purchase Rights or does not substitute
similar rights for such Purchase Rights, then the Participants&#8217; accumulated Contributions will be used to purchase Common Shares
(rounded down to the nearest whole share) within ten business days (or such other period specified by the Board) prior to the Corporate
Transaction under the outstanding Purchase Rights, and the Purchase Rights will terminate immediately after such purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">12.</FONT></TD><TD>AMENDMENT, TERMINATION OR SUSPENSION OF THE PLAN.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board may amend the Plan at any time in any respect the Board deems necessary or advisable. However, except as provided in Section&nbsp;11(a)&nbsp;relating
to Capitalization Adjustments, shareholder approval will be required for any amendment of the Plan for which shareholder approval is required
by Applicable Law.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board may suspend or terminate the Plan at any time. No Purchase Rights may be granted under the Plan while the Plan is suspended or after
it is terminated.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">Any benefits,
privileges, entitlements and obligations under any outstanding Purchase Rights granted before an amendment, suspension or termination
of the Plan will not be materially impaired by any such amendment, suspension or termination except (i)&nbsp;with the consent of the
person to whom such Purchase Rights were granted, (ii)&nbsp;as necessary to facilitate compliance with any laws, listing requirements,
or governmental regulations (including,&nbsp;without limitation, the provisions of Section&nbsp;423 of the Code and the regulations
and other interpretive guidance issued thereunder relating to Employee Share Purchase Plans) including without limitation any such regulations
or other guidance that may be issued or amended after the date the Plan is adopted by the Board, or (iii)&nbsp;as necessary to obtain
or maintain favorable tax, listing, or regulatory treatment. To be clear, the Board may amend outstanding Purchase Rights without a Participant&#8217;s
consent if such amendment is necessary to ensure that the Purchase Right and/or the Plan complies with the requirements of Section&nbsp;423
of the Code with respect to the 423 Component or with respect to other Applicable Laws.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">Notwithstanding
anything in the Plan or any Offering Document to the contrary, the Board will be entitled to: (i)&nbsp;establish the exchange ratio applicable
to amounts withheld in a currency other than U.S.&nbsp;dollars; (ii)&nbsp;permit Contributions in excess of the amount designated by
a Participant in order to adjust for mistakes in the Company&#8217;s processing of properly completed Contribution elections; (iii)&nbsp;establish
reasonable waiting and adjustment periods and/or accounting and crediting procedures to ensure that amounts applied toward the purchase
of Common Shares for each Participant properly correspond with amounts withheld from the Participant&#8217;s Contributions; (iv)&nbsp;amend
any outstanding Purchase Rights or clarify any ambiguities regarding the terms of any Offering to enable the Purchase Rights to qualify
under and/or comply with Section&nbsp;423 of the Code with respect to the 423 Component; and (v)&nbsp;establish other limitations or
procedures as the Board determines in its sole discretion advisable that are consistent with the Plan. The actions of the Board pursuant
to this paragraph will not be considered to alter or impair any Purchase Rights granted under an Offering as they are part of the initial
terms of each Offering and the Purchase Rights granted under each Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">13.</FONT></TD><TD>TAX QUALIFICATION; TAX WITHHOLDING.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Although
the Company may endeavor to (i)&nbsp;qualify a Purchase Right for special tax treatment under the laws of the United States or jurisdictions
outside of the United States or (ii)&nbsp;avoid adverse tax treatment, the Company makes no representation to that effect and expressly
disavows any covenant to maintain special or to avoid unfavorable tax treatment, notwithstanding anything to the contrary in this Plan.
The Company will be unconstrained in its corporate activities without regard to the potential negative tax impact on Participants.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Participant will make arrangements, satisfactory to the
Company and any applicable Related Corporation, to enable the Company or the Related Corporation to fulfill any withholding
obligation for Tax-Related Items. Without limitation to the foregoing, in the Company&#8217;s sole discretion and subject to
Applicable Law, such withholding obligation may be satisfied in whole or in part by (i)&nbsp;withholding from the
Participant&#8217;s salary or any other cash payment due to the Participant from the Company or a Related Corporation;
(ii)&nbsp;withholding from the proceeds of the sale of Common Shares acquired under the Plan, either through a voluntary sale or a
mandatory sale arranged by the Company; or (iii)&nbsp;any other method deemed acceptable by the Board. The Company shall not be
required to issue any Common Shares under the Plan until such obligations are satisfied.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
423 Component is exempt from the application of Section&nbsp;409A of the Code, and any ambiguities herein shall be interpreted to so
be exempt from Section&nbsp;409A and Section&nbsp;457A of the Code. The Non-423 Component is intended to be exempt from the application
of Section&nbsp;409A and Section&nbsp;457A of the Code under the short-term deferral exception and any ambiguities shall be construed
and interpreted in accordance with such intent. In furtherance of the foregoing and notwithstanding any provision in the Plan to the contrary,
if the Committee determines that an option granted under the Plan may be subject to Section&nbsp;409A and/or Section&nbsp;457A of the
Code or that any provision in the Plan would cause an option under the Plan to be subject to Section&nbsp;409A and/or Section&nbsp;457A,
the Committee may amend the terms of the Plan and/or of an outstanding option granted under the Plan, or take such other action the Committee
determines is necessary or appropriate, in each case, without the participant&#8217;s consent, to exempt any outstanding option or future
option that may be granted under the Plan from or to allow any such options to comply with Section&nbsp;409A and/or Section&nbsp;457A
of the Code, but only to the extent any such amendments or action by the Committee would not violate Section&nbsp;409A or Section&nbsp;457A
of the Code. Notwithstanding the foregoing, the Company shall have no liability to a participant or any other party if the option under
the Plan that is intended to be exempt from or compliant with Section&nbsp;409A and/or Section&nbsp;457A of the Code is not so exempt
or compliant or for any action taken by the Committee with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">14.</FONT></TD><TD>EFFECTIVE DATE OF PLAN.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">The Plan
will become effective immediately prior to and contingent upon the Effective Date. No Purchase Rights will be exercised unless and until
the Plan has been approved by the shareholders of the Company, which approval must be within 12 months before or after the date the Plan
is adopted (or if required under Section&nbsp;12(a)&nbsp;above, materially amended) by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">15.</FONT></TD><TD>MISCELLANEOUS PROVISIONS.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from the sale of Common Shares pursuant to Purchase Rights will constitute general funds of the Company.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(b)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A Participant will not be deemed to be the holder of, or to
have any of the rights of a holder with respect to, Common Shares subject to Purchase Rights unless and until the
Participant&#8217;s Common Shares acquired upon exercise of Purchase Rights are recorded in the books of the Company (or its
transfer agent).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Plan and Offering do not constitute an employment contract. Nothing in the Plan or in the Offering will in any way alter the at will nature
of a Participant&#8217;s employment or amend a Participant&#8217;s employment contract, if applicable, or be deemed to create in any way
whatsoever any obligation on the part of any Participant to continue in the employ of the Company or a Related Corporation or an Affiliate,
or on the part of the Company, a Related Corporation or an Affiliate to continue the employment of a Participant.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(d) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Plan and any documents hereunder shall be interpreted and construed in accordance with the laws of the Cayman Islands (without regard
to its choice of law provisions). Any reference in this Plan or in any document to a provision of law or to a rule&nbsp;or regulation
shall be deemed to include any successor law, rule&nbsp;or regulation of similar effect or applicability.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(e) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
any particular provision of the Plan is found to be invalid or otherwise unenforceable, such provision will not affect the other provisions
of the Plan, but the Plan will be construed in all respects as if such invalid provision were omitted.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">(f) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
any provision of the Plan does not comply with Applicable Law, such provision shall be construed in such a manner as to comply with Applicable
Law.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">16.</TD><TD STYLE="text-align: justify">DEFINITIONS.</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">As used in the Plan, the following definitions will apply
to the capitalized terms indicated below:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>423 Component</I></B>&#8221;
means the part of the Plan, which excludes the Non-423 Component, pursuant to which Purchase Rights that satisfy the requirements
for an Employee Share Purchase Plan may be granted to Eligible Employees.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Affiliate</I></B>&#8221;&nbsp;means
any entity, other than a Related Corporation, whether now or subsequently established, which is at the time of determination, a &#8220;parent&#8221;
or &#8220;subsidiary&#8221; of the Company as such terms are defined in Rule&nbsp;405 promulgated under the Securities Act. The Board
may determine the time or times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Applicable
Law</I></B>&#8221; means shall mean the Code and any applicable securities, federal, state, foreign, material local or municipal or other
law, statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, listing rule, regulation, judicial
decision, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority
of any Governmental Body (or under the authority of the NASDAQ Stock Market, the New York Stock Exchange or the Financial Industry Regulatory
Authority).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Board</I></B>&#8221;<I>&nbsp;</I>means the
board of directors of the Company.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Capitalization
Adjustment</I></B>&#8221; means any change that is made in, or other events that occur with respect to, the Common Shares subject to
the Plan or subject to any Purchase Right after the date the Plan is adopted by the Board without the receipt of consideration by
the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property
other than cash, large nonrecurring cash dividend, stock split, liquidating dividend, combination of shares, exchange of shares,
change in corporate structure or other similar equity restructuring transaction, as that term is used in Financial Accounting
Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the
conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Code</I></B>&#8221;<I>&nbsp;</I>means the
U.S. Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder<I>.</I></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Committee</I></B>&#8221;<I>&nbsp;</I>means
a committee of one or more members of the Board to whom authority has been delegated by the Board in accordance with
Section&nbsp;2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Common Share</I></B>&#8221; means shares of
the Company&#8217;s common stock, par value $0.0001.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Company</I></B>&#8221;
means Zura Bio Limited, a Cayman Islands exempted company formerly known as JATT Acquisition Corp, and except as utilized in the
definition of Change in Control, any successor corporation.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><I>&#8220;<B>Contributions</B></I>&#8221;
means the payroll deductions and other additional payments specifically provided for in the Offering that a Participant contributes to
fund the exercise of a Purchase Right. A Participant may make additional payments into his or her account if specifically provided for
in the Offering, and then only if the Participant has not already had the maximum permitted amount withheld during the Offering through
payroll deductions and, with respect to the 423 Component, to the extent permitted by Section&nbsp;423 of the Code.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Corporate Transaction</I></B>&#8221;
means the consummation, in a single transaction or in a series of related transactions, of any one or more of the following events:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(i) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
sale or other disposition of all or substantially all, as determined by the Board in its sole discretion, of the consolidated assets
of the Company and its subsidiaries;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(ii) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a sale or other disposition of more than 50% of the outstanding securities of the Company;</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(iii) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(iv)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a merger, consolidation or similar transaction following which the
Company is the surviving corporation but the Common Shares outstanding immediately preceding the merger, consolidation or similar
transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property, whether in
the form of securities, cash or otherwise.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>- &#8220;<I>Designated 423 Corporation</I>&#8221;</B>&nbsp;means
any Related Corporation selected by the Board to participate in the 423 Component.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>&#8220;<I>Designated
Company</I>&#8221;&nbsp;</B>means any Designated Non-423 Corporation or Designated 423 Corporation, provided, however, that at any
given time, a Related Corporation participating in the 423 Component shall not be a Related Corporation participating in the Non-423
Component.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>- &#8220;<I>Designated Non-423 Corporation</I>&#8221;</B>&nbsp;means
any Related Corporation or Affiliate selected by the Board to participate in the Non-423 Component.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Director</I></B>&#8221;<I>&nbsp;</I>means
a member of the Board.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>-</B>&#8220;<B><I>Effective
Date</I></B>&#8221; means the date on which the Plan takes effect, which is the date of the closing of the transactions contemplated
by the Business Combination Agreement by and among JATT Acquisition Corp, JATT Merger Sub, JATT Merger Sub 2, Zura Bio Holdings Ltd
and Zura Bio Limited, dated as of June&nbsp;16, 2022, provided that this Plan is approved by the JATT&#8217;s shareholders prior to
such date.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>-</B>&#8220;<B><I>Eligible
Employee</I></B>&#8221;<I>&nbsp;</I>means an Employee who meets the requirements set forth in the document(s)&nbsp;governing the Offering
for eligibility to participate in the Offering, provided that such Employee also meets the requirements for eligibility to participate
set forth in the Plan.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Employee</I></B>&#8221;<I>&nbsp;</I>means
any person, including an Officer or Director, who is &#8220;employed&#8221; for purposes of Section&nbsp;423(b)(4)&nbsp;of the Code
by the Company or a Related Corporation, or solely with respect to the Non-423 Component, an Affiliate. However, service solely as a Director,
or payment of a fee for such services, will not cause a Director to be considered an &#8220;Employee&#8221; for purposes of the Plan.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Employee Share
Purchase Plan</I></B>&#8221;<I>&nbsp;</I>means a plan that grants Purchase Rights intended to be options issued under an &#8220;employee
stock purchase plan,&#8221; as that term is defined in Section&nbsp;423(b)&nbsp;of the Code.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>-</B>&#8220;<B><I>Exchange Act</I></B>&#8221;<I>&nbsp;</I>means
the U.S. Securities Exchange Act of 1934, as amended and the rules&nbsp;and regulations promulgated thereunder.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Fair Market Value</I></B>&#8221; means, as
of any date, the value of a Common Share determined as follows:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; text-indent: 1in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(i)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the Common Shares are listed on any established stock
exchange or traded on any established market, the Fair Market Value of a Common Share will be the closing sales price for such share
as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the Common Shares) on the
date of determination, as reported in such source as the Board deems reliable. Unless otherwise provided by the Board, if there is
no closing sales price for the Common Shares on the date of determination, then the Fair Market Value will be the closing sales
price on the last preceding date for which such quotation exists.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 62.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the absence of such markets for the Common Shares, the Fair Market Value will be determined by the Board in good faith in compliance
with Applicable Laws and regulations and, to the extent applicable as determined in the sole discretion of the Board, in a manner that
complies with Sections 409A of the Code</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Governmental</I>&nbsp;<I>Body</I></B>&#8221;
means any: (a)&nbsp;nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature;
(b)&nbsp;federal, state, local, municipal, foreign or other government; (c)&nbsp;governmental or regulatory body, or quasi-governmental
body of any nature (including any governmental division, department, administrative agency or bureau, commission, authority, instrumentality,
official, ministry, fund, foundation, center, organization, unit, body or entity and any court or other tribunal, and for the avoidance
of doubt, any tax authority) or other body exercising similar powers or authority; or (d)&nbsp;self-regulatory organization (including
the NASDAQ Stock Market, the New York Stock Exchange and the Financial Industry Regulatory Authority).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Non-423 Component</I></B>&#8221;
means the part of the Plan, which excludes the 423 Component, pursuant to which Purchase Rights that are not intended to satisfy the requirements
for an Employee Share Purchase Plan may be granted to Eligible Employees.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.05pt">&#8220;<B><I>Offering</I></B>&#8221;<I>&nbsp;</I>means
the grant to Eligible Employees of Purchase Rights, with the exercise of those Purchase Rights automatically occurring at the end of one
or more Purchase Periods. The terms and conditions of an Offering will generally be set forth in the &#8220;<B><I>Offering Document</I></B>&#8221;
approved by the Board for that Offering.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Offering Date</I></B>&#8221; means a date
selected by the Board for an Offering to commence.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Officer</I></B>&#8221;<B>&nbsp;</B>means<B>&nbsp;</B>a
person who is an officer of the Company or a Related Corporation within the meaning of Section&nbsp;16 of the Exchange Act.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Participant</I></B>&#8221;<I>&nbsp;</I>means
an Eligible Employee who holds an outstanding Purchase Right.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Plan</I></B>&#8221;<I>&nbsp;</I>means
this Zura Bio Limited 2023 Employee Share Purchase Plan, as amended from time to time, including both the 423 Component and the
Non-423 Component.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Purchase Date</I></B>&#8221;<I>&nbsp;</I>means
one or more dates during an Offering selected by the Board on which Purchase Rights will be exercised and on which purchases of Common
Shares will be carried out in accordance with such Offering.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Purchase Period</I></B>&#8221;
means a period of time specified within an Offering, generally beginning on the Offering Date or on the first Trading Day following a
Purchase Date, and ending on a Purchase Date. An Offering may consist of one or more Purchase Periods.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Purchase Right</I></B>&#8221;<I>&nbsp;</I>means
an option to purchase Common Shares granted pursuant to the Plan.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Related
Corporation</I></B>&#8221;<I>&nbsp;</I>means any &#8220;parent corporation&#8221; or &#8220;subsidiary corporation&#8221; of the Company
whether now or subsequently established, as those terms are defined in Sections 424(e)&nbsp;and (f), respectively, of the Code.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Securities Act</I></B>&#8221;<I>&nbsp;</I>means
the U.S. Securities Act of 1933, as amended.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Tax-Related
Items</I></B>&#8221; means any income tax, social insurance, payroll tax, fringe benefit tax, payment on account or other
tax-related items arising out of or in relation to a Participant&#8217;s participation in the Plan, including, but not limited to,
the exercise of a Purchase Right and the receipt of Common Shares or the sale or other disposition of Common Shares acquired under
the Plan.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 31.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#8220;<B><I>Trading Day</I></B>&#8221;<B>&nbsp;</B>means
any day on which the exchange(s)&nbsp;or market(s)&nbsp;on which the Common Shares are listed, including but not limited to the New
York Stock Exchange, Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market or any successors thereto, is open
for trading.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>6
<FILENAME>tm2310353d1_ex10-13.htm
<DESCRIPTION>EXHIBIT 10.13
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 10.13</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">INDEMNITY AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 35.95pt">THIS INDEMNITY
AGREEMENT (the &#8220;<B>Agreement</B>&#8221;) is made and entered into as of March 20, 2023 between Zura Bio Limited, a Cayman Islands
exempted company (the &#8220;<B>Company</B>&#8221;), and the undersigned indemnified party (&#8220;<B>Indemnitee</B>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">WITNESSETH THAT<FONT STYLE="font-weight: normal">:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>,
highly competent persons have become more reluctant to serve companies and corporations as directors or in other capacities unless they
are provided with adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions against
them arising out of their service to and activities on behalf of the company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>,
the Board of Directors of the Company (the &#8220;<B>Board</B>&#8221;) has determined that, in order to attract and retain qualified individuals,
the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company
and its subsidiaries from certain liabilities. Although the furnishing of such insurance has been a customary and widespread practice
among United States-based corporations, companies and other business enterprises, the Company believes that, given current market conditions
and trends, such insurance may be available to it in the future only at higher premiums and with more exclusions. At the same time, directors,
officers, and other persons in service to corporations, companies or business enterprises are being increasingly subjected to expensive
and time-consuming litigation relating to, among other things, matters that traditionally would have been brought only against the Company
or business enterprise itself. The Second Amended and Restated Memorandum and Articles of Association of the Company (the &#8220;Articles&#8221;)
requires indemnification of the officers and directors of the Company. The Articles expressly provide that the indemnification provisions
set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between the Company and members of the
Board, officers and other persons with respect to indemnification;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>,
the uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such persons;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>,
the Board has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests of
the Company&#8217;s shareholders and that the Company should act to assure such persons that there will be increased certainty of such
protection in the future;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, it is
reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses on behalf of,
such persons to the fullest extent permitted by the Articles so that they will serve or continue to serve the Company free from undue
concern that they will not be so indemnified;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>,
this Agreement is a supplement to and in furtherance of the Articles and any resolutions adopted pursuant thereto, and shall not be deemed
a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>,
Indemnitee does not regard the protection available under the Articles and insurance as adequate in the present circumstances, and may
not be willing to serve as an officer or director without adequate protection, and the Company desires Indemnitee to serve in such capacity.
Indemnitee is willing to serve, continue to serve and to take on additional service for or on behalf of the Company on the condition that
he be so indemnified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>,
in consideration of Indemnitee&#8217;s agreement to serve as a director from and after the date hereof, the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">1.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Indemnity of Indemnitee</U>. The Company hereby agrees to hold harmless and indemnify Indemnitee to the fullest extent
permitted by the Articles, as such may be amended from time to time. In furtherance of the foregoing indemnification, and without limiting
the generality thereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></FONT><U>Proceedings
Other Than Proceedings by or in the Right of the Company</U>. Indemnitee shall be entitled to the rights of indemnification provided
in this <U>Section 1(a)</U> if, by reason of his Corporate Status (as hereinafter defined), the Indemnitee is, or is threatened to
be made, a party to or participant in any Proceeding (as hereinafter defined) other than a Proceeding by or in the right of the
Company. Pursuant to this <U>Section 1(a)</U>, Indemnitee shall be indemnified against all Expenses (as hereinafter defined),
judgments, penalties, fines and amounts paid in settlement actually and reasonably incurred by him, or on his behalf, in connection
with such Proceeding or any claim, issue or matter therein, if the Indemnitee acted in good faith and in a manner the Indemnitee
reasonably believed to be in or not opposed to the best interests of the Company, and with respect to any criminal Proceeding, had
no reasonable cause to believe the Indemnitee&#8217;s conduct was unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Proceedings by or in the Right of the Company</U>. Indemnitee shall be entitled to the rights of indemnification provided
in this <U>Section 1(b)</U> if, by reason of his Corporate Status, the Indemnitee is, or is threatened to be made, a party to or participant
in any Proceeding brought by or in the right of the Company. Pursuant to this <U>Section 1(b)</U>, Indemnitee shall be indemnified against
all Expenses actually and reasonably incurred by the Indemnitee, or on the Indemnitee&#8217;s behalf, in connection with such Proceeding
if the Indemnitee acted in good faith and in a manner the Indemnitee reasonably believed to be in or not opposed to the best interests
of the Company; <I>provided, however</I>, if the Articles so provide, no indemnification against such Expenses shall be made in respect
of any claim, issue or matter in such Proceeding as to which Indemnitee shall have been adjudged to be liable to the Company unless and
to the extent that a state or federal court in the Borough of Manhattan in the State of New York (the &#8220;NY Court&#8221;) shall determine
that such indemnification may be made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Indemnification for Expenses of a Party Who is Wholly or Partly Successful</U>. Notwithstanding any other provision of
this Agreement, to the extent that Indemnitee is, by reason of his Corporate Status, a party to and is successful, on the merits or otherwise,
in any Proceeding, he shall be indemnified to the maximum extent permitted by the Articles, as such may be amended from time to time,
against all Expenses actually and reasonably incurred by him or on his behalf in connection therewith. If Indemnitee is not wholly successful
in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such
Proceeding, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by him or on his behalf in connection
with each successfully resolved claim, issue or matter. For purposes of this Section and without limitation, the termination of any claim,
issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim,
issue or matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">2.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Additional Indemnity</U>. In addition to, and without regard to any limitations on, the indemnification provided for
in <U>Section 1</U> of this Agreement, the Company shall and hereby does indemnify and hold harmless Indemnitee against all Expenses,
judgments, penalties, fines and amounts paid in settlement actually and reasonably incurred by him or on his behalf if, by reason of his
Corporate Status, he is, or is threatened to be made, a party to or participant in any Proceeding (including a Proceeding by or in the
right of the Company), including, without limitation, all liability arising out of the negligence or active or passive wrongdoing of Indemnitee.
The only limitation that shall exist upon the Company&#8217;s obligations pursuant to this Agreement shall be that the Company shall not
be obligated to make any payment to Indemnitee that is finally determined (under the procedures, and subject to the presumptions, set
forth in <U>Sections 6</U> and <U>7</U> hereof) to be unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="color: #010000">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> <U>Contribution</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Whether or not the indemnification provided in <U>Sections 1</U> and <U>2</U> hereof is available, in respect of any threatened,
pending or completed action, suit or proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such
action, suit or proceeding), the Company shall pay, in the first instance, the entire amount of any judgment or settlement of such action,
suit or proceeding without requiring Indemnitee to contribute to such payment and the Company hereby waives and relinquishes any right
of contribution it may have against Indemnitee. The Company shall not enter into any settlement of any action, suit or proceeding in which
the Company is jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding) unless such settlement provides
for a full and final release of all claims asserted against Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></FONT>Without
diminishing or impairing the obligations of the Company set forth in the preceding subparagraph, if, for any reason, Indemnitee
shall elect or be required to pay all or any portion of any judgment or settlement in any threatened, pending or completed action,
suit or proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such action, suit or
proceeding), the Company shall contribute to the amount of Expenses, judgments, fines and amounts paid in settlement actually and
reasonably incurred and paid or payable by Indemnitee in proportion to the relative benefits received by the Company and all
officers, directors or employees of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if
joined in such action, suit or proceeding), on the one hand, and Indemnitee, on the other hand, from the transaction or events from
which such action, suit or proceeding arose; <I>provided, however</I>, that the proportion determined on the basis of relative
benefit may, to the extent necessary to conform to law, be further adjusted by reference to the relative fault of the Company and
all officers, directors or employees of the Company other than Indemnitee who are jointly liable with Indemnitee (or would be if
joined in such action, suit or proceeding), on the one hand, and Indemnitee, on the other hand, in connection with the transaction
or events that resulted in such expenses, judgments, fines or settlement amounts, as well as any other equitable considerations
which the Articles may require to be considered. The relative fault of the Company and all officers, directors or employees of the
Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding),
on the one hand, and Indemnitee, on the other hand, shall be determined by reference to, among other things, the degree to which
their actions were motivated by intent to gain personal profit or advantage, the degree to which their liability is primary or
secondary and the degree to which their conduct is active or passive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company hereby agrees to fully indemnify and hold Indemnitee harmless from any claims of contribution which may be brought
by officers, directors or employees of the Company, other than Indemnitee, who may be jointly liable with Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>To the fullest extent permitted by the Articles, if the indemnification provided for in this Agreement is unavailable to
Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee,
whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses, in connection with
any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all
of the circumstances of such Proceeding in order to reflect (i) the relative benefits received by the Company and Indemnitee as a result
of the event(s) and/or transaction(s) giving cause to such Proceeding; and/or (ii) the relative fault of the Company (and its directors,
officers, employees and agents) and Indemnitee in connection with such event(s) and/or transaction(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Indemnification for Expenses of a Witness</U>. Notwithstanding any other provision of this Agreement, to the extent that
Indemnitee is, by reason of his Corporate Status, a witness, or is made (or asked) to respond to discovery requests, in any Proceeding
to which Indemnitee is not a party, he shall be indemnified against all Expenses actually and reasonably incurred by him or on his behalf
in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Advancement of Expenses</U>. Notwithstanding any other provision of this Agreement, the Company shall advance all Expenses
incurred by or on behalf of Indemnitee in connection with any Proceeding by reason of Indemnitee&#8217;s Corporate Status within thirty
(30) days after the receipt by the Company of a statement or statements from Indemnitee requesting such advance or advances from time
to time, whether prior to or after final disposition of such Proceeding. Such statement or statements shall reasonably evidence the Expenses
incurred by Indemnitee and shall include or be preceded or accompanied by a written undertaking by or on behalf of Indemnitee to repay
any Expenses advanced if it shall ultimately be determined that Indemnitee is not entitled to be indemnified against such Expenses. Any
advances and undertakings to repay pursuant to this <U>Section 5</U> shall be unsecured and interest free.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Procedures and Presumptions for Determination of Entitlement to Indemnification</U>. It is the intent of this Agreement
to secure for Indemnitee rights of indemnity that are as favorable as may be permitted under the Articles. Accordingly, the parties agree
that the following procedures and presumptions shall apply in the event of any question as to whether Indemnitee is entitled to indemnification
under this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>To obtain indemnification under this Agreement, Indemnitee shall submit to the Company a written request, including therein
or therewith such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether
and to what extent Indemnitee is entitled to indemnification. The Secretary of the Company shall, promptly upon receipt of such a request
for indemnification, advise the Board in writing that Indemnitee has requested indemnification. Notwithstanding the foregoing, any failure
of Indemnitee to provide such a request to the Company, or to provide such a request in a timely fashion, shall not relieve the Company
of any liability that it may have to Indemnitee unless, and to the extent that, such failure actually and materially prejudices the interests
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></FONT>Upon
written request by Indemnitee for indemnification pursuant to the first sentence of <U>Section 6(a)</U> hereof, a determination with
respect to Indemnitee&#8217;s entitlement thereto shall be made in the specific case by one of the following four methods, which
shall be at the election of the Board: (i) by a majority vote of the disinterested directors, even though less than a quorum, (ii)
by a committee of disinterested directors designated by a majority vote of the disinterested directors, even though less than a
quorum, (iii) if there are no disinterested directors or if the disinterested directors so direct, by independent legal counsel in a
written opinion to the Board, a copy of which shall be delivered to the Indemnitee, or (iv) if so directed by the Board, by the
shareholders of the Company. For purposes hereof, disinterested directors are those members of the Board who are not parties to the
action, suit or proceeding in respect of which indemnification is sought by Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to <U>Section 6(b)</U>
hereof, the Independent Counsel shall be selected as provided in this <U>Section 6(c)</U>. The Independent Counsel shall be selected by
the Board. Indemnitee may, within ten (10) days after such written notice of selection shall have been given, deliver to the Company a
written objection to such selection; <I>provided, however</I>, that such objection may be asserted only on the ground that the Independent
Counsel so selected does not meet the requirements of &#8220;<B>Independent Counsel</B>&#8221; as defined in <U>Section 13</U> of this
Agreement, and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection,
the person so selected shall act as Independent Counsel. If a written objection is made and substantiated, the Independent Counsel selected
may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such objection is without
merit. If, within twenty (20) days after submission by Indemnitee of a written request for indemnification pursuant to <U>Section 6(a)</U>
hereof, no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition an NY Court
or other court of competent jurisdiction for resolution of any objection which shall have been made by the Indemnitee to the Company&#8217;s
selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the court or by such other
person as the court shall designate, and the person with respect to whom all objections are so resolved or the person so appointed shall
act as Independent Counsel under <U>Section 6(b)</U> hereof. The Company shall pay any and all reasonable fees and expenses of Independent
Counsel incurred by such Independent Counsel in connection with acting pursuant to <U>Section 6(b)</U> hereof, and the Company shall pay
all reasonable fees and expenses incident to the procedures of this <U>Section 6(c)</U>, regardless of the manner in which such Independent
Counsel was selected or appointed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>In making a determination with respect to entitlement to indemnification hereunder, the person or persons or entity making
such determination shall presume that Indemnitee is entitled to indemnification under this Agreement. Anyone seeking to overcome this
presumption shall have the burden of proof and the burden of persuasion by clear and convincing evidence. Neither the failure of the Company
(including by its directors or independent legal counsel) to have made a determination prior to the commencement of any action pursuant
to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor
an actual determination by the Company (including by its directors or independent legal counsel) that Indemnitee has not met such applicable
standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Indemnitee shall be deemed to have acted in good faith if Indemnitee&#8217;s action is based on the records or books of
account of the Enterprise (as hereinafter defined), including financial statements, or on information supplied to Indemnitee by the officers
of the Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise or on information or records given
or reports made to the Enterprise by an independent certified public accountant or by an appraiser or other expert selected with reasonable
care by the Enterprise. In addition, the knowledge and/or actions, or failure to act, of any director, officer, agent or employee of the
Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement. Whether or
not the foregoing provisions of this <U>Section 6(e)</U> are satisfied, it shall in any event be presumed that Indemnitee has at all times
acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Company. Anyone seeking
to overcome this presumption shall have the burden of proof and the burden of persuasion by clear and convincing evidence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></FONT>If
the person, persons or entity empowered or selected under <U>Section 6</U> to determine whether Indemnitee is entitled to
indemnification shall not have made a determination within sixty (60) days after receipt by the Company of the request therefor, the
requisite determination of entitlement to indemnification shall be deemed to have been made and Indemnitee shall be entitled to such
indemnification absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make
Indemnitee&#8217;s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of
such indemnification under the Articles; <I>provided, however</I>, that such sixty (60) day period may be extended for a reasonable
time, not to exceed an additional thirty (30) days, if the person, persons or entity making such determination with respect to
entitlement to indemnification in good faith requires such additional time to obtain or evaluate documentation and/or information
relating thereto and; <I>provided, further</I>, that the foregoing provisions of this <U>Section 6(f)</U> shall not apply if the
determination of entitlement to indemnification is to be made by the shareholders pursuant to <U>Section 6(b)</U> of this Agreement
and if (i) within fifteen (15) days after receipt by the Company of the request for such determination, the Board or the
Disinterested Directors, if appropriate, resolve to submit such determination to the shareholders for their consideration at an
annual meeting thereof to be held within seventy-five (75) days after such receipt and such determination is made thereat, or (ii) a
special meeting of shareholders is called within fifteen (15) days after such receipt for the purpose of making such determination,
such meeting is held for such purpose within sixty (60) days after having been so called and such determination is made thereat.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Indemnitee shall cooperate with the person, persons or entity making such determination with respect to Indemnitee&#8217;s
entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation
or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably
necessary to such determination. Any Independent Counsel, member of the Board or shareholders of the Company shall act reasonably and
in good faith in making a determination regarding the Indemnitee&#8217;s entitlement to indemnification under this Agreement. Any costs
or expenses (including attorneys&#8217; fees and disbursements) incurred by Indemnitee in so cooperating with the person, persons or entity
making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee&#8217;s entitlement to indemnification)
and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company acknowledges that a settlement or other disposition short of final judgment may be successful if it permits
a party to avoid expense, delay, distraction, disruption and uncertainty. In the event that any action, claim or proceeding to which Indemnitee
is a party is resolved in any manner other than by adverse judgment against Indemnitee (including, without limitation, settlement of such
action, claim or proceeding with or without payment of money or other consideration) it shall be presumed that Indemnitee has been successful
on the merits or otherwise in such action, suit or proceeding. Anyone seeking to overcome this presumption shall have the burden of proof
and the burden of persuasion by clear and convincing evidence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction,
or upon a plea of <I>nolo contendere</I> or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself
adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a
manner which he reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding,
that Indemnitee had reasonable cause to believe that his conduct was unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="color: #010000">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> <U>Remedies of Indemnitee</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>In the event that (i) a determination is made pursuant to <U>Section 6</U> of this Agreement that Indemnitee is not entitled
to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to <U>Section 5</U> of this Agreement,
(iii) no determination of entitlement to indemnification is made pursuant to <U>Section 6(b)</U> of this Agreement within ninety (90)
days after receipt by the Company of the request for indemnification, (iv) payment of indemnification is not made pursuant to this Agreement
within ten (10) days after receipt by the Company of a written request therefor, or (v) payment of indemnification is not made within
ten (10) days after a determination has been made that Indemnitee is entitled to indemnification or such determination is deemed to have
been made pursuant to <U>Section 6</U> of this Agreement, Indemnitee shall be entitled to an adjudication in an appropriate NY Court,
or in any other court of competent jurisdiction, of Indemnitee&#8217;s entitlement to such indemnification. Indemnitee shall commence
such proceeding seeking an adjudication within one hundred eighty (180) days following the date on which Indemnitee first has the right
to commence such proceeding pursuant to this <U>Section 7(a)</U>. The Company shall not oppose Indemnitee&#8217;s right to seek any such
adjudication.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>In the event that a determination shall have been made pursuant to <U>Section 6(b)</U> of this Agreement that Indemnitee
is not entitled to indemnification, any judicial proceeding commenced pursuant to this <U>Section 7</U> shall be conducted in all respects
as a <I>de novo</I> trial on the merits, and Indemnitee shall not be prejudiced by reason of the adverse determination under <U>Section
6(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>If a determination shall have been made pursuant to <U>Section 6(b)</U> of this Agreement that Indemnitee is entitled to
indemnification, the Company shall be bound by such determination in any judicial proceeding commenced pursuant to this <U>Section 7</U>,
absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee&#8217;s misstatement
not materially misleading in connection with the application for indemnification, or (ii) a prohibition of such indemnification under
the Articles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></FONT>In
the event that Indemnitee, pursuant to this <U>Section 7</U>, seeks a judicial adjudication of his rights under, or to recover
damages for breach of, this Agreement, or to recover under any directors&#8217; and officers&#8217; liability insurance policies
maintained by the Company, the Company shall pay on his behalf, in advance, any and all expenses (of the types described in the
definition of Expenses in <U>Section 13</U> of this Agreement) actually and reasonably incurred by him in such judicial
adjudication, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification, advancement of
expenses or insurance recovery.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company shall be precluded from asserting in any judicial proceeding commenced pursuant to this <U>Section 7</U> that
the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court that the
Company is bound by all the provisions of this Agreement. The Company shall indemnify Indemnitee against any and all Expenses and, if
requested by Indemnitee, shall (within ten (10) days after receipt by the Company of a written request therefore) advance, to the extent
not prohibited by the Articles, such expenses to Indemnitee, which are incurred by Indemnitee in connection with any action brought by
Indemnitee for indemnification or advance of Expenses from the Company under this Agreement or under any directors&#8217; and officers&#8217;
liability insurance policies maintained by the Company, regardless of whether Indemnitee ultimately is determined to be entitled to such
indemnification, advancement of Expenses or insurance recovery, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement to indemnification under
this Agreement shall be required to be made prior to the final disposition of the Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="color: #010000">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> <U>Non-Exclusivity; Survival of Rights; Insurance; Primacy of Indemnification; Subrogation</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The rights of indemnification as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee
may at any time be entitled under the Articles, any agreement, a vote of shareholders, a resolution of directors of the Company, or otherwise.
No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under
this Agreement in respect of any action taken or omitted by such Indemnitee in his Corporate Status prior to such amendment, alteration
or repeal. To the extent that a change in the laws of the Cayman Islands, whether by statute or judicial decision, permits greater indemnification
than would be afforded currently under the Articles and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy
by this Agreement the greater benefits so afforded by such change. No right or remedy herein conferred is intended to be exclusive of
any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given
hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder,
or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers,
employees, or agents or fiduciaries of the Company or of any other company or corporation, partnership, joint venture, trust, employee
benefit plan or other enterprise that such person serves at the request of the Company, Indemnitee shall be covered by such policy or
policies in accordance with its or their terms to the maximum extent of the coverage available for any director, officer, employee, agent
or fiduciary under such policy or policies. If, at the time of the receipt of a notice of a claim pursuant to the terms hereof, the Company
has directors&#8217; and officers&#8217; liability insurance in effect, the Company shall give prompt notice of the commencement of such
proceeding to the insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all
necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such proceeding
in accordance with the terms of such policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>In the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of
the rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including
execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable hereunder if
and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract, agreement or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company&#8217;s obligation to indemnify or advance Expenses hereunder to Indemnitee who is or was serving at the request
of the Company as a director, officer, employee or agent of any other company or corporation, partnership, joint venture, trust, employee
benefit plan or other enterprise shall be reduced by any amount Indemnitee has actually received as indemnification or advancement of
expenses from such other company or corporation, partnership, joint venture, trust, employee benefit plan or other enterprise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="color: #010000">9.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT> <U>Exception to Right of Indemnification</U>. Notwithstanding any provision in this Agreement, the Company shall not be
obligated under this Agreement to make any indemnity in connection with any claim made against Indemnitee:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>for which payment has actually been made to or on behalf of Indemnitee under any insurance policy or other indemnity provision,
except with respect to any excess beyond the amount paid under any insurance policy or other indemnity provision; <I>provided</I>, that
the foregoing shall not affect the rights of Indemnitee set forth in <U>Section 8(c), (d) and</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><U>(e)</U> above; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company
within the meaning of Section 16(b) of the Securities Exchange Act of 1934, as amended, or similar provisions of state statutory law or
common law; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or
any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless
(i) the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation or (ii) the Company provides the indemnification,
in its sole discretion, pursuant to the powers vested in the Company under the Articles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">10.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Duration of Agreement</U>. All agreements and obligations of the Company contained herein shall continue during the period
Indemnitee is an officer or director of the Company (or is or was serving at the request of the Company as a director, officer, employee
or agent of another company or corporation, partnership, joint venture, trust or other enterprise) and shall continue thereafter so long
as Indemnitee shall be subject to any Proceeding (or any proceeding commenced under <U>Section 7</U> hereof) by reason of his Corporate
Status, whether or not he is acting or serving in any such capacity at the time any liability or expense is incurred for which indemnification
can be provided under this Agreement. This Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties
hereto and their respective successors (including any direct or indirect successor by purchase, merger, consolidation or otherwise to
all or substantially all of the business or assets of the Company), assigns, spouses, heirs, executors and personal and legal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">11.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Security</U>. To the extent requested by Indemnitee and approved by the Board, the Company may at any time and from time
to time provide security to Indemnitee for the Company&#8217;s obligations hereunder through an irrevocable bank line of credit, funded
trust or other collateral. Any such security, once provided to Indemnitee, may not be revoked or released without the prior written consent
of the Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="color: #010000">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> <U>Enforcement</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company expressly confirms and agrees that it has entered into this Agreement and assumes the obligations imposed on
it hereby in order to induce Indemnitee to serve as an officer or director of the Company, and the Company acknowledges that Indemnitee
is relying upon this Agreement in serving as an officer or director of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and
supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject
matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company shall not seek from a court, or agree to, a &#8220;bar order&#8221; which would have the effect of prohibiting
or limiting the Indemnitee&#8217;s rights to receive advancement of expenses under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="color: #010000">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> <U>Definitions</U>. For purposes of this Agreement:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>&#8220;<B>Corporate Status</B>&#8221; describes the status of a person who is or was a director, officer, employee, agent
or fiduciary of the Company or of any other company or corporation, partnership, joint venture, trust, employee benefit plan or other
enterprise that such person is or was serving at the express written request of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>&#8220;<B>Disinterested Director</B>&#8221; means a director of the Company who is not and was not a party to the Proceeding
in respect of which indemnification is sought by Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT> &#8220;<B>Enterprise</B>&#8221; shall mean the Company and any other company or corporation, partnership, joint venture,
trust, employee benefit plan or other enterprise that Indemnitee is or was serving at the express written request of the Company as a
director, officer, employee, agent or fiduciary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>&#8220;<B>Expenses</B>&#8221; shall include all reasonable attorneys&#8217; fees, retainers, court costs, transcript costs,
fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service
fees and all other disbursements or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to
prosecute or defend, investigating, participating, or being or preparing to be a witness in a Proceeding, or responding to, or objecting
to, a request to provide discovery in any Proceeding. Expenses also shall include Expenses incurred in connection with any appeal resulting
from any Proceeding and any federal, state, local or foreign taxes imposed on the Indemnitee as a result of the actual or deemed receipt
of any payments under this Agreement, including without limitation the premium, security for, and other costs relating to any cost bond,
supersede as bond, or other appeal bond or its equivalent. Expenses, however, shall not include amounts paid in settlement by Indemnitee
or the amount of judgments or fines against Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="color: #010000">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>&#8220;<B>Independent Counsel</B>&#8221; means a law firm, or a member of a law firm, that is experienced in matters of
company or corporation law and neither presently is, nor in the past five years has been, retained to represent: (i) the Company or Indemnitee
in any matter material to either such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other
indemnitees under similar Indemnity Agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification
hereunder. Notwithstanding the foregoing, the term &#8220;Independent Counsel&#8221; shall not include any person who, under the applicable
standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee
in an action to determine Indemnitee&#8217;s rights under this Agreement. The Company agrees to pay the reasonable fees of the Independent
Counsel referred to above and to fully indemnify such counsel against any and all Expenses, claims, liabilities and damages arising out
of or relating to this Agreement or its engagement pursuant hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>&#8220;<B>Proceeding</B>&#8221; includes any threatened, pending or completed action, suit, arbitration, alternate dispute
resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether
brought by or in the right of the Company or otherwise and whether civil, criminal, administrative or investigative, in which Indemnitee
was, is or will be involved as a party or otherwise, by reason of his or her Corporate Status, by reason of any action taken by him or
of any inaction on his part while acting in his or her Corporate Status; in each case whether or not he is acting or serving in any such
capacity at the time any liability or expense is incurred for which indemnification can be provided under this Agreement; including one
pending on or before the date of this Agreement, but excluding one initiated by an Indemnitee pursuant to <U>Section 7</U> of this Agreement
to enforce his rights under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">14.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Severability</U>. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability
of any other provision. Without limiting the generality of the foregoing, this Agreement is intended to confer upon Indemnitee indemnification
rights to the fullest extent permitted by the Articles. In the event any provision hereof conflicts with any provision of the Articles,
such provision shall be deemed modified, consistent with the aforementioned intent, to the extent necessary to resolve such conflict.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">15.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Modification and Waiver</U>. No supplement, modification, termination or amendment of this Agreement shall be binding
unless executed in writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall
constitute a waiver of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">16.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Notice By Indemnitee</U>. Indemnitee agrees promptly to notify the Company in writing upon being served with or otherwise
receiving any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter which
may be subject to indemnification covered hereunder. The failure to so notify the Company shall not relieve the Company of any obligation
which it may have to Indemnitee under this Agreement or otherwise unless and only to the extent that such failure or delay materially
prejudices the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">17.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></FONT><U>Notices</U>.
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively
given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent
during normal business hours of the recipient, and if not so confirmed, then on the next business day, (c) five (5) days after
having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a
nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications
shall be sent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(a)</FONT></TD><TD STYLE="text-align: left">To Indemnitee at the address set forth below Indemnitee signature hereto.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="color: #010000">(b)</FONT></TD><TD STYLE="text-align: left">To the Company at:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Zura
Bio Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">c/o
Maples Corporate Services Limited,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">PO Box 309, Ugland House,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Grand
Cayman, KY1-1104, Cayman Islands</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Attn: Someit Sidhu, Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Email:
<U>someit.sidhu@jattacquisition.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">With
a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">McDermott
Will &amp; Emery LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">One Vanderbilt Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">New
York, NY 10017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Attn: Ari Edelman</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Email:
<U>aedelman@mwe.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">or to such other address as may have been furnished to
Indemnitee by the Company or to the Company by Indemnitee, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">18.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Counterparts</U>. This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same Agreement. Counterparts may be delivered via facsimile, electronic mail (including
pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, <I>e.g.</I>, www.docusign.com) or other transmission
method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">19.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT><U>Headings</U>. The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed
to constitute part of this Agreement or to affect the construction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">20.<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></FONT><U>Governing
Law and Consent to Jurisdiction</U>. This Agreement and the legal relations among the parties shall be governed by, and construed
and enforced in accordance with, the laws of the State of New York, without regard to its conflict of laws rules. The Company and
Indemnitee hereby irrevocably and unconditionally (a) agree that any action or proceeding arising out of or in connection with this
Agreement shall be brought only in the appropriate NY Court, and not in any other state or federal court in the United States of
America or any court in any other country, (b) consent to submit to the exclusive jurisdiction of the NY Court for purposes of any
action or proceeding arising out of or in connection with this Agreement, (c) waive any objection to the laying of venue of any such
action or proceeding in the NY Court, and (d) waive, and agree not to plead or to make, any claim that any such action or proceeding
brought in the NY Court has been brought in an improper or inconvenient forum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>Signature Pages To Follow</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the
parties hereto have executed this Indemnity Agreement on and as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ZURA
    BIO LIMITED</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Sandeep Kulkarni</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sandeep
    Kulkarni</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 138.05pt 0pt 138pt; text-align: center">[Signature Page to Zura Bio Limited
Indemnity Agreement]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>INDEMNITEE:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; font-size: 10pt; width: 6%"><FONT STYLE="font-size: 10pt">Address:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; width: 44%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[Signature Page to Zura Bio Limited
Indemnity Agreement]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>



<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.15
<SEQUENCE>7
<FILENAME>tm2310353d1_ex10-15.htm
<DESCRIPTION>EXHIBIT 10.15
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>&#8239;&#8239;Exhibit 10.15</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">LOCK-UP AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS LOCK-UP AGREEMENT (this
 &ldquo;<U>Agreement</U>&rdquo;) is dated as of March 20, 2023 by and between the undersigned (the &ldquo;<U>Holder</U>&rdquo;) and JATT
Acquisition Corp, a Cayman Islands exempted company (&ldquo;<U>SPAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>SPAC, JATT Merger Sub, a Cayman Islands exempted company and wholly-owned subsidiary of SPAC, JATT Merger Sub 2, a Cayman Islands
exempted company and wholly-owned subsidiary of SPAC, Zura Bio Limited, a limited company incorporated under the laws of England and Wales
(the &ldquo;<U>Company</U>&rdquo;) and Zura Bio Holdings Ltd, a Cayman Islands exempted company (&ldquo;<U>Holdco</U>&rdquo;), entered
into a Business Combination Agreement dated as of June 16, 2022 (the &ldquo;<U>Business Combination Agreement</U>&rdquo;). Capitalized
terms used but not defined in this Agreement shall have the meanings ascribed to them in the Business Combination Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>Pursuant to the Business Combination Agreement, SPAC will indirectly own 100% of the issued and outstanding stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>Pursuant to that certain Grant Agreement dated as of December 8, 2022, the Holder is entitled to receive 550,000 ordinary shares
of the SPAC upon the closing of the transactions contemplated by the Business Combination Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">NOW, THEREFORE, for and in consideration
of the mutual covenants and agreements set forth herein, and other good and valuable consideration, the receipt and sufficiency of which
is hereby acknowledged, the parties, intending to be legally bound, agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>AGREEMENT</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Lock-Up</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>During the Lock-up Period (as defined below), the Holder agrees that it, he or she will not offer, sell, contract to sell, pledge
or otherwise dispose of, directly or indirectly, any of the applicable Lock-up Shares (as defined below), enter into a transaction that
would have the same effect, or enter into any swap, hedge or other arrangement that transfers, in whole or in part, any of the economic
consequences of ownership of the Lock-up Shares or otherwise, publicly disclose the intention to make any offer, sale, pledge or disposition,
or to enter into any transaction, swap, hedge or other arrangement, or engage in any Short Sales (as defined below) with respect to the
Lock-up Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>For purposes hereof, &ldquo;<U>Short Sales</U>&rdquo; include, without limitation, all &ldquo;short sales&rdquo; as defined in
Rule 200 promulgated under Regulation SHO under the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;),
and all types of direct and indirect stock pledges, forward sale contracts, options, puts, calls, swaps and similar arrangements (including
on a total return basis), and sales and other transactions through non-US broker dealers or foreign regulated brokers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>The Lock-up Shares shall be subject to the restrictions set forth herein follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: #010000">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>One-third of the Lock-up Shares shall be restricted until the First Lock-up Date, one-third of the Lock-up Shares shall
be restricted until the Second Lock-up Date, and one-third of the Lock-up Shares shall be restricted until the Third Lock-up Date; <U>provided</U>,
that each portion of the Lock-up Shares will be freely tradable on the earlier of the date on which the closing price of the SPAC Shares
equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for
any 20 trading days within any 30-trading day period on a VWAP (as defined below) basis during the relevant Lock-up Period, or on the
date on which SPAC consummates a liquidation, merger, capital stock exchange, reorganization, or other similar transaction that results
in all of SPAC&rsquo;s stockholders having the right to exchange their SPAC Shares for cash, securities or other property. For purposes
of this Agreement, &ldquo;<U>VWAP</U>&rdquo; means, for any date, the daily volume weighted average price of the SPAC Shares for such
date (or the nearest preceding date) on the trading market on which the SPAC Shares are then listed or quoted as reported by Bloomberg
L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:00 p.m. (New York City time)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: #010000">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>The term &ldquo;<U>First Lock-up Date</U>&rdquo; means the date that is six (6) months after the Closing Date (as defined
in the Business Combination Agreement). The term &ldquo;<U>Second Lock-up Date</U>&rdquo; means the date that is twelve months (12) months
after the Closing Date. The term &ldquo;Third Lock-up Date&rdquo; means the date that is twenty-four (24) months after the Closing Date.
The term &ldquo;<U>Lock-up Period</U>&rdquo; means the period ending on the First Lock-up Date, Second Lock-up Date, or Third Lock-up
Date, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="color: #010000">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT>For the avoidance of any doubt, (i)&#8239;the&#8239;Holder shall retain all of its rights as a stockholder of SPAC during
the&#8239;Lock-Up&#8239;Period, including the right to vote, and to receive any dividends and distributions in respect of, any&#8239;Lock-up
Shares, and (ii)&#8239;the restrictions contained in this&#8239;<U>Section&#8239;1</U>&#8239;shall not apply to&#8239;any other SPAC Shares
acquired by any&#8239;Holder in any public or private capital raising transactions of SPAC or otherwise with respect to any SPAC Common
Stock (or other securities of SPAC) other than the&#8239;Lock-up Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Beneficial Ownership.</U> The Holder hereby represents and warrants that it does not beneficially own, directly or through
its nominees (as determined in accordance with Section 13(d) of the Exchange Act, and the rules and regulations promulgated thereunder),
any SPAC Shares, or any economic interest in or derivative of such shares, other than those SPAC Shares to be issued pursuant to the Grant
Agreement. For purposes of this Agreement, any SPAC Shares to be received by the Holder pursuant to the Grant Agreement which were not
purchased in the open market, are collectively referred to as the &ldquo;<U>Lock-up Shares</U>,&rdquo; <U>provided</U>, <U>however</U>,
that such Lock-up Shares shall not include SPAC Shares acquired by the Holder in open market transactions during the Lock-up Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing,
and subject to the conditions below, the undersigned may transfer Lock-Up Shares in connection with (a) transfers or distributions to
the Holder&rsquo;s officers or directors or any current or future direct or indirect affiliates (within the meaning of Rule 405 under
the Securities Act of 1933, as amended), or to any equityholder (including any shareholder, member or partner) of the Holder, or to the
estates of any of the foregoing; (b) transfers by bona fide gift to a member of the Holder&rsquo;s immediate family or to a trust or estate
planning vehicle, the beneficiary of which is the Holder or a member of the Holder&rsquo;s immediate family; (c) by virtue of the laws
of descent and distribution upon death of the Holder; (d) pursuant to a qualified domestic relations order, (e) transfers to the SPAC&rsquo;s
officers, directors or their affiliates, (f) pledges of Lock-up Shares as security or collateral in connection with a borrowing or the
incurrence of any indebtedness by the Holder, (g) transfers pursuant to a bona fide third-party tender offer, merger, stock sale, recapitalization,
consolidation or other transaction involving a change of control of SPAC; <U>provided</U>, <U>however</U>, that in the event that such
tender offer, merger, recapitalization, consolidation or other such transaction is not completed, the Lock-Up Shares subject to this Agreement
shall remain subject to this Agreement, (h) the establishment of a trading plan pursuant to Rule 10b5-1 promulgated under the Exchange
Act, provided that <FONT STYLE="background-color: white">the Holder shall not effect or cause to be effected, any public filing, report
or other public announcement regarding the establishment of the trading plan except as required by applicable law</FONT>; <U>provided
further</U>, <U>however</U>, that such plan does not provide for the transfer of Lock-up Shares during the Lock-Up Period, (i) transfers
to satisfy tax withholding obligations in connection with the exercise of options to purchase SPAC Shares or the vesting of stock-based
awards; (j) transfers in payment on a &ldquo;net exercise&rdquo; or &ldquo;cashless&rdquo; basis of the exercise or purchase price with
respect to the exercise of options to purchase SPAC Shares; and (k) transactions to satisfy any U.S. federal, state, or local income tax
obligations of the Holder (or its direct or indirect owners) arising from a change in the U.S. Internal Revenue Code of 1986, as amended
(the &ldquo;Code&rdquo;), or the U.S. Treasury Regulations promulgated thereunder (the &ldquo;Regulations&rdquo;) after the date on which
the Business Combination Agreement was executed by the parties, and such change prevents the transactions contemplated by the Business
Combination Agreement from qualifying as a &ldquo;reorganization&rdquo; pursuant to Section 368 of the Code (and the transactions contemplated
by the Business Combination Agreement do not qualify for similar tax-free treatment pursuant to any successor or other provision of the
Code or Regulations taking into account such changes), in each case, solely to the extent necessary to cover any tax liability as a result
of the transactions; <U>provided</U>, <U>however</U>, that, in the case of any transfer pursuant to the foregoing (a) through (e) clauses,
it shall be a condition to any such transfer that the transferee/donee agrees to be bound by the terms of this Agreement (including, without
limitation, the restrictions set forth in the preceding sentence) to the same extent as if the transferee/donee were a party hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Representations and Warranties.</U> Each of the parties hereto, by their respective execution and delivery of this Agreement,
hereby represents and warrants to the other that (a) such party has the full right, capacity and authority to enter into, deliver and
perform its respective obligations under this Agreement, (b) this Agreement has been duly executed and delivered by such party and is
a binding and enforceable obligation of such party and, enforceable against such party in accordance with the terms of this Agreement,
e<FONT STYLE="background-color: white">xcept as limited by applicable bankruptcy, insolvency, reorganization, moratorium and other laws
of general application affecting enforcement of creditors&rsquo; rights generally, and by general equitable principles</FONT>, and (c)
the execution, delivery and performance of such party&rsquo;s obligations under this Agreement will not conflict with or breach the terms
of any other agreement, contract, commitment or understanding to which such party is a party or to which the assets or securities of such
party are bound. The Holder has independently evaluated the merits of his/her/its decision to enter into and deliver this Agreement, and
such Holder confirms that it has not relied on the advice of Company, Company&rsquo;s legal counsel, or any other person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>No Additional Fees/Payment.</U> Other than the consideration specifically referenced herein, the parties hereto agree
that no fee, payment or additional consideration in any form has been or will be paid to the Holder in connection with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Termination</U>. This Agreement shall be binding upon Holder upon Holder&rsquo;s execution and delivery of this Agreement,
but this Agreement shall only become effective upon the Closing. Notwithstanding anything to the contrary contained herein, this Agreement
shall terminate (i) by written agreement of the parties hereto terminating this Agreement, or (b) in the event that Business Combination
Agreement is terminated in accordance with its terms prior to the Closing. Upon termination of this Agreement, all rights and obligations
of the parties hereunder shall automatically terminate and be of no further force or effect. The representations and warranties contained
in this Agreement shall not survive the Closing or the termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Notices.</U> Any notices required or permitted to be sent hereunder shall be sent in writing, addressed as specified
below, and shall be deemed given: (a) if by hand or recognized courier service, by 4:00 p.m. on a Business Day, addressee&rsquo;s day
and time, on the date of delivery, and otherwise on the first Business Day after such delivery; (b) if by email, on the date that transmission
is confirmed electronically, if by 4:00 p.m. on a Business Day, addressee&rsquo;s day and time, and otherwise on the first Business Day
after the date of such confirmation; or (c) five days after mailing by certified or registered mail, return receipt requested. Notices
shall be addressed to the respective parties as follows (excluding telephone numbers, which are for convenience only), or to such other
address as a party shall specify to the others in accordance with these notice provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>If to Company, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">Zura Bio Limited<BR>
Address: 3rd Floor 1 Ashley Road Altrincham WA14 2DT<BR>
Attention: Oliver Levy<BR>
E-mail: notices@zurabio.com<FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">with a copy to (which shall not constitute
notice):<BR>
<BR>
McDermott Will &amp; Emery LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Address: One Vanderbilt Ave., New York,
NY 10017-3852</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">Attention: Ari Edelman</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">E-mail: aedelman@mwe.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>If to the Holder, to the address set forth on the Holder&rsquo;s signature page hereto, with a copy, which shall not constitute
notice, to:&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left"><BR>
_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">Email:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">(c) &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
to SPAC, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">JATT Acquisition Corp</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">PO Box 309, Ugland House,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">Grand Cayman, Cayman Islands<BR>
Attention: Verender Badial<BR>
E-mail: verender.badial@jattacquisition.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">with a copy to (which
shall not constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">Loeb &amp; Loeb LLP<BR>
345 Park Avenue<BR>
New York, NY 10154<BR>
Attention: Mitchell Nussbaum<BR>
E-mail: mnussbaum@loeb.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">or to such other address(es) as any party may
have furnished to the others in writing in accordance herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Enumeration and Headings.</U> The enumeration and headings contained in this Agreement are for convenience of reference
only and shall not control or affect the meaning or construction of any of the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Counterparts.</U> This Agreement may be executed by facsimile, email or other electronic transmission and in any number
of counterparts, each of which when so executed and delivered shall be deemed an original, but all of which shall together constitute
one and the same agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Successors and Assigns.</U> This Agreement and the terms, covenants, provisions and conditions hereof shall be binding
upon, and shall inure to the benefit of, the respective heirs, successors and assigns of the parties hereto. The Holder hereby acknowledges
and agrees that this Agreement is entered into for the benefit of and is enforceable by Company and its successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Severability.</U> If any provision of this Agreement is held to be invalid or unenforceable for any reason, such provision
will be conformed to prevailing law rather than voided, if possible, in order to achieve the intent of the parties and, in any event,
the remaining provisions of this Agreement shall remain in full force and effect and shall be binding upon the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Amendment.</U> This Agreement may be amended or modified by written agreement executed by each of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Further Assurances.</U> Each party shall do and perform, or cause to be done and performed, all such further acts and
things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably
request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>No Strict Construction.</U> The language used in this Agreement will be deemed to be the language chosen by the parties
to express their mutual intent, and no rules of strict construction will be applied against any party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">14.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Dispute Resolution.</U> Section 11.9 of the Business Combination Agreement is incorporated by reference herein to apply
with full force to any disputes arising under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Governing Law.</U> Section 11.9 of the Business Combination Agreement is incorporated by reference herein to apply with
full force to any disputes arising under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">16.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Controlling Agreement.</U> To the extent the terms of this Agreement (as amended, supplemented, restated or otherwise
modified from time to time) directly conflicts with a provisions in the Business Combination Agreement, the terms of this Agreement shall
control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">17.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Other Agreements</U>. SPAC represents and warrants to Holder that this Agreement is in substantially the same form and
substance (including with respect to the types and percentage of holdings of securities subject to this Agreement, the time periods for
the transfer restrictions, and carve-outs from the transfer restrictions, which shall in each case be identical) as all other agreements
to be executed in connection with any other agreement by and between any other holder of shares of the Company and SPAC related to restrictions
on transfer similar to those set forth in this Agreement, except for the Letter Agreement, dated July 13, 2021, by and among SPAC, JATT
Ventures, L.P. and JATT officers and directors at the time of JATT&rsquo;s initial public offering, as amended, (the &ldquo;Other Lock-Up
Agreements&rdquo;), and each of SPAC and the Company hereby agrees that it will not change, amend or modify any of the terms of the Other
Lock-Up Agreements in a manner beneficial to any other holder of securities of the Company without similarly changing, amending or modifying
such terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">18.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Pro-Rata Release</U>. If, prior to the expiration of the Lock-Up Period set forth in this Agreement, the restrictions
on transfer in any Other Lock-Up Agreement are waived, terminated or suspended, in whole or in part, permanently or for a limited period
of time, then this Agreement shall be deemed to be automatically modified without any further action so that the restrictions on transfer
set forth in this Agreement are also waived, terminated or suspended on the same terms and for the same percentage of Lock-up Shares of
the Holder. SPAC and the Company shall, upon any such automatic modification of this Agreement, notify the Holder of such modification
in writing as promptly as reasonably practicable and in any event at least 12 hours prior to the open of trading markets on the date such
waiver, termination or suspension is to take effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: #010000">19.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT></FONT><U>Entire Agreement</U>. This Agreement constitutes the sole and entire agreement of the parties to this Agreement with
respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings, agreements, representations,
and warranties, both written and oral, with respect to such subject matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[Signature Pages Follow]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Lock-up Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: justify; text-indent: 0"><FONT STYLE="text-transform: uppercase"><B>JATT Acquisition Corp </B></FONT></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; width: 50%">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; width: 3%">By:</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; width: 35%"><U>/s/ Someit Sidhu</U></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; width: 10%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">Name: Someit Sidhu</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">Title: CEO</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page to Lock-Up Agreement &ndash; Page
1 of 2]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&#8239;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: justify; text-indent: 0"><B>HOLDER:</B></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: justify; text-indent: 0">Eli Lilly and Company</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; width: 50%">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; width: 3%">By:</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; width: 35%"><U>/s/ Kenneth Custer</U></TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0; width: 10%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: justify; text-indent: 0">Name: Kenneth Custer</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: justify; text-indent: 0">Title: Sr. VP of Business Development</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page to Lock-Up Agreement &ndash; Page
2 of 2]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.17
<SEQUENCE>8
<FILENAME>tm2310353d1_ex10-17.htm
<DESCRIPTION>EXHIBIT 10.17
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.17</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SUBSCRIPTION AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This SUBSCRIPTION AGREEMENT
(this &ldquo;<U>Subscription Agreement</U>&rdquo;) is entered into on March&nbsp;13, 2023, by and between JATT Acquisition Corp, a Cayman
Islands exempted company (the &ldquo;<U>Company</U>&rdquo;), and the subscriber named on the signature page&nbsp;hereto (&ldquo;<U>Subscriber</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, pursuant to, and
upon the terms and subject to the conditions set forth in, the Business Combination Agreement, dated as of June&nbsp;16, 2022 and as
amended from time to time (the &ldquo;<U>Business Combination Agreement</U>&rdquo;), among the Company, JATT Merger Sub, a Cayman Islands
exempted company and wholly owned subsidiary of the Company (&ldquo;<U>JATT Merger Sub</U>&rdquo;), JATT Merger Sub 2, a Cayman Islands
exempted company and wholly owned subsidiary of the Company (&ldquo;<U>JATT Merger Sub 2</U>&rdquo;), Zura Bio Limited, a limited company
incorporated under the laws of England and Wales (&ldquo;<U>Zura</U>&rdquo;) and Zura Bio Holdings Ltd, a Cayman Islands exempted company
(&ldquo;<U>Zura Holdco</U>&rdquo;), the following transactions (collectively, the &ldquo;<U>Transaction</U>&rdquo;) will occur on the
Closing Date (as defined below): (i)&nbsp;JATT Merger Sub will merge with and into Zura Holdco, with Zura Holdco continuing as the surviving
company of the merger and a wholly owned subsidiary of the Company; and (ii)&nbsp;immediately following the transaction described in
(i), Zura Holdco will merge with and into JATT Merger Sub 2, with JATT Merger Sub 2 continuing as the surviving company of the merger;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, in connection with
the Transaction, Subscriber desires to subscribe for and purchase from the Company, immediately prior to or substantially concurrently
with, and contingent upon, the consummation of the Transaction, that number of ordinary shares (<U>&ldquo;Ordinary Shares</U>&rdquo;),
set forth on the signature page&nbsp;hereto (the &ldquo;<U>Subscribed Shares</U>&rdquo;) and that number of private placement warrants
of the Company as shown on <U>Exhibit&nbsp;A</U> under the column &ldquo;Subscribed Amount New PIPE Subscriber Prorated Share of PPWs&rdquo;
attached hereto and made a part hereof, each whole warrant entitling the holder thereof to purchase one Ordinary Share for $11.50 per
share (the &ldquo;<U>Private Placement Warrants</U>&rdquo;) for a purchase price of $10.00 per share (the &ldquo;<U>Per Unit Subscription
Price</U>&rdquo; and the aggregate of such Per Unit Subscription Price for all Subscribed Shares and Private Placement Warrants being
referred to herein as the &ldquo;<U>Subscription Amount</U>&rdquo;), and the Company desires to issue and sell to Subscriber the Subscribed
Shares and Private Placement Warrants in consideration of the payment of the Subscription Amount by or on behalf of Subscriber to the
Company; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, prior to and substantially
concurrently with the execution of this Subscription Agreement, the Company has entered into and may enter into subscription agreements
(the &ldquo;<U>Other Subscription Agreements</U>&rdquo; and, together with this Subscription Agreement, the &ldquo;<U>Subscription Agreements</U>&rdquo;)
with certain other accredited investors (the &ldquo;<U>Other Subscribers</U>&rdquo; and, together with Subscriber, the &ldquo;<U>Subscribers</U>&rdquo;),
which are on substantially the same terms as the terms of this Subscription Agreement (other than the amount of Ordinary Shares and Private
Placement Warrants to be subscribed for and purchased by the Other Subscribers), pursuant to which such investors shall agree to purchase
on the closing date of the Transaction (the &ldquo;<U>Closing Date</U>&rdquo;) Ordinary Shares (the &ldquo;<U>Other Subscribed Shares</U>&rdquo;
and, together with the Subscribed Shares, the &ldquo;<U>Aggregate Subscribed Shares</U>&rdquo;) and Private Placement Warrants (the &ldquo;<U>Other
Private Placement Warrants</U>&rdquo; and, together with the Private Placement Warrants, the &ldquo;<U>Aggregate Private Placement Warrants</U>&rdquo;)
for aggregate subscription amounts, together with the Subscription Amount, of not less than $20 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions, herein contained, and intending
to be legally bound hereby, the parties hereto hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Subscription</U>.
Subject to the terms and conditions hereof, Subscriber hereby subscribes for and agrees to purchase at the Closing (as defined below),
and the Company hereby agrees to issue and sell to Subscriber, upon the payment of the Subscription Amount, the Subscribed Shares and
the Private Placement Warrants (such subscription and issuance, the &ldquo;<U>Subscription</U>&rdquo;). The Company hereby expressly
covenants and agrees that the Subscription Amount shall be used exclusively for the Transaction or after the consummation thereof by
the Company and its subsidiaries (including Zura) for working capital and other corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Closing</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
consummation of the Subscription (the &ldquo;<U>Closing</U>&rdquo;) shall be contingent upon, and occur on the Closing Date immediately
prior to or concurrently with the consummation of the Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;At
least five Business Days before the anticipated Closing Date, the Company shall deliver written notice to Subscriber (the &ldquo;<U>Closing
Notice</U>&rdquo;) specifying (i)&nbsp;the anticipated Closing Date and (ii)&nbsp;the wire instructions for delivery of the Subscription
Amount to the Company. No later than three Business Days after receiving the Closing Notice, Subscriber shall deliver to the Company
such information as is reasonably requested in the Closing Notice in order for the Company to issue the Subscribed Shares and Private
Placement Warrants to Subscriber. Subscriber shall two (2)&nbsp;business days prior to the expected Closing Date specified in the Closing
Notice, deliver to the Company, the Subscription Amount in cash via wire transfer to the account specified in the Closing Notice. At
the Closing, the Company shall issue the Subscribed Shares and Private Placement Warrants to the Subscriber and cause the Subscribed
Shares and Private Placement Warrants to be registered in book entry form, free and clear of any liens or other restrictions (other than
those arising under this Subscription Agreement or state or federal securities laws), in the name of Subscriber (or its nominee in accordance
with its delivery instructions) or to a custodian designated by Subscriber, as applicable. In the event that the consummation of the
Transaction does not occur within three Business Days after the anticipated Closing Date specified in the Closing Notice, the Company
shall promptly (but in no event later than three Business Days after the anticipated Closing Date specified in the Closing Notice) return
the funds so delivered by Subscriber to the Company by wire transfer in immediately available funds to the account specified by Subscriber;
provided that, unless this Subscription Agreement has been validly terminated pursuant to <U>Section&nbsp;6</U> hereof, neither the failure
of the Closing to occur on the Closing Date specified in the Closing Notice nor such return of funds shall (x)&nbsp;terminate this Subscription
Agreement, (y)&nbsp;be deemed to be a failure of any of the conditions to Closing set forth in this <U>Section&nbsp;2</U>, or (z)&nbsp;otherwise
relieve any party of any of its obligations hereunder, including Subscriber&rsquo;s obligation to redeliver the Subscription Amount and
purchase the Subscribed Shares and Private Placement Warrants at the Closing in the event the Company delivers a subsequent Closing Notice.
For the purposes of this Subscription Agreement, &ldquo;<U>Business Day</U>&rdquo; means any day other than a Saturday, Sunday or a day
on which the Federal Reserve Bank of New York is closed. Prior to or at the Closing, Subscriber shall deliver to the Company a duly completed
and executed Internal Revenue Service Form&nbsp;W-9 or appropriate Form&nbsp;W-8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Closing shall be subject to the satisfaction or valid waiver (to the extent a valid waiver is capable of being issued) by the party (the
Company, on the one hand, or Subscriber, on the other) entitled to the benefit thereof, of the conditions that, on or prior to the Closing
Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
Ordinary Shares shall have been approved for listing on the New York Stock Exchange (the &ldquo;NYSE&rdquo;), NYSE American Exchange
(the &ldquo;NYSE American&rdquo;) or the Nasdaq Capital Market (&ldquo;Nasdaq&rdquo;) subject to official notice of issuance, and no
suspension of the qualification of the Ordinary Shares for offering or sale or trading on NYSE, NYSE American or Nasdaq or, to the Company&rsquo;s
knowledge, initiation or threatening of any proceedings for any of such purposes, shall have occurred;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;all
conditions precedent to the closing of the Transaction set forth in the Business Combination Agreement, including, without limitation,
the required approval of the Company&rsquo;s shareholders, shall have been satisfied (as determined by the parties to the Business Combination
Agreement, and other than those conditions which, by their nature, are to be satisfied at the closing of the Transaction, but subject
to satisfaction or waiver thereof by the party entitled to the benefit thereof under the Business Combination Agreement, including to
the extent that any such condition is dependent upon the consummation of the purchase and sale of the Aggregate Subscribed Shares and
Aggregate Private Placement Warrants pursuant to the Subscription Agreements) or waived in writing by the party entitled to the benefit
thereof under the Business Combination Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;no
governmental authority shall have enacted, issued, promulgated, enforced or entered any judgment, order, law, rule&nbsp;or regulation
(whether temporary, preliminary or permanent) which is then in effect and has the effect of making consummation of the transactions contemplated
hereby illegal or otherwise restraining, prohibiting or enjoining consummation of the transactions contemplated hereby (except in the
case of a governmental authority located outside the United States where such judgment, order, law, rule&nbsp;or regulation would not
be reasonably expected to have a Company Material Adverse Effect (as defined below)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
obligation of the Company to consummate the Closing shall be subject to the satisfaction or valid waiver by the Company of the additional
conditions that, on or prior to the Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;all
representations and warranties of Subscriber contained in this Subscription Agreement are true and correct in all material respects at
and as of the Closing Date (other than (x)&nbsp;representations and warranties that are qualified as to materiality or Subscriber Material
Adverse Effect (as defined below), which representations and warranties shall be true in all respects or (y)&nbsp;representations and
warranties that speak as of a specified earlier date, which representations and warranties shall be true and correct in all material
respects (or, if qualified by materiality or Subscriber Material Adverse Effect, which representations shall be true and correct in all
respects) as of such specified date), in each case without giving effect to the consummation of the Transaction, and consummation of
the Closing shall constitute a reaffirmation by Subscriber of each of the representations and warranties of Subscriber contained in this
Subscription Agreement as of the Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subscriber
shall have wired the Subscription Amount in accordance with Section&nbsp;2(b)&nbsp;of this Subscription Agreement and otherwise performed,
satisfied and complied in all material respects with all covenants, agreements and conditions required by this Subscription Agreement
to be performed, satisfied or complied with by it at or prior to the Closing; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subscriber
shall have provided to the Company the information requested in Annex A hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
obligation of Subscriber to consummate the Closing shall be subject to the satisfaction or valid waiver by Subscriber of the additional
conditions that, on or prior to the Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;all
representations and warranties of the Company contained in this Subscription Agreement are true and correct in all material respects
at and as of the Closing Date (other than (A)&nbsp;representations and warranties that are qualified as to materiality or Company Material
Adverse Effect (as defined below), which representations and warranties shall be true in all respects or (B)&nbsp;representations and
warranties that speak as of a specified earlier date, which representations and warranties shall be true and correct in all material
respects (or, if qualified by materiality or Company Material Adverse Effect, which representations shall be true and correct in all
respects) as of such specified date), in each case without giving effect to the consummation of the Transaction, and consummation of
the Closing shall constitute a reaffirmation by the Company of each of the representations and warranties of the Company contained in
this Subscription Agreement as of the Closing; provided that in the event this condition would otherwise fail to be satisfied as a result
of a breach of one or more of the representations and warranties of the Company contained in this Subscription Agreement and the facts
underlying such breach would also cause a condition to Zura&rsquo;s obligations under the Business Combination Agreement to fail to be
satisfied, this condition shall nevertheless be deemed satisfied in the event Zura waives such condition with respect to such breach
under the Business Combination Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required
by this Subscription Agreement to be performed, satisfied or complied with by it at or prior to the Closing, except where the failure
of such performance, satisfaction or compliance would not or would not reasonably be expected to materially and adversely affect the
economic benefits to Subscriber under this Subscription Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;there
shall have been no amendment or modification to the Business Combination Agreement that materially, adversely and disproportionately
as compared to Other Subscribers affects the economic benefits to Subscriber under this Subscription Agreement without having received
Subscriber&rsquo;s prior written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Company
Representations and Warranties</U>. For purposes of this <U>Section&nbsp;3,</U> the term &ldquo;Company&rdquo; shall refer to (i)&nbsp;the
Company as of the date hereof, and (ii)&nbsp;for purposes of the representations contained in subsections (f), (i)&nbsp;and (I)&nbsp;of
this <U>Section&nbsp;3</U> and to the extent such representations and warranties are made as of the Closing Date, the combined company
after giving effect to the Transaction as of the Closing Date. The Company represents and warrants to Subscriber that as of the date
hereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company (i)&nbsp;has been duly incorporated and is validly existing as a corporation in good standing under the laws of the Cayman Islands,
(ii)&nbsp;has the requisite corporate power and authority to own, lease and operate its properties, to carry on its business as it is
now being conducted and to enter into and perform its obligations under this Subscription Agreement, and (iii)&nbsp;is duly licensed
or qualified to conduct its business and, if applicable, is in good standing under the laws of each jurisdiction (other than its jurisdiction
of incorporation) in which the conduct of its business or the ownership of its properties or assets requires such license or qualification,
except, with respect to the foregoing clause (iii), where the failure to be in good standing would not reasonably be expected to have
a Company Material Adverse Effect. For purposes of this Subscription Agreement, a &ldquo;<U>Company Material Adverse Effect</U>&rdquo;
means any event, circumstance, change, development, effect or occurrence (collectively &ldquo;<U>Effect</U>&rdquo;) that, individually
or in the aggregate with all other Effects, (a)&nbsp;is or would reasonably be expected to be materially adverse to the business, financial
condition or results of operations of the Company and its subsidiaries, taken as a whole; or (b)&nbsp;would prevent, materially delay
or materially impede the performance by the Company or its subsidiaries of their respective obligations under this Subscription Agreement,
the Business Combination Agreement or the consummation of the Transaction before the Outside Date (as defined below); provided, however,
that, in the case of clause (a), none of the following (or the effect of any of the following) shall be deemed to constitute, alone or
in combination, or be taken into account in the determination of whether, there has been or will be a Company Material Adverse Effect:
(i)&nbsp;any change or proposed change in applicable law or GAAP or IFRS, as applicable (including, in each case, the interpretation
thereof) or changes in enforcement policies or official interpretations thereof or decisions of general applicability by any governmental
entity, in each case, after the date of this Subscription Agreement; (ii)&nbsp;events, changes or conditions generally affecting the
industries or geographic areas in which the Company operates; (iii)&nbsp;any changes in general economic conditions, including changes
in the credit, debt, securities, financial or capital markets (including changes in interest or exchange rates, prices of any security
or market index or commodity or any disruption of such markets); (iv)&nbsp;acts of war, sabotage, civil unrest, protests, demonstrations,
cyberattacks or terrorism, or any escalation or worsening of any such acts of war, sabotage, civil unrest, protests, demonstrations,
cyberattacks or terrorism, or changes in global, national, regional, state or local political or social conditions; (v)&nbsp;any hurricane,
tornado, flood, earthquake, mudslide, wildfire, natural disaster, epidemic, disease outbreak, pandemic (including, for the avoidance
of doubt, the novel coronavirus, SARS-CoV-2 or COVID-19 and all related measures, strains and sequences) or other acts of God, (vi)&nbsp;any
actions taken or not taken by the Company as required by this Subscription Agreement, the Business Combination Agreement or any other
agreement executed and delivered in connection with the Transaction and specifically contemplated by the Business Combination Agreement,
(vii)&nbsp;any failure of Zura and its subsidiaries, taken as a whole to meet any projections, forecasts, guidance, estimates or financial
or operating predictions of revenue, earnings, cash flow or cash position (provided, that any Effect underlying such failure (except
to the extent otherwise excluded by other clauses in this definition) may be taken into account in determining whether a Company Material
Adverse Effect has occurred or would reasonably be expected to occur) or (viii)&nbsp;any Effect attributable to the announcement or execution,
pendency, negotiation or consummation of this Subscription Agreement or the Transaction (including the impact thereof on relationships
with customers, suppliers, employees, investors, or other third parties related thereto), except in the cases of clauses (i)&nbsp;through
(v), to the extent that the Company is materially and disproportionately affected thereby as compared with other participants in the
industry in which the Company operates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;As
of the Closing Date, the Subscribed Shares will be duly authorized and, when issued and delivered to Subscriber against full payment
therefor in accordance with the terms of this Subscription Agreement, will be validly issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;As
of the Closing Date, the Private Placement Warrants will be duly authorized and, when issued and delivered to Subscriber against full
payment therefor in accordance with the terms of this Subscription Agreement, will be enforceable against the Company in accordance with
their terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium and similar laws affecting
creditors generally and by the availability of equitable remedies..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Subscribed Shares and the Private Placement Warrants are not, and following the Closing, will not be, subject to any Transfer Restriction.
The term &ldquo;<U>Transfer Restriction</U>&rdquo; means any condition to or restriction on the ability of the undersigned to pledge,
sell, assign or otherwise transfer the Subscribed Shares and Private Placement Warrants under any organizational document, policy or
agreement of, by or with the Company, but excluding (i)&nbsp;the restrictions on transfer described in <U>Section&nbsp;4(e)</U>&nbsp;of
this Subscription Agreement with respect to the status of the Shares and the Private Placement Warrants as &ldquo;restricted securities&rdquo;
pending their registration for resale under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), in accordance
with the terms of this Subscription Agreement, and (ii)&nbsp;compliance with routine transfer registration provisions under the Company&rsquo;s
organizational documents and agreements and policies of the Company&rsquo;s transfer agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Subscription Agreement has been duly authorized, executed and delivered by the Company, and assuming the due authorization, execution
and delivery of the same by Subscriber, this Subscription Agreement shall constitute the valid and binding obligation of the Company,
enforceable against the Company in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency,
reorganization, moratorium and similar laws affecting creditors generally and by the availability of equitable remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
execution and delivery of this Subscription Agreement, the issuance and sale of the Subscribed Shares and the Private Placement Warrants
and the compliance by the Company with all of the provisions of this Subscription Agreement and the consummation of the transactions
contemplated herein will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default
under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of the Company pursuant
to the terms of (i)&nbsp;any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which
the Company is a party or by which the Company is bound or to which any of the property or assets of the Company is subject; (ii)&nbsp;the
organizational documents of the Company; or (iii)&nbsp;any statute or any judgment, order, rule&nbsp;or regulation of any court or governmental
agency or body, domestic or foreign, having jurisdiction over the Company or any of its properties that, in the case of clauses (i)&nbsp;and
(iii), would reasonably be expected to have a Company Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Assuming
the accuracy of all of Subscriber&rsquo;s representations and warranties set forth in <U>Section&nbsp;4</U> of this Subscription Agreement,
the Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration
with, any court or other federal, state, local or other governmental authority, self-regulatory organization or other person in connection
with the execution, delivery and performance of this Subscription Agreement (including, without limitation, the issuance of the Subscribed
Shares and Private Placement Warrants ), other than (i)&nbsp;filings required by applicable state securities laws, (ii)&nbsp;filings
with the United States Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;), including the filing of the Registration
Statement pursuant to Section&nbsp;5 below, (iii)&nbsp;filings required by the NYSE, including with respect to obtaining approval of
the Company&rsquo;s shareholders, (iv)&nbsp;filings required to consummate the Transaction as provided under the Business Combination
Agreement, (v)&nbsp;any filing of notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or any law or regulation
of any other jurisdiction related to competition or merger control, if applicable, (vi)&nbsp;those that will be obtained, made or given,
as applicable, on or prior to the Closing, and (vii)&nbsp;consents, waivers, authorizations, orders, notices or filings, the failure
of which to obtain would not reasonably be expected to have a Company Material Adverse Effect or have a material adverse effect on the
Company&rsquo;s legal authority to consummate the transactions contemplated hereby, including the issuance and sale of the Subscribed
Shares and Private Placement Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Other
than where the failure to timely file would not reasonably be expected to have a Company Material Adverse Effect, as of their respective
dates, all reports required to be filed by the Company with the Commission (the &ldquo;<U>SEC Reports</U>&rdquo;) complied in all material
respects with the applicable requirements in existence as of such dates of the Securities Act and the Securities Exchange Act of 1934,
as amended (the &ldquo;<U>Exchange Act</U>&rdquo;), and the rules&nbsp;and regulations of the Commission promulgated thereunder, and
none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to
be stated therein or necessary in order to make the statements therein, as of such dates, in the light of the circumstances under which
they were made, not misleading. Except as disclosed in the SEC Reports, the financial statements of the Company included in the SEC Reports
comply in all material respects with applicable accounting requirements and the rules&nbsp;and regulations of the Commission with respect
thereto as in effect at the time of filing and fairly present in all material respects the financial position of the Company as of and
for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements,
to normal, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;As
of the date hereof, and immediately prior to the Closing when the Company&rsquo;s amended and restated memorandum and articles of association
shall be amended and restated to effect the Transaction, the entire authorized share capital stock of the Company consists of 200,000,000
Class&nbsp;A ordinary shares (&ldquo;<U>Class&nbsp;A Shares</U>&rdquo;), 20,000,000 Class&nbsp;B ordinary shares, and 1,000,000 preference
shares, par value $0.0001 per share (&ldquo;<U>Preference Shares</U>&rdquo;). As of the Closing Date (and immediately after the consummation
of the Transaction), the entire authorized capital stock of the Company will consist of [9,950] Ordinary Shares and [</FONT>&#9679;<FONT STYLE="font-family: Times New Roman, Times, Serif">]
Preference Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Assuming
the accuracy of all of Subscriber&rsquo;s representations and warranties set forth in <U>Section&nbsp;4</U> of this Subscription Agreement,
no registration under the Securities Act is required for the offer and sale of the Subscribed Shares and Private Placement Warrants by
the Company to Subscriber and the Subscribed Shares and Private Placement Warrants are not being offered in a manner involving a public
offering under, or in a distribution in violation of, the Securities Act or any state securities law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Neither
the Company nor any person acting on its behalf has engaged or will engage in any form of general solicitation or general advertising
(within the meaning of Regulation D) in violation of the Securities Act in connection with any offer or sale of the Subscribed Shares
and Private Placement Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;No
broker or finder is entitled to any brokerage or finder&rsquo;s fee or commission from the Company solely in connection with the sale
of the Subscribed Shares and Private Placement Warrants to Subscriber.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company has provided Subscriber an opportunity to ask questions regarding the Company and made available to Subscriber all the information
reasonably available to the Company that Subscriber has reasonably requested to make an investment decision with respect to the Subscribed
Shares and the Private Placement Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Except
for such matters as have not had and would not reasonably be expected to have a Company Material Adverse Effect, the Company is in compliance
with all laws applicable to the conduct of its business. The Company has not received any written, or to its knowledge, other communication
from a governmental entity that alleges that the Company is not in compliance with or is in default or violation of any applicable law,
except where such non-compliance, default or violation would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;As
of the date hereof, the issued and outstanding Class&nbsp;A Shares are registered pursuant to Section&nbsp;12(b)&nbsp;of the Exchange
Act and listed for trading on the NYSE. There is no suit, action, claim, proceeding or investigation pending or, to the knowledge of
the Company, threatened against the Company by NYSE or the Commission with respect to any intention by such entity to deregister the
Class&nbsp;A Shares or to prohibit or terminate the listing of the Class&nbsp;A Shares on NYSE, excluding, for the purposes of clarity,
the customary ongoing review by NYSE in connection with the Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(p)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;There
are no shareholder agreements, voting trusts or other agreements or understandings to which the Company is a party or by which it is
bound relating to the voting of any securities of the Company, other than (1)&nbsp;as set forth in the SEC Reports and (2)&nbsp;as contemplated
by the Business Combination Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(q)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company has not engaged in any &ldquo;directed selling efforts&rdquo; (within the meaning of Regulation S) with respect to the Subscribed
Shares or the Private Placement Warrants, and the Company and its affiliates have complied with the offering restrictions requirement
of Regulation S. The Company is a &ldquo;foreign issuer&rdquo; as defined in Regulation S.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(r)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Other Subscription Agreements reflect the same Per Unit Subscription Price and other terms with respect to the purchase of the Other
Subscribed Shares and Other Private Placement Warrants that are no more favorable to the Other Subscribers thereunder than the terms
of this Subscription Agreement, other than terms particular to the regulatory requirements of such Other Subscribers or their affiliates
or related funds that are mutual funds or are otherwise subject to regulations related to the timing of funding and the issuance of the
related Other Subscribed Shares and Other Private Placement Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Subscriber
Representations and Warranties</U>. Subscriber represents and warrants to the Company that as the date hereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subscriber
(i)&nbsp;is duly organized, validly existing and in good standing under the laws of its jurisdiction of incorporation, and (ii)&nbsp;has
the requisite power and authority to enter into and perform its obligations under this Subscription Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Subscription Agreement has been duly executed and delivered by Subscriber, and assuming the due authorization, execution and delivery
of the same by the Company, this Subscription Agreement shall constitute the valid and legally binding obligation of Subscriber, enforceable
against Subscriber in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization,
moratorium and similar laws affecting creditors generally and by the availability of equitable remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
execution and delivery of this Subscription Agreement, the purchase of the Subscribed Shares and Private Placement Warrants and the compliance
by Subscriber with all of the provisions of this Subscription Agreement and the consummation of the transactions contemplated herein
will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result
in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of Subscriber pursuant to the terms
of (i)&nbsp;any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which Subscriber
is a party or by which Subscriber is bound or to which any of the property or assets of Subscriber is subject; (ii)&nbsp;the organizational
documents of Subscriber; or (iii)&nbsp;any statute or any judgment, order, rule&nbsp;or regulation of any court or governmental agency
or body, domestic or foreign, having jurisdiction over Subscriber or any of its properties that, in the case of clauses (i)&nbsp;and
(iii), would reasonably be expected to have a Subscriber Material Adverse Effect. For purposes of this Subscription Agreement, a &ldquo;<U>Subscriber
Material Adverse Effect</U>&rdquo; means an event, change, development, occurrence, condition or effect with respect to Subscriber that
would reasonably be expected to have a material adverse effect on Subscriber&rsquo;s ability to timely consummate the transactions contemplated
hereby, including the purchase of the Subscribed Shares and Private Placement Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(i)&nbsp;If
Subscriber is located in the United States or is a U.S. person, Subscriber (A)&nbsp;is a &ldquo;qualified institutional buyer&rdquo;
(as defined in Rule&nbsp;144A under the Securities Act) or an institutional &ldquo;accredited investor&rdquo; (within the meaning of
Rule&nbsp;501(a)(1), (2), (3), (7), (9)&nbsp;or (12) under the Securities Act), in either case satisfying the applicable requirements
set forth on Annex A hereto and an &ldquo;institutional account&rdquo; as defined in FINRA Rule&nbsp;4512(c), and is not an entity formed
for the specific purpose of acquiring the Subscribed Shares or the Private Placement Warrants and is an &ldquo;institutional account&rdquo;
as defined by FINRA Rule&nbsp;4512(c)&nbsp;and a sophisticated institutional investor, experienced in investing in private equity transactions
and capable of evaluating investment risks independently, both in general and with regard to all transactions and investment strategies
involving a security or securities; (B)&nbsp;is a sophisticated investor, experienced in investing in private equity transactions and
capable of evaluating investment risks independently, both in general and with regard to all transactions and investment strategies involving
a security or securities, (C)&nbsp;has exercised independent judgment in evaluating its participation in the purchase of the Subscribed
Shares and the Private Placement Warrants, (D)&nbsp;is acquiring the Subscribed Shares and the Private Placement Warrants only for its
own account and not for the account of others, or if Subscriber is subscribing for the Subscribed Shares and the Private Placement Warrants
as a fiduciary or agent for one or more investor accounts, each owner of such account is a qualified institutional buyer or an institutional
accredited investor and Subscriber has full investment discretion with respect to each such account, and the full power and authority
to make the acknowledgements, representations and agreements herein on behalf of each owner of each such account, and (E)&nbsp;is not
acquiring the Subscribed Shares or the Private Placement Warrants with a view to, or for offer or sale in connection with, any distribution
thereof in violation of the Securities Act (and has provided the Company with the requested information on Annex A), and (F)&nbsp;understands
that the offering meets the exemptions from filing under FINRA Rules&nbsp;5123(b)(1)(A), (C)&nbsp;and (J); and (ii)&nbsp;if located outside
the United States and not a U.S. person, (A)&nbsp;Subscriber is acquiring the Subscribed Shares and the Private Placement Warrants in
an &ldquo;offshore transaction&rdquo; meeting the requirements of Rule&nbsp;903 of Regulation S under the Securities Act, (B)&nbsp;Subscriber
understand that the offering meets the exemptions from filing under FINRA Rule&nbsp;5123(c), (C)&nbsp;Subscriber is are aware that the
sale to them is being made in reliance on a private placement exemption from, or in a transaction not subject to, registration under
the Securities Act, and the purchaser and the person, if any, for whose account or benefit the purchaser is acquiring the Securities
offered pursuant to this Subscription, was located outside the United States and was not a U.S. person at the time (x)&nbsp;the offer
was made to it and (y)&nbsp;when the buy order for such Subscribed Shares and Private Placement Warrants was originated, and continues
to be located outside the United States and not to be a U.S. person and has not purchased such Subscribed Shares or Private Placement
Warrants for the account or benefit of any person located in the United States or who is a U.S. person, or entered into any arrangement
for the transfer of such Subscribed Shares, Private Placement Warrants or any economic interest therein to any person located in the
United States or any U.S. person, (D)&nbsp;Subscriber is authorized to consummate the purchase of the Subscribed Shares and the Private
Placement Warrants offered pursuant to this Subscription in compliance with all applicable laws and regulations of the jurisdiction where
such sales are to be made. In either case, the Subscribed Shares and the Private Placement Warrants have not been registered under the
Securities Act or any other applicable securities laws of any other jurisdiction, are being offered in transactions not requiring registration
under the Securities Act, and unless so registered, may not be reoffered, resold or otherwise transferred except in compliance with the
registration requirements of the Securities Act or any other applicable securities laws, pursuant to any exemption therefrom or in a
transaction not subject thereto. Subscriber understands that each of the Subscribed Shares and the Private Placement Warrants may not
be offered, resold, transferred, pledged (other than in connection with ordinary course prime brokerage relationships) or otherwise disposed
of by Subscriber absent an effective registration statement under the Securities Act, except (i)&nbsp;to the Company or a subsidiary
thereof, (ii)&nbsp;to non-U.S. persons pursuant to offers and sales that occur outside the United States within the meaning of Regulation
S under the Securities Act or (iii)&nbsp;pursuant to another applicable exemption from the registration requirements of the Securities
Act, and, in each of cases (ii)&nbsp;and (iii), in accordance with any applicable securities laws of the states and other jurisdictions
of the United States, and that any book-entry positions or certificates representing the Subscribed Shares and the Private Placement
Warrants shall contain the legend set forth in this <U>Section&nbsp;4(d)</U>. Subscriber understands and agrees that the Subscribed Shares
and the Private Placement Warrants will be subject to transfer restrictions under applicable securities laws and, as a result of these
transfer restrictions, Subscriber may not be able to readily offer, resell, transfer, pledge (other than in connection with ordinary
course prime brokerage relationships) or otherwise dispose of the Subscribed Shares or the Private Placement Warrants and may be required
to bear the financial risk of an investment in the Subscribed Shares and the Private Placement Warrants for an indefinite period of time.
Subscriber understands that it has been advised to consult legal counsel and tax and accounting advisors prior to making any offer, resale,
pledge, transfer or disposition of any of the Subscribed Shares or the Private Placement Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Each book entry for the Subscribed Shares
and the Private Placement Warrants shall contain a notation, and each certificate (if any) evidencing the Shares shall be stamped or
otherwise imprinted with a legend, in substantially the following form (or to substantially the following effect):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">THE SECURITIES REPRESENTED HEREBY HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND MAY&nbsp;NOT BE OFFERED, SOLD,
PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE (NOTWITHSTANDING THE FOREGOING, THE SECURITIES REPRESENTED
HEREBY MAY&nbsp;BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES).
BY ITS ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN, THE ACQUIRER AGREES FOR THE BENEFIT OF ZURA BIO LTD. (THE &ldquo;COMPANY&rdquo;)
THAT IT WILL NOT OFFER, SELL, PLEDGE OR OTHERWISE TRANSFER THIS SECURITY OR ANY BENEFICIAL INTEREST HEREIN PRIOR TO THE DATE THAT IS
THE LATER OF (X)&nbsp;ONE YEAR AFTER THE ISSUE DATE HEREOF OR SUCH SHORTER PERIOD OF TIME AS PERMITTED BY RULE 144 UNDER THE SECURITIES
ACT OR ANY SUCCESSOR PROVISION THERETO AND (Y)&nbsp;SUCH LATER DATE,&nbsp;IF ANY, AS MAY&nbsp;BE REQUIRED BY APPLICABLE LAW, EXCEPT:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(A)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;TO
THE COMPANY OR ANY SUBSIDIARY THEREOF, OR</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(B)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;PURSUANT
TO A REGISTRATION STATEMENT THAT HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT AND IS EFFECTIVE AT THE TIME OF SUCH TRANSFER, OR</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(C)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;PURSUANT
TO OFFERS AND SALES TO NON-U.S. PERSONS THAT OCCUR OUTSIDE THE UNITED STATES WITHIN THE MEANING OF REGULATION S UNDER THE SECURITIES
ACT, OR</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(D)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;PURSUANT
TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT OR ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">PRIOR TO THE REGISTRATION OF ANY PERMITTED
TRANSFER IN ACCORDANCE WITH THE ABOVE, THE COMPANY RESERVES THE RIGHT TO REQUIRE THE DELIVERY OF SUCH LEGAL OPINIONS, CERTIFICATIONS
OR OTHER EVIDENCE AS MAY&nbsp;REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED TRANSFER IS BEING MADE IN COMPLIANCE WITH
THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. NO REPRESENTATION IS MADE AS TO THE AVAILABILITY OF ANY EXEMPTION FROM THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subscriber
understands and agrees that Subscriber is purchasing the Subscribed Shares and the Private Placement Warrants directly from the Company.
Subscriber further acknowledges that there have not been, and Subscriber hereby expressly and irrevocably acknowledges and agrees that
it is not relying on, any representations, warranties, covenants or, agreements or statements made to Subscriber by or on behalf of the
Company, Zura or the Company&rsquo;s or Zura&rsquo;s respective affiliates or any of the respective subsidiaries, control persons, officers,
directors, employees, partners, agents or representatives, or any other party to the Transaction or any other person or entity, expressly
or by implication, (including by omission), other than those representations, warranties, covenants, agreements and statements of the
Company expressly set forth in this Subscription Agreement, and Subscriber is not relying on any other purported representations, warranties,
covenants, agreements or statements (including by omission). Subscriber acknowledges that certain information provided by the Company
was based on projections, and such projections were prepared based on assumptions and estimates that are inherently uncertain and are
subject to a wide variety of significant business, economic and competitive risks and uncertainties that could cause actual results to
differ materially from those contained in the projections. Subscriber undertook this investment freely and after obtaining independent
legal advice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
making its decision to purchase the Subscribed Shares and Private Placement Warrants, Subscriber has relied solely upon independent investigation
made by Subscriber and upon the representations, warranties and covenants of the Company expressly set forth herein (and no other representations
and warranties). Subscriber acknowledges and agrees that Subscriber has received and had adequate time to review such information as
Subscriber deems necessary in order to make an investment decision with respect to the Subscribed Shares and the Private Placement Warrants,
including with respect to the Company and the Transaction (including Zura and its subsidiaries (collectively, the &ldquo;<U>Acquired
Companies</U>&rdquo;)). Subscriber acknowledges it has conducted its own investigation of the Company and the Subscribed Shares and Private
Placement Warrants and has been offered the opportunity to ask questions of the Company and received answers thereto, including on the
financial information, as Subscriber deemed necessary in connection with its decision to purchase the Subscribed Shares and the Private
Placement Warrants. Subscriber has made its own assessment and is satisfied concerning the relevant tax and other economic considerations
relevant to its investment in the Subscribed Shares and the Private Placement Warrants. Without limiting the generality of the foregoing,
Subscriber acknowledges that Subscriber has reviewed the SEC Reports. Subscriber represents and agrees that Subscriber and Subscriber&rsquo;s
professional advisor(s), if any, have had the full opportunity to ask such questions, receive such answers and obtain such information
as Subscriber and such undersigned&rsquo;s professional advisor(s), if any, have deemed necessary to make an investment decision with
respect to the Subscribed Shares and the Private Placement Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subscriber
became aware of this offering of the Subscribed Shares and the Private Placement Warrants solely by means of direct contact between Subscriber
and the Company or by means of contact from Zura or its subsidiaries and/or their respective advisors (including, without limitation,
attorneys, accountants, bankers, consultants and financial advisors), agents, control persons, representatives, affiliates, directors,
officers, managers, members, and/or employees, and/or the representatives of such persons (such parties referred to collectively as &ldquo;<U>Representatives</U>&rdquo;).
The Subscribed Shares and the Private Placement Warrants were offered to Subscriber solely by direct contact between Subscriber and the
Company, Zura or its subsidiaries and/or their respective Representatives. Subscriber did not become aware of this offering of the Subscribed
Shares and the Private Placement Warrants, nor were the Subscribed Shares and Private Placement Warrants offered to Subscriber, by any
other means, and none of the Company, Zura or its subsidiaries or their respective Representatives acted as investment advisor, broker
or dealer to Subscriber. Subscriber acknowledges that it is not relying upon, and has not relied upon, any statement, representation
or warranty made by any person or entity (including, without limitation, the Company, Zura and/or their respective Representatives),
other than the representations and warranties expressly set forth in this Subscription Agreement, in making its investment or decision
to invest in the Company. Subscriber acknowledges that the Company represents and warrants that the Subscribed Shares and Private Placement
Warrants (i)&nbsp;were not offered by any form of general solicitation or general advertising, including methods described in Section&nbsp;502(c)&nbsp;of
Regulation D under the Securities Act, and (ii)&nbsp;are not being offered in a manner involving a public offering under, or in a distribution
in violation of, the Securities Act, or any state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subscriber
acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Subscribed Shares and the
Private Placement Warrants. Subscriber has such knowledge and experience in financial and business matters as to be capable of evaluating
the merits and risks of an investment in the Subscribed Shares and the Private Placement Warrants, and Subscriber has had an opportunity
to seek, and has sought, such accounting, legal, business and tax advice as Subscriber has considered necessary to make an informed investment
decision, and has the ability to bear the economic risks of its prospective investment and can afford the complete loss of such investment.
Subscriber acknowledges that it (i)&nbsp;is a sophisticated investor, experienced in investing in business and financial transactions
and capable of evaluating investment risks independently, both in general and with regard to all transactions and investment strategies
involving a security or securities, and (ii)&nbsp;has exercised independent judgment in evaluating its purchase of the Subscribed Shares
and the Private Placement Warrants. Subscriber acknowledges that its purchase of Subscribed Shares and the Private Placement Warrants
(i)&nbsp;is fully consistent with Subscriber&rsquo;s financial needs, objectives and condition, (ii)&nbsp;complies and is fully consistent
with all of Subscriber&rsquo;s applicable investment policies, guidelines and other restrictions, (iii)&nbsp;has been duly authorized
and approved by all necessary action (corporate or otherwise), and (iv)&nbsp;does not and will not violate or constitute a default under
Subscriber&rsquo;s charter, by-laws or other constituent documents or under any law, rule, regulation, agreement or other obligation
by which we are bound and are a fit, proper and suitable investment, notwithstanding the substantial risks inherent in investing in or
holding the Subscribed Shares or the Private Placement Warrants. Subscriber understands that the purchase and sale of the Subscribed
Shares and the Private Placement Warrants, to the extent applicable, hereunder meets (i)&nbsp;the institutional accounts exemptions from
filing under FINRA Rule&nbsp;5123(b)(1)(A), (ii)&nbsp;the institutional customer exemption from filing under FINRA Rule&nbsp;2111(b),
(iii)&nbsp;the qualified institutional buyers exemption from filing under FINRA Rule&nbsp;5123(b)(1)(C)&nbsp;and (iv)&nbsp;the accredited
investors exemption from filing under FINRA Rule&nbsp;5123(b)(1)(J).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;Alone,
or together with any professional advisor(s), Subscriber represents and acknowledges that Subscriber has adequately analyzed and fully
considered the risks of an investment in the Subscribed Shares and the Private Placement Warrants and determined that the Subscribed
Shares and the Private Placement Warrants are a suitable investment for Subscriber and that Subscriber is able at this time and in the
foreseeable future to bear the economic risk of a total loss of Subscriber&rsquo;s investment in the Company. Subscriber acknowledges
specifically that a possibility of total loss exists.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;Subscriber
understands and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Subscribed Shares
or the Private Placement Warrants or made any findings or determination as to the fairness of this investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subscriber
is not (i)&nbsp;a person or entity named on the List of Specially Designated Nationals and Blocked Persons administered by the U.S. Treasury
Department&rsquo;s Office of Foreign Assets Control (&ldquo;<U>OFAC</U>&rdquo;) or in any Executive Order issued by the President of
the United States and administered by OFAC, or any other list of prohibited or restricted parties promulgated by OFAC, the Department
of Commerce, or the Department of State (&ldquo;<U>Consolidated Sanctions Lists</U>&rdquo;), or a person or entity prohibited or restricted
by any OFAC sanctions program, or a person or entity whose property and interests in property subject to U.S. jurisdiction are otherwise
blocked under any U.S. laws, Executive Orders or regulations, (ii)&nbsp;a person or entity listed on the Sectoral Sanctions Identifications
(&ldquo;<U>SSI</U>&rdquo;) List maintained by OFAC or otherwise determined by OFAC to be subject to one or more of the Directives issued
under Executive Order 13662 of March&nbsp;20, 2014, or on any other of the Consolidated Sanctions Lists, (iii)&nbsp;an entity owned,
directly or indirectly, individually or in the aggregate, 50 percent or more by, acting on behalf of, or controlled by, one or more persons
described in subsections (i)&nbsp;or (ii), (iv)&nbsp;organized, incorporated, established, located, resident or born in, or a citizen,
national or the government, including any political subdivision, agency or instrumentality thereof, of, Cuba,&nbsp;Iran, North Korea,
Myanmar, Venezuela, Syria, the Crimea region of Ukraine, the so-called People&rsquo;s Republics of Luhansk and Donetsk of Ukraine or
any other country or territory embargoed or subject to substantial trade restrictions by the United States, (v)&nbsp;a person or entity
named on the U.S. Department of Commerce, Bureau of Industry and Security (&ldquo;<U>BIS</U>&rdquo;) Denied Persons List, Entity List,
or Unverified List (&ldquo;<U>BIS Lists</U>&rdquo;), (vi)&nbsp;a Designated National as defined in the Cuban Assets Control Regulations,
31 C.F.R. Part&nbsp;515, or (vii)&nbsp;a non-U.S. shell bank or providing banking services indirectly to a non-U.S. shell bank (collectively,
(i)&nbsp;through (vii), a &ldquo;<U>Restricted Person</U>&rdquo;). Subscriber agrees to provide law enforcement agencies, if requested
thereby, such records as required by applicable law, provided that Subscriber is permitted to do so under applicable law. Subscriber
represents that if it is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section&nbsp;5311 et seq.), as amended by
the USA PATRIOT Act of 2001 and its implementing regulations (collectively, the &ldquo;<U>BSA/PATRIOT Act</U>&rdquo;), that Subscriber
maintains policies and procedures reasonably designed to comply with applicable obligations under the BSA/PATRIOT Act. Subscriber also
represents that, to the extent required, it maintains policies and procedures reasonably designed for the screening of its investors
against the OFAC and BIS sanctions programs, including for Restricted Persons, and otherwise to ensure compliance with all applicable
sanctions and embargo laws, statutes, and regulations. Subscriber further represents and warrants that, to the extent required, it maintains
policies and procedures reasonably designed to ensure that the funds held by Subscriber and used to purchase the Subscribed Shares and
Private Placement Warrants were legally and were not obtained, directly or indirectly, from a Restricted Person. Subscriber is not a
 &ldquo;foreign person,&rdquo; &ldquo;foreign government,&rdquo; or a &ldquo;foreign entity,&rdquo; in each case, as defined in Section&nbsp;721
of the Defense Production Act of 1950, as amended, including, without limitation, all implementing regulations thereof (the &ldquo;<U>DPA</U>&rdquo;).
Subscriber is not controlled, in whole or in part, by a &ldquo;foreign person,&rdquo; as defined in the DPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;Subscriber
does not have, as of the date hereof, and during the 30-day period immediately prior to the date hereof Subscriber has not entered into,
any &ldquo;put equivalent position&rdquo; as such term is defined in Rule&nbsp;16a-1 under the Exchange Act or short sale positions with
respect to the securities of the Company. Notwithstanding the foregoing, in the case of a Subscriber that is a multi-managed investment
vehicle whereby separate portfolio managers manage separate portions of Subscriber&rsquo;s assets and the portfolio managers have no
direct knowledge of the investment decisions made by the portfolio managers managing other portions of Subscriber&rsquo;s assets, the
representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the
investment decision to purchase the Subscribed Shares and the Private Placement Warrants covered by this Subscription Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
Subscriber is an employee benefit plan that is subject to Title I of ERISA, a plan, an individual retirement account or other arrangement
that is subject to Section&nbsp;4975 of the Internal Revenue Code of 1986, as amended (the &ldquo;<U>Code</U>&rdquo;), or an employee
benefit plan that is a governmental plan (as defined in Section&nbsp;3(32) of ERISA), a church plan (as defined in Section&nbsp;3(33)
of ERISA), a non-U.S. plan (as described in Section&nbsp;4(b)(4)&nbsp;of ERISA) or other plan that is not subject to the foregoing but
may be subject to provisions under any other federal, state, local, non-U.S. or other laws or regulations that are similar to such provisions
of ERISA or the Code, or an entity whose underlying assets are considered to include &ldquo;plan assets&rdquo; of any such plan, account
or arrangement (each, a &ldquo;<U>Plan</U>&rdquo;) subject to the fiduciary or prohibited transaction provisions of ERISA or Section&nbsp;4975
of the Code or other laws or regulations that are similar to such provisions, then Subscriber represents and warrants that neither the
Company, nor any of its respective affiliates (the &ldquo;<U>Transaction Parties</U>&rdquo;) has acted as the Plan&rsquo;s fiduciary,
or has been relied on for advice, with respect to its decision to acquire and hold the Subscribed Shares and Private Placement Warrants,
and none of the Transaction Parties shall at any time be relied upon as the Plan&rsquo;s fiduciary with respect to any decision to acquire,
continue to hold or transfer the Subscribed Shares and the Private Placement Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;At
the Closing, Subscriber will have sufficient funds to pay the Subscription Amount pursuant to <U>Section&nbsp;2(b)</U>&nbsp;of this Subscription
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subscriber
agrees that, notwithstanding <U>Section&nbsp;9(i)</U>&nbsp;of this Subscription Agreement, the Company and Zura may rely upon the representations
and warranties made by Subscriber to the Company in this Subscription Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(p)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;No
broker, finder or other financial consultant has acted on behalf of Subscriber in connection with this Subscription Agreement or the
transactions contemplated hereby in such a way as to create any liability on the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(q)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Except
for the representations and warranties contained in this <U>Section&nbsp;4, </U>Subscriber makes no express or implied representation
or warranty, and Subscriber hereby disclaims any such representation or warranty with respect to the execution and delivery of this Subscription
Agreement and the consummation of the transactions contemplated herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="text-transform: uppercase">5.</FONT></TD><TD STYLE="text-align: justify"><U>Registration
                                            of Subscribed Shares and Ordinary Shares Issuable Upon Exercise of Private Placement Warrants</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company agrees that, within 45 calendar days after the consummation of the Transaction (the &ldquo;<U>Filing Deadline</U>&rdquo;), the
Company will file with the Commission (at the Company&rsquo;s sole cost and expense) a registration statement (the &ldquo;<U>Registration
Statement</U>&rdquo;) registering the resale of the Subscribed Shares and the Ordinary Shares issuable upon exercise of the Private Placement
Warrants, and the Company shall use its commercially reasonable efforts to have the Registration Statement declared effective as soon
as practicable after the filing thereof, but no later than the 60th calendar day (or 120th calendar day if the Commission notifies the
Company that it will &ldquo;review&rdquo; the Registration Statement) following the Filing Deadline (such date, the &ldquo;<U>Effectiveness
Date</U>&rdquo;); provided, however, that the Company&rsquo;s obligations to include the Subscribed Shares and Ordinary Shares issuable
upon exercise of the Private Placement Warrants in the Registration Statement are contingent upon the undersigned furnishing in writing
to the Company such information regarding the undersigned, the securities of the Company held by the undersigned and the intended method
of disposition of the Subscribed Shares and the Ordinary Shares issuable upon exercise of the Private Placement Warrants as shall be
reasonably requested by the Company to effect the registration of the Subscribed Shares and Ordinary Shares issuable upon exercise of
the Private Placement Warrants, and shall execute such documents in connection with such registration as the Company may reasonably request
that are customary of a selling shareholder in similar situations. Notwithstanding the foregoing, if the Effectiveness Date falls on
a day which is not a Business Day or other day that the Commission is closed for business, the Effectiveness Date shall be extended to
the next Business Day on which the Commission is open for business. Further notwithstanding the foregoing, if the Commission prevents
the Company from including any or all of the shares proposed to be registered under the Registration Statement due to limitations on
the use of Rule&nbsp;415 of the Securities Act for the resale of the respective Aggregate Subscribed Shares and Ordinary Shares issuable
upon exercise of the Aggregate Private Placement Warrants, such Registration Statement shall register for resale such number of Aggregate
Subscribed Shares and Ordinary Shares issuable upon exercise of the Aggregate Private Placement Warrants that is equal to the maximum
number of Aggregate Subscribed Shares and Ordinary Shares issuable upon exercise of the Aggregate Private Placement Warrants as is permitted
by the Commission. In such event, the number of Subscribed Shares, Other Subscribed Shares or Ordinary Shares issuable upon exercise
of the Private Placement Warrants and Other Private Placement Warrants to be registered for each selling shareholder named in the Registration
Statement shall be reduced pro rata among all such selling shareholders. For purposes of clarification, any failure by the Company to
file the Registration Statement by the Filing Deadline or to effect such Registration Statement by the Effectiveness Date shall not otherwise
relieve the Company of its obligations to file or effect the Registration Statement set forth in this <U>Section&nbsp;5.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the case of the registration, qualification, exemption or compliance effected by the Company pursuant to this Subscription Agreement,
the Company shall, upon reasonable request, respond to Subscriber as to the status of such registration, qualification, exemption and
compliance. At its expense the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;except
for such times as the Company is permitted hereunder to suspend the use of the prospectus forming part of a Registration Statement, use
its commercially reasonable efforts to maintain the continuous effectiveness of the Registration Statement, and cause the Registration
Statement to be supplemented and amended to the extent necessary to ensure that such Registration Statement is available or, if not available,
that another registration statement is available for the resale of the Subscribed Shares and the Ordinary Shares issuable upon exercise
of the Private Placement Warrants, until the earliest of (i)&nbsp;the date on which the Subscribed Shares and the Ordinary Shares issuable
upon exercise of the Private Placement Warrants may be resold without volume or manner of sale limitations pursuant to Rule&nbsp;144
promulgated under the Securities Act, (ii)&nbsp;the date on which such Subscribed Shares and Ordinary Shares issuable upon exercise of
the Private Placement Warrants have actually been sold pursuant to Rule&nbsp;144 or pursuant to the Registration Statement, and (iii)&nbsp;the
date which is two years after the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;advise
Subscriber, as expeditiously as possible:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1.5in">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;when
a Registration Statement or any amendment thereto has been filed with the Commission;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1.5in">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;after
it shall receive notice or obtain knowledge thereof, of the issuance by the Commission of any stop order suspending the effectiveness
of any Registration Statement or the initiation of any proceedings for such purpose;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1.5in">(3)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;of
the receipt by the Company of any notification with respect to the suspension of the qualification of the Subscribed Shares or Ordinary
Shares issuable upon exercise of the Private Placement Warrants included therein for sale in any jurisdiction or the initiation or threatening
of any proceeding for such purpose; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1.5in">(4)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;subject
to the provisions in this Subscription Agreement, of the occurrence of any event that requires the making of any changes in any Registration
Statement or prospectus so that, as of such date, the statements therein are not misleading and do not omit to state a material fact
required to be stated therein or necessary to make the statements therein (in the case of a prospectus, in the light of the circumstances
under which they were made) not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">Notwithstanding anything
to the contrary set forth herein, the Company shall not, when so advising Subscriber of such events, provide Subscriber with any material,
nonpublic information regarding the Company other than to the extent that providing notice to the Subscriber of the occurrence of the
events listed in (1)&nbsp;through (4)&nbsp;above may constitute material, nonpublic information regarding the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;use
its commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of any Registration Statement
as soon as reasonably practicable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;upon
the occurrence of any event contemplated in <U>Section&nbsp;5(b)(ii)(4)</U>&nbsp;above, except for such times as the Company is permitted
hereunder to suspend, and has suspended, the use of a prospectus forming part of a Registration Statement, the Company shall use its
commercially reasonable efforts to as soon as reasonably practicable prepare a post-effective amendment to such Registration Statement
or a supplement to the related prospectus, or file any other required document so that, as thereafter delivered to purchasers of the
Subscribed Shares and Ordinary Shares issuable upon exercise of the Private Placement Warrants included therein, such prospectus will
not include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the
light of the circumstances under which they were made, not misleading;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;cause
the Subscribed Shares and Ordinary Shares issuable upon exercise of the Private Placement Warrants to be listed on each securities exchange
or market, if any, on which the Ordinary Shares issued by the Company have been listed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(vi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;use
its commercially reasonable efforts to allow Subscriber to review disclosure regarding Subscriber in the Registration Statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(vii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;for
as long as Subscriber holds Subscribed Shares or Private Placement Warrants, use commercially reasonable efforts to file all reports
for so long as the condition in Rule&nbsp;144(c)(1)&nbsp;(or Rule&nbsp;144(i)(2), if applicable) is required to be satisfied, and provide
all customary and reasonable cooperation, necessary to enable the undersigned to resell the Subscribed Shares or the Ordinary Shares
issuable upon exercise of the Private Placement Warrants, as applicable, pursuant to Rule&nbsp;144 of the Securities Act (in each case,
when Rule&nbsp;144 of the Securities Act becomes available to Subscriber); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(viii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;otherwise,
in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by Subscriber, consistent with
the terms of this Subscription Agreement, in connection with the registration of the Subscribed Shares and Ordinary Shares issuable upon
exercise of the Private Placement Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding
anything to the contrary in this Subscription Agreement, the Company shall be entitled to delay or postpone the effectiveness of the
Registration Statement, and from time to time to require any Subscriber not to sell under the Registration Statement or to suspend the
effectiveness thereof, (x)&nbsp;if (i)&nbsp;it determines that in order for the Registration Statement not to contain a material misstatement
or omission, an amendment or supplement thereto would be needed or (ii)&nbsp;the negotiation or consummation of a transaction by the
Company or its subsidiaries is pending or an event has occurred, which negotiation, consummation or event, the Company reasonably believes,
upon the advice of legal counsel, would require additional disclosure by the Company in the Registration Statement of material information
that the Company has a bona fide business purpose for keeping confidential and the non-disclosure of which in the Registration Statement
would be expected, in the reasonable determination of the Company, upon the advice of legal counsel, to cause the Registration Statement
to fail to comply with applicable disclosure requirements and (y)&nbsp;as may be necessary in connection with the preparation and filing
of a post-effective amendment to the Registration Statement following the filing of the Company&rsquo;s (including the combined company
after giving effect to the Transaction) Annual Report on Form&nbsp;20-F, or 10-K, as appropriate, for its first completed fiscal year
following the Closing (each such circumstance, a &ldquo;<U>Suspension Event</U>&rdquo;); provided, however, that the Company may not
delay or suspend the Registration Statement on more than three occasions or for more than ninety consecutive calendar days, or more than
a total of 120 calendar days, in each case during any twelve-month period. Upon receipt of any written notice from the Company of the
happening of any Suspension Event (which notice shall not contain material non-public information) during the period that the Registration
Statement is effective or if as a result of a Suspension Event the Registration Statement or related prospectus contains any untrue statement
of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein, in
light of the circumstances under which they were made (in the case of the prospectus) not misleading, Subscriber agrees that (i)&nbsp;it
will immediately discontinue offers and sales of the Subscribed Shares and Ordinary Shares issuable upon exercise of the Private Placement
Warrants under the Registration Statement (excluding, for the avoidance of doubt, sales conducted pursuant to Rule&nbsp;144) until Subscriber
receives copies of a supplemental or amended prospectus (which the Company agrees to promptly prepare) that corrects the misstatement(s)&nbsp;or
omission(s)&nbsp;referred to above and receives notice that any post-effective amendment has become effective or unless otherwise notified
by the Company that it may resume such offers and sales, and (ii)&nbsp;it will maintain the confidentiality of any information included
in such written notice delivered by the Company unless otherwise required by law or subpoena. If so directed by the Company, Subscriber
will deliver to the Company or, in Subscriber&rsquo;s sole discretion destroy, all copies of the prospectus covering the Subscribed Shares
and Ordinary Shares issuable upon exercise of the Private Placement Warrants in Subscriber&rsquo;s possession; provided, however, that
this obligation to deliver or destroy all copies of the prospectus covering the Subscribed Shares and Ordinary Shares issuable upon exercise
of the Private Placement Warrants shall not apply (i)&nbsp;to the extent Subscriber is required to retain a copy of such prospectus (a)&nbsp;in
order to comply with applicable legal, regulatory, self-regulatory or professional requirements or (b)&nbsp;in accordance with a bona
fide pre-existing document retention policy or (ii)&nbsp;to copies stored electronically on archival servers as a result of automatic
data backup.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall, notwithstanding any termination of this Subscription Agreement, indemnify, defend and hold harmless Subscriber (to the
extent a seller under the Registration Statement), and its officers, directors and agents, and each person who controls Subscriber (within
the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act) to the fullest extent permitted by applicable
law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys&rsquo;
fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as incurred, that arise out of or are based upon (i)&nbsp;any untrue
or alleged untrue statement of a material fact contained in the Registration Statement, any prospectus included in the Registration Statement
or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to
any omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein (in
the case of any prospectus or form of prospectus or supplement thereto, in light of the circumstances under which they were made) not
misleading, or (ii)&nbsp;any violation or alleged violation by the Company of the Securities Act, Exchange Act or any state securities
law or any rule&nbsp;or regulation thereunder, in connection with the performance of its obligations under this <U>Section&nbsp;5</U>,
except, in each case, to the extent, but only to the extent, that such untrue statements, alleged untrue statements, omissions or alleged
omissions are based upon information regarding Subscriber furnished in writing to the Company by Subscriber expressly for use therein
or such Subscriber has omitted a material fact from such information or otherwise violated the Securities Act, Exchange Act or any state
securities law or any rule&nbsp;or regulation thereunder; provided, however, that the indemnification contained in this <U>Section&nbsp;5
</U>shall not apply to amounts paid in settlement of any Losses if such settlement is effected by Subscriber without the consent of the
Company (which consent shall not be unreasonably withheld, conditioned or delayed), nor shall the Company be liable for any Losses to
the extent they arise out of or are based upon a violation which occurs (A)&nbsp;in reliance upon and in conformity with written information
furnished by a Subscriber, (B)&nbsp;in connection with any failure of Subscriber to deliver or cause to be delivered a prospectus made
available to Subscriber by the Company in a timely manner, (C)&nbsp;as a result of offers or sales effected by or on behalf of Subscriber
by means of a freewriting prospectus (as defined in Rule&nbsp;405) that was not authorized by the Company, or (D)&nbsp;in connection
with any offers or sales effected by or on behalf of a Subscriber in violation of <U>Section&nbsp;5(b)</U>&nbsp;of this Subscription
Agreement. The Company shall notify such Subscriber promptly of the institution, threat or assertion of any proceeding arising from or
in connection with the transactions contemplated by this <U>Section&nbsp;5</U> of which the Company is aware. The indemnity set forth
in this <U>Section&nbsp;5(d)</U>&nbsp;shall remain in full force and effect regardless of any investigation made by or on behalf of an
indemnified party and shall survive the transfer of the Subscribed Shares and Ordinary Shares issuable upon exercise of the Private Placement
Warrants by Subscriber.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
the total number of Ordinary Shares that Subscriber and any other person(s)&nbsp;intend to include in an underwritten offering exceeds
the number of Ordinary Shares that can be sold in an underwritten offering without being likely to have an adverse effect on the price,
timing or distribution of Ordinary Shares offered or the market for the Ordinary Shares as determined by the managing underwriter of
such offering, then the Ordinary Shares to be included in such offering shall include the number of Ordinary Shares that the managing
underwriter of the offering advises the Company can be sold without having such adverse effect, with such number to be allocated (i)&nbsp;first,
to the Company or other party or parties requesting or initiating such registration or to any other holder of securities of the Company
having rights of registration pursuant to an existing registration rights agreement and (ii)&nbsp;second, Subscribers, allocated among
Subscribers on the basis of the number of Ordinary Shares proposed to be sold by each applicable member of Subscribers in such underwritten
offering (based, for each such participant, described in this clause (ii), on the percentage derived by dividing (x)&nbsp;the number
of Ordinary Shares proposed to be sold by such participant in such underwritten offering by (y)&nbsp;the aggregate number of Ordinary
Shares proposed to be sold by all such participants) or in such manner as they may agree, and (iii)&nbsp;third, to other holders of Ordinary
Shares with registration rights entitling them to participate in such underwritten offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subscriber,
severally and not jointly with the Other Subscribers, shall indemnify and hold harmless the Company, its directors, officers, agents,
trustees, partners, members, managers, shareholders, affiliates, investment advisors and employees, and each person who controls the
Company (within the meaning of Section&nbsp;15 of the Securities Act and Section&nbsp;20 of the Exchange Act), to the fullest extent
permitted by applicable law, from and against all Losses, as incurred, arising out of or based upon any untrue or alleged untrue statement
of a material fact contained in the Registration Statement, any prospectus included in the Registration Statement, or any form of prospectus,
or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged
omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus,
or any form of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading to the extent,
but only to the extent, that such untrue statements or omissions are based upon information regarding Subscriber furnished in writing
to the Company by Subscriber expressly for use therein; provided, however, that the indemnification contained in this <U>Section&nbsp;5(f)</U>&nbsp;shall
not apply to amounts paid in settlement of any Losses if such settlement is effected without the consent of Subscriber (which consent
shall not be unreasonably withheld, conditioned or delayed) nor shall Subscriber be liable for any Losses to the extent they arise out
of or are based upon a violation which occurs in reliance upon and in conformity with written information furnished by the Company. In
no event shall the liability of any Subscriber be greater in amount than the dollar amount of the net proceeds received by Subscriber
upon the sale of the Subscribed Shares or Ordinary Shares issuable upon exercise of the Private Placement Warrants giving rise to such
indemnification obligation. Subscriber shall notify the Company promptly of the institution, threat or assertion of any proceeding arising
from or in connection with the transactions contemplated by this <U>Section&nbsp;5(f)</U>&nbsp;of which such Subscriber is aware. Such
indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of an indemnified party and shall
survive the transfer of the Subscribed Shares and Ordinary Shares issuable upon exercise of the Private Placement Warrants by Subscriber.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
person or entity entitled to indemnification herein shall (i)&nbsp;give prompt written notice to the indemnifying party of any claim
with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person&rsquo;s or
entity&rsquo;s right to indemnification hereunder to the extent such failure has not prejudiced the indemnifying party) and (ii)&nbsp;unless
in such indemnified party&rsquo;s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist
with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to
the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made
by the indemnified party without its consent (but such consent shall not be unreasonably withheld, conditioned or delayed). An indemnifying
party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of
more than one counsel for all parties indemnified by such indemnifying party with respect to such claims, unless in the reasonable judgment
of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with
respect to such claim. No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment
or enter into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying
party pursuant to the terms of such settlement), which settlement shall not include a statement or admission of fault and culpability
on the part of such indemnified party, and which settlement shall include as an unconditional term thereof the giving by the claimant
or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
the indemnification provided under this <U>Section&nbsp;5</U> from the indemnifying party is unavailable or insufficient to hold harmless
an indemnified party in respect of any Losses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified
party, shall contribute to the amount paid or payable by the indemnified party as a result of such Losses in such proportion as is appropriate
to reflect the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations;
provided, however, that the liability of Subscriber shall be limited to the net proceeds received by Subscriber from the sale of Subscribed
Shares or Ordinary Shares issuable upon exercise of the Private Placement Warrants giving rise to such indemnification obligation. The
relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action
in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material
fact, was made by (or not made by, in the case of an omission), or relates to information supplied by (or not supplied by, in the case
of an omission) such indemnifying party or indemnified party, and the indemnifying party&rsquo;s and indemnified party&rsquo;s relative
intent, knowledge, access to information and opportunity to correct or prevent such action. The amount paid or payable by a party as
a result of the Losses shall be deemed to include, subject to the limitations set forth in this <U>Section&nbsp;5,</U> any legal or other
fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. No person guilty of fraudulent
misrepresentation (within the meaning of Section&nbsp;11(f)&nbsp;of the Securities Act) shall be entitled to contribution pursuant to
this <U>Section&nbsp;5(h)</U>&nbsp;from any person or entity who was not guilty of such fraudulent misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subscriber
may deliver written notice (an &ldquo;<U>Opt-Out Notice</U>&rdquo;) to the Company requesting that Subscriber not receive notices from
the Company otherwise required by this <U>Section&nbsp;5;</U> provided, however, that Subscriber may later revoke any such Opt-Out Notice
in writing. Following receipt of an Opt-Out Notice from Subscriber (unless subsequently revoked), (i)&nbsp;the Company shall not deliver
any such notices to Subscriber and Subscriber shall no longer be entitled to the rights associated with any such notice and (ii)&nbsp;each
time prior to Subscriber&rsquo;s intended use of an effective Registration Statement, Subscriber will notify the Company in writing at
least two business days in advance of such intended use, and if a notice of a Suspension Event was previously delivered (or would have
been delivered but for the provisions of this <U>Section&nbsp;5(i))</U> and the related suspension period remains in effect, the Company
will so notify Subscriber, within one business day of Subscriber&rsquo;s notification to the Company, by delivering to Subscriber a copy
of such previous notice of Suspension Event, and thereafter will provide Subscriber with the related notice of the conclusion of such
Suspension Event immediately upon its availability (which notices shall not contain any material, nonpublic information or subject Subscriber
to any duty of confidentiality).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subscriber
acknowledges that it is not relying upon, and has not relied upon, any statement, representation, warranty or other information made
or provided by any person, firm or corporation, other than the statements, representations and warranties expressly contained in <U>Section&nbsp;3
</U>of this Subscription Agreement, in making its investment or decision to invest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;For
purposes of this <U>Section&nbsp;5,</U> (i)&nbsp;&ldquo;<U>Subscriber</U>&rdquo; shall include any person to whom the rights under this
<U>Section&nbsp;5</U> shall have been duly assigned, (ii)&nbsp;&ldquo;<U>Subscribed Shares</U>&rdquo; shall mean, as of any date of determination,
the Subscribed Shares acquired by Subscriber pursuant to this Subscription Agreement and any other equity security issued or issuable
with respect to such Subscribed Shares by way of share split, dividend, distribution, recapitalization, merger, exchange, replacement
or similar event and (ii)&nbsp;&ldquo;<U>Private Placement Warrants</U>&rdquo; shall mean, as of any date of determination, the Private
Placement Warrants acquired by Subscriber pursuant to this Subscription Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Termination</U>.
This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the parties
hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earlier to occur of (a)&nbsp;such
date and time as the Business Combination Agreement is terminated in accordance with its terms, (b)&nbsp;upon the mutual written agreement
of the Company and Subscriber to terminate this Subscription Agreement, or (c)&nbsp;April&nbsp;16, 2023 (the &ldquo;<U>Outside Date</U>&rdquo;);
provided, that nothing herein will relieve any party from liability for any willful breach hereof (including, for the avoidance of doubt,
a Subscriber&rsquo;s willful breach of <U>Section&nbsp;2(c)</U>&nbsp;of this Subscription Agreement with respect to its representations,
warranties and covenants as of the date of the Closing) prior to the time of termination, and each party will be entitled to any remedies
at law or in equity to recover losses, liabilities or damages arising from such breach. The Company shall notify Subscriber of the termination
of the Business Combination Agreement promptly after the termination thereof. For the avoidance of doubt, if any termination hereof occurs
after the delivery by Subscriber of the Subscription Amount for the Subscribed Shares and the Private Placement Warrants, the Company
shall promptly (but not later than five business days thereafter) return the Subscription Amount to Subscriber by wire transfer of immediately
available funds to the account specified by Subscriber without any deduction for or on account of any tax, withholding, charges, or set-off.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Short Sales</U>. Subscriber hereby agrees that, from the date of this Subscription Agreement until the Closing Date (or earlier termination
of this Subscription Agreement), neither Subscriber nor any Person acting on behalf of Subscriber or pursuant to any understanding with
the Subscriber will engage in any Short Sales (as defined below) with respect to securities of the Company, as applicable. For purposes
of this Section&nbsp;7, &ldquo;<U>Short Sales</U>&rdquo; shall mean all &ldquo;short sales&rdquo; as defined in Rule&nbsp;200 promulgated
under Regulation SHO under the Exchange Act, and all short positions effected through any direct or indirect stock pledges (other than
pledges in the ordinary course of business as part of prime brokerage arrangements), forward sale contracts, options, puts, calls, swaps
and similar arrangements (including on a total return basis), or sales or other short transactions through non-U.S. broker dealers or
foreign regulated brokers. Notwithstanding the foregoing, (i)&nbsp;nothing in this Section&nbsp;7 shall prohibit other entities under
common management with Subscriber that have no knowledge of this Subscription Agreement or of Subscriber&rsquo;s Subscription (including
Subscriber&rsquo;s controlled affiliates and/or affiliates) from entering into any Short Sales and (ii)&nbsp;in the case of an Investor
that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Investor&rsquo;s assets
and the portfolio managers have no knowledge of the investment decisions made by the portfolio managers or desks managing other portions
of such Investor&rsquo;s assets, the limitations set forth in the first sentence of this Section&nbsp;7 shall only apply with respect
to the portion of assets managed by the portfolio managers or desks that made the investment decision to purchase the Subscribed Shares
and Private Placement Warrants covered by this Subscription Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Trust
Account Waiver</U>. Subscriber hereby acknowledges that the Company has established a trust account (the &ldquo;<U>Trust Account</U>&rdquo;)
containing the proceeds of its initial public offering (the &ldquo;<U>IPO</U>&rdquo;) and from certain private placements occurring simultaneously
with the IPO (including interest accrued from time to time thereon) for the benefit of the public shareholders of the Company and certain
other parties (including the underwriters of the IPO). For and in consideration of the Company entering into this Subscription Agreement,
and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Subscriber hereby (i)&nbsp;agrees
that it does not now and shall not at any time hereafter have any right, title, interest or claim of any kind in or to any assets held
in the Trust Account, and shall not make any claim against the Trust Account, in each case, to the extent such claim arises as a result
of, in connection with or relating in any way to this Subscription Agreement or any other matter, and regardless of whether such claim
arises based on contract, tort, equity or any other theory of legal liability (any and all such claims are collectively referred to hereafter
as the &ldquo;<U>Released Claims</U>&rdquo;), (ii)&nbsp;irrevocably waives any Released Claims that it may have against the Trust Account
now or in the future as a result of, or arising out of, any negotiations, contracts or agreements with the Company, and (iii)&nbsp;will
not seek recourse against the Trust Account for any reason whatsoever; provided however, that nothing in this Section&nbsp;8 shall be
deemed to limit any Subscriber&rsquo;s right to distributions or redemptions from the Trust Account in accordance with the Company&rsquo;s
amended and restated memorandum and articles of association in respect of any redemptions by Subscriber of its Class&nbsp;A Shares currently
outstanding on the date hereof and acquired by any means other than pursuant to this Subscription Agreement. Subscriber agrees not to
seek recourse or make or bring any action, suit, claim or other proceeding against the Trust Account as a result of, or arising out of,
this Subscription Agreement, the transactions contemplated hereby, the Subscribed Shares or the Private Placement Warrants regardless
of whether such claim arises based on contract, tort, equity or any other theory of legal liability. Subscriber acknowledges and agrees
that it shall not have any redemption rights with respect to the Subscribed Shares or the Private Placement Warrants pursuant to the
Company&rsquo;s organizational documents in connection with the Transaction or any other business combination, any subsequent liquidation
of the Trust Account, the Company or otherwise. In the event Subscriber has any claim against the Company as a result of, or arising
out of, this Subscription Agreement, the transactions contemplated hereby, the Subscribed Shares or the Private Placement Warrants, it
shall pursue such claim solely against the Company and its assets outside the Trust Account and not against the Trust Account or any
monies or other assets in the Trust Account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;All
notices, requests, demands, claims, and other communications hereunder shall be in writing. Any notice, request, demand, claim, or other
communication hereunder shall be deemed duly given (i)&nbsp;when delivered personally to the recipient, (ii)&nbsp;when sent by electronic
mail, on the date of transmission to such recipient; (iii)&nbsp;one Business Day after being sent to the recipient by reputable overnight
courier service (charges prepaid), or (iv)&nbsp;four Business Days after being mailed to the recipient by certified or registered mail,
return receipt requested and postage prepaid, and, in each case, addressed to the intended recipient at its address specified on the
signature page&nbsp;hereof or to such electronic mail address or address as subsequently modified by written notice given in accordance
with this <U>Section&nbsp;9(a</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subscriber
acknowledges that the Company will rely on the acknowledgments, understandings, agreements, representations and warranties made by Subscriber
contained in this Subscription Agreement. Prior to the Closing, Subscriber agrees to promptly notify the Company if it becomes aware
that any of the acknowledgments, understandings, agreements, representations and warranties of Subscriber set forth herein are no longer
accurate in all material respects. The Company acknowledges that Subscriber and others will rely on the acknowledgments, understandings,
agreements, representations and warranties contained in this Subscription Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
of the Company and Subscriber is irrevocably authorized to produce this Subscription Agreement or a copy hereof to any interested party
as requested or required by law, rule&nbsp;or regulation in any administrative or legal proceeding or official inquiry with respect to
the matters covered hereby; provided that, with respect to production by the Company, such party will provide Subscriber with at least
three Business Days&rsquo; prior written notice of such production to the extent legally permissible and subject to <U>Section&nbsp;
9(s)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Regardless
of whether the Closing occurs, Subscriber shall pay all of its own expenses in connection with this Subscription Agreement and the transactions
contemplated herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Neither
this Subscription Agreement nor any rights that may accrue to Subscriber hereunder (other than the Subscribed Shares and the Private
Placement Warrants acquired hereunder, if any) may be transferred or assigned. Neither this Subscription Agreement nor any rights that
may accrue to the Company hereunder may be transferred or assigned (provided, that, for the avoidance of doubt, the Company may transfer
the Subscription Agreement and its rights hereunder solely in connection with the consummation of the Transaction and exclusively to
another entity under the control of, or under common control with, the Company). Notwithstanding the foregoing, Subscriber may assign
its rights and obligations under this Subscription Agreement to one or more qualified funds (including other investment funds or accounts
managed or advised by the investment manager who acts on behalf of Subscriber) or, with the Company&rsquo;s prior written consent, to
another person, provided that no such assignment shall relieve the original Subscriber of its obligations hereunder if any such assignee
fails to perform such obligations, unless the Company has given its prior written consent to such relief, and such assignee agrees in
writing to be bound by the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;[<I>Reserved.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;All
the agreements, representations and warranties made by each party hereto in this Subscription Agreement shall survive the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company may request from Subscriber such additional information as the Company may reasonably determine necessary to evaluate the eligibility
of Subscriber to acquire the Subscribed Shares and the Private Placement Warrants, to register the resale of the Subscribed Shares and
the Ordinary Shares issuable upon exercise of the Private Placement Warrants or otherwise consummate or evidence the transaction contemplated
by this Subscription Agreement, and Subscriber shall provide such information as may be reasonably requested, to the extent readily available
and to the extent consistent with its internal policies and procedures provided that Company agrees to keep any such information provided
by Subscriber confidential other than as necessary to include in any registration statement the Company is required to file hereunder
or in connection herewith. Subscriber acknowledges and agrees that if it does not provide the Company with such requested information,
the Company may not be able to register the Subscribed Shares and the Ordinary Shares issuable upon exercise of the Private Placement
Warrants for resale pursuant to <U>Section&nbsp;5</U> hereof. Subscriber hereby agrees that the Subscription Agreement, as well as the
nature of Subscriber&rsquo;s obligations hereunder, may be disclosed in any public announcement or disclosure required by the Commission
and in any registration statement, proxy statement, consent solicitation statement or any other Commission filing to be filed by the
Company in connection with the issuance of the Subscribed Shares and the Private Placement Warrants contemplated by this Subscription
Agreement and/or the Transaction, in each case without Subscriber&rsquo;s prior written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;This
Subscription Agreement may not be amended, modified, waived or terminated except by an instrument in writing, signed by each of the parties
hereto; provided, that this Subscription Agreement may be amended, modified, waived or terminated with the written consent of the Company
and the holders then committed to purchase a majority of the Aggregate Subscribed Shares to be purchased at the Closing, including each
holder (which includes Subscriber, its affiliates and accounts and funds controlled or managed by Subscriber or its affiliates) then
committed to purchase at least $[99,500] of the Aggregate Subscribed Shares (or, if after the Closing, the Company and the holders then
holding a majority of the then outstanding Aggregate Subscribed Shares. Upon the effectuation of such waiver, modification, amendment
or termination in conformance with this <U>Section&nbsp;9(i)</U>, such amendment, modification, waiver or termination shall be binding
on Subscriber and effective as to all of this Subscription Agreement. The Company shall promptly give written notice thereof to Subscriber
if Subscriber has not previously consented to such amendment, modification, waiver or termination in writing; provided that the failure
to give such notice shall not affect the validity of such amendment, modification, waiver or termination. Notwithstanding anything to
the contrary herein, (i)&nbsp;any amendment, modification or waiver that has a disproportionate effect on Subscriber (considered apart
from any disproportionate effect owing to the aggregate amount of the Subscribed Shares held by such Subscriber), relative to any of
the Other Subscribers shall require the consent of Subscriber and (ii)&nbsp;any amendment to <U>Section&nbsp;5</U> or <U>Section&nbsp;6
</U>of this Subscription Agreement shall require the consent of Subscriber.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;This
Subscription Agreement constitutes the entire agreement, and supersedes all other prior agreements, understandings, representations and
warranties, both written and oral, among the parties hereto, with respect to the subject matter hereof, except that any confidentiality
agreement with respect to the undersigned or its affiliates shall remain in full force and effect following the amendment, modification,
waiver or termination of this Subscription Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;Except
as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto and their
heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations, warranties,
covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors, administrators,
successors, legal representatives and permitted assigns. In addition to, and notwithstanding anything contained herein to the contrary,
(i)&nbsp;the Company acknowledges and agrees that Zura is a third-party beneficiary of the acknowledgments, understandings, agreements,
covenants, representations and warranties made by the Company contained in this Subscription Agreement, and (ii)&nbsp;the Subscriber
acknowledges and agrees that Zura is a third-party beneficiary of the acknowledgments, understandings, agreements, covenants, representations
and warranties made by the Subscriber contained in this Subscription Agreement. Each of the parties hereto shall be entitled to seek
and obtain equitable relief, without proof of actual damages, including an injunction or injunctions or order for specific performance
to prevent breaches of this Subscription Agreement and to enforce specifically the terms and provisions of this Subscription Agreement
to cause Subscriber to fund the Subscription Amount and cause the Closing to occur if the conditions in <U>Section&nbsp;2</U> this Subscription
Agreement have been satisfied or, to the extent permitted by applicable law, waived by the applicable party entitled to waive any such
condition. Each party hereto further agrees that neither the parties hereto nor Zura shall be required to obtain, furnish or post any
bond or similar instrument in connection with or as a condition to obtaining any remedy referred to in this <U>Section&nbsp;9(k)</U>,
and each party hereto irrevocably waives any right it may have to require the obtaining, furnishing or posting of any such bond or similar
instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
any provision of this Subscription Agreement shall be invalid, illegal or unenforceable, the validity, legality or enforceability of
the remaining provisions of this Subscription Agreement shall not in any way be affected or impaired thereby and shall continue in full
force and effect. Prior to or at the Closing, Subscriber shall deliver to the Company a duly completed and executed Internal Revenue
Service Form&nbsp;W-9 or appropriate Form&nbsp;W-8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Subscription Agreement may be executed and delivered in one or more counterparts (including by facsimile or electronic mail or in .pdf
or any other form of electronic delivery (including any electronic signature complying with U.S. federal ESIGN Act of 2000)) and by different
parties in separate counterparts, with the same effect as if all parties hereto had signed the same document. All counterparts so executed
and delivered shall be construed together and shall constitute one and the same agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Subscription Agreement were
not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties hereto and
Zura shall be entitled to seek an injunction or injunctions to prevent breaches or threatened breaches of this Subscription Agreement
and to enforce specifically the terms and provisions of this Subscription Agreement, this being in addition to any other remedy to which
such party is entitled to seek at law, in equity, in contract, in tort or otherwise. The parties hereto further agree not to assert that
a remedy of specific enforcement pursuant to this <U>Section&nbsp;9(n)</U>&nbsp;is unenforceable, invalid, contrary to applicable law
or inequitable for any reason and to waive any defenses in any action for specific performance, including the defense that a remedy at
law would be adequate. In addition, the prevailing party in any action to enforce the provisions of this agreement shall be entitled
to fees and expenses incurred in connection therewith. The parties acknowledge and agree that this <U>Section&nbsp;9(n)</U>&nbsp;is an
integral part of the transactions contemplated hereby and without that right, the parties hereto would not have entered into this Subscription
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Subscription Agreement shall be governed by, and construed in accordance with, the laws of the State of New York, without regard to the
principles of conflicts of laws that would otherwise require the application of the law of any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(p)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>EACH
PARTY HEREBY WAIVES ITS RESPECTIVE RIGHTS TO A TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OR RELATED TO
THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY IN ANY ACTION, PROCEEDING OR OTHER LITIGATION OF ANY TYPE BROUGHT
BY ANY PARTY AGAINST ANY OTHER PARTY OR ANY AFFILIATE OF ANY OTHER SUCH PARTY, WHETHER WITH RESPECT TO CONTRACT CLAIMS, TORT CLAIMS OR
OTHERWISE. THE PARTIES AGREE THAT ANY SUCH CLAIM OR CAUSE OF ACTION SHALL BE TRIED BY A COURT TRIAL WITHOUT A JURY. WITHOUT LIMITING
THE FOREGOING, THE PARTIES FURTHER AGREE THAT THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY IS WAIVED BY OPERATION OF THIS SECTION&nbsp;AS
TO ANY ACTION, COUNTERCLAIM OR OTHER PROCEEDING WHICH SEEKS,&nbsp;IN WHOLE OR IN PART, TO CHALLENGE THE VALIDITY OR ENFORCEABILITY OF
THIS SUBSCRIPTION AGREEMENT OR ANY PROVISION HEREOF. THIS WAIVER SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS
TO THIS SUBSCRIPTION AGREEMENT.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(q)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
parties agree that all disputes, legal actions, suits and proceedings arising out of or relating to this Subscription Agreement must
be brought exclusively in the state courts of New York or in the federal courts located in the state and county of New York (collectively
the &ldquo;<U>Designated Courts</U>&rdquo;). Each party hereby consents and submits to the exclusive jurisdiction of the Designated Courts.
No legal action, suit or proceeding with respect to this Subscription Agreement may be brought in any other forum. Notwithstanding the
foregoing, a final judgement in any such action may be enforced in other jurisdictions by suit on the judgment or in any other manner
provided by law. Each party hereby irrevocably waives all claims of immunity from jurisdiction and any objection which such party may
now or hereafter have to the laying of venue of any suit, action or proceeding in any Designated Court, including any right to object
on the basis that any dispute, action, suit or proceeding brought in the Designated Courts has been brought in an improper or inconvenient
forum or venue. Each of the parties also agrees that delivery of any process, summons, notice or document to a party hereof in compliance
with <U>Section&nbsp;9(a)</U>&nbsp;of this Subscription Agreement shall be effective service of process for any action, suit or proceeding
in a Designated Court with respect to any matters to which the parties have submitted to jurisdiction as set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(r)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Subscription Agreement may only be enforced against, and any claim, action, suit or other legal proceeding based upon, arising out of,
or related to this Subscription Agreement, or the negotiation, execution or performance of this Subscription Agreement, may only be brought
against the entities that are expressly named as parties hereto and then only with respect to the specific obligations set forth herein
with respect to such party. No past, present or future director, officer, employee, incorporator, manager, member, partner, shareholder,
affiliate, agent, attorney or other representative of any party hereto or of any affiliate of any party hereto, or any of their successors
or permitted assigns, shall have any liability for any obligations or liabilities of any party hereto under this Subscription Agreement
or for any claim, action, suit or other legal proceeding based on, in respect of or by reason of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(s)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall, by 9:00 a.m., Eastern Time, on or before the fourth Business Day immediately following the date of this Subscription Agreement,
issue one or more press releases or file with the Commission a Current Report on Form&nbsp;8-K (collectively, the &ldquo;<U>Disclosure
Document</U>&rdquo;) disclosing, to the extent not previously publicly disclosed, all material terms of the transactions contemplated
hereby (and by the Other Subscription Agreements), the Transaction and any other material, nonpublic information that the Company has
provided to Subscriber at any time prior to the filing of the Disclosure Document. Notwithstanding the foregoing, or anything contained
to the contrary in <U>Section&nbsp;9(c)</U>, the Company shall not publicly disclose the name of Subscriber or any affiliate or investment
advisor of Subscriber, or include the name of Subscriber or any affiliate or investment advisor of Subscriber in any press release or
in any filing with the Commission or any regulatory agency or trading market, without the prior written consent (including by e-mail)
of Subscriber, except as required by the federal securities laws, rules&nbsp;or regulations and to the extent such disclosure is required
by other laws, rules&nbsp;or regulations, at the request of the staff of the Commission or regulatory agency or under NYSE regulations,
in which case the Company shall provide Subscriber with reasonable prior written notice (including by e-mail) of such permitted disclosure,
and shall reasonably consult with Subscriber regarding such disclosure. Subscriber hereby consents to the publication and disclosure
in any Form&nbsp;8-K or Form&nbsp;6-K filed by the Company with the Commission, in any filing with the Commission made in connection
with the Business Combination Agreement and the Transaction, including any proxy statement, prospectus or registration statement related
thereto or any other filing with the Commission pursuant to applicable securities laws, of Subscriber&rsquo;s name and identity and the
nature of Subscriber&rsquo;s commitments, arrangements and understandings under and relating to this Subscription Agreement and, if deemed
required or appropriate by the Company, a copy of this Subscription Agreement. Any such disclosure under the foregoing two sentences
shall be made only after the Company as soon as practicable notifies Subscriber of such requirement to disclose (except where prohibited
by applicable law, legal process or regulatory request). The Company shall provide a draft of any proposed disclosures under this <U>Section&nbsp;9(s)</U>&nbsp;to
subscriber reasonably in advance of the release of such disclosures, but in no event less than one Business Day prior to release, and
shall consider in good faith any revisions to such disclosure proposed by Subscriber. Notwithstanding the foregoing or anything contained
to the contrary in <U>Section&nbsp;9(c)</U>, the Company may make disclosures to an auditor or governmental or regulatory authority pursuant
to any routine investigation, inspection, examination or inquiry without providing Subscriber with any notification thereof, unless Subscriber
is the subject of any such investigation, inspection, examination or inquiry (in which case the preceding sentence shall govern).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(t)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
obligations of Subscriber under this Subscription Agreement are several and not joint with the obligations of any Other Subscriber or
any other investor under the Other Subscription Agreements, and Subscriber shall not be responsible in any way for the performance of
the obligations of any Other Subscriber under this Subscription Agreement or any other investor under the Other Subscription Agreements.
The decision of Subscriber to purchase Subscribed Shares and the Private Placement Warrants pursuant to this Subscription Agreement has
been made by Subscriber independently of any Other Subscriber or any other investor and independently of any information, materials,
statements or opinions as to the business, affairs, operations, assets, properties, liabilities, results of operations, condition (financial
or otherwise) or prospects of the Company or any of its subsidiaries which may have been made or given by any Other Subscriber or investor
or by any agent or employee of any Other Subscriber or investor, and neither Subscriber nor any of its agents or employees shall have
any liability to any Other Subscriber or investor (or any other person) relating to or arising from any such information, materials,
statements or opinions. Nothing contained herein or in any Other Subscription Agreement, and no action taken by Subscriber or investor
pursuant hereto or thereto, shall be deemed to constitute Subscriber and other investors as a partnership, an association, a joint venture
or any other kind of entity, or create a presumption that Subscriber and other investors are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the this Subscription Agreement and the Other Subscription Agreements.
Subscriber acknowledges that no Other Subscriber has acted as agent for Subscriber in connection with making its investment hereunder
and no Other Subscriber will be acting as agent of Subscriber in connection with monitoring its investment in the Subscribed Shares and
the Private Placement Warrants or enforcing its rights under this Subscription Agreement. Subscriber shall be entitled to independently
protect and enforce its rights, including without limitation the rights arising out of this Subscription Agreement, and it shall not
be necessary for any Other Subscriber or investor to be joined as an additional party in any proceeding for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature pages&nbsp;follow.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF, </B>each
of the Company and Subscriber has executed or caused this Subscription Agreement to be executed by its duly authorized representative
as of the date first set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">JATT ACQUISITION CORP</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-size: 10pt">/s/
    Verender S. Badial</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: Verender S. Badial</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: Chief Financial Officer</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Address for Notices:</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">PO Box 309, Ugland House,</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Grand Cayman, Cayman Islands</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Signature Page&nbsp;to JATT Acquisition Corp
Subscription Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">SUBSCRIBER:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Signature of Subscriber:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 46%"><FONT STYLE="font-size: 10pt">Eugene
    Investment&nbsp;&amp; Securities Co., Ltd</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: Koh, Kyeongmo</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: Representative, CEO</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Date: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><U>March&nbsp;13, 2013</U></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name of Subscriber:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(Please print. Please indicate name
    and</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">capacity of person signing above)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Lee,
    Youngjun /s/ Lee, Youngjun</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name in which shares are to be registered</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">(if different):</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email Address: <U>joshlee@eugene.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subscriber&rsquo;s EIN: <U>116-81-34177</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jurisdiction of residency: <U>Republic of Korea</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Number of Subscribed Shares subscribed for:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; <U>9,950</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Price Per Subscribed Share and Private Placement &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;$10.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Warrant:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subscription Amount:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; <U>$ 99,500</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You must pay the Subscription
Amount by wire transfer of United States dollars in immediately available funds to the account of the Company specified by the Company
in the Closing Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Signature Page&nbsp;to JATT Acquisition Corp
Subscription Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Private Placement Warrant Schedule</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Signature Page&nbsp;to JATT Acquisition Corp
Subscription Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>ANNEX A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ELIGIBILITY REPRESENTATIONS OF SUBSCRIBER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">This Annex A should be completed and signed by
Subscriber<BR>
and constitutes a part of the Subscription Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">A.</TD><TD STYLE="text-align: justify">QUALIFIED INSTITUTIONAL BUYER STATUS (Please check the box, if applicable)
                                 Subscriber is a &ldquo;qualified institutional buyer&rdquo; (as defined in Rule&nbsp;144A under the
                                 Securities Act).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">B.</TD><TD STYLE="text-align: justify">FINRA INSTITUTIONAL INVESTOR STATUS (Please check the box)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subscriber is a &ldquo;institutional
investor&rdquo; (as defined in FINRA Rule&nbsp;2111).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">C.</TD><TD STYLE="text-align: justify">ACCREDITED INVESTOR STATUS (Please check the box)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Subscriber is an &ldquo;accredited
investor&rdquo; (within the meaning of Rule&nbsp;501(a)&nbsp;under the Securities Act) and has marked and initialed the appropriate box
below indicating the provision under which it qualifies as an &ldquo;accredited investor.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">D.</TD><TD STYLE="text-align: justify">NON-U.S. PERSON STATUS (Please check the box)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in"><FONT STYLE="font-family: Wingdings">&#168;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;Subscriber
is a non-U.S. person located outside of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">E.</TD><TD STYLE="text-align: justify">AFFILIATE STATUS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(Please check the applicable box)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">SUBSCRIBER:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">is:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">is not:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">an &ldquo;affiliate&rdquo; (as defined
in Rule&nbsp;144 under the Securities Act) of the Company or acting on behalf of an affiliate of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Rule&nbsp;501(a), in relevant
part, states that an &ldquo;accredited investor&rdquo; shall mean any person who comes within any of the below listed categories, or
who the issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that
person. Subscriber has indicated, by marking and initialing the appropriate box below, the provision(s)&nbsp;below which apply to Subscriber
and under which Subscriber accordingly qualifies as an &ldquo;accredited investor.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
bank, registered broker or dealer, insurance company, registered investment company, private business development company, or small business
investment company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political
subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(3)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company, or registered
investment advisor makes the investment decisions, or if the plan has total assets in excess of $5,000,000;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(4)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
corporation, similar business trust, partnership or any organization described in Section&nbsp;501(c)(3)&nbsp;of the Internal Revenue
Code, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(5)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated
person; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(6)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
entity, of a type not listed in items (1), (2), (3), (4), or (5)&nbsp;herein, not formed for the specific purpose of acquiring the securities
offered, owning investments in excess of $5,000,000; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(7)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
 &ldquo;family office,&rdquo; as defined in rule&nbsp;202(a)(11)(G)-1 under the Investment Advisers Act of 1940: (i)&nbsp;with assets
under management in excess of $5,000,000, (ii)&nbsp;that is not formed for the specific purpose of acquiring the securities offered,
and (iii)&nbsp;whose prospective investment is directed by a person who has such knowledge and experience in financial and business matters
that such family office is capable of evaluating the merits and risks of the prospective investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">F.</TD><TD STYLE="text-align: justify">FINRA INSTITUTIONAL ACCOUNT STATUS</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(Please check the applicable
subparagraphs):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Wingdings">&#168;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subscriber
is an &ldquo;institutional account&rdquo; under FINRA Rule&nbsp;4512(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Wingdings">&#168;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subscriber
is not an &ldquo;institutional account&rdquo; under FINRA Rule&nbsp;4512(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SUBSCRIBER:<BR>
Print Name:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Eugene Investment&nbsp;&amp; Securities
    Co.,&nbsp;Ltd.</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By: /s/ Eugene Investment&nbsp;&amp;
    Securities Co.,&nbsp;Ltd.</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: Koh, Kyeongmo</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: Representative, CEO</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 31; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-14.1
<SEQUENCE>9
<FILENAME>tm2310353d1_ex14-1.htm
<DESCRIPTION>EXHIBIT 14.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: right; margin: 0pt"><B>Exhibit 14.1</B></P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CODE OF ETHICS<BR>
OF<BR>
ZURA BIO LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt; text-align: justify"><B>I.</B></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Introduction</U></B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors (the
 &ldquo;<B>Board</B>&rdquo;) of Zura Bio Limited, a Cayman Islands exempted company (the &ldquo;<B>Company</B>&rdquo;), has adopted this
code of ethics (this &ldquo;<B>Code</B>&rdquo;), as may be amended from time to time by the Board and which is applicable to all of the
Company&rsquo;s directors, officers and employees to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt; text-align: justify">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">promote the full, fair, accurate, timely and understandable disclosure in reports and documents that the Company files with, or submits to, the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;), as well as in other public communications made by or on behalf of the Company;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">promote compliance with applicable governmental laws, rules and regulations;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">deter wrongdoing; and</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">require prompt internal reporting of breaches of, and accountability for adherence to, this Code.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Code may be amended and
modified by the Board. In this Code, references to the &ldquo;<B>Company</B>&rdquo; mean Zura Bio Limited and, in appropriate context,
the Company&rsquo;s subsidiaries, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt; text-align: justify"><B>II.</B></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-variant: small-caps"><B><U>Honest, Ethical and Fair Conduct<BR>
</U></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each person owes a duty to
the Company to act with integrity. Integrity requires, among other things, being honest, fair and candid. Deceit, dishonesty and subordination
of principle are inconsistent with integrity. Service to the Company should never be subordinated to personal gain and advantage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each person must:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-family: Symbol; font-size: 12pt">&middot;</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: justify">act with integrity, including being honest and candid while still maintaining the confidentiality of the Company&rsquo;s information where required or when in the Company&rsquo;s interests;</TD>
</TR>
<TR>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol; font-size: 12pt">&middot;</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: justify">observe all applicable governmental laws, rules and regulations;</TD>
    </TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: justify">&nbsp;</TD>
    </TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">comply with the requirements of applicable accounting and auditing standards, as well as Company policies, in order to maintain a high standard of accuracy and completeness in the Company&rsquo;s financial records and other business-related information and data;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adhere to a high standard of business ethics and not seek competitive advantage through unlawful or unethical business practices;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">deal fairly with the Company&rsquo;s customers, suppliers, competitors and employees;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refrain from taking advantage of anyone through manipulation, concealment, abuse of privileged information, misrepresentation of material facts or any other unfair-dealing practice;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">protect the assets of the Company and ensure their proper use;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">until such time as such person ceases to be an officer or director of the Company, to first present to the Company for its consideration, prior to presentation to any other entity, any business opportunity suitable for the Company and presented to such person solely in his or her capacity as an officer or director of the Company, subject to any other fiduciary or contractual obligations such officer may have; and </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 48px"></TD><TD STYLE="width: 48px; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;</TD><TD STYLE="text-align: justify">avoid conflicts of interest, wherever possible,
    except as may be allowed under guidelines or resolutions approved by the Board (or the appropriate committee of the Board) or as disclosed
    in the Company&rsquo;s public filings with the SEC. Anything that would be a conflict for a person subject to this Code also will be a
    conflict for a member of his or her immediate family or any other close relative. Examples of conflict of interest situations include,
    but are not limited to, the following:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any significant ownership interest in any supplier or customer;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>any consulting or employment relationship with any supplier or customer;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>the receipt of any money, non-nominal gifts or excessive entertainment from any entity with which the Company has current or prospective
    business dealings;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>selling
anything to the Company or buying anything from the Company, except on the same terms and conditions as comparable officers or directors
are permitted to so purchase or sell;<BR>
<BR></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any
other financial transaction, arrangement or relationship (including any indebtedness or guarantee of indebtedness) involving the Company;
and</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>any other circumstance, event, relationship or situation in which the personal interest of a person subject to this Code interferes
    - or even appears to interfere - with the interests of the Company as a whole</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: justify"><B>III.</B></TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Disclosure</U></B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P></TD>
    </TR>
  <TR>
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company strives to ensure that the contents
of and the disclosures in the reports and documents that the Company files with the SEC and other public communications shall be full,
fair, accurate, timely and understandable in accordance with applicable disclosure standards, including standards of materiality, where
appropriate. Each person must:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt; text-align: justify">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">not knowingly misrepresent, or cause others to misrepresent, facts about the Company to others, whether within or outside the Company, including to the Company&rsquo;s independent registered public accountants, governmental regulators, self-regulating organizations and other governmental officials, as appropriate; and</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">in relation to his or her area of responsibility, properly review and critically analyze proposed disclosure for accuracy and completeness.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the foregoing,
the Chief Executive Officer (&ldquo;<B>CEO</B>&rdquo;) and Chief Financial Officer (&ldquo;<B>CFO</B>&rdquo;) of the Company and each
subsidiary of the Company (or persons performing similar functions), and each other person that typically is involved in the financial
reporting of the Company must familiarize himself or herself with the disclosure requirements applicable to the Company as well as the
business and financial operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each person must promptly
bring to the attention of the Chairman of the Board any information he or she may have concerning (a) significant deficiencies in the
design or operation of internal and/or disclosure controls that could adversely affect the Company&rsquo;s ability to record, process,
summarize and report financial data or (b) any fraud that involves management or other employees who have a significant role in the Company&rsquo;s
financial reporting, disclosures or internal controls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt; text-align: justify"><B>IV.</B></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Compliance</U></B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is the Company&rsquo;s
obligation and policy to comply with all applicable governmental laws, rules and regulations. All directors, officers and employees of
the Company are expected to understand, respect and comply with all of the laws, regulations, policies and procedures that apply to them
in their positions with the Company. Employees are responsible for talking to their supervisors to determine which laws, regulations and
Company policies apply to their position and what training is necessary to understand and comply with them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Directors, officers and employees
are directed to specific policies and procedures available to persons they supervise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 48px; text-align: left"><B>V.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Reporting and Accountability</U></B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board is responsible for
applying this Code to specific situations in which questions are presented to it and has the authority to interpret this Code in any particular
situation. Any person who becomes aware of any existing or potential breach of this Code is required to notify the Chairman of the Board
promptly. Failure to do so is, in and of itself, a breach of this Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Specifically, each person
must:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt; text-align: justify">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Notify the Chairman of the Board promptly of any existing or potential violation of this Code.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Not retaliate against any other person for reports of potential violations that are made in good faith.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will follow the
following procedures in investigating and enforcing this Code and in reporting on the Code:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt; text-align: justify">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">The Board will take all appropriate action to investigate any breaches reported to it.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify; width: 48px">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Upon determination by the Board that a breach has occurred, the Board (by majority decision) will take or authorize such disciplinary or preventive action as it deems appropriate, after consultation with the Company&rsquo;s internal or external legal counsel, up to and including dismissal or, in the event of criminal or other serious violations of law, notification of the SEC or other appropriate law enforcement authorities.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No person following the above
procedure shall, as a result of following such procedure, be subject by the Company or any officer or employee thereof to discharge, demotion,
suspension, threat, harassment or in any manner, discrimination against such person in terms and conditions of employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt; text-align: justify"><B>VI.</B></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Waivers
    and Amendments</U></B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any waiver (defined below)
or an implicit waiver (defined below) from a provision of this Code for the principal executive officer, principal financial officer,
principal accounting officer or controller, and persons performing similar functions or any amendment (as defined below) to this Code
is required to be disclosed in a Current Report on Form 8- K filed with the SEC. In lieu of filing a Current Report on Form 8-K to report
any such waivers or amendments, the Company may provide such information on a website, in the event that it establishes one in the future,
and if it keeps such information on the website for at least 12 months and discloses the website address as well as any intention to provide
such disclosures in this manner in its most recently filed Annual Report on Form 10-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A &ldquo;<B>waiver</B>&rdquo;
means the approval by the Board of a material departure from a provision of the Code. An &ldquo;<B>implicit waiver</B>&rdquo; means the
Company&rsquo;s failure to take action within a reasonable period of time regarding a material departure from a provision of the Code
that has been made known to an executive officer of the Company. An &ldquo;<B>amendment</B>&rdquo; means any amendment to this Code other
than minor technical, administrative or other non-substantive amendments hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All persons should note that
it is not the Company&rsquo;s intention to grant or to permit waivers from the requirements of this Code. The Company expects full compliance
with this Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt; text-align: justify"><B>VII.</B></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Insider
    Information and Securities Trading</U></B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s directors,
officers or employees who have access to material, non-public information are not permitted to use that information for securities trading
purposes or for any purpose unrelated to the Company&rsquo;s business. It is also against the law to trade or to &ldquo;<B>tip</B>&rdquo;
others who might make an investment decision based on inside company information. For example, using non-public information to buy or
sell the Company securities, options in the Company shares or the shares of any Company supplier, customer or competitor is prohibited.
The consequences of insider trading violations can be severe. These rules also apply to the use of material, nonpublic information about
other companies (including, for example, the Company&rsquo;s customers, competitors and potential business partners). In addition to directors,
officers or employees, these rules apply to such person&rsquo;s spouse, children, parents and siblings, as well as any other family members
living in such person&rsquo;s home.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 48px; text-align: left"><B>VIII.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Financial Statements
and Other Records</U></B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of the Company&rsquo;s
books, records, accounts and financial statements must be maintained in reasonable detail, must appropriately reflect the Company&rsquo;s
transactions and must both conform to applicable legal requirements and to the Company&rsquo;s system of internal controls. Unrecorded
or &ldquo;off the books&rdquo; funds or assets should not be maintained unless permitted by applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Records should always be retained
or destroyed according to the Company&rsquo;s record retention policies. In accordance with those policies, in the event of litigation
or governmental investigation, please consult the Board or the Company&rsquo;s internal or external legal counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt; text-align: justify"><B>IX.</B></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Improper
    Influence on Conduct of Audits</U></B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No director or officer, or
any other person acting under the direction thereof, shall directly or indirectly take any action to coerce, manipulate, mislead or fraudulently
influence any public or certified public accountant engaged in the performance of an audit or review of the financial statements of the
Company or take any action that such person knows or should know that if successful could result in rendering the Company&rsquo;s financial
statements materially misleading. Any person who believes such improper influence is being exerted should report such action to such person&rsquo;s
supervisor, or if that is impractical under the circumstances, to any of the Company&rsquo;s directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Types of conduct that could
constitute improper influence include, but are not limited to, directly or indirectly:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify; width: 6%">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify; width: 88%">offering or paying bribes or other financial incentives, including future employment or contracts for non-audit services;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">providing an auditor with an inaccurate or misleading legal analysis;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">threatening to cancel or canceling existing non-audit or audit engagements if the auditor objects to the Company&rsquo;s accounting;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">seeking to have a partner removed from the audit engagement because the partner objects to the Company&rsquo;s accounting;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&#9679;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">blackmailing; and</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&#9679;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">making physical threats.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><B>X.</B></TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Anti-Corruption
    Laws</U></B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P></TD></TR>
  <TR>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 88%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company complies with
the anti-corruption laws of the countries in which it does business, including the U.S. Foreign Corrupt Practices Act (&ldquo;<B>FCPA</B>&rdquo;).
Directors, officers and employees will not directly or indirectly give anything of value to government officials, including employees
of state-owned enterprises or foreign political candidates. These requirements apply both to Company employees and agents, such as third
party sales representatives, no matter where they are doing business. If you are authorized to engage agents, you are responsible for
ensuring they are reputable and for obtaining a written agreement to uphold the Company&rsquo;s standards in this area.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt; text-align: justify"><B>XI.</B></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Violations</U></B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Violation of this Code is
grounds for disciplinary action up to and including termination of employment. Such action is in addition to any civil or criminal liability
which might be imposed by any court or regulatory agency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt; text-align: justify"><B>XII.</B></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Other
    Policies and Procedures</U></B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any other policy or procedure
set out by the Company in writing or made generally known to employees, officers or directors of the Company prior to the date hereof
or hereafter are separate requirements and remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt; text-align: justify"><B>XIII.</B></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps"><B><U>Inquiries</U></B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All inquiries and questions
in relation to this Code or its applicability to particular people or situations should be addressed to the Company&rsquo;s Secretary,
or such other compliance officer as shall be designated from time to time by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective: March 20, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>PROVISIONS FOR CHIEF EXECUTIVE OFFICER AND SENIOR
FINANCIAL OFFICERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The CEO and all senior financial
officers, including the CFO and principal accounting officer, are bound by the provisions set forth therein relating to ethical conduct,
conflicts of interest, and compliance with law. In addition to the Code, the CEO and senior financial officers are subject to the following
additional specific policies:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. Act with honesty and integrity,
avoiding actual or apparent conflicts between personal, private interests and the interests of the Company, including receiving improper
personal benefits as a result of his or her position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. Disclose to the CEO and
the Board any material transaction or relationship that reasonably could be expected to give rise to a conflict of interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. Perform responsibilities
with a view to causing periodic reports and documents filed with or submitted to the SEC and all other public communications made by the
Company to contain information that is accurate, complete, fair, objective, relevant, timely and understandable, including full review
of all annual and quarterly reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. Comply with laws applicable
to the Company, including but not limited to rules and regulations of U.S. federal, state and other local governments and with the rules
and regulations of private and public regulatory agencies having jurisdiction over the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. Act in good faith, responsibly,
with due care, competence and diligence, without misrepresenting or omitting material facts or allowing independent judgment to be compromised
or subordinated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. Respect the confidentiality
of information acquired in the course of performance of his or her responsibilities except when authorized or otherwise legally obligated
to disclose any such information; not use confidential information acquired in the course of performing his or her responsibilities for
personal advantage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7. Share knowledge and maintain
skills important and relevant to the needs of the Company, its shareholders and other constituencies and the general public.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8. Proactively promote ethical
behavior among subordinates and peers in his or her work environment and community.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9. Use and control all corporate
assets and resources employed by or entrusted to him or her in a responsible manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10. Not use corporate information,
corporate assets, corporate opportunities or his or her position with the Company for personal gain; not compete directly or indirectly
with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11. Comply in all respects
with this Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12. Advance the Company&rsquo;s
legitimate interests when the opportunity arises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board will investigate
any reported violations and will oversee an appropriate response, including corrective action and preventative measures. Any officer who
violates this Code will face appropriate, case specific disciplinary action, which may include demotion or discharge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any request for a waiver of
any provision of this Code must be in writing and addressed to the Chairman of the Board. Any waiver of this Code will be disclosed as
provided in Section 6 of this Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is the policy of the Company
that each officer covered by this Code shall acknowledge and certify to the foregoing annually and file a copy of such certification with
the Chairman of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>OFFICER&rsquo;S CERTIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I have read and understand
the foregoing Code. I hereby certify that I am in compliance with the foregoing Code and I will comply with the Code in the future. I
understand that any violation of the Code will subject me to appropriate disciplinary action, which may include demotion or discharge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding: 0.25pt; font-size: 10pt; text-align: justify">Dated:</TD>
    <TD STYLE="width: 35%; padding: 0.25pt; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 60%; padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify">Name:</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0.25pt; font-size: 10pt; text-align: justify">Title:</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>10
<FILENAME>tm2310353d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: #181717; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit
99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SUMMARY UNAUDITED PRO FORMA CONDENSED COMBINED
FINANCIAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following summary unaudited pro forma condensed
combined financial information (the &ldquo;Summary Pro Forma Information&rdquo;) presents the combination of the financial information
of JATT and Zura after giving effect to the transactions contemplated by the Business Combination Agreement, including the Business Combination,
and related adjustments further described in the section entitled &ldquo;<I>Unaudited Pro Forma Condensed Combined Financial Information.</I>&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20"><B>Selected Unaudited Pro Forma Condensed Combined<BR>
Statement of Operations &ndash; Nine Months Ended September&nbsp;30, 2022</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pro Forma Combined<BR>
</B>(in thousands, except<BR>
share and per share data)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 79%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Total expenses</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">$</FONT></TD>
    <TD STYLE="width: 18%; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">11,842</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Operating loss</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">(11,842</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Net loss</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">(9,924</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Basic and diluted net loss per share</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">(0.34</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Basic and diluted weighted average shares outstanding</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">29,037,831</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20"><B>Selected Unaudited Pro Forma Condensed Combined</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20"><B>Statement of Operations &ndash; Period Ended March&nbsp;31, 2022</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Total expenses</FONT></TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">$</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">28,628</FONT></TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Operating loss</FONT></TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">(28,628</FONT></TD>
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Net loss attributable to common shareholders</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">(33,818</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Basic and diluted net loss per share</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">(1.16</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Basic and diluted weighted average shares outstanding</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">29,037,831</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20"><B>Selected Unaudited Pro Forma Condensed Combined</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20"><B>Balance Sheet Data as of September&nbsp;30, 2022</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Total assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">46,429</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Total liabilities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">2,575</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Temporary equity</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">22,500</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Total shareholders&rsquo; equity</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">21,354</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL
INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>. As used in this unaudited pro forma condensed combined financial
information, &ldquo;Zura&rdquo; refers to Zura Bio Limited, a company incorporated under the laws of England and Wales, and &ldquo;JATT&rdquo;
refers to JATT Acquisition Corp prior to the Business Combination.</I></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The unaudited pro forma condensed combined financial
information has been prepared in accordance with Article&nbsp;11 of Regulation S-X and presents the combination of the historical financial
information of JATT and Zura, adjusted to give effect to the Business Combination and the other events contemplated by the Business Combination
Agreement. Unless otherwise indicated or the context otherwise requires, references to the &ldquo;Combined Company&rdquo; refer to Zura
Bio Limited (formerly JATT Acquisition Corp), a Cayman Islands exempted company, and its consolidated subsidiaries after giving effect
to the Business Combination.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The unaudited pro forma condensed combined balance
sheet as of September&nbsp;30, 2022, combines the historical balance sheet of JATT as of September&nbsp;30, 2022, and the historical balance
sheet of Zura as of September&nbsp;30, 2022, on a pro forma basis as if the Business Combination and the other events contemplated by
the Business Combination Agreement had been consummated on September&nbsp;30, 2022. The unaudited pro forma condensed combined statement
of operations for the fiscal year ended March&nbsp;31, 2022, combines the historical statement of operations of JATT for the period from
March&nbsp;10, 2021 (inception) through December&nbsp;31, 2021 and the historical statements of operation of Zura for the period from
January&nbsp;18, 2022 (inception) through March&nbsp;31, 2022 and the unaudited pro forma condensed combined statement of operations for
the nine months ended September&nbsp;30, 2022, combines the historical statement of operations of JATT for the nine months ended September&nbsp;30,
2022 and the historical statement of operations of Zura for the period from January&nbsp;18, 2022 (inception) through March&nbsp;31, 2022
combined with the six months ended September&nbsp;30, 2022 on a pro forma basis as if the Business Combination and the other events contemplated
by the Business Combination Agreement had been consummated on April&nbsp;1, 2021, the beginning of the earliest period presented.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The historical statement of operations of Zura
for the period from January&nbsp;18, 2022 (inception) through March&nbsp;31, 2022, including its most significant transaction, research
and development expense &mdash; license acquired of $7.5 million, is included the unaudited pro forma condensed combined statement of
operations for both the year ended March&nbsp;31, 2022 and the nine months ended September&nbsp;30, 2022.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The unaudited pro forma condensed combined financial
information and accompanying notes have been derived from and should be read in conjunction with:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">&bull;</FONT></TD><TD STYLE="text-align: justify">the historical audited financial statements of JATT as of December&nbsp;31, 2021 and for the period from
March&nbsp;10, 2021 (inception) through December&nbsp;31, 2021 and the related notes, which are included in JATT&rsquo;s Annual Report
on Form&nbsp;10-K filed with the SEC on April&nbsp;11, 2022 (the &ldquo;<U>JATT 2021 10-K</U>&rdquo;) and incorporated by reference;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">&bull;</FONT></TD><TD STYLE="text-align: justify">the historical unaudited financial statements of JATT as of September&nbsp;30, 2022 and the related notes,
which are included in JATT&rsquo;s Quarterly Report on Form&nbsp;10-Q filed with the SEC on November&nbsp;14, 2022 (the &ldquo;<U>JATT
2022 10-Q</U>&rdquo;) and incorporated by reference;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">&bull;</FONT></TD><TD STYLE="text-align: justify">the historical audited financial statements of Zura as of March&nbsp;31, 2022 and for the period from
January&nbsp;18, 2022 (inception) through March&nbsp;31, 2022 and the related notes included in the proxy statement/prospectus and incorporated
by reference;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">&bull;</FONT></TD><TD STYLE="text-align: justify">the historical unaudited financial statements of Zura as of September&nbsp;30, 2022 and for the six months
ended September&nbsp;30, 2022 and the related notes included in the proxy statement/prospectus and incorporated by reference; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">&bull;</FONT></TD><TD STYLE="text-align: justify">other information relating to JATT and Zura included in the proxy statement/prospectus, including the
Business Combination Agreement and the description of certain terms thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The unaudited pro forma condensed combined financial
information should also be read together with the sections of the JATT 2021 10-K, the JATT 2022 10-Q, the financial statements of Zura
as of and for the period ended March&nbsp;31, 2022, the financial statements of Zura as of and for the six months ended September&nbsp;30,
2022 and the section of the proxy statement/prospectus entitled &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition
and Results of Operations,&rdquo; as well as other financial information included elsewhere in the proxy statement/prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in; color: #181717"><I>Business
Combination Agreement</I></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On June&nbsp;16, 2022, JATT entered into a Business
Combination Agreement, as amended on September&nbsp;20, 2022, November&nbsp;14, 2022, and January&nbsp;13, 2023 (as it may be amended,
supplemented or otherwise modified from time to time), by and among JATT, JATT Merger Sub, JATT Merger Sub 2, Holdco (to become a party
before Closing, as described below) and Zura.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the Business Combination Agreement,
(a)&nbsp;before the closing of the Business Combination, Holdco was established as a new holding company of Zura and became a party to
the Business Combination Agreement; and (b)&nbsp;on the Closing, in sequential order: (i)&nbsp;Merger Sub merged with and into Holdco,
with Holdco continuing as the surviving company and a wholly owned subsidiary of JATT; (ii)&nbsp;immediately following the Merger, Holdco
merged with and into Merger Sub 2, with Merger Sub 2 continuing as the surviving company and a wholly owned subsidiary of JATT; and (iii)&nbsp;JATT
changed its name to &ldquo;Zura Bio Limited&rdquo;.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In connection with the Business Combination, the
cash held in the Trust Account after giving effect to any redemption of shares by JATT&rsquo;s public shareholders will be used to pay
certain fees and expenses in connection with the Business Combination, and for working capital and general corporate purposes.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in; color: #181717"><I>Business
Combination Consideration</I></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Upon the consummation of the Business Combination,
(i)&nbsp;each outstanding Holdco ordinary share as of immediately prior to the Effective Time was cancelled in exchange for the right
to receive a number of New JATT Class&nbsp;A Ordinary Shares equal to the Exchange Ratio and (ii)&nbsp;each option to purchase Holdco
ordinary shares that was then outstanding was converted into the right to receive an option relating to the New JATT Class&nbsp;A Ordinary
Shares upon substantially the same terms and conditions as were in effect with respect to such option immediately prior to the Effective
Time (each, a &ldquo;<U>New JATT Option</U>&rdquo;) except that (y)&nbsp;such New JATT Option relates to that whole number of New JATT
Class&nbsp;A Ordinary Shares (rounded to the nearest whole share) equal to the number of Holdco ordinary shares subject to such option,
multiplied by the Exchange Ratio, and (z)&nbsp;the exercise price per share for each such New JATT Class&nbsp;A Ordinary Share equals
the exercise price per Holdco share of such option in effect immediately prior to the Effective Time, divided by the Exchange Ratio (rounded
to the nearest full cent).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The total merger consideration received by securityholders
of Holdco at the Closing was the issue of (or grant of options to purchase) New JATT Class&nbsp;A Ordinary Shares with an aggregate value
equal to approximately $165 million, comprised of 16,053,700 shares of New JATT Class&nbsp;A Ordinary Shares and 446,300 New JATT Options,
each multiplied by the redemption value of $10.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><B>Accounting
for the Business Combination</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Business Combination is accounted for as a
recapitalization in accordance with GAAP. Under this method of accounting, JATT is treated as the acquired company and Zura is treated
as the acquirer for financial reporting purposes. Accordingly, for accounting purposes, the financial statements of the Combined Company
represent a continuation of the financial statements of Zura, with the Business Combination treated as the equivalent of Zura issuing
stock for the net assets of JATT, accompanied by a recapitalization. The net assets of JATT are stated at historical cost, with no goodwill
or other intangible assets recorded. Operations prior to the Business Combination are those of Zura. Zura has been determined to be the
accounting acquirer based on an evaluation of the following facts and circumstances:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="color: #181717">&bull;</FONT></TD><TD STYLE="text-align: justify">Zura&rsquo;s existing shareholders have a majority of the voting power;</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="color: #181717">&bull;</FONT></TD><TD STYLE="text-align: justify">the Combined Company&rsquo;s board is expected to consist of seven directors, four of whom can be designated
by Zura and two of whom can be designated by JATT;</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="color: #181717">&bull;</FONT></TD><TD STYLE="text-align: justify">all of Zura&rsquo;s existing management will continue in their key positions in the management team of
the Combined Company; and</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="color: #181717">&bull;</FONT></TD><TD STYLE="text-align: justify">Zura&rsquo;s operations prior to the Business Combination comprise the ongoing operations.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Upon the Business Combination, the purchase consideration
will be recorded as a credit to shareholders&rsquo; equity and a debit to net assets. The purchase consideration amounts to $160.6 million
(16,053,700 shares of New JATT Class&nbsp;A Ordinary Shares multiplied by the redemption value of $10 which approximates fair value).
The 446,300 New JATT Options will continue to be recorded as stock-based compensation over the remaining pre-combination service period
of the options to purchase Holdco ordinary shares, as the fair value of the New JATT Options approximates the fair value of the options
to purchase Holdco ordinary shares that will be exchanged for New JATT Options.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><B>Basis of Pro Forma Presentation</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The unaudited pro forma condensed combined financial
information has been prepared in accordance with Article&nbsp;11 of Regulation S-X. The adjustments in the unaudited pro forma condensed
combined financial information have been identified and presented to provide relevant information necessary for an illustrative understanding
of the Combined Company upon consummation of the Business Combination and the other events contemplated by the Business Combination Agreement
in accordance with GAAP.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Assumptions and estimates underlying the unaudited
pro forma adjustments set forth in the unaudited pro forma condensed combined financial information are described in the accompanying
notes. The unaudited pro forma condensed combined financial information has been presented for illustrative purposes only and is not necessarily
indicative of the operating results and financial position that would have been achieved had the Business Combination occurred on the
dates indicated, and does not reflect adjustments for any anticipated synergies, operating efficiencies, tax savings or cost savings.
Any cash proceeds remaining after the consummation of the Business Combination and the other events contemplated by the Business Combination
Agreement are expected to be used for general corporate purposes. Further, the unaudited pro forma condensed combined financial information
does not purport to project the future operating results or financial position of the Combined Company following the consummation of the
Business Combination. The unaudited pro forma adjustments represent management&rsquo;s estimates based on information available as of
the date of the unaudited pro forma condensed combined financial information and are subject to change as additional information becomes
available and analyses are performed. JATT and Zura have not had any historical relationship prior to the transactions discussed in this
Prospectus. Accordingly, no pro forma adjustments were required to eliminate activities between the companies.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The unaudited pro forma condensed combined financial
information contained herein reflects JATT shareholders&rsquo; approval of the Business Combination on March&nbsp;17, 2022, that JATT
Class&nbsp;A ordinary shareholders holding 13,617,502 shares elected to redeem their shares prior to the Closing (including 1,506,480
at the Closing), the purchase of 1,301,633 JATT Class&nbsp;A ordinary shares by the Backstop Investor, and the issuance of an additional
2,500,000 JATT Class&nbsp;A ordinary shares to the Backstop Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The shares redeemed by JATT Public shareholders
are assumed to have been redeemed at approximately $10.17 per share for an aggregate payment of approximately $138.4 million (Includes
market appreciation and interest on the marketable securities and/or balances held in the Trust Account), leaving a balance of approximately
$63.0 million (including $20.0 million from the PIPE Financing, $30.0 million from the Forward Purchase Agreement and approximately $13.0
million of Redemption Backstop) before subtracting approximately $7.5 million in JATT transaction costs.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The unaudited pro forma condensed combined balance
sheet and statement of operations do not include adjustments for the outstanding warrants issued in connection with JATT&rsquo;s initial
public offering, as such securities are not exercisable until 30 days after the Closing.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following summarizes the pro forma Ordinary
Shares issued and outstanding immediately after the Business Combination:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>%</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">JATT Public shareholders</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">182,498</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">0.6</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">JATT shares issued &ndash; Lilly license</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">550,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">1.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Redemption Backstop</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">1,301,633</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">4.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Redemption Backstop Consideration</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">2,500,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">8.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">JATT Founders</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">3,450,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">11.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">PIPE</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">2,000,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">6.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Forward Purchase Agreement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">3,000,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">10.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Zura Equityholders</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">16,053,700</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">55.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Shares outstanding</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">29,037,831</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">100.0</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE
SHEET</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS OF SEPTEMBER 30, 2022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Dollars in Thousands)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>September&nbsp;30,</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>September&nbsp;30,</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>September&nbsp;30,</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>September&nbsp;30,
    </B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>2022</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Transaction</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>2022</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>2022</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Transaction
    </B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>2022</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Transaction</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Accounting</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Accounting
    </B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Accounting</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Zura</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Adjustments</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Pro Forma</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>JATT</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Adjustments
    </B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Pro Forma</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Adjustments</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Pro Forma</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(Historical)</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(Note 2)</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Zura</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(Historical)</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(Note 2)</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>JATT</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(Note 2)</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Combined</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>ASSETS</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Current
    assets</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 31.5pt; text-indent: -0.25in; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Cash</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">3,049</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">7,600</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(a)</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">3,649</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">75</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">75</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">140,283</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(f)</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">46,096</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.5in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(7,000</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(b)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">13,016</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(q)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.5in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">20,000</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(h)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.5in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">30,000</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(i)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.5in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(12,500</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(j)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.5in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(10,000</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(n)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.5in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(138,427</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(p)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 22.5pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Receivable
    from Zura&rsquo;s subsidiary Z33</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">4,488</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(b)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">4,488</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(4,488</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(o)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 22.5pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Prepaid
    expenses and other current assets</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">211</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">211</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">122</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">122</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">333</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Total current assets</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">3,260</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">600</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">3,860</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">197</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">4,488</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">4,685</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">37,884</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">46,429</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Marketable
    securities held in Trust Account</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">140,283</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">140,283</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(140,283</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(f)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Deferred
    transaction costs</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,911</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,911</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(1,911</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(j)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Total
    assets</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>5,171</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>600</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>5,771</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>140,480</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>4,488</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>144,968</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(104,310</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>)</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>46,429</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>LIABILITIES
    AND STOCKHOLDERS&rsquo; EQUITY (DEFICIT)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Current
    liabilities</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 22.5pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Accounts
    payable and accrued expenses</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">2,196</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">2,196</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">995</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">995</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(1,911</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(j)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,280</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 22.5pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Accounts
    payable &ndash; related party</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">49</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">49</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">49</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 22.5pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Payable
    to JATT</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">4,488</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(b)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">4,488</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(4,488</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(o)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 22.5pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Note
    payable, net</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">7,600</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(a)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">7,600</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(7,600</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(n)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 22.5pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Note
    payable &ndash; related party</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">300</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">300</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">300</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Total current liabilities</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">2,196</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">12,088</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">14,284</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,344</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,344</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(13,999</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,629</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Deferred
    underwriting commissions</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">4,010</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">4,010</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(4,010</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(j)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Derivative
    liabilities</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">2,050</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">2,050</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(1,104</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(m)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">946</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Total
    liabilities</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">2,196</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">12,088</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">14,284</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">7,404</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">7,404</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(19,113</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">2,575</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Commitments
    and contingencies</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Class&nbsp;A
    ordinary shares subject to possible redemption</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">140,183</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">140,183</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(140,183</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(g)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Series&nbsp;A1
    &ndash; Preferred stock</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">12,500</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">12,500</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">12,500</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Redeemable
    non-controlling interest</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">4,943</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(c)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">10,000</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">10,000</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(5,379</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(d)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">10,436</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(e)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Stockholders
    &lsquo;equity (deficit)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-indent: -6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Common
    stock</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(g)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">3</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(h)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(i)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(l)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-indent: -6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Ordinary
    shares</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(l)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-indent: -6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Class&nbsp;A
    ordinary shares</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(l)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-indent: -6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Class&nbsp;B
    ordinary shares</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(l)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-indent: -6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Additional
    paid-in capital</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">321</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(321</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(e)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">4,488</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(b)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">4,488</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">140,182</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(g)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">54,764</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">13,016</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(r)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">20,000</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(h)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">30,000</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(i)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(5,000</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(j)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(10,597</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(k)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(l)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,104</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(m)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">20,400</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(r)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(20,400</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(r)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(138,427</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(p)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Accumulated deficit</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(9,846</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(11,488</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(b)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(31,013</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(7,107</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(7,107</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,490</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(j)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(33,413</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(4,943</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(c)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">10,597</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(k)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,797</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(d)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(2,400</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(n)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">3,583</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(d)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(10,115</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)(e)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Total stockholders&rsquo;
    equity (deficit)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(9,525</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(21,488</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(31,013</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(7,107</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">4,488</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(2,619</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">54,986</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">21,354</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Total
    liabilities stockholders&rsquo; equity (deficit)</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>5,171</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>600</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>5,771</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>140,480</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>4,488</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>144,968</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(104,310</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>)</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>46,429</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT
OF OPERATIONS <BR>
FOR THE PERIOD ENDED MARCH&nbsp;31, 2022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Dollars In Thousands, Except Share and Per Share Amounts)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>For
    the Period</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>For
    the Period</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>For
    the Period</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>For
    the Period</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>from</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>from</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>from
    March&nbsp;10, </B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>from
    January</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>January&nbsp;18,
    2022</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>January&nbsp;18,
    2022</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>2021
    (Inception)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>18,
    2022</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(Inception)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(Inception)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>through</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(Inception)</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>through</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>through</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>December&nbsp;31,</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>through</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>March&nbsp;31,
    2022</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Transaction
    &nbsp;</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>March&nbsp;31,
    2022</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>2021</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Transaction</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>March&nbsp;31,
    2022</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Accounting</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Accounting</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Zura</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Adjustments
    </B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Pro
    Forma</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>JATT</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Adjustments</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Pro
    Forma</B></FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(Historical)</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(Note
    2)</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Zura</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(Historical)</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(Note
    2)</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Combined</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt"><B>Expenses</B></FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.125in; vertical-align: bottom; width: 27%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">General and
    administrative</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">319</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">319</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">720</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">3,490</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(dd)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">4,529</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Research and development
    - license acquired</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">7,500</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">16,431</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(aa)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">23,931</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">23,931</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.125in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">General and administrative
    - related party</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">168</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">168</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Total expenses</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">7,819</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">16,431</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">24,250</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">888</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">3,490</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">28,628</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Operating loss</B></FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(7,819</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(16,431</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(24,250</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(888</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,490</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(28,628</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Other income (expense)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Loss upon issuance of
    private placement warrants</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(1,773</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(1,773</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Offering costs associated
    with derivative warrant liabilities</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(747</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(747</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Change in fair value
    of derivative warrant liabilities</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">10,238</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(5,451</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(ee)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">4,787</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Investment income on
    Trust Account</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">19</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(19</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(ff)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Change in fair value
    of note payable</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(2,400</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(bb)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(2,400</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(2,400</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Total other income (expense)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(2,400</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(2,400</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">7,737</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(5,470</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(133</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Net loss before non-controlling
    interest</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(7,819</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(18,831</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(26,650</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">6,849</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(8,960</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(28,761</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Non-controlling interest</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,797</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,797</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,797</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Net loss</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(7,819</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(17,034</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(24,853</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">6,849</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(8,960</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(26,964</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Adjustment to Zura subsidiary's
    preferred stock to redemption value</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(6,854</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(cc)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(6,854</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(6,854</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>Net loss attributable
    to common stockholders</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(7,819</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(23,888</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(31,707</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">6,849</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(8,960</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(33,818</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Weighted average Class&nbsp;A
    ordinary shares outstanding, basic and diluted</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">7,834,343</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Basic net income (loss)
    per Class&nbsp;A ordinary share</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">0.62</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Diluted net income (loss)
    per Class&nbsp;A ordinary share</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">0.61</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Weighted average Class&nbsp;B
    ordinary shares outstanding, basic</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">3,130,303</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Weighted average Class&nbsp;B
    ordinary shares outstanding, diluted</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">3,310,606</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Basic net income per
    Class&nbsp;B ordinary share</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">0.62</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Diluted net income per
    Class&nbsp;B ordinary share</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">0.61</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Basic and diluted net
    loss per ordinary share</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">(7,818,712</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Basic and diluted weighted
    average ordinary shares outstanding</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">1</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Basic and diluted net
    loss per common share</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>$</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt"><B>(1.16</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">)</FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">Basic and diluted weighted
    average common shares outstanding</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">29,037,831</FONT></TD>
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT
OF OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nine Months</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nine Months</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nine Months</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ended</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ended</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ended</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>September&nbsp;30,</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>September&nbsp;30,</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transaction</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>September&nbsp;30,</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2022</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2022</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accounting</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2022</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Zura</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>JATT</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Adjustments</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pro Forma</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Historical)</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Historical)</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Note 2)</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Combined</B>&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Expenses</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 38%; padding-left: 31.7pt; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,814</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,688</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(dd)</B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,502</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 31.7pt; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development - license acquired</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,500</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,500</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 31.7pt; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 31.7pt; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative - related party</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">340</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">340</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,814</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,028</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,842</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operating loss</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,814</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,028</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,842</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other income (expense)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(32</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(32</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering costs associated with derivative warrant liabilities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of derivative warrant liabilities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,020</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,070</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ee)</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,950</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment income on Trust Account</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">885</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(885</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(ff)</B></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total other income (expense)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(32</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,905</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,955</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,918</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Net loss</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,846</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,877</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,955</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,924</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average Class&nbsp;A ordinary shares outstanding, basic and diluted</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,800,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net income (loss) per Class&nbsp;A ordinary share</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.17</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average Class&nbsp;B ordinary shares outstanding, basic and diluted</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,450,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net income per Class&nbsp;B ordinary share</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.17</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss per ordinary share</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,205.28</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted weighted average ordinary shares outstanding</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,587</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss per common share</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(0.34</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted weighted average common shares outstanding</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,037,831</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><B><I>Notes to Unaudited Pro Forma
Condensed Combined Financial Statements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>1.</B></TD><TD><B>Basis of Presentation</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Business Combination was accounted for as
a recapitalization in accordance with GAAP. Under this method of accounting, JATT was treated as the &ldquo;acquired&rdquo; company for
financial reporting purposes. Accordingly, for accounting purposes, the financial statements of the Combined Company represent a continuation
of the financial statements of Zura, and the Business Combination was treated as the equivalent of Zura issuing stock for the net assets
of JATT, accompanied by a recapitalization. The net assets of JATT are stated at historical cost, with no goodwill or other intangible
assets recorded. Operations prior to the Business Combination are those of Zura.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The unaudited pro forma condensed combined balance
sheet as of September&nbsp;30, 2022, gives pro forma effect to the Business Combination and other events contemplated by the Business
Combination Agreement as if they had been consummated on September&nbsp;30, 2022. The unaudited pro forma condensed combined statement
of operations for the year ended March&nbsp;31, 2022 and the pro forma condensed combined statement of operations for the nine months
ended September&nbsp;30, 2022, give pro forma effect to the Business Combination and the other events contemplated by the Business Combination
Agreement as if they had been consummated on April&nbsp;1, 2021.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The unaudited pro forma condensed combined financial
information and accompanying notes have been derived from and should be read in conjunction with:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">&bull;</FONT></TD><TD STYLE="text-align: justify">the historical audited financial statements of JATT as of December&nbsp;31, 2021 and for the period from
March&nbsp;10, 2021 (inception) through December&nbsp;31, 2021 and the related notes, which are included in JATT&rsquo;s Annual Report
on Form&nbsp;10-K filed with the SEC on April&nbsp;11, 2022 (the &ldquo;<U>JATT 2021 10-K</U>&rdquo;), which are included elsewhere in
this Prospectus;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">&bull;</FONT></TD><TD STYLE="text-align: justify">the financial statements of JATT as of September&nbsp;30, 2022 and the related notes, which are included
in JATT&rsquo;s Quarterly Report on Form&nbsp;10-Q filed with the SEC on November&nbsp;14, 2022 (the &ldquo;<U>JATT 2022 10-Q</U>&rdquo;),
which are included elsewhere in this Prospectus;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">&bull;</FONT></TD><TD STYLE="text-align: justify">the historical audited financial statements of Zura as of and for the period from January&nbsp;18, 2022
(inception) through March&nbsp;31, 2022 and the related notes, which are included elsewhere in this Prospectus;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">&bull;</FONT></TD><TD STYLE="text-align: justify">the historical unaudited financial statements of Zura as of and for the six months ended September&nbsp;30,
2022 and the related notes, which are included elsewhere in this Prospectus; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">&bull;</FONT></TD><TD STYLE="text-align: justify">other information relating to JATT and Zura contained in this Prospectus, including the Business Combination
Agreement and the description of certain terms thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The unaudited pro forma condensed combined financial
information should also be read together with the sections of the JATT 2021 10-K, the JATT 2022 10-Q, the financial statements of Zura
as of and for the period ended March&nbsp;31, 2022, the financial statements of Zura as of and for the six months ended September&nbsp;30,
2022 and the section of this Prospectus entitled &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results
of Operations,&rdquo; as well as other financial information included elsewhere in this Prospectus.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Zura management has made significant estimates
and assumptions in its determination of the pro forma adjustments. As the unaudited pro forma condensed combined financial information
has been prepared based on these preliminary estimates, the final amounts recorded may differ materially from the information presented.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The pro forma adjustments reflecting the consummation
of the Business Combination are based on certain currently available information available and certain assumptions and methodologies that
management believes are reasonable under the circumstances. The unaudited condensed pro forma adjustments, which are described in these
notes, may be revised as additional information becomes available and is evaluated. Therefore, it is likely that the actual adjustments
will differ from the pro forma adjustments and it is possible the difference may be material. The unaudited pro forma condensed combined
financial information does not reflect the income tax effects of the pro forma adjustments as based on the statutory rate in effect for
the historical periods presented, as management believes income tax adjustments to not be meaningful given the combined entity incurred
significant losses during the historical periods presented. Zura management considers this basis of presentation to be reasonable under
the circumstances.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">One-time direct and incremental transaction costs
anticipated to be incurred prior to, or concurrent with, the closing of the Business Combination are reflected in the unaudited pro forma
condensed combined balance sheet as a direct reduction to Zura&rsquo;s additional paid-in capital and are assumed to be cash settled.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transaction
Accounting Adjustments to Unaudited Pro Forma Condensed Combined Financial Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Transaction Accounting Adjustments to Unaudited Pro Forma Condensed
Combined Balance Sheet</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The transaction accounting adjustments included
in the unaudited pro forma condensed combined balance sheet as of September&nbsp;30, 2022, are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><B>Pro Forma Zura Only</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">(a)</FONT></TD><TD STYLE="text-align: justify">Reflects the issuance of a $8.0 million promissory note with a $0.4 million original issue discount and
9% interest.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">(b)</FONT></TD><TD STYLE="text-align: justify">Reflects the $7.0 million cash and $4.5 million (550,000 shares @ $8.16 per share) in JATT Class&nbsp;A
Ordinary shares (that will convert to JATT commons shares) for the upfront payment on a compound license. Also, reflects the Zura subsidiary
Z33&rsquo;s payable to JATT and the JATT receivable from Zura&rsquo;s subsidiary Z33 related to the JATT Class&nbsp;A Ordinary shares
(that will convert to JATT commons shares) (see tickmark (o)).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">(c)</FONT></TD><TD STYLE="text-align: justify">Reflects Zura&rsquo;s subsidiary Z33&rsquo;s issuance of 4,900,222 shares of Series&nbsp;Seed Preferred
stock. Half with an embedded derivative valued at $4.6 million and half without an embedded derivative valued at $0.3 million.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">(d)</FONT></TD><TD STYLE="text-align: justify">Reflects the 10.94% non-controlling interest in Zura&rsquo;s subsidiary Z33.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">(e)</FONT></TD><TD STYLE="text-align: justify">Reflects the adjustment of Zura&rsquo;s subsidiary Z33&rsquo;s Series&nbsp;Seed Preferred stock to redemption
value.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><B>Pro Forma Combined</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">(f)</FONT></TD><TD STYLE="text-align: justify">Reflects the liquidation and reclassification of cash and investments held in the Trust Account (as defined
in this proxy statement) that became available for general corporate use following the Business Combination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">(g)</FONT></TD><TD STYLE="text-align: justify">Reflects the transfer of JATT&rsquo;s Class&nbsp;A Ordinary Shares subject to possible redemptions as
of September&nbsp;30, 2022 to permanent equity.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">(h)</FONT></TD><TD STYLE="text-align: justify">Represents the PIPE Financing issuance of 2,000,000 ordinary shares at $10 per share generating gross
proceeds of $20.0 million.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">(i)</FONT></TD><TD STYLE="text-align: justify">Represents the Forward Purchase Agreement issuance of 3,000,000 ordinary shares at $10 per share generating
gross proceeds of $30.0 million.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">(j)</FONT></TD><TD STYLE="text-align: justify">Represents preliminary estimated transaction costs to be incurred by Zura and JATT of $5.0 million and
$7.5 million, respectively, for legal, financial advisory and other professional fees. The JATT estimated transaction costs includes $4.0
million of deferred underwriting commissions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>For the Zura transaction costs:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">&bull;</FONT></TD><TD STYLE="text-align: justify">$5.0 million was reflected as a reduction of cash and additional paid in capital and $1.9 million was
reflected as a reduction in deferred transaction costs and accounts payable and accrued expenses.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>For the JATT transaction costs:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">&bull;</FONT></TD><TD STYLE="text-align: justify">$7.5 million was reflected as a reduction of cash, over $4.0 million as a reduction in deferred underwriting
commissions and almost $3.5 million reduction in retained earnings.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">&bull;</FONT></TD><TD STYLE="text-align: justify">The amount of total estimated JATT transaction costs recognized by JATT through September&nbsp;30, 2022
was not material. The costs expensed through retained earnings are included in the unaudited pro forma condensed combined statement of
operations for the period ended September&nbsp;30, 2022.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">(k)</FONT></TD><TD STYLE="text-align: justify">Reflects the elimination of JATT&rsquo;s retained earnings of $10.6 million to additional paid-in capital.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">(l)</FONT></TD><TD STYLE="text-align: justify">Reflects the recapitalization of equity as a result of the Business Combination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">(m)</FONT></TD><TD STYLE="text-align: justify">Reflects the reclassification of the public warrants&rsquo; derivative warrant liability of $1.1 million
to equity. JATT&rsquo;s public warrants are expected to be equity classified upon consummation of the Business Combination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Public</B></P> <!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Private</B></P> <!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Total</B></P> <!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 58%; font-size: 10pt; color: #231F20">IPO, fair value</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">8,625,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">7,683,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">16,308,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Change in fair value</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(5,451,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(4,787,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(10,238,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">December&nbsp;31, 2021, fair value<FONT STYLE="color: #231F20"></FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,174,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,896,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">6,070,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Change in fair value</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(2,070,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,950,400</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(4,020,400</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">September&nbsp;30, 2022, fair value</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,104,000</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">945,600</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,049,600</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #181717">(n)</FONT></TD><TD STYLE="text-align: justify">Reflects the repayment of the $8.0 million face amount of the promissory note, the amortization of the
$0.4 million original issue discount upon the Business Combination, and the payment of an additional $2.0 million triggered by an event
of default. Interest expense for the note is not reflected as the note is assumed to be repaid as of September&nbsp;30, 2022 (upon the
Business Combination).</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="color: #181717">(o)</FONT></TD><TD STYLE="text-align: justify">Reflects the payment of the Zura payable to JATT and the receipt of the JATT receivable from Zura.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="color: #181717">(p)</FONT></TD><TD STYLE="text-align: justify">Reflects the redemption of 13,617,502 of JATT Class&nbsp;A Ordinary Shares prior to the Closing at a redemption
price of approximately $10.17 per share totaling approximately $138.4 million (includes interest on the marketable securities and/or balances
held in the Trust).</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="color: #181717">(q)</FONT></TD><TD STYLE="text-align: justify">Reflects the Redemption Backstop of 1,301,633 JATT Class&nbsp;A Ordinary Shares at a price of $10.00 per
share, totaling approximately $13.0 million.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="color: #181717">(r)</FONT></TD><TD STYLE="text-align: justify">Reflects the issuance of an additional 2,500,000 JATT Class&nbsp;A Ordinary Shares to the Redemption Backstop
investors at fair value as of the Closing.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Transaction Accounting Adjustments to Unaudited Pro Forma Condensed
Combined Statement of Operations</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The transaction accounting adjustments included
in the unaudited pro forma condensed combined statement of operations for the periods ended March&nbsp;31, 2022 and September&nbsp;30,
2022 are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><B>Pro Forma Zura Only</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in"><FONT STYLE="color: #181717">(aa)</FONT></TD><TD STYLE="text-align: justify">Reflects $16.4 million in payments for a compound license. The payments include $7.0 million in cash,
$4.5 million in JATT Class&nbsp;A Ordinary Shares (that will convert to JATT common shares), calculated as 550,000 shares at a price of
$8.16 per share, and a $4.9 million finder&rsquo;s fee delivered through the issuance of 4,900,222 shares of Series&nbsp;Seed Preferred
Shares by Z33, Zura&rsquo;s consolidated subsidiary. Half of the Series&nbsp;Seed Preferred Shares that include an embedded derivative
are valued at $4.6 million and the other half of the Series&nbsp;Seed Preferred Shares without an embedded derivative are valued at $0.3
million. The finder&rsquo;s fee is included as a cost to acquire the compound license.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in"><FONT STYLE="color: #181717">(bb)</FONT></TD><TD STYLE="text-align: justify">Reflects the amortization of the original issue discount of $0.4 million on the $8.0 million promissory
note as well as the payment of an additional $2.0 million triggered by an event of default.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><B>Pro Forma Combined</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in"><FONT STYLE="color: #181717">(cc)</FONT></TD><TD STYLE="text-align: justify">Reflects the adjustment of Z33&rsquo;s, Zura&rsquo;s consolidated subsidiary&rsquo;s preferred stock to
redemption value.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in"><FONT STYLE="color: #181717">(dd)</FONT></TD><TD STYLE="text-align: justify">Reflects an adjustment for the transaction costs as if the Business Combination had been consummated on
April&nbsp;1, 2021.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in"><FONT STYLE="color: #181717">(ee)</FONT></TD><TD STYLE="text-align: justify">Reflects the reclassification of the $1.1 million in public warrants to permanent equity as of April&nbsp;1,
2021 and eliminates the fair value change of these public warrants historically recorded on the statement of operations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.35in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in"><FONT STYLE="color: #181717">(ff)</FONT></TD><TD STYLE="text-align: justify">Reflects an adjustment to eliminate investment income related to the JATT Trust Account.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss
per Share</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Represents the net loss per share calculated using
the historical weighted average shares of Zura Ordinary Shares outstanding, and the issuance of additional shares in connection with the
Business Combination and other related events, assuming the shares were outstanding since April&nbsp;1, 2021. As the Business Combination
and other related events are being reflected as if they had occurred at the beginning of the period presented, the calculation of weighted
average shares outstanding for basic and diluted net loss per share assumes that the shares issuable in connection with the Business Combination
have been outstanding for the entire period presented. No unexercised stock options and warrants were included in the earnings per share
calculation as they would be anti-dilutive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: -0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20"><B>Nine Months Ended September&nbsp;30, 2022</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 87%; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Pro forma net loss</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,924,000</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Pro forma weighted average shares outstanding - basic and diluted</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,037,831</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Net loss per share - basic and diluted</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.34</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20"><B>Period Ended March&nbsp;31, 2022</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: -0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro forma net loss attributable to common stockholders</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(33,818,000</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Pro forma weighted average shares outstanding - basic and diluted</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,037,831</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Net loss per share - basic and diluted</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1.16</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20"><B>Pro Forma Weighted Average Shares</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JATT Public Shareholders</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">182,498</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JATT shares issued - Lilly license</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">550,000</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption Backstop</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,301,633</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption Backstop Consideration</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500,000</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JATT Founders</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,450,000</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PIPE</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward Purchase Agreement</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,000,000</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zura Equityholders</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,053,700</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">Pro forma weighted average shares outstanding, basic and diluted</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,037,831</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">JATT had an aggregate of 12,810,000 warrants outstanding
which had no intrinsic value and were anti-dilutive. Additionally, Zura had stock options on 3,547 and -0- shares as of September&nbsp;30,
2022 and December&nbsp;31, 2021, respectively, which had no intrinsic value and were anti-dilutive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.4pt 0pt 42.3pt; color: #181717; text-align: center; text-indent: -0.5pt"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>zura-20230320.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17cc -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWa+EubOdzZR+uYkxtmBzbSmqfyMjtGuprinTl1PWkX4P -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:zura="http://jattacquisitioncorp.com/20230320" elementFormDefault="qualified" targetNamespace="http://jattacquisitioncorp.com/20230320">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://jattacquisitioncorp.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="zura-20230320_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="zura-20230320_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="zura-20230320_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="zura_UnitsMember" name="UnitsMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>zura-20230320_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17cc -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://jattacquisitioncorp.com/role/Cover" xlink:href="zura-20230320.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://jattacquisitioncorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapWarrantMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>zura-20230320_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17cc -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US">Ordinary Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentInformationLineItems_lbl" xml:lang="en-US">Document Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="zura-20230320.xsd#zura_UnitsMember" xlink:label="zura_UnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zura_UnitsMember" xlink:to="zura_UnitsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="zura_UnitsMember_doc" xml:lang="en-US">UnitsMember</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>zura-20230320_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17cc -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://jattacquisitioncorp.com/role/Cover" xlink:href="zura-20230320.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://jattacquisitioncorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiDocumentInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140539854166240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 20, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 20,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Zura
Bio Limited<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001855644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4225 Executive Square<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite
600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">La Jolla<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">247-0520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Ordinary Shares, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ZURA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ZURAW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>tm2310353d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="zura-20230320.xsd" xlink:type="simple"/>
    <context id="From2023-03-20to2023-03-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001855644</identifier>
        </entity>
        <period>
            <startDate>2023-03-20</startDate>
            <endDate>2023-03-20</endDate>
        </period>
    </context>
    <context id="From2023-03-202023-03-20_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001855644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-20</startDate>
            <endDate>2023-03-20</endDate>
        </period>
    </context>
    <context id="From2023-03-202023-03-20_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001855644</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-20</startDate>
            <endDate>2023-03-20</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-03-20to2023-03-20">0001855644</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-03-20to2023-03-20">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-03-20to2023-03-20">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-03-20to2023-03-20" id="xdx2ixbrl0018">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:DocumentType contextRef="From2023-03-20to2023-03-20">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-03-20to2023-03-20">2023-03-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-03-20to2023-03-20">Zura Bio Limited</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-03-20to2023-03-20">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-03-20to2023-03-20">001-40598</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-03-20to2023-03-20">4225 Executive Square</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-03-20to2023-03-20">Suite 600</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-03-20to2023-03-20">La Jolla</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2023-03-20to2023-03-20">CA</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="From2023-03-20to2023-03-20">92037</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-03-20to2023-03-20">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-03-20to2023-03-20">247-0520</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-03-20to2023-03-20">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-03-20to2023-03-20">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-03-20to2023-03-20">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-03-20to2023-03-20">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-03-202023-03-20_us-gaap_CommonClassAMember">Class A Ordinary Shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-03-202023-03-20_us-gaap_CommonClassAMember">ZURA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-03-202023-03-20_us-gaap_CommonClassAMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2023-03-202023-03-20_us-gaap_WarrantMember">Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-03-202023-03-20_us-gaap_WarrantMember">ZURAW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-03-202023-03-20_us-gaap_WarrantMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-03-20to2023-03-20">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2023-03-20to2023-03-20">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M$K$P/$#0CDNTXWW0QM"-"KIPD@3\F7SD+W5PN)(#+3;H]?K=+H+E.I5U.ON
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M 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ,")>%;B4MNJ[P   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( ,")
M>%:97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ P(EX5DL8-Z!/!0  2Q<  !@
M ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( ,")
M>%:?H!OPL0(  .(,   -              "  9,-  !X;"]S='EL97,N>&UL
M4$L! A0#%     @ P(EX5I>*NQS     $P(   L              ( !;Q
M %]R96QS+RYR96QS4$L! A0#%     @ P(EX5JK$(A8S 0  (@(   \
M         ( !6!$  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( ,")>%8D
M'INBK0   /@!   :              "  ;@2  !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( ,")>%9ED'F2&0$  ,\#   3
M      "  9T3  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(
' .<4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2310353d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://jattacquisitioncorp.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2310353d1_8k.htm">tm2310353d1_8k.htm</File>
    <File>tm2310353d1_ex10-11.htm</File>
    <File>tm2310353d1_ex10-12.htm</File>
    <File>tm2310353d1_ex10-13.htm</File>
    <File>tm2310353d1_ex10-15.htm</File>
    <File>tm2310353d1_ex10-17.htm</File>
    <File>tm2310353d1_ex10-2.htm</File>
    <File>tm2310353d1_ex14-1.htm</File>
    <File>tm2310353d1_ex3-1.htm</File>
    <File>tm2310353d1_ex99-1.htm</File>
    <File>zura-20230320.xsd</File>
    <File>zura-20230320_def.xml</File>
    <File>zura-20230320_lab.xml</File>
    <File>zura-20230320_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2310353d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2021q4": 28
   },
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "zura-20230320_def.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2310353d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "zura-20230320_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "zura-20230320_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "zura-20230320.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 65,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 25,
   "memberCustom": 0,
   "memberStandard": 2,
   "nsprefix": "zura",
   "nsuri": "http://jattacquisitioncorp.com/20230320",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2310353d1_8k.htm",
      "contextRef": "From2023-03-20to2023-03-20",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://jattacquisitioncorp.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2310353d1_8k.htm",
      "contextRef": "From2023-03-20to2023-03-20",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary Shares [Member]"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://jattacquisitioncorp.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001104659-23-036697-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-23-036697-xbrl.zip
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M/GV7 M7W8V<P<.QC2_>\HT]<X-<3'4 $4WZ-USWV@_S)@,7<#2VS:_IBK<P
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MG<NL;EUN7H/O-+>[D]T\^>Q3W[S'*W8QJ5CHE]P%#34.''B"Q.LZD26I;P)
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MR\!Q0H/4/&PU<XFSR!J^3FT#37><=>Y9EV(P8)0?0)0Y!I>72ZD "=,CF@L
MNL:@B&O7N?7[,.A@B$$3NL<,WC-MD?(D?,6UEK)MI1S%\&V]W6BP;=SX_BOR
M%ZN'34J6&F*R%$;*X$CE$G"0'2UGL(0U48S:#$=%HV+T7FS<ZOS,;(\?\*0
MP ^RAK])Q'JJH=_3R,=BX'Q#N-Z]_D7[^.;7XV^SM(/[;L"S0:"YRR+(:K6Q
M%O!E/<@"[\AI;\0EPF"YW"MIIJ.5RJ4^7#AN\:X/%\YVR*H<@"2$C\&\,B@*
M"\V:(I"#TEY)K,+)K'N<_=:$N1&W;-@2_.+R&Y"FX"D0M>PN>JWU+F69X<-8
MY=?07<,3X5!&S*0-I")FTVYLZZ%-.WX_JP]#X60(_LG=5;@ID<J;C[]MZ_[/
MUGOK-^?K7/TX18N:U'\SE-5XEA.'MZ8K*A-W+C9RP@Q%49DI"LC$#**Y!61B
M!69F5RQFIK#"*5[!\W\'Z#2#8<5\)#%FMUY8'F=L:9X]$OB&R9/(Q+RJ^D^9
MZ5VN_]CI<,!X6..0UAR?<J_@,*>=,GX",P;^4P7VG@)/<XR@ZSN@FWYV?#[C
M6.R\.A4WW+TQ^>W\9YIE793">:Y0,I,%7U5%"F C*MH7Q<X.1P;4,RT1Z"NB
MHBFVRL>JQ\*Y;&+]8G2$U"M,H_\VJC6-_MNHL!9]TZ)O6NJ;%OUWKP(\T&!M
M> +9EIJXRK[8JNQ%396]0)Z&P>X:N95>FX?'EN-1H!>6DP!J3RH#/5%_]:+"
ML)(!BQ4R@*F8)3Z&@EV4K E?1HYR2[^E=),3^QK3M&F-WW0+(+V=6 %.D9FX
M7/IP='4%7#<LY,V.81*</IG\C3:4P3"^G.3H.$QV6S3X)Y!A8*V706?$L!0C
M(!0$6#_:>ZQ[YMRBFN %'<\T3#3JP#9IR.3<T01C5\"T";96+CUF#4Q+KX*V
M%)[P+XY%$@P[\XV)%I.<"%_O.MF-@K3B!8,!(0>B15<@G!*P2,33NR+^@B0;
M40'<0 D2'W@3P..8N01R=0>K"B(N'%V[G)1Y0!2#GOX0V)S5]PC/$9:@ZPV$
M$ F/7W)8.=7LE#<!GOCLW(BOZJ(FC$;0^*#; 0*SWA WIH++(.P=.+!H!)8X
MNTH"?<3G<DF=)+P@X)%SXT9O* O *(P_S#"X0<E66A !@(ZR+5YSF[NZ!92%
M<U\"&1<;IK>031'PQT"RTP=&AM 1-$+"+H]&G"0F>2\F@3W3'*D%T][IG-6Y
MP_8HI]L+8);X<5=8$35* V%V^N[<HV>R$YS'XF8F0&BV;;XHEV+7%E4M0&.I
MZZ!UPG<D=E7$MQ+5\/:8=D"92AY-Y07 :&_PBS@1T\>3D,S!B/6DS^45$ '3
M?,',P8 ;F/0"@R;15;Q744O,W4N2"M)O\:\FV9>@C _9&$SAD73KL]P]XC(!
M49UKLBF)U44;"[%=E#.(8S<RCJFI6?9&Y+V0.09:!IP$' 5M4V5BF3XL@U*V
M ,QRV#1'5_O,$0T$;-,  3T[P[]9LM;1^ES>4QO1SY:F 3K](H**9H6AXR'Y
M!6@3]Z'*28H/X1FYW/,)'09\  *3;00#<271Z8>B$2"J[GE.UQ28 0,)8P@A
MAB$-*R)4A4[Z5L<8/1"27"%:1MR6Z>521R%/-T*>BGP=WQ3,!-=6S$R8XB6*
M780L4E,L$M>FF K:,+5*O5ZO($M-\1_@ VIT;WP 1@Y*TIX+@CFRG%.YUPAZ
MILO(>0%0*I< 6G#CY->REP:9EG2O3\!@^ 3(.V1Z4LXY M>=.1"$[M_U6E7;
MBRT7!P HZM=PG:_Q!&)C@/@0V'YFD'+IWW6M6=&TO4JS5:ON-:LL!^.$(6H$
M#P[)4!ZUR)P/KM$P2*B&(>J5%F@0S8-:N92N+UP$/[80\(E3&@T_&*4%D,/U
M-ZL'M2H[=TT89@2GK:0A$9X68FZCLE??!X!H:>0JEQX&C ?@!.RIT:[L'6B5
M=J-5;397FGYBO4['EEWC"$U#BRJJAD"X?%0@$\=5+B5XW5R5]Z63_G0+^(<3
M^&2MQJLM)2>)6#KA;5S>&H[#>';+X79UL<6=90GO5ACWB.A)AOD(F;L<R\SH
M3*2_D^1N\UN8R,08?^  20JN2/P82IXG6$Q!R/\.)%M-V.0O<']L.^FY&P]D
MH?<"H%D<SLY0Z* PR3  A4CW>&R+77UH^D M3=!E2. AH"HX"K^$@AD^KT9+
MAX0D0#D&#@Q[Y!DL&#IVSKZKY1+Z@GT'EX5LWS2XJ)>E#I&$3D]ZD6-43V(4
MT&D<5:I<8@@/99/TB8]9)N@ &.N2!S[4^ 0,7RB9/T8*!;+0V>)K_Z[OM=C
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MS)R]?VRL\X_T[P5[_T;:4%#Y78SW;[3U!  SVON73T8?[@-D^2[ L(3DXGR
MF5FH!N#B?8 LQP58+HWQ >8?RRP\@=GH.FG-D+5I0E.(/M(4,KDE9 2GSE@^
MZO4P*.2YFCX*P/50IU_1_9[>]=<22</K;=OHA)X=@?ZRI,1%O'@6_A)+.<&B
M3J*<UMJH'@6.P%#RBB6LQYQUY5).07Y5C"9,DA-E=_MA.P9CM,4]74QD7-%8
MJ4HHE=C.+Q'BIL\SP8EE=;11X8,)A,@>?T;A$9>L ^(3L$@>UD4/^Q_$.\J-
M+HJ&!&3D[.S: <YK>U)0BCV)I#7F7*0C'1.0V*/.TU3L31HVL6B)%^HH79 E
M'0HC,?A =<*4D!J:U]?W.QV]^T/1^?AJRB4)YCQE:M(X27P6"R"@R.,+LI7#
M34>""R381[D69I>\'2_B5Q0T,YXZ9=#AD6G=JTS'QC+;',C-ULDP\F@>XF'0
MGH&#H7/XR[T![ *P$&NO+ZA[\R**&J>L:UHL>5QL^>SL.%OTI5Q2Q5XL4^^8
M%JH.JNDE/*9?2X* ABO7L61]^]\0%=#XQ-Z RH*%CE%N<08<$.G2-/I!RE9'
M"\BI)I<*KA]&AV)CEGB6-Q8<7LHVE<UF0RN(>-=R=%L8T01X4(>TN^80-T&-
MQ7(+XX;/'-$SF1FQMNY!U(4GGJ@.JJ!Y39T*R'['#-/KJ@9F_VZ*<FM1FY^P
MR+-+K=S"+C_M:NTGLK;HMAT,*G1&Z"D7^B+HR%7V-30'YD*I(K_NZT;2$*!W
MN]S""FN\^&65_2Z[7(5-V,+UU3587^A93D*+9)/ XUFI(>S-$';^OMQIBB1[
MLE<4RV6B&"P&X1B\:^F(19'HHY+Y3HZ9B$<1?CD6-GVHBT)OC5BO[] FG;HU
MGGF-^!*U[[[580J76=)M'(R&>@X.?Q,#")_P)!45Q,!1!05:@>B1J8XN$GJR
MQ?F4A#S4[R50Q8! .HJ/;#O67RHLKZC$DS!1\$76X%@NI<W\!,P>G8LZR%0T
MR.02:GA<6*0O=EXN'^JFD7L,V#''YU3C 3FHLBGFGQ8B%<IW."$W<N2]_->F
M%//&-_*8103)-"87LJ$A).48A70V:U9I+#:@)+?*"RH"UR[2PQW)&>'F^'P!
MC/AQRYDDWJ&UB7>83[S#3#%I$QVQV.@([:FC(X[#$%NBG4=82< S50#L6],;
M.NI/^-7SN.^M9Y0$LDB4:2W'P]1NV"CJQ2#-2AX7,;535"&, "/Q)5>.<Q2]
MXZ!4DZJ*D]"$91UA> 81A'! ,!_XYE@4W0(>1S5ZE#QYL/-QI176HU#RB$<9
M")&J(.1[9$NU1%/!4!>(AHKWQHOY_&(:#7 =K.& \ESTP(N7BP-R1&KCI#5-
M>J=>1(R2 AL0W!7S0?2A!_=>?=HBQ@2$5C&H#'UL_A2MF.YXZK%<RAQ[MYA*
M7=X/.HY%HQ\T7B4)R123M+61LTQ+"[7]2JNE5;#L\CC3:D[GS'&OC&^>F6-
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M!#%\LM!_5P_$XNZ=()0I/$X5TXK@3!DQ43V36(<@U_1^B/4'M@R 1%&KP@9
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M7%(P %&$D6O$SA]2D99(=D4(5:*&M,A8*+@Z.WEXTD &3.R'ZN,1@33NBOC
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M:/L27_HTJD<5$"@56OG2R"-%9@6U49D>'3U E0N%$UD!#FM 5<+0T<"R,.Q
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MPLNWX>D\7P1L/@P!N]$I=#&$L$>Y!'H(^57'LD+B)0GYREN>KXA=1C$5$7;
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MR]*''IR;^K1%X!YAQ!%'N*5.I;BJR2LFEQN=.F)"CE$H C@9*%+CYHSR9"\
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MI-6>8M.@B(7W\G_G;'BI0KI,RB9+L+(2T*FHZC_[]N![[OHA0-4:'8#I1$^
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M8P-!"554&Q$\SDA)]N0&4HQIE144IK,&1TU_F^7XWQA;R9N.K (,UHP.NMV
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M*A\^/KZ%OO+5\$\/=E"G3PQU>K"#.GUSH@TUX732YXV]5+8=OQT39!Q3<E$
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M!;T^<=#KX2[H=<7S>3O;YSWHM<]CE(8P4MSJ]GDC[%#' U 5,.)R_8@ [>T
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M9:"[,]+[V'H$/$G-GD98 T$[TPNSL'*[CX]*IQ-7C"B *5BP[ ._0.H]#+S
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M4&#4%1^.CK$QK3EL"/B6S>F$&IDQ-BN8._=7'*@H&NVPD_P#G@#'/BD1B#D
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M]CA2&)GA>("EVV#^!72BIN)$91#FF:&OQ!M$?=EJD-E5?@*R17N_H L)8TK
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M\YK-0- I-17XR9_(?0PMQE$UFD5=6<ZX@0X<J)J"!8\/G;$%]E$;KV8?P6D
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M*#64\EC1G59)DEO=P'E4;C^<+QP18WR9D^@N7_,B!V6YA=UY%=&RT8ZAB-K
MD(&#Q,DG3;8^':($R^9(B=<8'RYL>.Z[EP?95L?9E_;J%P@(9^BCJ2:,WKB(
M0ZE13S1Q';>*F18>'F3R*;VUPC@Z'74?G#Q(29U)&WH,+PN#4T\9#+?-N26R
M[HJ9VZ-=YO939VZ/=IG;;T'!WQCDGS81GDY^XRIR'T7//Z#\:LMM0)OO<XB.
MPI!UMZ-X[- &C'H5>LH)4*&H=U*E]45=A&P2V (03VIFGUKF("N;U%-B=(%=
M'O@5+@=+KQS2W4.Z6*8FP&ZR9 (N6-\3UE)_4-0ZLQ%&YTJ\)]7N%,@KS[7A
M50 %YI13[D6V8;[4V9:=2!NW1)WTY[K&G%.F643<!,/RMW?_X;Y2_?G1#BS
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MFKO[!H5TQ>]Q UNAQJ&R>3(")7RB9YS.&;:_Q<>"T#ZU!01\WBDP2[]07);
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M(G.A7%2M"JZ*/X:63)TI;E1"]2DG8-FJ"X3WCV+&]$U%E()V"5;LMU*D],[
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MK1M<T?X?7,7?FUR0ECL_A\'N]NZNY?2"/S!9B6G5J8Z"4[&E*MU2*;J"RW!
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MN8ZS_ZAJ/%U9\E;!)L!OVCG]?J^"@Y@KD@M[=5U.-+_3&C%AOF)$Q'!0@2:
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M6!B!B&[Q*[0WA9J 8$>S" 1UL$E&]+:D&F&?RG&.2M9H-_^"+T?FRJ?9,4D
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M@TL9MMYSZ20;P38>@<TU)2:+:DZ,R>-Q=,*=5LS1CU9CN4CNE15)%M^8)N_
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M"0Y-J.8[\MY$*.#\=C=]OP$8$2W#;=$I]?1:>2?DH<,![BSNA>54C7W<<:?
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M+,5#GIZX%4Z7<VQ;6>>@N6K7P09GB!-H"(YF78U,36CA1@8BFQP1/JMG%A+
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M%"*.$ =#(6/Z!D:N)GHA/V)Z5TFVW!^,.$GLHF+^W&_/)"0PB[*0>FIFH*&
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M&97\CMP5EVB*_ZRH.)(;6XV2__YS]^[N[OV?1IU65Y=GPGM- S\>E',%VOU
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MZ@))HUZ8:<OKGK3(I@;!Y'W,.<.4HU@:\#K-Y8^=@QT#M$_V#U[_\YUAW7T
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MW@;<>_'^U9]X'>_]?OCVS?/_#U!+ P04    " # B7A66NH)@ZD@  #0N@
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M5"R-%UC><=GOBNY56.H&-JK.<X%!Z<$J"]XDL+\8\8R"[2*25&E?67&B.]^
MOPUA.X8VUL5!.!_+RVS4)60/XW4ZQW.J8C%IP(H0ZJ^G;ME1MAR86Q.V7DOG
MH1F!H4>*]"=* AWFM0@2W6H4-G@6D&(#UK)!4%A%C$.:IZ&\[+3DIT!^:35V
M9*2A1LYV*4.<"A(WAR=PT1HM+1[;FCO;/*#C?O'[1D>!!0(=HQ*?K[.0"8B:
MI4_6+[!^+Q;5^K68O?>9.(P9N\$6OP$PMG'.+BJ;O+-:54+]^+E ^Z![F*EQ
M.4D$4[$_R#YK)UE0;9HQS<!SQ,. SB<&OJKF4A_*5FN0<?*&!6YPA=$CJ5W7
ME"#Y..OEAS+SS3'M+1*-.T\YQ8?-*>X\Y13_RCG%:PW'RT=D.*ZH>(B4,[59
MP.K6V197Z-5;)$]9)JN:@]\]R/@"9PD;;+5VU,I2;%BB*.C($73T7GS?&UL'
MO"Z:F5TP+9CB[ =I7,"0,'I5IEC9M+:D1&&IH2@B#;!Z JBN !/E@6F[W^AO
MY !W'=&!>4.W:C8]TQ86"VJ9*)/H)M1:W840D[T> /L^=5K1YP-1K-KAUGHH
MYVC:([X5MO>1JG"MC/>96N"+ @\7%CA4M.,FC#@80@/.*@CR:RBE2AO*X#IO
M\=8GWENOMLV6P+>P"@)A4^9C;5LPN!IQEXZX;O'?''"X3FF]6E2E=1WH!=YS
M09U#@)4I?U!EOC)R;(8HP[&-3AJ*:30XV7V.#3?0*\2H)&!8X$W#AX<L1*:8
M-A>$4,C>W1PC0\6B#UP(FX Q'=U#]3$@D<)@4I3U4^PPB.Y7KJEV.$>'C2).
MU?DARB=YO7 LI]4\E%>QL9QRU0H>+^HX!Y!3$CVO<H,&5%3=;"_KT4F'< B;
MUB"?T]W,U16\"$S4)O5AJD8E0VT,J2UMG*<*BU18XYAG*:N&CGW0ER]35*N\
MY6+" RJ.(AS4Y\E)+KA#G1RMPOUCQ4<3^2Y<*6H/F"RV>.,*"=J_/IXHRZGP
M!XEAVR2XGEW(< J/G)%-0AYT%@7CZIZ1JF/T+B+G5&O5D$NLJ,^^TA_H.!ID
MJ1)IB14D('(<R\ 8!9W^RU+@.,V%#V T?5D.+9G(!03A\3D)P3$.GALS];06
ME31SHFM&6>FJDBOW?-+_J2?3?)WXKH>;Z ,_1?;XFS!L-5M5LF/7[(*[?W0!
MPQTRBX,7E<?B39*!$&R)0TRX3V$D&8O#I,!PZ$ .Q<?#K1=B^_C*WEG8)D>[
MXHP#<J=J/.7O3M90V'>=6?GQCQ*=O6P=<.F?Y(2 2M:6W2FQOK:L7#>6K<V*
MLA$IE!4;EO4@#>- A2Y*K*9C@J[N,IGYWY^C8[#4X)"*CQ@+>BZ'X-B?#-%W
M.#T]O^,E^#:HGI'.0.G^(A$B='52B,.Q6N\(=[@7?)?WOV*P8NL?:SO?O]R^
M%P('G'J8:W$"IAH>=R]#.T&0B@?]<3A1) 7W,?C#*?P%ZJ#5KO##HD;[IS/V
M5;;<0J6&FXYES)*JAC%$Y-.?@10[K'&=").IN4\MP[KB_V[Z[U$RYG5C/:WX
M859\0HKOSMMPXV#W W>_? ;H)WT=[?6N1Z6=_#J#KXE1%X2L<WB(W@G1?*'(
MO8Q\?B:.LL]B9_.'COC KWYXFY5&=>YE=#PL&=L71'0:+XJ8 =^_8-(1 S)'
M,M8RJ0/PL?URO4M?_OB;+ I9$?310I$OY]M6E.UB#74;+3S*_C;$[#137>LV
MT*_H-1 7[;QX*<YE_@E!?%HJ_M!#>4%(?NOEBQF6_%D7T4 !7=^7QG1E.:PS
MY3"U'_^8P'"/E@?G.$+-,)(#EBL*R[@-'V>@6-(0@V[4 KE7YJDV@RK05464
M;%2U$5Q"U(D<?<>!^'LCVFTR\R^>,O,/FYE_\929_\K"M9A9^'\\OH3625H.
M7:44@35%![M,U5Q$-:X8V"MF&_$$F=+6;$&OJO3"!M#)-,AH62#!AQ!S6YY:
M/SB<,]+(R\CE5H-#NE6*X"GI>BV/?K]P/-K"E:_Q9(S*T=I[3JSQ%YZ%[ZK:
MZ::>C.@(C^IP^K ZFU.E!FL)1/?R'>0B3G91^4$4C-WALSC^H/4$.SV:;%Y)
M>C,Y*['04,,>X@DW+#VQ3;K"*%>1]17-,@QU8?[-G76B@R7RB9=;>/F'A>/E
M^2Q]Z<Z,<<G)H<%P:#MS^U-N6&?3J=[_U FU'%X4](S@-QO,U$XM+V$)4U@Z
MH%.,P%JTS-T$N"5;(TV,)U*P-6]]VI*GW5Z2M-[2C"IX;92QKR (WLG2L!K\
MBC(2)2I:=R=\JVG:<QZUXQHPRNO@K998H=0^ZR?9"=_-M+DXPM,F+G@,T9YE
M9"%YQ_:^<="RR3_@/;NR&YV.@4HQG^ (&<:U%L9CNO1B&#K(X9Z[O.0JP[%^
M(Z/B$CSHG*NQ+=5(Y$0 (/+E[=BY$<_;ZYX89<!J7;1!U(&,#JK@4<^!5N/P
M%3=- :(S2-864;E>AT_,<,L"[K\]'^"(6G\#?"\"GN7B\C<Z!L5HJE8_5"NN
M;)'E)UD)9&7Q7F36(C*'>$J].G_1CIC<:V- !(99S-5&K46G(;12<T\O/K%)
MR":+UUBRA4W>V.I80"!ECC&Q\(AJ6*L59^'AO$ZSSTCL0*J]@#J.8(D7:E-7
M@HMO"^+S950E;4(D8CFL=C3-/Z!Q. ]A$%?'1=S=1Y,G./3G7>,L*NV%-E1H
M#YFY@*'5]F  IMC;@HKG:DHZDCD6C9=%J*8)/434=T8;/M WO].C!VZ^W7_P
M6H9K6A8P5'H2I5"4%N\<>/L1N$OJ%@  M(I,5*&31*;]$L-AI6F-DCB@8=U%
MEJLBO#'"WJ1IHWD'I335YQ%57?#1<?NJ6.9:%K(TL_U5J<,,S;(6/W&#TZE@
M=%;MJ6<?9O_F&/(6H?273Z'TAPVEOWP*I7^SA]RV%N]X=(M1.-9FA+#F0H$P
MEY5!\'VQM]9_<*#@ABY%VE ?+, ;N6N^Y"/H[A5XZ%YB2WMT6XM!Z/G9ACHQ
MS\?X3EAM_1.^.5U_+9\MWFG*%C[["1L_46C@5$[NA<5L8[@G%OL*++9 9]]:
M\R^4B:-H5[B!B&MKK<BN[;=5=<[#&!MP$'V.?^7<Y#:NO0QC><E')*A]7*&'
M'*C6^,XK_VH"U^#%N,KA(#)VJ[<6=:Z=M7WGG\U%/C%MR+0+E-]N85IN..)W
MTO#A<NI+>4US+)NNF)..X':Q>-J[X-=D^(P<]1.QG7/H@DB%C:A;7@UN7[QL
M0R8(@B4WW[6-1ME3JYH$7=.GEIZ&XL%OEC+\_L-:,]2PD1T[A)',QVHM*V'=
M+%_S+P\3E&%#0@JK(\.@J\!%69C1;,1JR#\-L[-M+95G&S#QNW;P''<QP1XM
MU275^XN,[:'JFD)6:1^[S]REDEY,5"V(7C?ME^H;/2)=\=4?C39_=5+;YK8N
M%76JBB+DL@X=^8S%O[!3V=9.1VQO;F]UW%+D, ->X.ICK,E=7OH%[BGI#23T
M%D"\B(IU?=]U[K'M.EN[[H>XU[!HO+3JXIUJ9$K_'B)LMLS'B .]&_8790&Q
MC7"#4_^F:F-*V0(;[26*NI"6([5+ZP5)/!UVW[)OK:3Q?9!Y&E9J!(I7<9.@
MY277G+>:$B5#0(T!U^3!BVH<XICABUIOK7#"[@7N=M?1@. <F5!#]THV-U%*
MF7(+RG;[\&000H.P0,4D+0;A/,_6+F0AP15+%&@O-@CO>IUZ[PKU>:3S6JRV
MWBOZ>OW0;!I:US4VI5>3O$:9U$3B6X Z8=\->F.I&5D1QEI6X'3%[8TI-M>A
M'@,RY;9P_,I[>K$L-Q%DJ\#--/20WQPPIYE%,_I8;[#A 9F3(NJD5<7VJ957
M5G5IK75/#>@ ,C6?AD0%F<!S;B"%.U=&]I?E$]634\WT<=VR-MJ!9[WPG1?K
M[1J.Z-+AO*AO2.O)8DD2R?;^'ATJ@>_57F7DV@&$=U)W$5>A++D[] CWDIJH
MNT0%?(Q$YEZ00;42-W0!FB-;%V)K&S1AF3=:LM#KDW""M3?9FEI3!6Y"2&3/
M*[+;7OQ,=V/[[^-3Y2?7'.=)#89J<('JD%I+/ O $Q6/MC9=JJK/N!LL-IZV
M+53I[KG=B&;0:7O[> =F08@*+G9K=$?B?N38$U+%BG$EL[,M=,)\60;J1&6E
MJ7?D1'@;Y D;#7[LVW:J%C\ S@ ]5!EOPBE8H->$[/R^N-J\'S?;<Z!ZLR50
M39^UA>C_Y](?VL5@M!%OJ&7(_]X1'=RPC25?GY-Y]923>=B<S*NGG,Q?.2?S
M[KWX^.[J_<GEI?CX]N3BY.Q-K3\KUR^ OJ0#650A$K-)<.BK,@VV<J36U;NM
M_;EM.8[-J[AK /S!+8NL]2'TPJV8L(XMXD(*V<W&]_PF[#DZNM(5H6YHZHZZ
M5%0*X79SG:MBGA'?7J](GCG>KH1SA"UTT_[N+1=>$]?J8:_/<,GO__EL^]F?
M?G -3=&7[$AD.0AP.4*,+W&9^T?M)YW%_L:1!T#UZ7V%M9)J>N04;GWP8Z*-
M-Z,O-[_[JLOQ#T8;>C3=_<H/?0E/!4R^83;$9394NA"7.AZ4B,F_[DA;#;H\
M--<NQ,,8N=0)_VA%8)$)?:6+!"C]^N3L+@ELX>&]>T4/Z9'=*0Z<X_8A;IL-
M7CY/8VD&>W3%\M(60K/M.W<,O^[JZ=^=N:W9OL@-_<>=.I]S_)5J@O?G(\T9
M\YZ<I/:6%$]X^S_"VT<';\].CT\N=ADX_]5,XA-BOEO:G"1:G.K$'NBWB90G
M4OTEV>@OX'C]6Z6I*@;B=8D-MO_ZKM?7X%OVG)J4>[1<?(>4LJ[/9;XN?CE'
M4%SUBE=CE60CSL$]>47?@E>T_1B]HEL-<HTG]/V>..,WA.^*4RQ06!S'Z%Z=
M%$^KC:.SXU\/\)>W5S^?'OP_4$L#!!0    ( ,")>%88LI^-\XD  ./J @ 7
M    =&TR,S$P,S4S9#%?97@Q,"TQ-RYH=&WL?6USVT:6[G=5Z3_@YLZ=DJI@
MQ;*=9)QD745+=,Q96]*5Y/AFM_8#2((28A+@ *!DSJ^_YZV[3S< DI*E1+&]
M53NQ2!#]=OJ\G^?\_/K\[9L7VUL_O^[W#N&_$?[?S^>#\S?]%S]_R_^%;[^5
MKW]^>7SX6W1V_MN;_G]\,RGR^L=H__&\CLZS65I%1^EU=%K,DCSF#^+H+"VS
MR3?P0_CIR4U_]U,T2\J++/\QPD<?_Q35Z<?Z43+-+N"C,KNXK+]Y\?/+%_V/
ME]DPJ^&%>_L__/SM2YCWR7V,.$KS.BV_>?'W?%C-?[KG06!=9^]>GAV<#D[.
M!\='4>^7TW[_;?_H_$X7>,^+^7U1U=ED*1]F^3C%ES[>^R[+OWEQ?IE54?L:
MM[=V:OSV[]/QOQ;%3S^_>W&V&%:C,IO769%'O8LR36?PKI^_???B[R4]LQO!
M\[1WZ3C*\KJ(X,&W23FZY!7N/XVC)X^?P/\.EU&2CZ-A6E^G:1[]LW=^'O5&
M_UID549O/RC*>1PET4&RA-5N;PVJ*3P/+_^8SN8UO'U4S.9)OHQ@CJF:X@%_
MK.<4TTCX6,7S'Z9EE"<S> D,1)_#/B7UHDRC>7*1\E0O80TP_YW&ZN'7^NU[
MGP49O'_=/^WWSN)HOBBK19+745W0OFUO+>:R2W"JLXKV$O;Q]W2$S] 7HR(?
MTZE54976T:0HZTLX_9B^?+FHLCRM*CC1V3"#;?9H)X[&"9YF4D7%)/KG(I?=
MW_^>".4)#9=4VUMP7##C<30IBUE4PYII</QO0 "KQPOH8E;D%S1+(9N8"?%M
M6EX C<"!.Q*,A *WMQHDB'.\OBRFTV547.<I[4^5C;.D7.*JU/LU.04C^3,+
MOHR>_'$3B9[X4_FO19E$+[,B>I/-,A@-9S+E?YJ!M[>R? 07MBCI,!=P4B6-
M-DVNZ6#[^<643A+^_WTR!0I6X^, '@_!I^RHKXOI.,LOJNA-/6YN0H,? -/R
MWTPO&!7^FG!N$]BGXCI# BB3O$I&3,$[(_@<B#N[2J=+?M*]\-P]Z<WX.IM.
MHV(T6I3"4K:W#J9%A2\_A"V)=H"^Q^DDPS,9IC#L[H_13K;+M![N/[ULAG_#
M/^$FX780+U7+B?DK]0G>PCK+%S@FC,;LKKS*KN"#[2U#(4(%,QZ-CF1#BOF)
MGM[)S*RS&3#0#!8'/U5;B7S";1(LFEDFK@".)C/T)'/N7&H+_=,#C<]7+3MJ
M7?7=\=<'P;"S'+<@3WF_<9.VMW"QBE3CR(DN/)&LA!G!)EMQB"R;]AZX_^@R
MJ5)ALYHQZO.>EQG\ *5[22^I06!D"1(13 4N00DSG<)5Q-FP].53NH#/(Y0G
ML9$;U6(V8Q8M9^1-N[Y,ZBA?S'#>\'U1 B= RJPN$US"#MQ(N9O'YJLS^LJ[
M[=M;3BIM(/#]&V]W;MSR:E$LO$G"WESAE9]/DQ&)G.@Z*6%1-3#L@ <#O5:7
M<.UP5C"4:- \FQZ.HS@I<*7%+#<34[/JS8H%#(($=C(XZ>NC/BF%(=/,<7(G
M)^\KF3R(U+I.1I?PM:P<%S-+QBFPA'E2UO1Q,8FC%)XB)I&:I:"*E]53<^'A
M*YDF_@#IPM)1D:>1?S9$:W_;W]_[[G$T3TLX'/HTV/83V<43NXOO91>]_2>Z
M=:/!WH]HG7\#*^0QO3]J?SU\\2X':T5KM-M;)_A[-8!5'),+4" N<$+P\FH!
M^]'ZAHA>P+,"QM:@'7I?]]) -!"S+M-)6J(&#3N)>PI77%A;ERI.--"N\QIB
M4_<^JZI%RHI<"M.$3Q31X&_<Q+>W-ILY<R&0'&GI7><Y2&M\4/YLF35: @6)
MS6%ZF4PG^*B>3B'B5$FASXN!6V8JFK7CIBBV'3ME 8B["#K/:.%V&0VX5L,L
M]@@ ;HAOFO%]7_*'_%&EWY.8]U1D"6KJ.\:[WC%J%5P@F$5QD=(/9 5K)KS.
MWO18  L9,-C+.@$B+&B<9#2"59*&FN57:547916R &\)0&GKINV>[)AE\ Z4
M.]>7&; *XKUY("A)"B4S:U55RL1:?:K1#B\2Y X+LX3O$?PJD(+ZT@)S:]Y:
M./&ALHK'#3U@C+<3QVCLUJYG*D:\4N*,;L>!]0)[(3+20@'D($]\)"KR6!AK
M(/\;IKW2J#TI$"Y[]4FW"'*0A6UTFC9_%)Y]SPJ&]8K""O;9-F,21^N%8/L5
M2U>,UKV&S:3N]A:1B?V5SS2(&*L5FZF9?XS'GA=U-$6+G2CZ;T\>1S,P"^"A
MS\.U<G3\'EZ%W/[5\6D_;HA*JQ;"KJ87!1DR(KMGBWJ13*,RG0,]P3OI>9B1
MJ&&97/%1<97F?+(KO3.QT290&T_0&(V-Q97F8U(]F"-,X6"120WAC%@]'(HI
MC(HA#BLJ(W\E5QQX&!N"U8^?Q<']_.KXZ-P,1P^090O'-/L1K!A0+D? S;YY
ML;_W]__]CR=/G_]TI__Y^5L<_D4@!?$>[H%2YA^Q\\PI5YQ1WY4R)<=E&7YE
M&3Z=8.6I[F#5D/H@7+?IPHB);?HZAJ*'M:IF'%G7XGHU,6[GQ^RB7,WOHAV2
M2SZ;0K*O4'R-TE5:A^?IC<Z;2TT_XMVL6%F3:^CMZ*7L8YOJRP(2+MP"16WZ
M<31=5.1WHG,)Q2$>U:2V]J"RG8WE-5SR7APH?V &\[%.';RZ.UD.X^!U)U<,
M&U'71?F!/";)/*N!Y> O6<VP?CVDC'E1I=4#9LO?N*#,_WKT*'J5I=/QC]$)
MV/@_P?/_6J1PW/#:Z-$C";+]?#CXU8S);WI4%W-XY,F\-N]^-"SJNH [_SU^
M-BQ*X-SVLY= ;A^B?1B\*J;9&"9PXK^/9L;S^OE;&*UEX&&9)A\>#5,4 #^2
M1\(.39/YOF4N.,'-!U.;\2WN!F_ 0SS!>^#/3^Z9/PN')-;\<*\&_>]^EM]@
M@W>2W?O8N7.TY]M\?QZ+;%?^/:7:LL^&=Y'8EW+'1YXW7KDRM[>T+[/=W%[C
MIOS,SGQX+V?>J[>WIFE2U=$$!)P+"AXF2W1[(>=C6Q8.<I3-R6NIS\QW9?#!
MC],IO MD5YG5H,"B'8'>-]^=U4Y&VUM']+!/3O-T!/M"RHZ)<JR:4Q 0P4>O
M,UA'EE=UN9!P$@I7F>BRC<ZWMT07$%5.EK@7'171-*F=G8\:MK]MK R4Z2CE
M:(>F<UZ>I_SYF^8/M[TEICLR3R9T4/>R"MZ>5$6>#.$^E"@_*_:IM(R%GY)H
MM+J+.2VK!G9J<.N<%&X5>\T5U==%M/-$#F%H=FB,.V3O-GO-X'P;9\B'GC56
M92@D[MBQN%.I0_LJJ2ZCJRQA>F"IY-Z0C$:L_74,+1NZ%^&E49^WW8$--[9-
M*Y;9J/TD R(!7?263F V'L&(S2KC9@1UJ?B 'L:2=-I9'$W(5,21@!]0Q 17
M,\U2N"SH!R:E$P:KR\Q$9)V_"_>C0-NDS&BG3'RDVUF&$:J:_$M F"G:W%,P
M18#+9V3'8H!Z-S8'@$DA@?]Y!WZ'*G1>S("PB,KQ_,HQ6@[B?,3O[1W7MW\W
M$L]N- *>6X#,H8@H!9_8MZ:M(;AQR7P^S49PW>#T!SRG] J78<V(%F&TO:6M
MA'&15N128?F'$\Q6\8^5'&X-B<8!#R&2G)?P-PK0G>&";D->R"(VXF>?,I]=
M()QZ4>9\;28+3!"H"G,VX8X'-QJ_].\KC*&CGLE5DDWQ;.3-G=?9&^4G5#&*
MJPR35_ 4P>K-Q=O53;7HJQ]B7M05R.PQNHO!PL^8:K3;%:U5COPR^_N>HH;&
M\L_33&X.3!GFOBA3%X.4C4/%IU-16K/=<+(E^WQYVY$>9=.)$G8^&M%H9M]<
M-,@_Y_W?61HVGL*AI3,.@0TQ(BGS-_Q"5J'<'?"@F9U.0N(1PWVB%)<8;^?.
MOV5(8C+7&;JG2Z 7H%@:"!U>2S4JWO5B"(I4XKPLQ(60B1B[VIW^W\L*E0O]
M&YPIT**1*AU2A/P:UA=S*P8?.' RGY_HR"!-!7Y C@(RD^M0&&UOO1*Q;MP
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MO9+@Z!146Z0%.4?+9<[J8O0AZG\$=IU?^.DF1[^=]5U:!OX%/!XV9@1\SOS
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M07G'&0+<7]@5YYFF%$;XDA8RPDF;U32%PMK0AQEZL_50@:UM/+7L6I KADR
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M%E#T6R KK:N4WZ1X8ZTF[H]S._0B30#HV5J:+N[X&&UT"S*G.^8\3<<8_:5
M'-L>C _!&**Z5%>ZOEBPM' TU2JRO?>X*G]4ISLG71//[6*1(<QS[I6I^D6/
MJC#7!TYWN =\,C!665R)AHN0R?;Z&Q>^P=%/O:)%@[B37<DPXR(UD'3CR*(O
ML[*8KH9+UK?7;@)B(==L3C[B^MS2MKKD%Y%'SZ'WEJ9X%.&4DVN&XXT5:$+L
MHQ3SRQS^.B%7,]+P-0LXAB"6*"QA7]6QX.J*TU) R]TIH4E=X_':=@544]PB
M*3G>V^ R6&B$C=T^ <II=>5^0RZW][Z^D1M!Q#WH+,3 +?G&D>LKPR@^.QJ*
MN14[L I1?C#(L0[F1V$R9=TC<)-"#!WXQ>@KW_]D?W\?WA\+-K)[]TK,LNI&
M8Z@U>)!2]G+5#/0B@&?$W4EBW7J8?^X^8$/L-KIQ=B^ZL?3&G!8YU@U3X=Y%
M2GS#(@IT!BA61&W6A8),K)AR(9+I\M\21R9)@LDQ5ELC)\Z=JZ3TR#CEWJ'I
MN,VE<@/^(-RSA5M2S6?#H]I(UJ-?T0S@#PJ?L^(C(= "]Y;Z9, &(9Y]M^Y)
MNP1?(_"ZT25;9$]S%]>YI[:W#-ZJE'-B7@^B/U29ZW*AQJ46-P_9&7*;._C[
M/=[!3=,\\R*:I&/2H$VVF$#L,\P@QITEPX1<KF-@HG*/Q,H34;@V)L7\8#7E
M(R0FM:Q'WV$F#5?)$6KZ\G+&AY&@DR0KR<8P?GYEXSQ<6MG0<?;D2W:</?GJ
M./OS&-.'>W><2:C(-=-HQG7R9,;IH'C1WP#[)^&#4H-$QF&*F0_DCSA*6)5D
M[O9R6HP^P*<G$DA-QL X#-R:)*Q2T=TYMJ58( ;-(6:@$M>P(NV8 KLXY"MI
M&]KCOBD'$BO><6'7XU>] QUK-;$ 8&)];C9TE4;'E(0F_=]E&B? %MD!:-JD
M-[$1P^GC8$%6]50VQ_0Q)_P%:^ BHIY$D>&!V6)ZD=3Z53BLVP ";,*NZVF)
M33^$9;OOZ1!(2J@-@#TA9D(O/DMR<;?@H7E!:)YW\ZB[)DXF)JX39PJ&EWDQ
M/']1)K.NUS&:I^UYP\H/PR16#/,MWZ@\8:((#QW0:XH),Q&R<D8S_82!Y()C
MEDQXBSZHS:R6^>+Y.5(_H^0"D,=N(P=((PS%P6XSM?=G9P./]NBFS#!+.3$X
M\K1[/H*2TU7-]^S453NB(:I%IA]2C)^\.4S(!B0P)//]I]]__P1_]38!RUD,
MP\=Q].3Q_K-8"AX<_=H0=S<5Q7YO(;-SZ",?V_H$ZHZ(GCCY*Z9_7V7C!7$,
MOI5D&EY<H)>P!@+_[C&>QTA\'+18; ^3<%LV79=A>ECA[9_2QL7>'DGB!OIY
M5;0271DFW=UR.T:"(^O[RGYDVSJZ5HSX%Q MJ.I9=8E_")PG83,)X\ V2"4:
M,G(;1ED-K\$<F5S8HKG$KHV2CK&230;;CL[=*4X7=TS<U*P'%KI#%:?NU09P
M#___8#%,#"1"B=+HB +?_PF;DL TWBZ3'"12'/V:YNF_%^DT 4&U++-$0O,(
M_)40N!UGE[[[4"+E\K=5\0@M!&+GQ1P,<\.?3U..PY+J]V9QF>1@K>!-/X0S
MJ=ERD3>1C\A1&WE-&(\=+D&949_==#8$H5DP U*70'NBZA)54P]^S8@3']QN
MYZKSKN.I*+%&+,1GKH[WO@33+%G@9X-\#/*Z9%9V9KS3B@F\')QY3. PS3,E
M O$* 9/B.T-_D#+^#I3EDETRQ#7\%[:Q[YTKQ\9:!'#0D(..%XBC(3M/%6O<
MWGJZ'QWLO=H[W0/]KZR-Z^4[HF<8T(UH 1WA,B#<4))_L)WFN*P%/L'_5FF)
M@9M*\0*N!6E[@Y].K1S?]66) 2.>@]]KZ]3)5MYC+]7*,WK%UBI,T0Q*#-->
MDN,W>,O(3YU-''"[@%HBDZ'@#:P"]'@*OQG .G)!>["WL8:%;];P(<NOI?'6
MN$#HU@9\(+Q$3Q]S/JTKAH,+$Q/BC'0NM77H>9"%</XO<8N!9&'^2T:PA^/&
M(SC8"S(YGN[O1RE8)>F_]G89LG"&\11<INA&9[WHI'=^.C@^9SS-"<B3Q_LV
M21YKPFA+!<K68O^N3)A_>=;[5KW5I_=@%[$"@P5K9<,+-#QL^R@=+TK*U+.]
MSL8I)^=RTA[,3A#ZU7ZW-<6%3?/GY!/4M"H:QQ*ZE V)Q'A8MYNS[8L#1Y<:
MI%.7HE24E>NRBL^1$D'Z-[".AJI6:9&#KV[<((FO*8!@["9<H7MJ-=XSHM#G
M*L GK%PT,^E!*&]75.%MJJDY794CM=D>;V_=D#!DC=9ER$W9@3V-VRI]!.MQ
M?;7!JIP 3F$TG75IH39_:\AJ8QQUJ53D-D^:Y[<7<!L*;8&U+#=-.C,:F''3
M,2'X5JDHY@E2:H+'I"S4/&(0;AFCVY=!'H_YX<F^!:0]3"?4DO.D++#>A;+R
MF*GL/__NL69 BG3;,PR1'CN9CZA*T8[/=@Y/>D%Z;G/[G+)):8)@UDQ3T6)1
M8^#,T34;W)3(,/(#]HW=QETQ_8/\J#9DBS441"%"2ZK!/?,9N/$F(/GT\:-Q
MLC0(K]D,VS5SJ,)"KP:O"*,;.&*J>@O$K,W*N<^!&)$37253CGHS**LZ?](?
MT-Y#NFIO0?=]\FA?R9_^1^X&:F"KL>%)S8%/!]#<6A.BLA?]Q.4]L J:@5Y7
M^V.HT[1;]9JELN:!.L=L,:VS1YQK[V?77*67V0@F>"T( !5JU=1O!.8^ 9Y<
MV!1]^8?_B*DN:\LO8.W51&Y:7BB8!,805?E5L@LM136536ON>"G]@P0OR::-
M)AESC,?/4U;9R,FPP,HC@NNDUEDH1Y>M=8HR'AT&;X#9]JXI\SDQR '.HJV2
MZ,:E<FWR"^M8K3>O,[?Z 7.Y#2, 3[_D",#3KQ& /T^DSNZGK+[1C15=>5(>
M9=OQS*=4;<$L7YF3YUD-_'V #*E_.CCKH4F.S\8<R#>>O@C;U95B6[MF/])A
M0;?D:1G#!_Q__L-WAH$/\#*@B^,4^V4O4*Z-4]86__&]9ZX&BAX^U_2!NV5C
MB5_+NA._ZSE]M[-"M7VZ\_3)KMT:<E>,+I'1;O33I[ND%[O?NMX9[M==-1C/
M,$?FF2W"D+>X/??6Y??S\I6 :+BHT<1>!IYH<FI4NM^!=>9)[)KMO)0=I-/8
M3=].PJ3$^:JYH(E4H,Q/$X&99HP2&=!MB\/@&:?V#'6\@:;&E4]&82#;U>6>
M%&)(6/*@G>&'K;G#6/H\#29NIF'RV"GRC7;0YO'=4B J/4]48Z=U,TH5=-&M
M;=1FZZ4W+H8UI/@B?.(^D]Z2K\@!\LN5<NG*5'OEA+E#.D)'13L:4G ]-?K"
M"8?)O!VD]")3-4=J">RQRG>5#66'JDT=E4(WS#+#.5$:>=S0LD(, >XMQ]DZ
MF--XJRK#F/-4=>U@RQI%!90&+)0C1*TP;'W>ZN4VED)-+9M+(60B;@F'GUY*
M%RC;2.*V&N #5NUN(VWS>Y&VO9K]I@?3@@OKU.VBA&.R6JH%1KHSRBXCUQ,R
MW&2ICT;TZAF)4MVW*.R0\P0D =T>(PH:VOGVUE]!/;_-&1;W7VSDTK:::=/A
M43S?R=8<A2Y"U76B>/NH3!8%<6EAB>IF^6N(_A.UX!,%H#>KJV$_,Y*8WPM)
M'!6@,E*I=DPY<MR/1]0A&Y)Q^ =*A'DP@UH1;^+;K#@ET82\CGA4$E6C3DL!
M0?'!&#"3!(AD*6E[([#,:L[P XELDCW]K-'/BPS^=2]DT*<>>:ZOZ)K2] !M
MKJV]61PAPU!D@=5LJ+&;NG;R/5.M3@A'Z)7K=V%R8BOQ:9+-*J?A!GXJ7?/?
MYI)*.<U$.L-B30^82,MHC:"Q^H3M6JIPK%;3<);?(RV>$V;S0?_-FY/>(;8\
M^8]O'G]#?Y^=] [,W^\'A^>O_^.;_<>/_\\WMYW!.N?-^:EY,Y7A@PEE*!M^
M^,T+G.NA>>(Z&]>7EKA__O;\\$7WM]HK1'>#-;^BA*$7<TR\2:KTFQ??[5F7
MCO^Z5@1QBK_K1J71#?ZOLQ[NV/3#E,\&%:@Y&*)]A]*O+X5^^/MNM92Z _(:
MOCT_Q?_!(_Z,6%ER/^T_-*"JI^5(O\UGWT4C#&^,P78<)\M*T"Z[[K2'J.>;
M>Z^XWN<P3<98$!A&^]4\2$,&J]$UHJ74' 9-C79\< UK(2$>#LRIJFUA=5ZE
MNU'2U0,UF)Y/UV?F,<\B->UV'=Q;>T5::$V%!)X9 B?U+E4$WFI[.=@/UUS=
M[!4;DPB"FI%WGC*8.$W71KU3[-*%^&QD"*+E@6_0"X[L>M&4G!(FK&LB2_7;
M H8V+_%T.8/"D8+4<MG<M.&"RAN0FRL(E^\?UY<>-5&#L?TGC8^S27CHH'-C
MME3E$XJIF":"D:-D;#KCT^E>Z*YJ8H9/!>0I(%!C<FWYE-(W&X/E#]M;A_"(
MII*?;"90#%;W=7J%VF((">-PI%46BO)2==-3%RUM;VU&3"Z4(V&_#CH0#QH&
MU?%/:X@HY#O,W<BSZE+J0:_+3' (?,.C 1O*9>)FX]4+X]6!3)N:$<[#7 I,
M-29',*/7D)\LZ)9YKQ=5U9&YQGP8$K3I)S;)+,!OIG04HBMA+.I,5LYZXQFS
M0V(=M@-/FI4]@4ET=<LMMHJHDFJVXKPRZV)+-ER_! "(QJC2-6%=$@$ IG0/
M*UP..JW81C+N2SC(A4DB6A?5YFWS;FN$ES6:P!J!MI"A$;OA2FJ3.!.]-.@)
MA\G2V7?C9.G=8L.9X&>C*7;D)G^C0[7N&-NV:Z14)DH7+/AH<O@D&#N7J36'
M+$"Z>0/N1:\DD:JMJKNY+>IU8 =<I00\H ^.DHW\7&7TIS(2 %U3)CC,Z"\D
M-VJ81JXCO4IJZ!(U[)IT^3Q\*'2[^9:Y/(EG^S8>%/3V=E:8%L;* ]TS*>=W
MPU'=ZU9=)KH8'>MF&C [10N0R=.O\@6"&.)P=B@5N[O=[=]XYC9:A&6]4V/]
MS9*/V6PQV]YJF=NG,J;-IX;@>2J7EDI4?%K>BP;B]R"2YEOHYMR8:1P=TYUI
MA2[8; 4V&+.F1ID'6K7QX?U!NJ#DNC:>R+GL+2)<Z:Z.V<#K%@@4 Y<U@L>2
M*)D5>*FG4]ZMEA&0HQ32!:%B48R*H2V%813!29)-%V7:E&8$A;!2T92?A'H7
MYV6)+%QUB^3WG3R6<BIK6T1$ 191?2V"*D>K AV,)HY[[^1QUT5>V[@>S>MW
M+QZN4\VW0#GO9,,,F6=?<H;,LR\T0Z:=7AZ >V1X;\TH=&IDJ)O'!EK%\$2'
M<4(5:S9YGGE)4^W7(;U582)?-R,&%[,<4E:^*-=4H@9?A8#!KG:?,O,=.MF&
M*Z+4=K>FO:C'@%?B:FFZ)1Y\LUVDG3\?N255X01.&*:%!(:45T7DL(HHGZ-"
M^+-(Z<V4(RJ8=7#0:'JCD,74=3:SV@5:C+_'3EP;>9),X85Q!F*N00&CI9Y$
MEMET#<@H=(NJJ2IH1<94R,XETU]L?I/WY5>'>+" NL9CE3:!>5]7H,QP:5!)
M=A*9@^;#V-BLN0$Q:_4J>N]I-TT^U?VP@<8)!PG',>5=24J$>*.#]S"M*._=
MLS%O/K.;>YTDQPQ>@ADIIJ;CJI@N9ES0R["_R)MPS[1QJ)FERJ!_]HS:1=CR
M^F[L81]QRU\_$<<]^UC8^<K=JA"Z'?.5:!LZ5Q:Q"JYDQ.JKY -_;6_1&JU_
MH[XNHB70@_;B2XK*@P_\WIA7WP^S)M@L;8^7E(&*,I#@%1<5=P9@/*5I^N!E
MX&:[NB^[NG\OFWI]F9(SKH,W2VXA<7L6!]QER"7]H<DV;HL6W67=P /8_B?W
M0]/(#*@!I_%,<9<<#+J,.,&4V^.XVIK:H1"PYQU9(BJZ#9>,3:L%TT;:@8G"
M8IR3J1]/D>>[:8$]_7#9K'M<P.U&:<JP55:3$N_%9T8%3^^%"HSXHM.?UZ&E
M(MO,@3@V#EH31?APS<GC)YY!T:T$*8^;1>R[=?Q%XFAC)M2,?>6D4 @ZD(<W
MTT)4^ FE2^44TFH069/&4/Y^7G3V[%[H3!+C;9A09;VO:]AA\.Y&H-:5Y'"1
M<R%O+ROY4AM>B=_Z@Y3/XU-<65D9$N@R-CA!W]A.52$)$8DSF%U46/5X-91F
M6EH _YNFB01/QHCZ0!Y)4&?):&.X/]N@-)HDN"<68$(LGIHT6O-JF%D3\[QC
M&CN-JDZW*%OR"51P69MM'67E:#'#N-$((0-9C;;&P9(KU3'/=#=8WP/6'3?T
M97[W)?LRO_M"?9E_+H]%#AM&L($K8=*52Z$@& *\[&%O6#]OW 8\8JS!1IN2
MX7WQG<H!:-@7AWLM8HU?G"!8P88O(9A5D4OCG>XD#JLEU*YID^>4(=[LX()$
MM0S;&9;M+)Y,69ZU06Q##K<?H@692C@NM49/@T)RMRN*;K"@!Z\YWMPLOBN[
M^":N0K$?<&.1PL9E<IU,C5A>;Q1$*VT"RDO#!#5&:+*Y)BI5[?,[QJN[.L6Y
M2;GHTJJ\S&PXQ$:($VM0@:K@]KFJ%[J!&#Q UW:TN6=[>ZO-M:WZR/ ')E5L
MT=1M;N#L;K)0R:.D,,<ZFEY+=)A8,V= <3 0ZD<JH=)Y,HI57FDN/%5^;\,P
MRY2/0ZMT1<F1:\>&K3)I4K@\99841?8#2CJ_#W!45I;UWD6&QPV,M=B6J)HS
MQ01/%$2U39#$52*8X$(IOWS:GD9-S@M?Y5;"C1_95*4V6O/V5K?:''5KS7&@
M-7]V/.FN6)*TIDE(P-Q!YN,Z\F-3RR'!2LZ-#1VD LE#MQ'VZ4-:NY[.7ORD
M;4K-F"\% <AMR6-^?H3P9Z@8"29S!^6/G O.U4\%Q0&=DN?7X'7'53[#T_GD
MXYD0K"OHXI1$YK=H*Z;CJMV[MS)<6:6;'#(+.')14\-Y"9H7=B9B-'&GJP!I
MZ]FSG=&N-1JP],#_$E28)]*MW2(<[J)V$CIE@$(JA&Z-#<X@6E&P(=.IRF9F
MS$.[B%&!P->24Q%$J.F!.LAI)_+%O+QN=VD+RT%X]]NQ00924?V05L0D6_-P
M=SPLP.TMLD0W^2%WC=9Q<R]O9?<OX5F]Q2V\_36T:8TQM;F]*(HQ9F+6E[&E
MLU0KI=?T%;=6_"!9QHI2#8)G%6;K#VU.41I 8L9A2SJ6U AUYSJ"K.B[W*QY
MOK.BA^VMS8G^K^^Y_/Y+]EQ^_]5S^>=E7([N"6+!<XD2WB;Y1*/0);HN6-2T
M[K'J!F&CIH+##48TPS&!=3Y'T)Y6QQ-9?*MR;JA2AG!\<(KR7]$9R-Q4ZA&:
M@-0<%YT-Z^ICBC"]#UB;-SL;A=_Y:#J&JAROK';-)DQ=1R[>-I.9UC&R3%.0
M"[11C5%]SSU12)R?H."<8X,\/LYM(0D;U\4"*_A2ZE'*B/]^3E:>7A0J!AN6
M&"<>7A;;5:X<%#$2:L*4J[)QEI19*@4C[%84X#!R:J$O21Q>XU@L.#5V'(Q<
MZGH2,YPG**FX !&@;*&D=#"&61/<,S4_@'./91,L@8Q9684GE)T2F(RK2S5A
M"'L^RJ,M"8N^Z8GP=D,8#0&E4M<H6(+81!<?TG2.^P5;,*%.%Z8A-1U0D3]2
M\X2A);MLU0Q!&30'CXE2HUI@E5GJ6QW9;S7FUW[&T?J-18IM3275,T$K(LFF
M*X#A/7.1#FEFL=!VEB;$8#,9G3+?H=>P&S"QX!E<+,TY!2L]@RN.W*]=EO)K
M?\=LB?&.J^)C!CH;$AK)B)\#%DM.P(N,>C";JA<>7M7S[T:]/%\0#"/:7NCY
M> 6D9CK,/'I%+LC]QX_^TY@293$O,PJ53^1J3K*RJFV/;-R*"EN?8$XBFG)Z
M39*7R%A[HK(J3YN/OG?FDD[Z5T'5_D;UV'28P/6PA8Q(!9U6W77Q<NX_(Q7N
M('J0J20"X<=<UCV0PZ[7')(R+7L\:(4XTH]C/AQW842DRR>/PV>UM65 KZGT
MZCJ=7J6/9L"Z+P7Z>H^!-$QBCWCWL5P;U'<3BF,IYB?\$'>]A).T70A8G/F;
M'>T(_^07N>HK(SXL<T+FT8R\[6K,;@'KMN?3E:21J3QS8OP3(CJTF;%9L\!8
M!Q-=+6N;3G6S@JK5W2PWN-7?7*UR.-]9D@=2P2V]T8W\D-HK&0A3/#P$.]W$
M4FD;V"R<X/@=SCJR4@-"2%TJ*]O'N?H$$^\FD!GKU:R=]*/M,6#THN2JR,:)
MQ,+&Q6((LI]GC=ZE!;=VZW*0[$KVO=_,A7(J\?=S03;0@1UN%67J&10%[G@5
MX!Y,"Z&SSN8U19THTK3+9S(J2H1"EQ0HI;#M5+;E%1"O*&[VPS*% Q*RY @Z
M^[!DXB9D?RG(E9V2B[-RT:?C7]%%/B65VC@O#*B'5\CKX7JP.Z+"R@ 2 "$)
MV9QWI_$2"8:5*5:-D>ZVK%*YT+\)0)$WA48*F*,+D 4S;:Q)=PC"=D/<TVI>
MI'FR%PTFZ*MDH/K&NV*/7F@=,FR(Y$?E*1JQU<? P4N'0,RPL#&V"BF6W"?#
M49Y_UQG3O;.+.T,-WF&PKVWBF"[/K:D[Q36JLYDNUA4;CG:(&M726C]EJ3?@
M/)N4?3M)R%#_KOK&2XWQ8;FU<(!39/,+UK.TZ3N:.R2&\@D'3J+F'7HM:<NQ
M@0<N2NQOE4XGC]P'DOKHFH1[^B\::T,['H$CEV/5&HCL"JS['I/.^X@:1^->
MV_ SK ?O(6).8*>>96#_%>;<L,<1(A!AYZBRR*53-:K/Y>@2VVU0FS%B!8',
M7Z!/$ZXL5;[ C)+1A\7\K^_E^^%+]O+]\-7+]^=Y^<;W#SLGU<PA;@TI J$_
M8&5489S.<EA)C'#[:+E9,&]@Y#.2TXK5[C 3QF@!<6&&'DK+M?KB;FS;WA74
MJ;BL3,NNHC1=WE.+J$1&FO2BO+XL3&<I?RX,ML<QE%F:&&O+R[/J!, )(>+!
M5I0'=3.A78M$OX!E@A4NZW9%Q5Y/0S KL*DAMQRC)7&_.0-3C))M2D([CAA:
M%#8AF<'*X1\&799:*R(DGW9"M#?R4FZ@!&YAF:?+2K0#$"F@[^YJ6+]&8T'G
M"GA#D_+1!1/*,1)GGR!/D;:R(*E!Z/XI"(O*(+"[YMC6[N-<+!CS@DI,UV<>
M!;"OJ^HVEUJFVVRH-2XUJ8I#+1:'5V\H; _L=?Y8]^0<\5%FK/@$666X5T20
M=K?(4F:?O+1WM<5>;H_L9UW5#G=G!R-U^4 -P9ZR+Z9EGYI[0JKUK4SJ778@
M::/9TV]P3E=9,;4^9;-3[L-FS57SOL>-'F%<7D?(-_9)NK_FR]):IUY["%XR
M+:@S* OL@>PD,85#N!S#+-N@;_ .QLA?,0?4=U@%#1T9,)*:8@6?N[K]\,I5
M<>=M1+(5XJO4/CN3MPKO>WL>N-^E,J=&T KH,#3+?/1U 6Z>T@V-Q"N-Q$HW
MUZ\VY_85A?#A\)H0#VZ *!:ZJ3A34#J^&;EL;ZDLMQN1RVJ?JI'$IN1O/0#V
M=Z#= +6$!A,Z(JCU 1B(2<9-O=.ZGCJ>"[-EAH\.0(&RL@]8'V&8O6 ED/@'
M*GF=%TT2SXOYVLUMB(DZ078%(E/&+O.(0UOD2D['N]P>A5_@$4Q*DE* (M1:
M#"2@K9T -K-&8B6*B_#$*;P%@K+G3#;D\723^2?Y6&X]I4P;X&_C^O B28[^
MJ?&E3@39>>D&"#F(A@CS<>]]VUW"-B0&G*_%2^M&#@O"ICU'J"5>EE H=KH4
M0 F8YX$+W6B;49Q*4A_JDPQ>LG;@?O)9H:HFKKP)Z*&&+W@&>D??QV>/OQ-O
MW;7TF03;];(HL0]]PS&$8N2P;9?13R3;?)-E)$'VHY)*D];\_LT[BT3G;75)
MH)4W6)YU7IH2<M?).HZX^);H'&Z$ZX;HU^ :S80X)/HT.X18-]*\:6/8*KQ<
M=-.C+2"?:[A]O%3A=;4JT:)IM+\5S"FWE:;8'KV5> JHF$?4G)Q570[$L3B:
MJBH8[NUHG&"F\4?CC'.<AS!B]"DG9;U4&*_5HKS*! _/-@7Z@USR'C-^P-Z9
MVQC,Z;VU[Z.3HHB@0[0,SR3L/4^FFBT(83/4.OP9+EG#3I,QP$J=$0/$5R@P
M_!&OG:#$KIG!*,E)HT?C>]4[C1P>IOC7-/N0LM1GG)P<0_TP91-',+U*YB7V
M](*)9#/)ZQBCA90-%X9/A).B 5DHDXE-2?PVV!,^33Q;$F<L,[8M8>U*:/V@
M0]G(!*G\-::]MKV5I9NV[KQ?RK74 .!K-EG/2LJU[;3H2_MJ!JWQJZ[T$9EC
M@&VGF5#C&&_K8P7W+-/B]6#:_8A8J;69*<@?-V# 75-"XD0%_P-53\DQE;,T
M* QF(GY::&E:GO&[! T57>-=J.$8P:9EE6C4T;?>*W48#_.#C-?:>TA^FWB-
M39QI!X,76*;F;AZ;)[(UA+:J,8,J0\J@P65VPMWG'8 LTZ$!79(]I3S\L[2!
M=%M6EM+T%<3PA1#'#FF1L8*;I2 #GLTH@PVL8[\!)4FVT90T-MR!V%Y+$  8
MRKQ '0ZX/]\=Z@U*XWS4>5ZT5 JB;+C6<%:MRW(D#[^PN3H4T+4 P\U=MG C
M'4-;F%PU?+4KSA/Z0D#+N "!DTF(5%I N;)R3-:OIM^J=3:"KM*D0DYBE"C6
MC+O&R<3J=/6^?&;"=G+/G=]B-)&OL,WIE'4G5-1_+T!PFO@:<?K:PY#&NV^8
MN;BD6US1GH)/[2B-"SE6?F7Q)&/#+]B(%/<.SSJG+_FZXS^D;WGL 3C'JO=F
MK-N@DS@POFK3#'>=NSJPC;D[S*W\U=2B:@.'==SNL=[>ZG!91QT>:SB(-^*I
M]AS!3;^FMJ==PL\*OV]K"M#].GYCXZ5I.C2Y$^H?YOJ-.CR_SL_6YA:_1X0;
M;SOC-1[R._?\:L ?WXNYO74+]V:D<JOOQE_9T,@V=%C>N;,/V'9@!7-M]YT[
M_3K<?%[D33OY@-O?WLNGG'S:,=7MX],Y(+Z+C]C*#7Q\G^#:BSS/GJ(.;*6
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M+[:=>&L\K#DOF,XU"TG*>(ZJ.3#JF(L-J&&0K@C"ZSM*YED-!/AON>NSM+Q
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M*))?JTY2C?=Q1<5\LRVF6H"EX#7WQZ8<LPT7O,7<8W2C=".?<K,K[W="49R
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M$N?6(65L MO[R".WR*H_E]DPJXW7!17:S-2O<FMC<I%BS;C3Q+7Q@^8'^:'
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M1N.*U$R]1WU)#\^D)ZLNID)$\-^+4A#A\4<]VX>Y>8WX;IH?CR,3M#5!4.<
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M\N:W2-:$K^O_WW?XBAZ\Z!!?!O1PVC_JO^^]@7^=O8/':0RDC.CM\>'@U>"
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M4KMG5^<?P>W:?=_\[>+T_U!+ P04    " # B7A6+*8"P8=J   \L@( %@
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M;&JQ\9P 5?(D&SV99H-/\0Q.,;X!FR[VS6V^\*"*+AQOK#7CX^N?MM79_L*
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MSGO'1V=!Y^@@.'[[MGO:.WIW=O]*94^OY5[M-'T#2'?CO,%AJ09-$T@':47
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MQG0?(WQC5<^5RJ*OFN=7 <IJQVJ4&/&TU@#*[J<JM_*M:I.@=16\-@A2TR3
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M)RZ&"BZ< 4_"?MX[/OA(TOW[^?O#-_\?4$L#!!0    ( ,")>%:72@&B 2$
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M>:ZKZ0#7HJQ'(+9PAP[HLC,%S]655CS0T><(UG!"MZ>:Z-^57F='!TMB9ZY
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MT1\<9BSBLA70<Q9B#ILI8E\3;&+<<6@7.IT'!O)43Z9^# [_8D S8J.5YJ?
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MIX8I)%M$@3=1:P +X)H$.'<KCP<M9PF!98Y2CBZ;( +O@Z=PE1C*'QO>YNO
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MVVU#&R 5?*]@L)ZP_\\3\G3"PH\O[B!Z?//.[G6#^%!SM%)N@ (PH:E.P$_
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MB-D^+DIC.H)!-H+ F(0[X1)%;C, HFCU47I!4Q ROT=-Y:=KG.44P46GZ5%
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M^I$6J"_BM69<!C(E>B;#)V)1X<62@@!;YGT<M VB/*(Z0SN3!"H0BB14Y?0
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M:0=X%>3E4@N^8V4#)<JN([86XTG".#5H>BQT66^"%$$WN.]95Q5C[;M>TT*
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MI; B'#(=6?IS9;4)4GC2:RBKN,Y)JYNRX@Q6,\6_7)*/;7"* WRPU3*K;=_
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MR*<#?+]"\,5U>6D897 1HCVT+[=QQSV9ID'G!.QO)'!XDYY14-Y3"F"HW24
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M*2?N_L% DN-M(@^8<J5-1,P2T!TQ>H*B.V%0EFKSC?A]^(20V$J0\4/W>YR
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M/F,R5>D$#_]%3UR:JI)"7ZTKID(P^/Z*(NQ)\/8K>./X1=^=VF'16\,5KO&
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M;]FGKLO4/+%44\'K&0*.G,O"<(O9 >]XPM]C<(BL8?2Y^ 9T.X\4(0(8*;Y
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MR;![<Y4R1PB:OFP?RXT*^$#K #"/2OQ4OA<6B!/[T%A>=D&,'B3YZ\X.DV(
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M R)^J L#Q*G:263W*[+C0:U!C*F7&1+QX9:'V"GP!!1D2Q H!)46M4 !B-N
M\OK4$:Z!6PJA._.^.$L8SPH$GE)2R).OUB8W%;:>]\:IM+\BQ!;F'!VV*\@D
MHJE,O1W2\AS_3BVRGII"$EXX;&J"@E2I5;8@P9.J<KC!JI6Z\@W1IMIUUJYK
M5\\ 1C%LSUH+W05N$%:$Z%S,!V=B$O#]"OAX*&S<$FV<E4*PU;*J0*Y K=H+
M-:O 1FE.,+J!.-%3>%W+E7J4!&::7=+]&XN$^*2FZ]J"/!XJQR,U8VB;MA+
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M5G^6SY,WM+WJ9D(=[M.[>#ZV#6;L75#4R=-8;F>O]$WB5#4?=A*,OMKHN"5
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MQVNKB42U!,K5E8H@D%Y.32V5&4+;2(,Q<H:NNTJ5J UA>V)D"^5\L)GSRH^
M&,90L7 ]!NU/?@/&^W$_&RF^,M19NJS\;H$WIQH)$Y(6I5C<S;_E9_B?)_&O
M]37RB4MQS_)\W;J]%!O;"?<[9TDNU9.@G1W5'UPM<H>K7[>L^<&=Q/3%(>=T
MCU!8_<_$".]@IC!^IVIQ19TUZRC#,<G.?F7GNK4M[M0^%;C<%<*CVNT<]!0C
MHR7A*IHTO)CI]>7DIUK0AK4GMM_VJN@004-]DHBCH5M2E9AH99_[EC2Z*]F2
M?'E$!$O9.(G0A)P56G9V;BYX<.P%DH^:H=O<YLT%T5NRA<=D>0Y5&0YNR)R$
M=V[8/DNHF;GA:EC%4B(^(<T8%-F=%ZI&)WMR53&]'!A$ <V/P+7HWGRNH.+N
MS1:.LKL(G#WE5+I/R,L]P[Z!(!1+4Y^J#5MWRO8B%5(G[48:[U+5KAYS/#:L
M#:=L D'24Z8:,2F*)H,=?"DN/D%OJ8-"H+.'5G??!]WZ"NYD>8T8$\ =X(VN
M@UT'L]W%KTSJ:;_J:5RUQPV8:E?[:R -%# B-:;TV@@)*I8770!2=SL$DDWE
M!E6ME.WA78+OQ+KK%A03,WQYSK77R[(F$3Y#19P2P0I[:FO;3'*Y7[F\)J3?
MM=7FXU.,?'1[KSY"Y\0M8"@EP,JLI183T;G <#4&<E0<G\*[R3_K,"M ]0&*
MUN+"D %VMP7516FQL>-R]D1V@3''M058>4U,T4)=DBM8E]Y_Y#.%DM;5!&P!
MG-W5A.Y8!/&HS.X74V;WAC.[7SS,S.Y?A&N_]<I^7+/MXT"#SP?UM[),>_V.
M?=8)(<@N,J)MT6J.F:S%=-?">[(_%IADPP,?.:17UJ$$&?G+76D2L'/^;$G_
MGYNJPA!LS?W7N%<-%PO6C=2K^D9T0=\UDZ95H';=[><.,DG=>.'K/ZA439#'
M\]&W$B3D*JM@()@L5NX0R<1QP:Y:]67ER]*T+UWAG2I]!'9?QK_];$2C8P_)
MEW'Q^RO&2=J7]Z8N<F""6 CA1E%UNIRW9W* MUM+HANGGD&AVFC\O'3.9']X
MQ"5N5]@]NB50Z])FFZ9V)W"0F1HP5F%Y%F71UN+B;A.V0,A<7-&5YQ#('68R
M&MMD5^Y7U8SK>3X^IV$JKW7,B4'\WBVRG^[]<H[LGWUU^(SM]J4II.^ QY1K
M&%8ZO=-UE5WC4B=ML<Q-ACJ56AK,#NKL ZJ!YK3VK7,PHI^X1\3IMVVQ/.Q,
MY34)8UF+488]#AS/#AJ[JV#1$+#"+%@Z/Z_I1!@BL/D^:A\ADX(5T4V&B5_I
M5B6QG9ZJPY E/U'.CR"]>NF&XHF5+E-V 4=GZ\X 7@A6\:-6L[=*,!CJ/&&4
M.0'#<+!B%["-;W3!W%D&I\G*9HU$%AP-'VP!HKR[/YKB/D-:7CS9!=+RO=ED
M#::PR2F_Y_YS/RH7%O<O=2HL!]1J+%QN3!$F7T&9(46=9@96'?VD,191)V2A
M,O;B,&;)'D8"$/\(CP)NE5INQHWD6GQ;O-61\GM</KR&F4V48"0OT0[V@(.
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M=+@ME'M;3ZJKO?DN@@%$:0R^*5;*&&YJNJI@Y?'DR%<M2(0]R2V/3CY)[<K
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M' VTD6&^?'J-(?Y;U_@O%?Q/G'>MKGZM586;HB8@ ]2[&@I.S^Z @7L/@,<
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M%!S#_?S*Y.R6"F.UE$:G"F8QM>E_.+,"9UOLL+A4E5:]GK"RG5U9A8Y:TW^
MG8S)E?5$F<%,^KJQ;3<>A/$S0#&C+9=X*U^E"BO9UU\4IEIF7R3Q\9C5JG/J
M6)U3R.J< +?"6"?;$.1VOCH;;)+7J\*<+BQ\$C=&CX/5SM;(5(_5]DQYWE2-
MS5A["9LTS3Y:[QPWPM06J5R)8VE !S#W@XHW4?"=T1QL\$-(KA<$ID3\CL^M
M07F1(0IL/K+V1J)]H[NXQ!V<CDEY=$FTJ&OD+)GETKM6_;@Z(7/BS=[5JK$O
MQ.DB>,?MU>UE>(*/E4V\JR?^[*OM/+/=J-O0YTT?7YV3U3$XS7 0OGR/4G>A
M-SHDP<D9B%,@%M#%+OKT.+&N4F%?C'C<P$-NG+N3VY%:BWLO]FT>K@4G*^>6
M0GR9,54,[;!Z-E?4N/63#CI,G:6 -8['8XC@4(4]& #'P>DR7JX:Q[\C8L>@
MTI6;!RNI,$F]"C'QBQM;+ 73;]$5/EFW\ 6+8_PW2.A.]#]71QZHAFD]KKIX
M&?!$CDG!V%::<L4WUV8WW[K?KGZ__NW@_/+ZX?)N@^VV8$^K4WT?3?$Z"%(;
MNS 9A_\Z6.U^@_@U!JO?K7-^PQ@$'FH1^3.Q1F_9M9)1+_N4[@$0ES=Q>*1Q
M<Y",W+U?B;',KC29:5+1:KS/\A:'19'0TGLF M+4]\NOHUSS9\WW6[X#4NW4
ME,;)\CL@LV%55HE4CY-O(DR@/SLBWN?R;L))TB*:-\-[Q+\9[ 16T.$TC]<1
M-IL\.?!&TN7A1SU><$59+D"]F^NP$A9;>81RE%(K#)@;QPON7\L%F+?HH1,0
M/'O4.W]XCC*WA<%S9T$,D@\\[\8Y\^#CJRTJ0?((X[K2*%J,D>\@8XM^F26+
M\XC9&L-KH3#;RC5D=^-Z%^]AY!'3]<)A6JT>+XCU<P'J+?IA7G9SR8OVER4!
MEZIV>?)V>=9KG<1O]K")SABD9,:%D4RSF6N#6B'S/F:E,=9C)._:<7.<J4B#
M[;;8'MO2+.P"^I8A:(-'$BM:^'.D;_L]DVX9=[43I5IO*YVZ*H%P"B!/M5H]
M3G9N.[.#!68N\<7AJU66-;"R+,O*LI1U^M;+X,^ZW[K7YY?ETOT?EY</J5X"
MOY"T[CVY^4KN+V\?+K^?7=Z1\"J*[;R]<L$J(1Q^8.IA:/LNNS7Z< OOWJ@F
M9-,B$'9B.]4JD*3UT.**!N$XVW%#6^*[4QTSH4HCJRJ,=EAB,G</P<*JC.*+
M<8<T2R4'A!.*41XQHE6F#Z> ' 35OH-JM?'7?7#UU%%!PK3EB\?LBFE#"Y^L
M0?82Q9L+[F%R(*60\D-@HF#S)=@M6GR!HR"$9_[AN<?RP[!4.F'G9LP=&.WD
MP@"TV;V'$<HA/7,J<(0F/<U2R0%],\93>1'VYEAEI:%[C-(W&/FD"PK*;P/Y
M10V147H;2(\="T/!O<UL]S[20^/=.091?IF@;ZMAY6PQM<JJ:[/06_8ODC"M
M7_DCZ@Y\^*JUH"HR5<6U[5%20S7L5@TK+=E0!>B4]D,5Z)1D4,-*"U)4 5I"
MX=40WBNRB1K6EL3J"Y<-3TQGOA:^O[]\N$]M(9>(C*WM3B#92#:2C63O+=EO
MFXYF.^+,3I0F'7CA>7H^+T4W;@:'U].<Q=DE<>R60T:+N-4V_4DJU4SNPK82
MLB(4N4?ND7OD'KE'[O/ ?>9K[>DXIZZRIDS)=XM'G4M.4KJO@;-\KKG#I<(/
M7EI+?.EZ>DSYO@G^VG>KO+&=W<T;G(BZ4FTD]UI=B?44I9@3A;0R5DA;:2UH
M]3A#2#U-UBO:8>$UE[TIM="49%)(._D^"M1&XAL[&6OCPXA?0K3E&3O7DW_6
M*D$#D4D;:J.JU#K)+8TSG?L'Q9_[3S+67:.E5$_><&7=SM/4U6-^02NNL//Q
MX%K<;^H7VHOO7TCM)8>57K+WD5RFL@(#N4?ND7OI?*E:5ZIJAM?)"8?]$UUI
M2D'3VNEOC)^*:_.R,H'<(_?(/7(O5:136W)K7WJ1SA CG90B'4P/R<L$<H_<
M(_?(/7(O37A3WTIX8V!XDU)X@XF<7#"!W"/WR#URC]Q+$^E4U)K2W,+^_U\8
MZZ04ZV J1UXFD'OD'KE'[I%[B0*<;>1R#BL6!C@I!3B8S,D%$\@]<H_<(_?(
MO42Q#DR9C5H[\V!GC,%.2L'.:MF<6BVI[<;).$WPW%&=&D]:SZ2"F(%CCPAK
MZ_W!<7_Z]F>7N'[/-?J&YKR0_]233S!*CH ,#C6C"T)1H:A05+*(JJ$T.IVL
M*U?R>9IS&Q+=9^A5MH&]PXJ]3^!+T_-M.2VWC:#UUJ%CS>@+2NBO,;5<>%RS
M^L3VAM0ANNB8&S7+S4+],[W]>].]_=_>3F/Y^-EVO*BIJF3&5F1IRQ7F[(/$
M$=_;E+9:JZ&TT9L45N*(;\1WD25>3RGKFV[*/#W^3L^^/-B>9LXM&_)YQ\;&
M'6YKK97K9?8YW[&HA3.*:09/'<332N'#R<H[M_LL)LS'KBRH5B>Y]R\*:MI#
MM95.IR$)PU)+JM%2&K7D]O>29Z.W<$/;=\WY0;U)!85+(8XT/ /&&%*S3PR+
M/#B^ZY&NK@,OWA[A1JZU&HH*1;5GHEK6=AY%A:A"5&4LJLJ:LMJX/&+!/0_%
ME*H\Y1'2W!-\00?4<6A0$^$YFN5JNF?8%M%M%VL@-G!RR@GN$N.^3H$EC@A'
MA*/$4>(H\3Q+O+*6&Y>FD],^J$:>9<H:>?-04D$9]]87,F$UAB#PE5*,I<2G
M#IXS#AX^-NG;?L^DZ?+][E4^7R4H6T #C4U%;:N[T@>J>5MJYD4NJ.1B*[FI
MM-&6BZ]FEH)N=-">"Z_HH$0*U5QL-:N-AG+20D477M$5%99L=35%S[TY+8>X
M!I,&%V$YWE844I#]41#;MZONV=6WJX>KRWM!3_>:T7-S_K]_W'R[N+R[#UH>
MD<M__'GU\&]2N;C\>G5^]; 8^I+OKLM:>('<(_?(/7*/W"/W>>!^:WLOVXR&
MSL5A5T&+:6@]P^2'%C#8D>1!Y!ZY1^Z1>^0>N<]-L"-/8^O@M*4K2!EK+^R$
M)N\1J.FZX]-^U#@P<]UOR,&[MT-DT_YHBGK2DL0DBB!/N:HBBR!11&BZ\CPY
MD;AE1.ZDB?:.^)19FCFM&2^"Z%6EUDFG+=:6LY*[B]D_6-R;$H>:F@=Q^UAS
MO!=)O '.)B@J%%7!1=5(I_55P:6$@$) (:!R#:BBY'YO1>0H*/%L\O?NP\,>
MH0$-!^]-RX=$]QEZ:*4H*A35#D6%%Q?*#;\")CBO;8].)3<58E'L"(WN*4%4
M;66-FT8V=8':/CFGM22ZS]!#*T51H:AV&9INP_D?5JQ]\O[RA*;R)$KGXM%M
M;+:'CV#KOVV;%TH<)8X2SZ_$Z](L7_9!VHAOQ'>1I8WXSBN^,\N,I\?JW*7:
M!6@Q4,RS2O((2JTI5:P=6.T&-J6&5]>N=MZBWD!!Y2X:D%I4B*F5SYG5E9.3
ME6M3-\UC[Y%$5:4EQ47<TO3UG+[W$"BDSC.[?=MZ)+H]&AFN:]A6]BT>Y$$(
M^G$4%8IJIP705566-);4@D),(:8RJ.E=0U(R=S:01Z;R%$[(V$KU CY^TCSC
M*2BDF,IS9J'J(B?(Y9H24.(H<91X_B5>4ZI-6:*G?9 W(AP17FQY5U1%K:Z\
M!;#Q,F.$EVZOWRFPD<Y>>T'RX]/7:6=:A+$/Z)*IEF,?Y"U52<A>"%RFRI)]
M$'A;::P>2:"\<7&2.XDCPK>].#E15+6>KZJ;?5!,36FVTVEC7KQM%'8C':O7
M\48T:@#-+FO1X7= "+7T'!>.R[HCB]PC]\@]<H_<(_=YX+X@.=ES4W-=P5U7
M4 -!J6%IS@MQAYH#0[E^[R^J>ZQW\=AV78-UYG!HGX[&GF%;>01$(5;K*"H4
MU9Z)2FU4%;6S<C)AGT6%J$)499'-6T]6&Q<;/&)-\RZB4AF3<>QC&D:HJJ G
M; QWZP0G[HCKV?J//<*,6E.:TC2HD5I2.!,BJ!!4*"H4%8IJ+T65HE<O2,[S
MCO8I'4UN9;-LZXCM[3JV:;)F#8;E48>Z>!<&VE/B^>>31M8KX(J^3PM@M:I4
M,>Y$,T51H:A05$4158I>?0=9S3R54:RE35F9D!K+E:92;V?>.[#2SV74)RLP
MD'OD'KE'[O/$_;8R;'G2IP1JR0OWFX?JC?K*1\DWC:$H1C<R/(C<(_?(/7*?
MN^A&QNJTT[,O]ZST;&B;?>H$9T4_F.Y/W_Y,?_J&]T(J?3HP=,,[Q!.CDCR(
MW"/WR#URC]PC][F)?E;+[52/:TW#F@UZ6JG&/*PWAFT)0O:M[A[W?U%4*"H4
M%8H*1;6?HE*SWB;8J[.?Z1P[WG)>3029>5HV2!#](_?(/7*/W"/W,G*_G;AQ
MTY!HF,N0*.]9M#Q9B02*0>Z1>^0>N4?N9>1>[@#'P  GI0 'DSGY8 *Y1^Z1
M>^0>N9<FUJEE'>68&.6D%.7(4PQU$W3+%Z2(EOEYU#)NG*.H4%0H*A05B@I%
M)5^&+)^QHP3PVTDZ+>,"_-?N;$*HH*="4:&H4%0H*A05B@H#T-P&H/)D.F-1
MYQE&G>B>4%0H*A05B@I%A:+"J%,V^!4P[=F%%[(KYS53$#/6C#Z\B^C:V/ T
M<X^ 4J^M? I[GWU490TY;=RS/Y]=;27P4"@J%)5X?4-I=#I91Q*]?;+3M22Z
MS] 3%]IG7OFY5SU-F@VEW6I($,7.YDZ+BGU9F4#ND7OD'KE'[J69F]6Z4E4S
MO^G%R66XDPTM6T[$X>5.A35Y69E [I%[Y!ZYERK0J:UU^S0V9MMUH(-75TK+
M!'*/W"/WR#UR+TUT4]]*=(-=V=**;C"-DP<FD'OD'KE'[I%[:0*=2G,+@<YA
MY2^,=%**=#"/(RT3R#URC]PC]\B]/.&-6E6:)^W,XYL?&-^D%-]@)B</3"#W
MR#URC]PC]_*$.ED?LCK,:;, &:,<S.)(RP1RC]PC]\@]<B]-:*,J:G7E\\Z;
MAD\C#&Y2"FXPA9,')I![Y!ZY1^Z1>VGBG%I5:61?=8R'Q],*=#"+(RT3R#UR
MC]PC]\B]--%-92OAS2'&-YC(R9&&D'OD'KE'[I%[&;G?N.P89LQ&+?NZXS'&
M.BG%.F_+Y6QZXX:N^R/?U#S:)WTZ,'3#RZ,^-[62$Z73R+I79BX-9&.WHVZA
MT__A?K7ZK]15I:K6$:;I2;2MJ-7,Y\8]$BA>A8+8VYU[5!HGV$ @99F"4+<[
MY6"B4/;E35ZXWQ3S#>6DD3GD*WHN_8BLP$#ND7OD7CI?NI6F!]CS0)+<8R&0
M+BL3<MNYTL[>S/MHYC(\B-PC]\A]=K5I6RE-L]"7IA0R8<8I#TQ(;?-UI=G)
M.N&$T9,<#R+WR#URC]SG+LZ930WM3H0]V^E3YTB0"B2;0"M1QQYQ;=/H;R[/
MU<;_3'(-X%P)\0V]=E6UF?DBBJ8<4N5*-PAP%"(*$86(0D0AYD"(DB3Y-HPU
M'FQ/,XGKV?J/H6V"C-T/COO3MS\+,NA/W_!>2"4XN;'/8<GF)T":M<PC1M3+
M^MLA6SE(@HK9B\,H>Z&8')XKV >]--;Q8Q@/IC!S*"WU!.U -KTT&\I)9^6S
MMF@(;Q8X1%#UYLI-J[>X@S"[<@JE4SMNCKW/9'Y!%<C)L/K4@H^.4EYDG9Z)
M=98@T#2TGF$:G@%#)"R\$M9<9U^68B"1S=2A=<:AQ<<F?=OOF31=";U[E<]7
M"<H6[D!C4U';ZJ[T@6K>EII;K$X.E5QL)3>5-MIR\=6L-JJP/D)[+KRB@V4P
MJKG8:E8;L,QKH:(+K^B*6FTH=35%S[TY+;@&DP<7C9;2J)UL22&3O,3'A^[9
MMTOX]^EM_/%/1*T"[Z^P,=*<1P/$P7Y:G;SG%H9+9<!HJ+\='9&O!C7[G\BM
M]@C*N*<_?6KIP&&3'!V%8KJX^F?X3C'2D6>/PU1(\$DHN!;[+%'M\336[?1X
MG+(XHZ<?X9T)K^\Y5/MQU*,#VP$:QYSF.$FM!(J"[,Q:KXP)YB.3C!!&BMI,
M6:?39J13RZ,.A_^?U]T_+ZX>+B_([=T-^7IS][U+SF^N+RZO[^&S\YOO9U?7
ME\P*N@^7WR^O'\JEFZ_DYO;RKOMP=7-]3T[/&*#A.?+PQR6!SZ]N+L@E/']!
MOG?OSO\0?-15A=2JM9HPLZQYJES8IJDY+KFRR,/0]EW-ZL,8E[]T"L_=#S6'
M$OB(W%(G^*L[LGW+<P^W0U^HV]B[N#<@YY??OMW?=L^OKG__[:!ZP/^^[5Y<
MA'^O3<^ST?>&[*?5]Y'1Z4PX8Q?,(_S7P6RJ=#XE^KP@)9J<5'W[1+4H69LH
MT4W?=7[#I'W]VT'M()WW;CX+?;4=09<WI R7AMU_=4K:BHQVHH]Z2OIX&X\P
M82#@]@-PJ ^Y]"&' T#,I;L#BV'%MC4\<.P1NA&,(Q!AA5: (.R[YNA#0;5:
M5<@>:T4.N]\?Y/U=LWS-><'@H5#Z#;0:>)2.(HB<I/%V+:H]=BV%#BD0=U*J
M!12@"L(J5Q;+I!NV]?I&9G$U(H<G*#KJ5K/_' 08,_L^VU#Q"J^42-,[\2J2
M:R4#'[,YQYL%'0C"O(-P]UKQAN"7'X=2B0?=PGYA<!7/L"&_F.Z00<%;=S+2
MZ4".%4VA<QL(LMWKX(+J=-2C3E2:N,?:D,/DBXZXUZP^!^D+B;6ZO)C\,]F5
MUF/[L>!D,(N=HKMY0^,$1[-<36=QO*!OJ\D01'91D2V_TMC^S1XK2"K7(X<>
M<@3>M3T.AE2["Y0EY'%/74Y7U]G!-L-ZE#/ R;7=H(WF]UW%L-$B00TG[#QF
MMO[C.YH<L-U7[]'_RW>]$8SL!O3E:*+/7CRWCBWH^FH[HWU&ZNY5\??NP\,>
M*T J5R&''B0"YXI^8KM!RFS/(94UK\DJ<EGC9?N;AJK\8;B>[;!7K]_#:WL2
MW3D!"5Y/6I5>VQX-$HHIZ72O]X966A&@:>1!E>CMT-OM6J3R6\FY/>H9%GV]
M74^"-->6T&H!Y0JW &YZANGRUYA:+MUT!9'5JFT[J\$W7@59+-&@R).3:?DA
MM@#RSN>X*'(4>?''357DV01*K]WT):[TJAZKM:9A+0XQ@S:[M?;[%$/+WZE%
M'<UDG8H%?5I_9%BP(G,TSWBB&RDD[ ><2&<Z.E_ZB@U%\>XME'3>KPC$#8FK
M+[B\479=H+HW(N[#J*^Y0^GTP7..P?CU?=+W"9HWJCL]XMJU:BYU45!U9SYY
M*XT3V16>[,[?D /N]S=O;B(=0K)V" VE65L^ VR.A-2RN6NM5U(4SAUU*3N9
MP:]3Z=,G:MIC5F B"#PBIJ&S;#'1])^^X; <N32KTQVO>C>=GI1F=1-_E3<I
MYE,[:DMIU%4IV%V0B'[#K*%IF\X:^51FK:Z<2*+,?(XKZSH\;W)$_<@MQWSJ
M9XE[DSC7GDU^?2:U'D:O#C4UC_;)6'.\%ZF ,5,+TYN[/W,G[T6'@OHMAGXS
M+.- Y>Y:N6B\6:Q\.Q+I '6+MBO3N'+:9@YJCS?D^,'V(+"G4:FR-$#(YU*Q
MK70VV@3/FQ3SJ1WYD\[[JYL:^,$F[M?(JIY.9Q^BUGSJ9M/*C+Q),9_:J764
M5FV;8>6B[/$BH8;O64<1VWDF43'RDIL;%GGP46#^]D"%R.*N6(Q_F)]U_NG9
MEYLQ99MVUB,Q;1=/):<AU4J:Z_T-:3B42-HYU6*J>8&MJ!'3![,Z3#5_@*:X
M*S6FEV= '>Y*AVGF(U"+.W.H:^4MTM!3-NF-5$-H;T@=8EBZ/:*D$NR:R5;K
MO6.\R<Q"WL;-M<B+&Z/*S$+>QD61H\C3V!N1EZ#B%@]]LUV7^&/;(H;K^IJE
M4V(/!!ECQWC2/$K&IJ93=LZ5/&N.H_&&ZM(80CXC<RPR1/U@#%8 Y>1SW*QS
M\4J[7<?D4;ZUB%8FMWZ66)F4N3TN"\/J0QSYB1Q%!U]W=1[V9C" +ZQ'HMNN
MYQ+-=6W=8.=?!>'/AC<D?<HC8..)AI$O,0VM9YB&9V"A/7J8G8^[/_K!(%AB
MY>1SW*S+BAIM#('SK4.T,;GUL]#&=AH RY#5/1]JUB,EAD4&FN&0)\WT@SXO
M]@##6O0:<H^[/_K!L%9BY>1SW(R/7U?9O"81NWD;-^.(J*DTFKFJ@L^BQ*]"
MI2OHR[IK=[NS<B2\@^.IJ3%Z93U1<:E[6,%I6X**!\=W/=+5=:#3DTCQ^004
M3L.H'XQA"Z"<?(Z;<0R+W9UD54VE*"=QWQ"\#@;[%;PN<Y?%K;M=FJ&U;%9V
MJ[UH/7.3FR^SPT&N&X+*[%919:E.(S6ED=K%0;ML!O"&::37V_S:,\1,'C"#
MG@/7;JA?U*]<N-F9EY:RZCGS*4,T_[87-#7(#6J*B=;]\3;[J=_\Q8QXU<_>
M0P =019W1K3K:95[HYN73;NLJJ:--KYS=&6]]U27\#BE#'L5U]3C_89)CPYL
MAQ++MH \RW-LTS2L1T&087G4H2[6WKP9A]B0N A:5#M*!QL2YUN'M9;2PH;$
M>5=C2^DTL.1'5NU4.LI)"VTL[UJL=91V*WFZV\_$_/5TD"QC?+R?JWE,RA=;
MOZK2/I$C%X?)]L*J%@T7'3/J%_4K%VYVY7UW5J8?=@\,Y5$[;HZ]+70//#V+
MDN*O%MF^F<;UD#.#D#..$/Y.TK?]GDFW()YWV5"X\[S[KN"V/#^! ,L)P-2V
M4JTWBHNP5-8["*\W7)_8:2[ONYUK>*$#VS'"7M](V;(F$3CY ,X*>SSHF1!@
M;]NI/VEM$%IEA:2W;4Y)UBN_V__+#[HN>3;YC^]HQ/5[KM$W-.?E_[B"_+%#
M!]1Q:)^XG@V@@%_"'W0T]@S;$N?;<Y1)*68&9W\R</NIWPI$:,WE7G#'$VJ<
M>^;&MI.KJ^@Z'H8O%I#0G>!T@?I%_<J-FYU[Z1W,M]D<<I%@IX]HGN<8/=]C
M;;D$@;#(T>W1"!8X?-$SM$T  VX)%B:M@%N""+!L\U9UI=-9WD\_UPC#+<&=
MPJNN*NWJ\HK)7,,+'1AN"2)P\@@<W!)$@&4\]T%HI6X06LFY)5B,?,F.#S?*
MS$+>QLVUR(O;ZD!F%O(V+HH<19[&<1=Y"=K9P1W)*IS^11G2:)]H\"KMD9)S
M4W-=P7]7$ ]1KF%IS@MQAYH#8]N^YWJ:Q<A52$]S#9W 7Z1OF#X,))%)[;6I
M%FO<7(L<8ZXB07''(M^X3VNGWE#JC>6G9(HAR;TVBN(0E$V(MK.V2&<\4K)H
M=(%OA956' 8UY-29BKQF@BZ)C&"OC:M8X^9:Y!A4%0F*6]NSV47L53UNU227
MM<SCYL)LBD/0SC)CF7N&"Y&APA@LUY96K'%S+7*,P8H$Q:+'8&E=29 W'>Z-
MV12'H.VFOG*T)7FVZI:D1+:SUS99K'%S+7*,UHH$Q7QN0]85M5Y5ZE7<ABRX
M412'(*P42R<LP_JP'+&0MW%S+7(,S(H$Q;P&9G6UJK2J+8DXSMNXN3"*XA!4
M]/JP,74$%?% "S<EI;2J8HV;:Y%C-%4D*!9]4Q(+PPIN-L4A:*\*PS#XRH^)
M%6O<7(L<@Z\B0;'HP1=6A!7<;(I#D*S)+IDANM?0+]:XN18Y!D5%@B**O##C
MYD+DQ2&HN FDL]DN6"R5),C@]V>PHX6YRAT59I7'+[+H*&TUK41[ >[TVFMW
MBD&:3"SD;5P4.8H<@[3T$DV2U;C/QW'/0=6[H#PL?5]2Z"Z1Y>2S$A63\@7W
ME1B!R<1"WL9%D:/(,0+;<9I,9K3NM144:]Q<BQS#F2)!$45>F'%S(?+B$"1K
MY5*&6WVZ/1K95BXV^O;&H(HU;JY%CI%1D:"((B_,N"CR;400IV>L3N;LBW0[
M+T!813U66PN)RZ@<)K4$5DYW$^/A(NXEHLM!D6/L*!<+>1L718XB+_ZXV4:#
MM1.E6F?7AB87Y&R>UOOXT#W[=@G_/KV-/_Z)J-6Q]QJ5(\UY-(!;]M/JY#VW
M,)R< T9#_>WHB'PUJ-G_1&XAZOL,O__I4TL'D;7(T5$HV8NK?X;O%",=P90'
M;ZZ-O7#L(Z%^>(Y]UK.=/G6BS\Y,B)R)"B]W;=/H P&WT^-QRN*,GGZ$=R:\
MON=0[<=1CPYL!V@<<YKC)+42*&)DKOO*F& ^,LD(8<BHS6F#TV&901V^;/KS
MNOOGQ=7#Y06YO;LA7V_NOG?)^<WUQ>7U/7QV?O/][.KZDEES]^'R^^7U0[ET
M\Y7<W%[>=1^N;J[OQ8(K:R*!+/+PQR6Y!EK(=S#,/^[))= (=%W> EUGEW>D
M7E5(K5JKI4K1G!ZX R#GE]^^W=]VSZ^N?__MH'K _[[M7ER$?Z_]TF>C[PW9
M3ZOO([. Q:.IC5T </BO@]FEYB*GG;R\G)%KR%F2UU[Y]^<W3!#7OQW4#I8]
MFX9K5ZO!2O_:L"CY#E\,W5>3$<CXCAA/XUV%E'Q2RF@_[?C2ZK.FZI(#>0]9
M+I;MIB)SM-I0G/=T[-%1CSJ"(@B[I,<S\I\B_P^.9KF:[AFVE1KC\G"7OG9S
MXSEF5N.]Z=7X@K59FK*?K-XDL264R-;MKZOKMF]Y? =QV\YE>3HJ)^K.C;O)
M7)K_\1UMOXSG[]V'A_WBN-O_RW>]$0R=7D9$'NYN'9M\M9W1FV'\)J<0UJ!$
MB7*6/%\716\;1$9G7?G#<#W;82(\?%4_*$.4858RO+8]2FJ[D]_JLEJ9@E0%
M=&Z/>H8E4D K;%AO(J;5_>MGLE%YX'0=H-A1G2X9#+8O4TV<_1I3RZ6+9]8U
MIL^$>2K8]5]Y#'S;&]_V-I0N.K84;%W6.^]GRU7KZG%['JC58U;#FB94?Z<6
M=323EZMJ_9%AP:3B:)[QM/P$4[CG^GZYQXO]+#V2EW<;#%]9?Y]9G8P@0U4Z
M:B-E(4DJRUKVLFQU.OLA2S5K67X8]35WN'R>7D],C53%Q,*N?O_UD"MX>6T'
M.JIFK:.ZTJPN[TR:K*$MQTK;FH3NJ$LU1Q^*0Q/TB9KVF.4ER!$Q#9W%4433
M?_J&L^ >\50B@/38:8-VJV\D='?4+_,?2+\LZ,DF'I7+_/-@ZVCI2'^6V"GH
MC+]XV0ESOD--C1V;'&N.][*Z=E?;>5X>\:ZS:RTIGG,OAGKCK2XU]R)8&PG9
M<RRQM%8!3+KQ4HK$/]@>^$$:I8OE#WE.%B:^\C#IUI1J+3G5E ?J\Q[RJ*K2
M:21G/HJ_)W0SIBS&L1YYR[!L=X;2([RRQ-[3>TOR13FRB6*)\]@S4>3=$566
M>:*,=+F-G,VV7)DWI XQ+-T>45()HI?%.?T";@@7^6T%G'XY8//@6"OU[3HE
M6>60]PDF[_1O&X=%F1QO!@/X!F)\W78]EVBN:^L&3V<^&]Z0].'+)Y'H?-8<
M1[,\8AI:SS -S\C'\C_OP$;Z\T%_ 8.0\Z%F/5((F\E ,QSRI)D^)?8 G<+.
MZ6_ PCZ_&[DL+]%>0'[F86.ZE6%TW57D=M*6RDE3CIJ,;;BI*^N)BH-AX0K?
MMLB#X[L>"8Z8RK0Q)=M67#'%T.DT]UT$E84RR-K'KBJZ=%WQ8/!ZD6YNE;G'
M4:C8<;879'#WQK'+E6C+O3@;RDD5IX@:!(J23Q*%%#P$Z.KK51W9!N@AY[7C
M)G/B.]F7NZ;>\N*"I42OI6!Q6IL_1_JVWS/I]@[JO$I*UG9^HG0:K4T$O"TO
M@/I]6Y%8I]U.6[ZHDHRF5C2Y(NCW1#FI+3]/O5W];GGE=[((*P6L+RGRV[:1
M!#Z9CR5/TK6$?P4WED67E9V;FNL*-KL$7(5A:<Y+PMUE"C U<_U942K"4ERM
MU)5.M:I4MWYVL$BFLHF'S=AJ$B^)CG)L;%UVR"^*7F),TAK+MN*03 VO>JPF
MA_5H<D69G<YP=GIS<Y)&$R>G_9J<9F:E62.2UDAP5D);FSN<NR=2*_+;MNQ]
MM[$[D^Q_V:* >]^-'6XA7&"EI=2JS>-<'ZZ4RX+R9*_RE#[.&^GS[%ICR?(B
M#Y7:JM+L['>TD2?+V&@FPWV$ KRMN!YU*NR!U>?(MB1?91;Y;:F6'[U;Z[*5
MU.<V5K5</:XW%I\@2?5=<^71>[%JF0N(XB:\I7 H5Q8F]=M2K)DZ4:KUMM*I
MJVO487[D=\)_R>*V^;</& WUMZ,C\M6@9O\3N07$?X;?__2II0/O;7)T%#)Y
M<?7/\)UBI"//'H=F&GP2UJZTV&?+[[\! FZGQ^.4Q1D]_0CO3'A]SZ':CZ,>
M'=@.T#CF-,=):B50%'B.M5X9$\Q')ADA#!FU*?Y[W&X:UL+NIBF_J[;L73!Q
M7'VYMCT8U+/)GY;F]PWF5*-KR\JE<YL]Y<*'X2T\(&M+LW1#,\F]IWDTN+OM
MZHN8B%(#_HSLN8V2\\MOWVZ[%Q=7U[__=E ]X'_?WW;/P[__=77Q\,=O!VJU
M^OY@4PH$.JL)Z!1S[N)I%1YD\V7,V04=]+D=,Y\S_\U$%^JQD*#X'?N$S7LN
M.YM]"Y,:B%F;W-D;.K")\\H4\'&GS2[L,P8OPOMN\)89.(82>!A2<N:[ #&(
MR@78.+_D67.))HY\ OK FQ#-+9<TXE!=&QL>4/5?\4/#XK]S^@!/*CI=_-[M
MWAX#LL'#$6\(PAQ1;VCWF4RUZ*)2A;![%_E[//!9/*R ?P(]'\S^3]_^'/;]
M_^#P/UFP,=:L%T9+N32(S,&A8]OAK?7&OC.V7>H>\[.J+%?S:+XH@O;HM=&O
M%/ZNR3AN9%:,3O9=9'OGP9OA50(21 -JV' ^ET&Y%#RQ:#1VIZ;"0REOF;QG
MY  SC?&DF>Q]P1C$<%V?,>%Z-LP7C#/V0[:LTER7>BZGA,E5X2PSL@T8L/="
MYC5W3!ZFGB7!HP2".4$_4.*18737'.]KH@@56S9YM.W^LV&:!*@(CY1!^/=H
M]$P*2!%CPDO93-<_)D$+1-N"U9]C,,KMQ=)@) !D7!IR?KP3Z]BQ8?K1W#"&
MN6' Y@:&NV!JT$-X]C23V5ZYY XIUR83VOR-W(3=DZN01^.)NK$!Z6! =6^Y
M-@"X0L/TB4.:@9^.QJ)7-X K_B2;O2:/=A\=RNV D65P*WDA0PV>HM1BX[C^
M:,2'@1\OH%D =45A1(;'3<&>@"XTEA>J 1_P7)]\9U</!.]2Q;LB(UWM)23Y
M'1;\BL#*R!N".,2[ENIC?76P+U=62?SI<FDME73!5DU!LI"0BI:X&!>1_R^7
M#(O_*E)8Z(Y?F/NV>/0WA&6T$#KO L.>=^P1_[4[M'V3:00<*&C&X'KYR[=T
M,5> !_Z$05]RT!>%],LCO_CB-\C"_(_:4=MJ&^31\TWS\U1Z)WDE'2#NX NS
MMMA$&8)E43P@IEG^SPNJQ]U"8&0<!*$W ?]BV (<Y5+,9ZG5X,<5 ]S_F$'C
M$!YP;/]QN&Q<-F9XT0)'(LSI0X-=PN*P#D6ZZ3.'!9AC9'YP7!9]N:1K0;1C
MDCL>;H%SM?AB):3DZ'^!63-L=<;><']Y/NM 0A];B45YIW_R^[<%=6R<TX]_
M?@E"OL-$PJCITF?P?.RC<HG'E[!T<L?@-GWW\[:"=#22C8QD!8M8,%.N#EWF
M?*>Q^P]?<SSJF"\!?,DL>O^Q +W7]E.,%+6Q', U!N!_3 &X7'H%P00!G"L
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MZ0=8"XECT=38MJ:.-$D!ONW4MY]@??M6ZMM7<R4A^T*N8(VF-G9! N&_/I/
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MQ$XR+$%P&O/C6\7B=CJO9]-\^#Y^A?#D IG%;8CS)[C=-"Q^[6[F\$Z"Y5=
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MN61WM':SW7)WEM.4"G,B57I,Q]ARB.S.8L[&C"8!,EA-J''9JS-,Z.;"Y6W
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M.O2IDA;:X%R. 21WNAOE!P'#GU!+ P04    " # B7A6VL=X4^@(  #5:@
M%0   'IU<F$M,C R,S S,C!?9&5F+GAM;-6=6W/;-A;'WW>FWX&K/LNZ.&X;
M-]Z.HM@=39/8:[G)[KYX(!*2L(8 %P!MJ9]^ 5YD7G!(*K7A11X<F3J'^./\
M0 "'!.AWOVPW-'C 0A+.SGJCHV$OP"SD$6&KL][O\_YD/IW->H%4B$6(<H;/
M>HSW?OG'=W\+]+]W?^_W@PN":70:?.!A?\:6_.?@,]K@T^!7S+! BHN?@R^(
MQN8(OR 4BV#*-_<4*ZR_2 L^#4Z.1C^&8=#O=SCQ%\PB+GZ_GNU/O%;J7IX.
M!H^/CT>,/Z!'+N[D4<@WW4XX5TC%<G^VX7:8_4O=WU'"[D[-CP62.- !8_)T
M*\E9SY2;%?MX?,3%:C >#D>#?WWZ. _7>(/ZA)G A;B7>YFSV/Q&;]^^'23?
MYJ8UR^U"T+R,XT$N9W]F_6VD]@Y%XY-!^F71E#2<NB!:DE.9U.0C#Y%*FDBK
MH@"T,+_U<[.^.=0?C?O'HZ.MC'HYIR38@E-\C9>!^5^#WI?Z7Z04"O^(B21&
M3<C%O<$\,':#*=?M6(M.SK 6>'G6^S,62!<T/AX>CX>FF.]+1FIWK]NS)*8Y
M]H)!20(28:["9EPL!:AP'G=3TY.D\+4^A0CC!>Y'9(.9:?J]("NH6,W]60A3
M VTZR&P&UA.\O.Y]8?V(;Q Y4'3=VX'BI*3^!F\6!O=!<LNN+Z\547J8PL3A
MY74QKB:'2LM]G+9)O$0Q5=_<*'/WLF9]F+"DE_FH?RWIQENEAR <Y<K-";^A
MBU)$&;]LK!D%?3,PQ5J6TA]3RTQ1KHGRL"2$FEZ9BWH$95YUB<.C%7\81)CH
M,(Y'?[PQ'_OIQS2.F-SFY9I!46Q05FD\4W@C\Y-3M, T*?)6NS1[#/ZR[B62
MBX1;+/LKA.X3\0-,E<R/)'7H#T?9^/%]=OC6#.;82+M!BZ?&55"?&5;MJIJ?
M^$]$KCYK/!VOT+3%GH:<*=UBSFE2FF[U>&4^Y,J6@F\ZAC4+(6^L1S'.6DXO
MX"+"0D_MAD^**)<X.NLI$5LJ_BJPIA1)>;F<*Q[>3;;$UNJJ]:V[/"M"ZU!;
M1=;,   %U=7"['7I%(5^R(9N"(O-]EEYU&<1;3# ./-6Y1"0\=!G(K<CB_SG
M@I*/HH?V>L]&+:D=!.[XM<'QS8:S1/3D4S:S!,'5;%\ 7'F2"T!IN#1X%\E@
MO_;*'=M7) 1BJ@U$R>S6=NW_/S&HJP5[L6<)_V%3RQM]UN:II+&X?>,XR ?.
MN6QRH2@_2X_3+<@3+2@RHBXH6MFC7#+Q(,QUO2\Z23HPSA^P# 6Y5X5)(1#N
M@J5/4:_*!KL2]SW)-5X1J412E_VLH;EKL;IX@*-=/SC?<<]EPEB,Z#6^YZ(%
M1]'2(PHUV5#PW[@/_C]C)!06=-<E_A5CCQ#8E$,43EYADJ,G8.EMORX8JM8>
M<;!*AT#\X![$?(TI-8\9$>MT1=3M/8(!B(=P_/BZ.,X?S/1"CV'=B>Q=/(52
MU@]Q^<D]ERLL"(_TC$)T(%(Q]HB%33E$X>UK43AG45<&F:EW!(JZFQY3N 9P
M062(:*KQ0A]K>>95,_<(A%W[R]ZG^Q88_\9(=$:Q-_8.1%DYB,%AECV-A2C)
M:^R7(&L/0#1*!TDXS*O/F2)J9U;,?8Z!^]3:K&KE0>2MDL&(.TRF4V'YS1:F
MS.K IJB7+;V)O$4V&'V'270J;JIK(Q"=L0AO?\.[IO!73+V)OTTW",!A\IRJ
MNQ)D@\1N3L+V;J=JZPT"JW"0@<.,.95W@[:S2->)+$FZ[+8=!>#B#9$F_2 8
MARESJG*6K.?CA3OQ4Q[KJWDWY5'C4-'HZ VD]EJ J!SFU:G6210)+&7VGZG;
MJ F0Q=P;+)!V\*&=PQP;4C@^#,;88QCC9A@.<VQ(X?%A,(X]AG'<#,-AIEU2
M.-4?+\4-?P36$P#&OH&H* <Q.$^S,WW)F'8IK@1_(.D.J#86%0_?@-CD@U2<
MI^)YJTDG&5VNC-32-PI%V6#TG:?BF;@K+A6B_R'W;7-<F[UO).KB01X.,_.L
M?9@;-]""LY*)!U&OZP4#[3#]-N/31& $-_6BA0]AKLH%H^PPE_[(S3.H-6>-
M=[:K5AY$VRH9C+C+E-CL6)1@Y['_VH,8E[5"P7V>_1[=@OM5$*4UF3T0,<ON
M7@'/+:VF'@0=U@T"<)C6SCDEH8X56WW2LUE!$+5'OV[G0>@!T6#<'6:P5P*;
M%H%UXI L"C2;HL7E<@GUZ+"]!QQ:Q(,\'*:R%8DS*6,L#J52\_*/C;T*("&'
M:>T<A['N2G>C\>+&[/X'^JF*E0<$K)+!B#M,93_S&X',VXSFN\V"4WB#E,70
M@[A#JL'0.\Q:2\KL02^9>!#NNEXPT ZSUOSB.]^&:\16&%ZW8K/T(.R@;##Z
M#K/9IZYOU:E/7_G7IZ\Z].D.L]E<6+K905^/EPM*5@C>C=G@X!$'2#V$Q%:S
MET*2[HTK5.A"?[##L)IZ@ '6#0)PN34YCHC"42KR@C#$0ITJ[C>+ O<CVKQ\
MP-*E"B AY\][OV)*?V/\D<TQDISA*$U6FIZK "X>L&G7#X)Q_@3X"Z<Q4T@D
M"Y,%<+U83;T!8=,- G#^L#=;D+\?Y=*WLC9QL'MX@Z-!/DC%^4/@&5-8H%"1
M!_P!*91I;J)B]_"&2H-\D(KS1=K)!3S50]R*-Z^+*!EZPZ"N&@R]\[79\PVB
M]'TL=25D8^]4,O0F]'758.B=K[X^WV"QTAWEKX(_JG6VN;H)@=7!&Q2P>A")
M\U76Y]NG5T&DNTH;>=2L_8%AEPZ1.'F%;<R3,#2+:M*9!(N0 %C ]A[0:!$/
M\G"8BE^J-1;%65TBSU2H:;E+FY<';#I5 23D/!4OOJ*C<2 OV'E  1 -QMUY
MIGT5+R@)+RA'C7E$P<R;J%<U@T%WGEV_1^Q.Q/<JW%T)'F)L'F/)_;7:(:WK
M= )O0'6O#8C0_=;HY"6[R8M@YVLDL+R,5?)W>;3BQMLD#7[> &NM!,CI%5X_
M)I\V2N+H_>X:+[$PBU-N\%:]UX7=-4_,6MT]H'9874!XA?3^W:!235W\G?XN
M.VY^F+\KI(_\#U!+ P04    " # B7A6%1;Q%/4+  !$D@  %0   'IU<F$M
M,C R,S S,C!?;&%B+GAM;,V=77/;N!6&[SO3_X#5WK0SD679[7;B37;'<>P=
MSSJV&RE)VTPG Y&0S#$%>$'*EOKK"X ?(@$<DO:V '+AR,1[P!?$8P#\.GKS
M\W:=HD?"LX31MZ/IP>$($1JQ.*&KMZ-/L_'I[.SR<H2R'-,8IXR2MR/*1C__
M],<_(/'OS7?C,;I(2!J?H/<L&E_2)?L17>,U.4&_$$HXSAG_$7W&Z49N81=)
M2C@Z8^N'E.1$%!0[/D%_/9C^+8K0>#R@XL^$QHQ_^GA95WR7YP_9R63R]/1T
M0-DC?F+\/CN(V'I8A;,<YYNLKNUP>UC^*\+?I F]/Y$_%C@C2!PPFIULL^3M
M2.ZWW.W3\0'CJ\G1X>%T\H\/5[/HCJSQ.*'RP$5D5$7)6FQQT]>O7T]4:24U
ME-L%3ZM]'$\J.W7-HC3IT#><9,E)INQ=L0CGJM][=X- A?QM7,G&<M-X>C0^
MGAYLLWA4'7QU!#E+R4>R1*J9)_GN0;"4)1*%4;GMCI.EW4S*^43&3RA9X9S$
M<D>OY8ZF/\@=?5]NOL(+DHZ05 H^P':];M55!DU<F[TE/&'Q.7V9:SW:DWWQ
MM\/SW]& 9KSS)LQ9CM,7F6]&.K=]35YVQ/=Q[H^T&.C)RXYT(_+_8CLW+3_[
M\-J/:RHW7HE/+8MDFXL)C,2525E%QPBL]J FAK+NNG86M>I-Y6C.N-EV.3.J
M.I<X6ZB*-]EXA?&#V,'1=$+2/*NVC.66\>&T'+^_+S=_DS,D61.:GZ4XRVZ6
MLYQ%]Z?;)*OVIIKZ=C1 /]&;(2-/>=46S*.> U(J)A$3T]E#/DZ+0U^$+SE;
M#[)1'CDV0/PM7=3U%X=:6  :TI)QDK$-C\BS>KK9FJ%'M72X3D6$7+<1.OXT
M&_VD9(@MD1*BKU+Z[S>3?=4>B1)KP#6CRN'I![)>$ XTVB9TR1!LM F/J0J&
M&M":CLL-%ZM^S'=H=H>%"?2U4(="S!?,.:9Y)RR:QB4G5GM-1%J"8.BPN=+!
M*#7!$5&/AW.\V$_ZT*!9BKS,/RV#UDE'*8*APFI+QZ(6H:]*]K_%(B/1P8H]
M3F*2*")^^XO\."X^*@S$K]_$J?Q&6I"G\WRMSF;%@HM<"F/ZVJ1?[@*-H:8E
M)'U:[[@,-*B#4X6@1@SZ*J.0"O,)TES4VM'*HM@U*$U3.ABR+"@0&H; CI<:
M#YU\*G8>2P,7*5Y9FJ"5N^IFJZVJGUN%072TS9'>T[4&29'/KGY/LH@G#W*,
MZ6I+2^:\XRTFC?YO:,+"P#0&T]#0>ASD/Y)5DN5<33SU*J9C2 /TKJ>!3MOZ
MO& 5!P'.$(?@S-$,0G641Y9.*=W@]"-Y8+P+H;;,-3DVDSHP34U0G%B,@7@4
M6E2(/5+Q]PWF.>'IKA<,0^F:#<"JCH<F"XH0NS<0DEKNGY,YQS1+Y&#6"XHI
M=7X: I@U3DDT75"L .;@4Y5:[Y^6V1U)4_GT!*;] XM-[)H8V+#.C*D,BAK0
M'LB-BD!E2%CHG#_*5;M8.@UL<$/O$R##=A=#M3A8C'2' TE284C&>:2I\>Q&
M#T>&TC5!@%6='4T6%#5V;R OA1PI?1B@G--X$":US@\DFDT[(J4H0$#:SOKP
M$&K?<%PD6833PL^%V-9UQ\:B=0T):%<'Q1 &!0OD#@2F"*BX42'>H?DGP7P8
M,@VE'V ,JW9<:EF L.C>^E"1>F^@G&TX;SF'9Q]8Z@J5/K,5*Y N"%AZS!F/
MI17R%BP>9Z-SFB?Y3KZ9<+VQ/%IDE[CB S)7<:&7!\$#8$KGH) AJ4.%T%OO
M5W<5:"[?" &;I,O<4F WV2:AK0F(!JLQ@(B]5KV@XXV*,S%*<9Q>TIAL?R4[
ML&V&SBT7@,TV&)HH(#+LS@ T2C%2:B3DWN"XY<D:\]TLB7JF#5/H%@_(:)L/
M7140(( U@)!2C6:79[YGE3G>7L8"V&29%"_:]9 "ZMT"TV.[S0T@#@B?;H<
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M4&9[Y#?+I77V[Q*[ J/?< 4(K P"E%Y[.C B8!PU(E 1@E2,?W0NLVQ#^+,
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MV=QT)3Z)S=4F\6.!,R*V_!=02P,$%     @ P(EX5KIAB%PZ"   ;64  !4
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M!@&PXP ,-.(T(",LA+U;<,42J $;*#A5"T[_/;8>U>\3&2.:1]77^RJ>%Y3
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M^:"_+;XQO\R_QM![_@502P$"% ,4    " # B7A65$@WCS=G   )?0, $@
M            @ $     =&TR,S$P,S4S9#%?.&LN:'1M4$L! A0#%     @
MP(EX5O4SM:5^4P  #.P! !<              ( !9V<  '1M,C,Q,#,U,V0Q
M7V5X,3 M,3$N:'1M4$L! A0#%     @ P(EX5BLH('.-/0  0G4! !<
M         ( !&KL  '1M,C,Q,#,U,V0Q7V5X,3 M,3(N:'1M4$L! A0#%
M  @ P(EX5MB9#PQS.@  2%H! !<              ( !W/@  '1M,C,Q,#,U
M,V0Q7V5X,3 M,3,N:'1M4$L! A0#%     @ P(EX5EKJ"8.I(   T+H  !<
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M   1              "  <PU P!Z=7)A+3(P,C,P,S(P+GAS9%!+ 0(4 Q0
M   ( ,")>%;:QWA3Z @  -5J   5              "  ;@Y P!Z=7)A+3(P
M,C,P,S(P7V1E9BYX;6Q02P$"% ,4    " # B7A6%1;Q%/4+  !$D@  %0
M            @ '30@, >G5R82TR,#(S,#,R,%]L86(N>&UL4$L! A0#%
M  @ P(EX5KIAB%PZ"   ;64  !4              ( !^TX# 'IU<F$M,C R
C,S S,C!?<')E+GAM;%!+!08     #@ . + #  !H5P,    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
